11/2008
‫התשס"ט‬/'‫ד‬
‫רשומות‬
ISRAEL STATE RECORDS
‫כ"ג בסיוון התשס"ט‬
June 15, 2008
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
PATENTS
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Patents expired
Applications patent for
extension
Notices
Changes in particulars entered
in register
Country codes
Indices of applications accepted
DESIGNS
Designs registered
Designs renewed
Designs void
‫עמוד‬
Page
4453
4666
4894
4895
4897
4898
4899
4900
4901
‫פטנטים‬
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקעו‬
‫פטנטים שחודשו לעשרים שנה‬
‫פטנטים שפג תוקפם‬
‫בקשות להארכת פטנטים‬
4906
i
‫הודעות‬
‫שינויים בפרטים רשומים‬
‫בפנקס‬
‫קודים למדינות‬
‫מפתחות לבקשות שקובלו‬
4908
4919
4920
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שחודשו‬
‫מדגמים שבוטלו‬
4903
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
‫ ירושלים‬,4 ‫ רח' הסדנא‬,‫רשם הפטנטים והמדגמים‬
‫ ירושלים והיא פתוחה לציבור בימי חול‬,‫ תלפיות‬,4 ‫לשכת הפטנטים נמצאת ברח' הסדנא‬
.12:30 -‫ ו‬8:30 ‫שאינם ערבי שבת או מועד בין השעות‬
‫ שקלים בעד כל‬2.50 ‫לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של‬
.‫עמוד או חלק ממנו‬
'‫אגרות ללשכת הפטנ טים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬. 0-24145-2
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem
The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on
weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs.
The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50
per page or part thereof.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together
with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
‫זכות היוצרים בתקצירים אלה שמורה‬
‫ אין להעתיק מת‬,‫למדינת ישראל‬
‫קצירים‬
.‫אלה אלא ברשות לשכת הפטנטים‬
Price per single issue (incl. VAT) : NIS 96.
.₪ 96 ).‫מ‬.‫ע‬.‫ לכל חוברת בודדת (כולל מ‬:‫מחיר‬
Annual subscription (incl. VAT):
NIS 1,152.
Available at the Distribution Service of
Government Publications, 29 B-Street,
Hakirya, Tel-Aviv.
June 15,
.₪ 1,152 ).‫מ‬.‫ע‬.‫דמי חתימה לשנה (כולל מ‬
:‫אפשר להשיג אצל‬
'‫ רחוב ב‬,‫שרות ההפצה של פרסומי הממשלה‬
.‫אביב‬-‫ תל‬,‫ הקריה‬,29 '‫מס‬
– ‫כ"ג בסיוון התשס"ט‬
4452
2009
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
Applications complying with the
Provisions of rule 32(a) of the Patent
Regulations, 5728-1968
‫ לחוק הפטנטים‬16 ‫הודעה לפי סעיף‬
1967 - ‫תשכ"ז‬
‫להלן רשימת בקשות חדשות‬
‫הממלאות אחר הדרישות שנקבעו‬
,‫(א) לתקנות הפטנטים‬32 ‫בתקנה‬
:1968–‫תשכ"ח‬
‫פרטי הבקשות מובאים לפי‬
:‫סדר זה‬
Particulars of the applications are
given in the following order:
Number and date of application
And the first four symbols of the
International Classification
Title of invention
(as proposed by applicant)
‫מספר הבקשה – ותאריך הגשתה‬
‫וארבעה הסמנים הראשונים של‬
‫הסיווג הבינלאומי‬
‫שם האמצאה (כפי שהוצע ע"י‬
)‫המבקש‬
‫המבקש‬
Applicant
Priority right: Convention country –
Number and date of
Foreign application
– ‫ מדינת האיגוד‬:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
International Application Number
‫מספר בקשה בינלאומית‬
International Publication Number
‫מס' פרסום בינלאומי‬
4453
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
31/03/2006
186038
C09G )2009.01(
‫מעכבים פולימריים עבור פלאנאריזציה‬
‫משופרת‬
POLYMERIC INHIBITORS FOR
ENHANCED PLANARIZATION
CABOT MICROELECTRONICS
CORPORATION
PCT/US/2006/012196
WO/2007/114814
24/03/2005
186199
SUBMERGIBLE STORAGE
CONTAINER AND PLATFORM
ISRAEL AEROSPACE INDUSTRIES
LTD.
B63G )2009.01(
‫יחידת אחסנה ופלטפורמה תת–ימית‬
‫התעשייה האוירית לישראל בע"מ‬
PCT/IL/2005/000339
WO/2006/100660
13/03/2006
186308
NOVEL PHARMACEUTICAL
FORMULATION CONTAINING A
BIGUANIDE AND A
THIAZOLIDINEDIONE DERIVATIVE
WATSON PHARMACEUTICALS, INC.
US
11/093742
30/03/2005
PCT/US/2006/009082
WO/2006/107528
June 15,
A61K )2009.01(
‫תכשיר רוקחות חדש המכיל ביגואניד‬
‫ונגזרת תיאזולינדיון‬
– ‫כ"ג בסיוון התשס"ט‬
4454
2009
31/03/2006
ANTIBODIES AND MOLECULES
DERIVED THEREFROM THAT BIND
TO 161P2F10B PROTEINS
AGENSYS, INC.
US
60/667588
31/03/2005
60/700975
20/07/2005
US
PCT/US/2006/012314
WO/2006/105488
12/04/2006
C07K )2009.01(
186385
‫נוגדנים ומולקולות נגזרות מהם‬
P2F10B161 ‫המתקשרים לחלבוני‬
C07K )2009.01(
186514
‫טיהור חלבונים עם חומר פעיל שטח‬
‫קטיוני‬
PURIFICATION OF PROTEINS WITH
CATIONIC SURFACTANT
SAVIENT PHARMACEUTICALS, INC.
PCT/US/2006/013751
WO/2008/051178
28/07/2005
H04L )2009.01(
186547
‫ממשק לאימות זהות‬
CREDENTIAL INTERFACE
MICROSOFT CORPORATION
US
11/112844
22/04/2005
PCT/US/2005/026853
WO/2006/115518
12/05/2006
METHODS OF USING PHHLA2 TO COSTIMULATE T - CELLS
ZYMOGENETICS INC.
US
60/680478
12/05/2005
PCT/US/2006/018540
WO/2007/149067
4455
C07K )2009.01(
186830
T ‫ לגירוי תאי‬PHHLA2–‫שיטות לשימוש ב‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
27/04/2006
186998
TEMPERATURE MEASURING DEVICE
PARTICULARY OF A PATIENT
TECNIMED S.R.L
IT
MI2005A000772 29/04/2005
PCT/IB/2006/003859
WO/2006/054821
10/05/2006
‫התקן מדידת חום במיוחד של חולה‬
A61M )2009.01(
187273
‫מנגנון לייבוש נוזלים‬
‫ ) בע"מ‬1987( ‫אורידיון מדיקל‬
FLUID DRYING MECHANISM
ORIDION MEDICAL (1987)LTD.
US
60/679890
10/05/2005
PCT/IL/2006/000554
WO/2006/120683
13/02/2006
187281
OLIGONUCLEOTIDES OR THEIR
FUNCTIONAL HOMOLOGUES, A
COMPOSITION COMPRISING THE SAME
AND A METHOD OF TREATING B CELL
NEOPLASM
CHANGCHUN HUAPU
BIOTECHNOLOGY CO. LTD.
CN
200510069576.4 17/05/2005
PCT/CN/2006/000215
WO/2006/122463
10/05/2006
187284
NOVEL PORTABLE
ELECTROCHEMICAL DEVICES FOR
DUAL ACTION WOUND HEALING
OGENIX CORPORATION
US
60/679541
10/05/2005
PCT/US/2006/018031
WO/2006/122169
June 15,
A61B )2009.01(
C07H )2009.01(
‫אוליגונוקלאוטידים או הומולוגים‬
‫ תרכובת המכילה‬,‫פונקציונאליים שלהם‬
B ‫אותם ושיטה לטיפול בגידול תאי‬
A61N )2009.01(
‫התקנים אלקטרוכימיים ניידים חדישים‬
‫לריפוי פצע בפעולה כפולה‬
– ‫כ"ג בסיוון התשס"ט‬
4456
2009
19/05/2006
‫רקיחת–ממתק מאווררת מאוד‬
HIGHLY AERATED CONFECTION
NESTEC S.A.
EP
05104299.2 20/05/2005
PCT/EP/2006/004770
WO/2006/122823
16/05/2006
‫תכשירי ננוחלקיקים בעלי שחרור מבוקר‬
‫המכילים צפלוספורינים‬
‫ עם שדה ראייה בעל רזולוציה‬CT ‫סורק‬
‫מדורגת‬
‫ארינטה בע"מ‬
B64C )2009.01(
187921
APPARATUS FOR GENERATING
HORIZONTAL FORCES IN AERIAL
VEHICLES AND RELATED METHOD
URBAN AERONAUTICS LTD.
US
60/687857
07/06/2005
PCT/IL/2006/000663
WO/2006/131920
4457
A61B )2009.01(
187780
GRADED RESOLUTION FIELD OF
VIEW CT SCANNER
ARINETA LTD.
US
60/685418
31/05/2005
PCT/IB/2006/051737
WO/2006/129282
07/06/2005
A61K )2009.01(
187431
NANOPARTICULATE AND
CONTROLLED RELEASE
COMPOSITIONS COMPRISING A
CEPHALOSPORIN
ELAN PHARMA INTERNATIONAL
LTD.
US
60/681265
16/05/2005
PCT/US/2006/018835
WO/2008/010784
31/05/2006
A23G )2008.04(
187320
‫התקן ושיטה ליצור כוחות אפקיים בכלי‬
‫טייס‬
‫אורבן איירונוטיקס בע"מ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
09/06/2006
187988
IMINO AND AMINO SUGAR
PURIFICATION
AMICUS THERAPEUTICS INC.
C07H )2009.01(
‫זיקוק של סוכרים אימינו ואמינו‬
PCT/US/2006/022756
WO/2008/045015
29/06/2006
188074
INDUCING PERIPHERAL BLOOD
VESSEL VASODILATION
MARS, INCORPORATED
US
60/695557
29/06/2005
PCT/US/2006/025429
WO/2007/002854
28/06/2006
‫גרימה להתרחבות כלי דם פריפרלים‬
188186
GLIOMEDIN, FRAGMENTS THEREOF
AND METHODS OF USING SAME
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/694438
28/06/2005
60/696782
07/07/2005
US
PCT/IL/2006/000753
WO/2007/000768
22/06/2006
C07K )2009.01(
‫ פרגמנטים של גליומדין והשימוש‬,‫גליומדין‬
‫בהם‬
188295
METHOD AND SYSTEMS FOR
OFFERING AND SELLING
ADVERTISING
CHRISTINA TUTONE
AU
2005903286 22/06/2005
2005100915
28/10/2005
AU
PCT/AU/2006/000883
WO/2006/135981
June 15,
A61H )2009.01(
‫ידע חברה למחקר ופיתוח בע"מ‬
G06Q )2008.04(
‫שיטה ומערכות להצעה ומכירה של‬
‫פרסומות‬
– ‫כ"ג בסיוון התשס"ט‬
4458
2009
30/06/2006
‫מצע תאי ושיטות לאחסון תאים‬
‫אנימליים‬
CELL MEDIUM AND METHODS FOR
STORAGE OF ANIMAL CELLS
CYTONET GMBH &CO. KG
DE
102005031532.1 01/07/2005
PCT/EP/2006/006401
WO/2007/003382
06/01/2008
‫שירותים מבוססים על עיבוד תמונה עבור‬
‫מוצרי אלקטרוניקה עממיים‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫תכשירים ושיטות ליצור ושימוש‬
‫בננואמולסיות‬
H04L )2009.01(
188772
A METHOD TO EXTEND THE
PHYSICAL REACH OF AN
INFINIBAND NETWORK
OBSIDIAN RESEARCH
CORPORATION
US
60/595576
17/07/2005
PCT/CA/2006/001161
WO/2007/009228
4459
A61K )2009.01(
188666
COMPOSITIONS AND METHODS FOR
MAKING AND USING
NANOEMULSIONS
UNIVERSITY OF MASSACHUSETTS
LOWELL
US
60/700224
18/07/2005
PCT/US/2006/026918
WO/2008/010788
17/07/2006
G06K )2009.01(
188601
IMAGE PROCESSING BASED
SERVICES FOR CONSUMER
ELECTRONICS PRODUCTS
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
11/07/2006
A01N )2009.01(
188461
‫שיטה להאריך את ההישג הפיזי של רשת‬
)INFINIBAND( ‫אינפיניבאנד‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
27/07/2006
189005
‫גלאי חומר אנרגטי‬
ENERGETIC MATERIAL DETECTOR
L-3 COMMUNICATIONS CYTERRA
CORPORATION
US
60/702616
27/07/2005
60/743083
29/12/2005
US
60/743402
03/03/2006
US
PCT/US/2006/029301
WO/2008/030218
11/09/2006
189027
SYSTEMS AND METHODS FOR
DESCRIBING A DEPLOYMENT UNIT
TASER INTERNATIONAL, INC.
US
60/716809
13/09/2005
11/307572
13/02/2006
US
PCT/US/2006/035101
WO/2008/030242
11/09/2006
F23Q )2009.01(
‫מערכת ושיטות לתיאור יחידת פריסה‬
189029
SYSTEMS AND METHODS FOR
MULTIPLE FUNCTION ELECTRONIC
WEAPONRY
TASER INTERNATIONAL, INC.
US
60/716809
13/09/2005
11/428892
06/07/2006
US
PCT/US/2006/035102
WO/2008/030243
June 15,
B01L )2009.01(
H01T )2009.01(
–‫מערכות ושיטות לנשק אלקטרוני רב‬
‫תפקודי‬
– ‫כ"ג בסיוון התשס"ט‬
4460
2009
26/07/2006
A61B )2009.01(
189044
‫התקן ניתוחי‬
SURGICAL DEVICE
POWER MEDICAL INTERVENTIONS,
INC.
US
11/191851
27/07/2005
PCT/US/2006/029287
WO/2007/016290
27/07/2006
SYSTEM AND METHOD FOR
FORMING STAPLE POCKETS OF A
SURGICAL STAPLER
POWER MEDICAL INTERVENTIONS,
INC.
US
60/703493
27/07/2005
PCT/US/2006/029612
WO/2007/014353
27/07/2006
‫מערכת ושיטה ליצירת נרתיקים של שדכן‬
‫ניתוח‬
A61B )2009.01(
189046
SHAFT, E.G., FOR AN ELECTROMECHANICAL SURGICAL DEVICE
POWER MEDICAL INTERVENTIONS,
INC.
US
60/703227
27/07/2005
PCT/US/2006/029614
WO/2007/014355
26/07/2006
A61B )2009.01(
189045
‫ציר ווסת סיבובי עבור התקן ניתוחי‬
‫אלקטרו–מכאני‬
A61B )2009.01(
189047
‫התקן ניתוחי‬
A SURGICAL DEVICE
POWER MEDICAL INTERVENTIONS,
INC.
US
11/191665
27/07/2005
PCT/US/2006/029285
WO/2007/016288
4461
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
27/07/2006
189174
‫מערכת דיכוי אנפרא–אדום‬
INFRARED SUPPRESSION SYSTEM
SIKORSKY AIRCRAFT
CORPORATION
US
11/194229
01/08/2005
PCT/US/2006/029419
WO/2008/041964
08/09/2006
189293
10/08/2006
189335
OPTICAL LENS SYSTEMS
GLOBAL BIONIC OPTICS PTY LTD.
AU
2005904334
11/08/2005
2005905635
12/10/2005
AU
AU
PCT/AU2005/001675 03/11/2005
2006902230
28/04/2006
AU
2006903397
23/06/2006
AU
2006904322
09/08/2006
AU
PCT/AU/2006/001137
WO/2007/016743
189341
VARIABLE INTEGRATED INDUCTOR
TELEFONAKTIEBOLAGET LM
ERICSSON (PUBL)
US
11/214076
29/08/2005
PCT/EP/2006/065437
June 15,
G06Q )2008.04(
‫ניווט משורשר‬
THREAD NAVIGATION
MICROSOFT CORPORATION
US
60/715725
09/09/2005
11/332822
13/01/2006
US
PCT/US/2006/035079
WO/2007/030727
18/08/2006
F02C )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
G02B )2009.01(
‫מערכות עדשות אופטיות‬
H01F )2009.01(
‫סליל השראה משולב משתנה‬
4462
2009
WO/2007/025875
19/07/2006
REAL-TIME ACTIVITY MONITORING
AND REPORTING
NETMANAGE, INC.
US
60/707630
11/08/2005
11/230987
19/09/2005
US
PCT/US/2006/028438
WO/2007/021452
10/08/2006
‫מערכת להעברת תרופה לטיפול מקומי‬
‫מיה ביוטק בע"מ‬
G06F )2008.04(
‫ מערכת ומוצר תוכנת מחשב‬,‫שיטה‬
‫לבקרת גישה‬
C07D )2009.01(
189460
METHOD FOR PRODUCING
BETAMIMETICS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
05107470.6 15/08/2005
PCT/EP/2006/065217
WO/2007/020227
4463
A61K )2009.01(
189431
A METHOD, SYSTEM AND
COMPUTER PROGRAM PRODUCT
FOR ACCESS CONTROL
IBM CORPORATION
GB
0516510.5
11/08/2005
PCT/EP/2006/065025
WO/2007/017460
10/08/2006
‫פעילות של פיקוח ודיווח בזמן אמת‬
189411
DRUG DELIVERY SYSTEM FOR
TOPICAL ADMINISTRATION
MAYA-BIOTECH LTD
US
60/706757
10/08/2005
PCT/IL/2006/000922
WO/2007/017875
03/08/2006
G06F )2009.01(
189401
‫שיטה לייצור בתאמימטיקים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
07/09/2006
189462
‫תחבושות היגייניות עם תחליבים‬
‫הידרופוביים‬
SANITARY NAPKINS WITH
HYDROPHOBIC LOTIONS
THE PROCTER & GAMBLE
COMPANY
US
11/222654
09/09/2005
PCT/IB/2006/053158
WO/2007/029198
11/08/2006
189485
METHOD FOR THE SANITARY
SLAUGHTER OF AN ANIMAL, AND
BAG FOR USE WITH THE SAID
METHOD
HARM KIEZEBRINK
NL
1029721
12/08/2005
1030379
09/11/2005
NL
PCT/NL/2006/000420
WO/2007/021178
13/02/2008
A22B )2009.01(
,‫שיטה של שחיטה סניטרית של בעל חיים‬
‫ושקית לשימוש בשיטה‬
189513
CONTROL PROTOCOL
ENCAPSULATION
MARVEL SOFTWARE SOLUTIONS
ISRAEL LTD.
US
60/889802
14/02/2007
11/933764
01/11/2007
US
June 15,
A61L )2009.01(
H04Q )2009.01(
‫כימוס פרוטוקול שליטה‬
‫מרול פטרונות תוכנה ישראל בע"מ‬
– ‫כ"ג בסיוון התשס"ט‬
4464
2009
13/02/2008
LOGICAL BRIDGING SYSTEM AND
METHOD
MARVELL ISRAEL (M.I.S.L) LTD
US
60/889809
14/02/2007
60/916065
04/05/2007
US
26/07/2007
‫מערכת גישור לוגית ושיטה‬
‫אל) בע"מ‬.‫אס‬.‫איי‬.‫מארוול ישראל (אמ‬
E02D )2009.01(
189533
FRICITION TUBING ANCHOR AND
INFLATION ADAPTER THEREOF
ATLAS COPCO MAI GMBH
AT
A1382/2006 17/08/2006
PCT/AT/2007/000366
WO/2008/019409
17/10/2006
H04Q )2009.01(
189514
‫צינור חיכוך עוגני ומתאם ניפוח עבורו‬
G02B )2009.01(
189551
‫מערכת ושיטת יישור‬
ALIGNMENT SYSTEM AND METHOD
ONDINE INTERNATIONAL LTD.
US
60/729626
24/10/2005
11/549702
16/10/2006
US
PCT/US/2006/040936
WO/2007/050432
12/09/2006
1,2-DIARYLIMIDAZOLES FOR USE AS
CB1 MODULATORS
ASTRAZENECA AB
GB
0518817.2
15/09/2005
PCT/GB/2006/003356
WO/2007/031720
4465
C07D )2009.01(
189556
‫–דיארילאימידאזולים לשימוש‬2,1
CB1 ‫כמודולטורים של‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
17/08/2006
189560
WEAPON HAVING LETHAL AND
NON-LETHAL DIRECTED ENERGY
PORTIONS
RAYTHEON COMPANY
US
11/207049
18/08/2005
PCT/US/2006/032117
WO/2007/022339
17/08/2006
‫נשק בעל חלקים של אנרגיה מונחית‬
‫קטלנית ולא קטלנית‬
189561
LICE EXTERMINATION SYSTEM AND
METHOD
Y.K. HOLDINGS LTD.
US
60/709353
17/08/2005
60/715545
08/09/2005
US
60/771937
08/02/2006
US
PCT/IL/2006/000964
WO/2007/020649
26/08/2005
F41H )2009.01(
‫השמדת כינים מערכת ושיטה‬
‫ אחזקות בע"מ‬.‫ ק‬.‫י‬
189562
SYSTEM FOR BLOCKING THE
MOVEMENT OF REGULATING
ELEMENTS IN A CISTERN
FOMINAYA, S.A.
A61N )2009.01(
E03D )2009.01(
‫מערכת לחסימת תנועה של גורמי בקרה‬
‫במיכל‬
PCT/ES/2005/000478
WO/2007/023193
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4466
2009
20/08/2006
‫מערכת הכוללת יחידת אחסון ניידת‬
‫המצויידת בגלאי לזיהוי קרבת משתמש‬
‫ושיטה למניעת אובדן יחידת האחסון‬
‫הניידת‬
SYSTEM INCLUDING A PORTABLE
STORAGE DEVICE EQUIPPED WITH
A USER PROXIMITY DETECTOR AND
METHOD OF PREVENTING THE LOSS
THEREOF
AVI HADAD
US
60/709125
18/08/2005
PCT/IL/2006/000967
WO/2007/020650
21/08/2006
B05C )2009.01(
‫שיטה לייצור חלקיו של חומר מרוכב בעל‬
‫חוזק מוגבר‬
A61K )2009.01(
189589
METHOD FOR PREPARATION OF
PHARMACEUTICAL COMPOSITION
HAVING IMPROVED
DISINTEGRATABILITY
EISAI R&D MANAGEMENT CO., LTD.
2005JP
01/09/2005
253305
PCT/JP/2006/317307
WO/2007/026864
4467
‫אברהם גיל‬
189582
METHOD OF PRODUCING
COMPOSITE MEMBERS HAVING
INCREASED STRENGTH
WILLIAM LEE JOHNSON, SR.
US
60/709628
19/08/2005
PCT/US/2006/032674
WO/2008/024107
01/09/2006
F41H )2009.01(
189563
‫שיטה להכנת הרכב פרמצבטי בעל יכולת‬
‫התפוררות משופרת‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
18/08/2006
189591
METHOD AND APPARATUS FOR
DETECTING A WIRELESS
COMMUNICATION NETWORK IN
OVERLAPPING FREQUENCY BANDS
QUALCOMM INCORPORATED
US
60/709644
18/08/2005
60/713507
31/08/2005
US
11/283115
17/11/2005
US
PCT/US/2006/032370
WO/2007/022429
28/08/2006
‫שיטה ומתקן לזיהוי רשת תקשורת‬
‫אלחוטית ברצועות תדרים חופפים‬
189596
WEAR ASSEMBLY FOR
EXCAVATING MACHINES
ESCO CORPORATION
US
60/712915
30/08/2005
60/758179
10/01/2006
US
PCT/US/2006/033593
WO/2007/027639
15/09/2006
E02F )2009.01(
‫מכלול לבוש עבור מכונות חפירה‬
189606
METHOD AND DEVICES FOR
TERMINATION
GUIDED DELIVERY SYSTEMS, INC.
US
11/232190
20/09/2005
PCT/US/2006/035933
WO/2007/035449
June 15,
H04Q )2008.04(
A61B )2009.01(
‫שיטות והתקנים לסיום‬
– ‫כ"ג בסיוון התשס"ט‬
4468
2009
24/08/2006
A PROCESS FOR THE PREPARATION
OF A 1-PHENYL-2-OXATRIAZATRIDECAN-13-OIC ACID FOR
USE AS A DIAGNOSTIC CONTRAST
AGENT
BRACCO IMAGING S.P.A.
EP
05019852.2 13/09/2005
PCT/EP/2006/065634
WO/2007/031390
23/08/2006
F41B )2009.01(
‫מכשיר ושיטות לניטרול פעילות חשמלית‬
‫בשריר‬
G06F )2009.01(
189743
COMMUNICATION AND TASK
MANAGEMENT SYSTEM FOR
COOPERATIVE PARATOILS
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
4469
–‫–אוקסא‬2–‫–פניל‬1 ‫תהליך להכנת חומצת‬
‫–אוית לשימוש כחומר‬13–‫טריאזאטרידקנ‬
‫ניגוד איבחוני‬
189683
ELECTROMUSCULAR
INCAPACITATION DEVICE AND
METHODS
AEGIS INDUSTRIES, INC.
US
11/208762
23/08/2005
60/736132
11/11/2005
US
60/736603
14/11/2005
US
60/764787
02/02/2006
US
60/764785
02/02/2006
US
60/794325
21/04/2006
US
60/794919
24/04/2006
US
PCT/US/2006/032910
WO/2008/051191
25/02/2008
C07C )2009.01(
189643
‫מערכת תקשרות וניהול משימות‬
‫למצנחים בקבוצה‬
‫מוסד הטכניון למחקר ופתוח בע"מ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
01/09/2006
189752
C07J )2009.01(
ANTITUMOR AGENT
OTSUKA PHARMACEUTICAL CO.,
LTD.
2005JP
02/09/2005
255517
PCT/JP/2006/317316
WO/2007/026869
‫גורם נגד גידולים‬
12/12/2006
H04N )2009.01(
189753
FOCAL PLANE AND METHOD FOR
ADJUSTING A FOCAL PLANE OF
THIS TYPE
DEUTSCHES ZENTRUM FUR LUFTUND RAUMFAHRT E.V.
‫משטח פוקאלי ושיטה עבור התאמת‬
‫משטח פוקאלי מסוג זה‬
PCT/EP/2006/011939
WO/2008/071203
30/08/2006
189854
BORON ION IMPLANTATION USING
ALTERNATIVE FLUORINATED
BORON PRECURSORS, AND
FORMATION OF LARGE BORON
HYDRIDES FOR IMPLANTATION
ADVANCED TECHNOLOGY
MATERIALS, INC.
US
60/712647
30/08/2005
PCT/US/2006/033899
WO/2007/027798
June 15,
H01L )2009.01(
‫השתלה של יוני בור ע"י שימוש‬
‫בפרקורסורים חלופים של בור המותמרים‬
‫בפלואור ויצירת הידרידים גדולים של בור‬
‫להשתלה‬
– ‫כ"ג בסיוון התשס"ט‬
4470
2009
08/09/2006
ISOQUINOLINES DERIVATIVES AS IGF-1R
INHIBITORS
ANALYTECON S.A.
US
60/715170
09/09/2005
WO
PCT/IB2005/002667 09/09/2005
PCT/IB/2006/002474
WO/2007/029107
04/03/2008
‫מערכת ושיטת מדידה אינרציאלית עם‬
‫ביטול של מטה חיישן‬
4471
G01S )2009.01(
‫מערך הקרנה אחיד ושיטה להגדרתו‬
‫אופטיקה אלאופ‬-‫אלביט מערכות אלקטרו‬
‫בע"מ‬
G01B )2009.01(
189997
BUILDING PROTECTION SYSTEM
AND METHOD
BUILDING PROTECTION SYSTEMS,
INC.
US
11/242297
03/10/2005
PCT/US/2006/038622
WO/2008/048248
11/03/2008
G01C )2009.01(
189946
UNIFORM IRRADIATION
CONFIGURATION AND A METHOD
FOR DETERMINING THE SAME
ELBIT SYSTEMS ELECTRO-OPTICAL
ELOP LTD.
03/10/2006
R1 – ‫נגזרות של איזוקוינולין כמעכבי‬
IGF
189911
INERTIAL MEASUREMENT SYSTEM
AND METHOD WITH SENSOR BIAS
CANCELLATION
CUSTOM SENSORS &
TECHNOLOGIES, INC.
US
11/726389
20/03/2007
05/03/2008
C07D )2009.01(
189884
‫מערכת ושיטה להגנת מבנה‬
G06F )2009.01(
190113
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
METHOD AND SYSTEM FOR
OPTIMIZING THE CONTROLLING OF
REMOTE APPLICATIONS BY MOBILE
DEVICES
VOLLEE LTD
16/03/2008
‫שיטה ומערכת לאופטימיזציה של‬
‫השליטה על אפליקציות מרוחקות‬
‫באמצעות מכשירים ניידים‬
‫ווליי בע"מ‬
190185
METHOD AND APPARATUS FOR
REDUCING SIMULTANEOUS
SWITCHING OUTPUTS
MARVELL ISRAEL (M.I.S.L) LTD
US
60/894798
14/03/2007
12/047754
13/03/2008
US
31/03/2008
‫שיטה ומערכת להקטנת פלטי מיתוג בו‬
‫זמניים‬
‫אל) בע"מ‬.‫אס‬.‫איי‬.‫מארוול ישראל (אמ‬
190536
EXTENSION UNIT SYSTEM AND
METHOD
ADI GLICK
31/03/2008
METHODS FOR TRANSFERRING
POINTS OF INTEREST BETWEEN
IMAGES WITH NON - PARALLEL
VIEWING DIRECTIONS
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
02/10/2005
June 15,
H03K )2009.01(
G01C )2009.01(
‫מערכת יחידת הארכה ושיטה‬
‫עדי גליק‬
190539
G06T )2009.01(
‫שיטה להעברת נקודות בעלות עניין בין‬
‫הדמיות בעלות כיווני ראייה בלתי מקבילות‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
190580
– ‫כ"ג בסיוון התשס"ט‬
H01S )2009.01(
4472
2009
‫לייזרים סיביים‬
FIBER LASERS
EL-OP ELECTRO-OPTICS
INDUSTRIES LTD. KIRYAT
WECIZMANN
09/04/2008
‫אופטיקה בע"מ‬-‫אל אופ תעשיות אלקטרו‬
A METHOD FOR REMOTE SPECTRAL
ANALYSIS OF GAS PLUMES
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
17/04/2008
‫שיטה לניתוח ספקטרלי מרחוק של עננת‬
‫עשן‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫מערכת ושיטה לזיהוי והצלבת נתוני זיהוי‬
‫סלולארים עם מאפיינים ביומטרים‬
‫יפית זיגמן‬
A METHOD AND SYSTEM FOR
COOLING AND/OR GENERATING
ENERGY USING SOLAR ENERGY
MOSHE LEVI
15/05/2008
4473
G06F )2009.01(
191094
COMPARING DATA
REPRESENTATIONS TO STORED
PATTERNS
MARVELL ISRAEL (MISL) LTD.
US
60/913437
23/04/2007
01/05/2008
H04L )2009.01(
190980
A SYSTEM AND METHOD FOR
IDENTIFYING AND CROSSREFERENCING CELLULAR IDS AND
BIOMETRICAL CHARACTERISTIC
YAFIT ZIGMAN
27/04/2008
G06T )2009.01(
190757
‫משווה ייצוג נתונים לתבניות מאוכסנות‬
‫ ) בע"מ‬MISL( ‫מרבל ישראל‬
F24J )2009.01(
191194
‫או לייצור אנרגיה‬/‫שיטה ומערכת לקירור ו‬
‫באמצעות אנרגיית השמש‬
‫משה לוי‬
H04Q )2009.01(
191487
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
SYSTEM AND METHOD FOR ENTRY
AND QOR EXIT DETECTION OF
MOBILE COMMUNICATION DEVICES
INTUCELL LTD
US
60/998895
15/10/2007
190425
25/03/2008
IL
18/05/2008
‫או יציאה‬/‫מערכת ושיטה לזיהוי כניסה ו‬
‫של מכשיר קשר נייד‬
‫אינטיוסל בע"מ‬
191514
ACTIVE PRE-PROGRAMMABLE
REMINDER SYSTEM FOR SPECIAL
MOMENTS
OREN PARTUCK
21/05/2008
‫מערכת אקטיבית הניתנת לתכנות מראש‬
‫לתזכור רגעים מיוחדים‬
‫אורן פרטוק‬
191593
191709
COMPOSITIONS COMPRISING RED
MICROALGAE POLYSACCHARIDES
AND METALS
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
27/05/2008
June 15,
A61K )2009.01(
‫תכשירים המכילים רב–סוכרים של‬
‫מיקרואצות ומתכות‬
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ופיתוח‬
191743
A61K )2009.01(
‫תכשירים קוטלי כינים‬
‫פישר תעשיות פרמצבטיות בע"מ‬
PEDICULICIDE COMPOSITIONS
FISCHER PHARMACEUTICALS LTD.
29/05/2008
A63B )2009.01(
‫סימולאטור לאימון בגלישת גלים וסקי‬
‫שלג‬
‫אסף פרדס‬
A SURFING AND ALPINE SKIING
SIMULATOR
ASSAF PARDES
26/05/2008
H04B )2009.01(
191836
– ‫כ"ג בסיוון התשס"ט‬
F16C )2009.01(
4474
2009
SINGLE-STAGE THERMAL PROCESS
FOR MANUFACTURING
TRANSPARENT SINTERED SPINEL
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
03/06/2008
‫תהליך תרמי חד–שלבי לייצור ספינל‬
‫מסונטר שקוף‬
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
AUTOMATIC SIGNALING METHOD
AND DEVICE FOR
TELECOMMUNICATION SERVICES
ETHOS NETWORKS LTD.
19/06/2008
‫שיטה והתקן לאיתות אוטומטי עבור‬
‫שירותי תקשורת‬
‫אתוס רשתות בע"מ‬
4475
‫תהליך להכנת סינאכלצט‬
A01H )2009.01(
192333
PHOTOBIOREACTOR, SYSTEM AND
METHOD FOR THE CULTIVATION OF
MICROALGAE
NAHSHON EDELSON
27/12/2006
C07B )2009.01(
192294
A PROCESS FOR THE PREPARATION
OF CINEACALCET
DIPHARMA FRANCIS S.R.L.
IT
MI2007A1261 22/06/2007
19/06/2008
H04M )2009.01(
191927
‫ מערכת ושיטה לעיבוד של‬,‫כור פוטוביולוגי‬
‫מיקרואצות‬
‫נחשון אידלסון‬
G06F )2008.04(
192439
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫מכשיר ומערכת לניהול קשרי תקשורת‬
‫מחשבים‬
COMPUTER SESSION MANAGEMENT
DEVICE AND SYSTEM
ATOMYNET INC.
US
60/753395
27/12/2005
06/001171
05/10/2006
IL
60/850253
10/10/2006
US
PCT/IL/2006/001497
WO/2007/074458
26/06/2008
192480
MOBILE NETWORK ACCESS AND
INFRASTRUCTURE APPARATUS
CELLCOM ISRAEL LIMITED
30/06/2008
‫התקן גישה ותשתית ברשת סלולארית‬
‫סלקום ישראל בע"מ‬
192523
UNIVERSAL PROCESS AND
APPARATUS FOR OXYGEN/AIRLESS
GASIFICATION OF MIXTURES
CONTAINING CARBON AND/OR
REDUCING ELEMENTS
VICTOR FELIX DE BOTTON
18/12/2006
June 15,
C07B )2009.01(
‫תהליך ומתקן אוניברסלי לגזיפיקציה של‬
‫או יסודות‬/‫תערובות המכילות פחמן ו‬
‫מחזרים ללא אוויר או חמצן‬
‫ויקטור פליקס דה בוטון‬
192558
COMBINATION OF TRIAZINE
DERIVATIVES AND INSULIN
SENSITISERS
MERCK PATENT GMBH
FR
06/00344
13/01/2006
PCT/EP/2006/012185
WO/2007/079917
02/07/2008
H04Q )2009.01(
A61K )2009.01(
‫קומבינציה של נגזרות טריאזין ומרגשי‬
‫אינסולין‬
192584
– ‫כ"ג בסיוון התשס"ט‬
H04L )2009.01(
4476
2009
METHOD FOR IMPROVING
COEXISTENCE BETWEEN ADJACENT
DIFFERENT WIRELESS NETWORKS
ALVARION LTD.
02/07/2008
‫אלווריון בע"מ‬
‫שיטה ואמצעים לגרימת בלעיה אנתלפית‬
‫ להפקת אנרגיה‬,‫של מינרלים במיקמם‬
‫אלתא מערכות בע"מ‬
4477
C12N )2009.01(
192631
–1 ‫הרכבים ושיטות לשימוש בנוגדני‬
4 ‫או‬/‫ ו‬DICKKOPF
G06F )2009.01(
192664
SATELLITE COMMUNICATION
SYSTEM AND METHOD
DR.ZION HADAD
08/07/2008
G01S )2009.01(
‫ מערכת ושיטה‬,‫שידור‬/‫מכשיר גילוי‬
COMPOSITIONS AND METHODS OF
USE FOR ANTIBODIES OF
DICKKOPF-1 AND/OR-4
NOVARTIS AG
US
60/759216
13/01/2006
PCT/US/2007/000777
WO/2007/084344
07/07/2008
‫תובל מירון‬
192601
SENSING/EMITTING APPARTUS,
SYSTEM AND METHOD
ELTA SYSTEMS LTD.
12/01/2007
D02G )2009.01(
192585
METHOD AND MEANS FOR THE INSITU ENTHALPIC DEGRADATION OF
MINERALS AS A SOURCE OF
ENERGY
WEISS YONA
03/07/2008
‫שיטה לשיפור פעולתן במקביל של‬
‫רשתות אלחוטיות סמוכות שונות‬
‫מערכת ושיטה לתקשורת לווינים‬
‫ד"ר ציון חדד‬
A47J )2009.01(
192686
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫הרכבי שמן‬
OIL FORMULATIONS
ROHM AND HAAS COMPANY
US
60/963297
03/08/2007
08/07/2008
192687
COMPOSITION FOR COATING,
PROCESS FOR COATING AND
FROZEN COATED CONFECTION
UNILEVER PLC
EP
07113487.8 31/07/2007
07113488.6
31/07/2007
EP
09/07/2008
‫ תהליך לציפוי וקונפקציה‬,‫תכשיר לציפוי‬
‫קפואה מצופה‬
192708
COSMETIC AND DERMATOLOGICAL
COMPOSITION
SIMA COHEN
13/01/2007
192736
June 15,
A61K )2009.01(
‫תרכובת קוסמטית ודרמטולוגית‬
‫סימה כהן‬
C05B )2009.01(
‫תכשירים מיוצבים המכילים אמוניום‬
‫ניטרט‬
STABILIZED COMPOSITIONS
COMPRISING AMMONIUM NITRATE
HONEYWELL INTERNATIONAL INC.
US
60/758642
13/01/2006
11/622878
12/01/2007
US
PCT/US/2007/060535
WO/2007/084873
13/01/2007
B28B )2009.01(
192737
– ‫כ"ג בסיוון התשס"ט‬
C05B )2009.01(
4478
2009
COMPOSITIONS COMPRISING
AMMONIUM NITRATE DOUBLE
SALTS
HONEYWELL INTERNATIONAL INC.
US
60/759121
13/01/2006
11/622939
12/01/2007
US
PCT/US/2007/060534
WO/2007/084872
22/01/2007
‫צורת מינון ושיטה למתן תרופות ממכרות‬
4479
H01R )2009.01(
192748
DEVICES FOR CONNECTING
ELECTRICAL APPLIANCES
ZVI PERACH
17/01/2007
A61K )2009.01(
192743
DOSAGE FORM AND METHOD FOR
THE DELIVERY OF DRUGS OF
ABUSE
ABBOTT GMBH & CO. KG
US
60/760707
21/01/2006
PCT/US/2007/060864
WO/2007/085024
10/07/2008
‫תכשירים המכילים כפל מלחים של‬
‫אמוניום ניטרט‬
‫מתקנים לחיבור של מכשירים חשמליים‬
‫צבי פרח‬
C12N )2009.01(
192761
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
COMPOSITIONS AND METHODS FOR
HUMANIZATION AND
OPTIMIZATION OF N-GLYCANS IN
PLANTS
BIOLEX THERAPEUTICS, INC.
US
60/759298
17/01/2006
60/790373
07/04/2006
US
60/791178
11/04/2006
US
60/812702
09/06/2006
US
60/836998
11/08/2006
US
60/860358
21/11/2006
US
PCT/US/2007/060642
WO/2007/084922
15/07/2008
–N ‫תכשירים ושיטות להאנשה וייעול של‬
‫גליקנים בצמחים‬
192814
DIGITAL CONTENT PLATFORM
WHICH OPENS NEW OPPORTUNITIES
FOR SUPPLYING, DISTRIBUTING
AND SELLING OF DIGITAL CONTENT
VIA INTERNET & MOBILE PHONES
OFER EITAN - DATOMO LTD
15/07/2008
192818
OPTICAL FLOW CELL FOR USE IN
HIGH TEMPERATURE AND/OR HIGH
PRESSURE ENVIRONMENTS
LOCKHEED MARTIN CORPORATION
US
11/888565
01/08/2007
15/07/2008
June 15,
192819
– ‫כ"ג בסיוון התשס"ט‬
G06F )2009.01(
‫פלטפורמה חדשנית להפצה ומכירת‬
‫תכנים סלולריים ואינטרנטיים‬
‫עופר איתן חברת דאטומו בע"מ‬
G01N )2009.01(
‫תא שטף אופטי לשימוש בסביבות של‬
‫או לחץ גבוה‬/‫טמפרטורה גבוהה ו‬
H02H )2009.01(
4480
2009
A METHOD AND DEVICE FOR
GENERATING AN ELECTRICAL
SIGNAL IN RESPONSE TO LIGHT
LOCKHEED MARTIN CORPORATION
US
11/826670
17/07/2007
05/02/2007
NOVEL COMPOUNDS
FERRING B.V.
US
60/771870
PCT/US/2007/003213
WO/2007/095021
16/01/2007
‫שיטה והתקן ליצירת אות חשמלי בתגובה‬
‫לאור‬
‫תרכובות חדשות‬
10/02/2006
4481
‫מודולטורים של רצפטור קניבינויד‬
H04L )2009.01(
192835
COMMUNICATION SYSTEM AND
METHOD
CELLCRYPT LIMITED
GB
0713785.4
16/07/2007
16/07/2008
C07D )2009.01(
192830
CANNIBINOID RECEPTOR
MODULATORS
SCHERING CORPORATION
US
60/760007
18/01/2006
60/846965
25/09/2006
US
PCT/US/2007/001024
WO/2007/084450
16/07/2008
C07K )2009.01(
192824
‫מערכת תקשורת ושיטה‬
H04L )2009.01(
192836
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
CALL PROCESSING SYSTEM AND
METHOD
CELLCRYPT LIMITED
GB
0713786.2
16/07/2007
09/03/2007
‫מערכת לעיבוד שיחה ושיטה‬
192837
IMMUNOMODULATORY COMPOUNDS
AND TRETMENT OF DISEASES RELATED
TO AN OVERPRODUCTION OF
INFLAMMATORY CYTOKINES
OM PHARMA
WO
PCT/IB06/050748 09/03/2006
PCT/IB/2007/000567
WO/2007/102081
29/01/2007
192847
BENZAMIDE AND HETEROARENE
DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
06101372.8 07/02/2006
PCT/EP/2007/050812
WO/2007/090749
16/07/2008
June 15,
‫תרכובות מאפננות אימונית וטיפול‬
‫במחלות הקשורות לייצור יתר של‬
‫ציטוקינים דלקתיים‬
C07D )2009.01(
‫תולדות בנזאמיד והטרוארן‬
192858
E05B )2009.01(
‫מערכת הגנה לצילינדר‬
‫משה אהרון‬
CYLINDER PROTECTIVE SYSTEM
MOSHE AHARON
16/07/2008
C07F )2009.01(
192859
– ‫כ"ג בסיוון התשס"ט‬
A47C )2009.01(
4482
2009
‫מזרון מוקצף מחוזק‬
RE-ENFORCED FOAM MATTRESS
POLYCART TECHNOLOGIES LTD
US
60/949878
16/07/2007
17/07/2008
‫הרכב חדש של ג'ל לציפוי‬
NEW GEL COAT FORMULATION
EVONIK DEGUSSA GMBH
US
11/780765
20/07/2007
09/02/2007
–2 ‫גילוי סרטן באמצעות רמות גבוהות של‬
BCL
4483
‫להב לרינגוסקוף ממתכת עם הרכבת‬
‫לתאורה‬
‫תרופאטק אינטרנשיונל בע"מ‬
C07K )2009.01(
192874
PEPTIDE CONJUGATES AND USES
THEREOF
HEMOSTEM LTD.
17/07/2008
A61B )2009.01(
192873
METAL LARYNGOSCOPE BLADE
WITH ILLUMINATION ASSEMBLY
TRUPHATEK INTERNATIONAL LTD.
17/07/2008
G01N )2009.01(
192866
DETECTION OF CANCER BY
ELEVATED LEVELS OF BCL-2
UNIVERSITY OF SOUTH FLORIDA
US
60/771677
09/02/2006
PCT/US/2007/003608
WO/2007/092627
17/07/2008
C09J )2009.01(
192865
‫צימודי פפטידים ושימושיהם‬
‫המוסטם בע"מ ע"י רבינוביץ אשר‬
H04N )2009.01(
192902
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
SYSTEM AND METHOD FOR
SEGMENTING STRUCTURES IN A
SERIES OF IMAGES
INNOVEA MEDICAL LTD.
US
11/826776
18/07/2007
20/07/2008
‫מערכת ושיטה לחלוקה למקטעים בסדרת‬
‫תמונות‬
192909
FORMULA DISPENSER INSERT FOR
NURSING BOTTLES
ORI SHAASHUA
21/07/2008
‫מנפק תרכובת פנימי לבקבוקי הזנה‬
‫מור רוטברט‬
192923
SECURED COMPUTER MOUSE
SYSTEM
BENJAMIN FIROOZ GHASSABIAM
21/07/2008
‫בנימין פירוז גסביאן‬
192927
June 15,
A44C )2009.01(
‫תכשיט עשוי מיהלום גולמי‬
‫גדעון אשר רומנו‬
192942
OPTICAL MONITORING AND
OPTICAL LANCING CALIBRATION
OF THE GLUCOSE AND SUBSTRATES
IN BLOOD
ALEXANDER AVRAHAM
22/07/2008
G06F )2009.01(
‫עכבר מאובטח למחשב‬
JEWEL MADE OF A RAW DIAMOND
GIDON ASHER ROMANO
22/07/2008
B65G )2009.01(
‫מניטורינג אופטיכלי ללא פולשניים וטסט‬
‫גלוקוזה וחומרים בדם על–ידי מחט‬
‫אופטיכל‬
192943
– ‫כ"ג בסיוון התשס"ט‬
A61B )2009.01(
‫אלכסנדר אברהם‬
A23L )2009.01(
4484
2009
‫ממרח שום–בריאותי‬
‫שרה כהן‬
GARLIC SPREAD-HEALTHY
SARA COHEN
22/07/2008
B62B )2009.01(
192945
‫כיסוי לעגלת ילדים‬
COVER FOR CHILD CARRIAGE
ROBIN NATHALIE
29/01/2007
METHODS FOR IDENTIFYING
PATIENTS WITH AN INCREASED
LIKELIHOOD OF HAVING OVARIAN
CANCER AND COMPOSITIONS
THEREFOR
TRIPATH IMAGING, INC.
US
60/762760
27/01/2006
PCT/US/2007/061205
WO/2007/090076
25/01/2007
4485
‫שיטות לזיהוי מטופלים בעלי אפשרות‬
‫מוגברת ללקות בסרטן השחלות‬
‫ותכשירים בשל כך‬
C07D )2009.01(
192976
PIPERIDINYL DERIVATIVES AS
MODULATORS OF CHEMOKINE
RECEPTOR ACTIVITY
BRISTOL-MYERS SQUIBB COMPANY
US
60\762801
27/01/2006
11/625874
23/01/2007
US
PCT/US/2007/061012
WO/2007/092681
23/07/2008
G01N )2009.01(
192974
‫נגזרות פיפרידיניל כמודולטורים לפעילות‬
‫של רצפטור כמוקין‬
B62B )2009.01(
192984
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
A NOTEPAD COMBINES WITH A
UNIT ADAPTED TO FIT
SUPERMARKET TROLLEYS INSTEAD
OF COINS
INBAL COHEN
23/07/2008
‫פנקס משולב עם יחידה המותאמת‬
‫למנגנון הכנסת הכסף בעגלות קניות‬
‫ענבל כהן‬
193002
‫מחפה מתקפל‬
‫גדעון אבנשפנגר‬
FOLDABLE SHIELD
GIDON EBENSPANGER
23/07/2008
193003
OPEN PROBE METHOD AND DEVICE
FOR SAMPLE INTRODUCTION FOR
MASS SPECTROMETRY ANALYSIS
AVIV AMIRAV
23/07/2008
‫אביב עמירב‬
June 15,
G09F )2009.01(
‫הקצאה והפצה של שטחי פרסום בגלילי‬
‫נייר קבלות‬
‫אורטל וקנין‬
193009
THIN TELESCOPE FOR MEDICAL
APPLICATIONS
RAN CARMELI
24/07/2008
G01N )2009.01(
‫שיטה והתקן "מבחן פתוח" להכנסת‬
‫דוגמה לאנליזת מס ספקטרומטריה‬
193007
ALLOCATION AND DISTRIBUTION
OF ADVERTISING AREAS IN
RECEIPT PAPER ROLLS
ORTAL VAKNIN
23/07/2008
F41J )2009.01(
A61B )2009.01(
‫טלסקופ דק ליישומים רפואיים‬
‫רן כרמלי‬
193015
– ‫כ"ג בסיוון התשס"ט‬
A61C )2009.01(
4486
2009
OPEN CIRCUIT DELAY DEVICES,
SYSTEMS, AND METHODS FOR
ANALYTE MEASUREMENT
LIFESCAN, INC.
US
11/782865
25/07/2007
24/07/2008
)AIOL( ‫עדשה מסתגלת תוך עינית‬
‫מאוחדת בעל אלמנט אופטי עם קפסולה‬
‫ג'ל סיליקון‬
‫ניולנס בע"מ‬
‫בובה מבודדת חום ומזמרת לכיסוי בקבוק‬
‫האכלה לתינוק‬
‫מיקה מור‬
4487
‫כיסא עבודה למנתחים ומצנתרים‬
‫יצחק דרימר‬
B23C )2009.01(
193030
CERAMIC DRILL BIT FOR HIGHSPEED DRILLING OF COMPOSITES
SNECMA
FR
0705457
26/07/2007
24/07/2008
A61B )2009.01(
193029
WORK CHAIR FOR SURGEONS AND
CARDIAC CATHETERIZATION
SPECIALISTS
ITZHAK DERIMAR
24/07/2008
A63H )2009.01(
193028
INSULATING AND SINGING DOLL
COVER FOR BABY FEEDING
BOTTLES
MICA MOR
24/07/2008
G02C )2009.01(
193021
UNITARY ACCOMMODATING
INTRAOCULAR LENS (AIOL)
HAVING OPTICAL ELEMENT WITH
SILICON GEL CAPSULE
NULENS LTD.
24/07/2008
‫ מערכת ושיטות השהיה במעגל‬,‫מתקן‬
‫פתוח למדידת אנליט‬
‫מקדח קרמי לקדיחה במהירות גבוהה‬
‫בחומר מרוכב‬
G01V )2009.01(
193061
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
INSPECTION METHOD AND
APPARATUS, LITHOGRAPHIC
APPARATUS, LITHOGRAPHIC
PROCESSING CELL AND DEVICE
MANUFACTURING METHOD
ASML NETHERLANDS B.V.
US
11/882610
02/08/2007
27/07/2008
,‫ מכשיר ליטוגרפי‬,‫שיטת בחינה ומכשיר‬
‫תא עיבוד ליטוגרפי ושיטה לייצור המכשיר‬
193072
A BOX FOR STORING A MULTI
SOCKET EXTENSION AND CABLES
IN USE
ISRAEK BLAZBERG MIRKIN
27/07/2008
‫תיבה לאחסון של רב–שקע וכבלים‬
‫בשימוש‬
‫ישראל בלזברג‬
193073
AN ACTIVE NOISE CONTROL
SYSTEM AND A METHOD THEREFOR
MICHAL KFIR
27/07/2008
193075
A NEW COMPOSITION FOR HAIR
GROWTH
PILOGICS
27/07/2008
G10L )2009.01(
‫מערכת אקטיבית לבקרת רעש ושיטה‬
‫עבור זה‬
‫מיכל כפיר‬
A61K )2009.01(
‫תכשיר חדש לגידול שיער‬
‫פילוג'יקס‬
193083
CODE OBFUSCATION BY
REFERENCE LINKING
ALADDIN KNOWLEDGE SYSTEMS
LTD
US
11/838247
14/08/2007
June 15,
H02G )2009.01(
G06F )2009.01(
‫הסתרת קוד על "ד" צמוד הפנייה‬
‫אלדין מערכות ידע בע"מ‬
– ‫כ"ג בסיוון התשס"ט‬
4488
2009
28/07/2008
‫שעון לא ליניארי‬
‫הרב תדהר אילון אזולאי‬
NONLINEAR TIMER
RABII TIDHAR EYLON AZOLAY
28/02/2007
C07K )2009.01(
193094
IMPROVED ANTITUMORAL
TREATMENTS
PHARMA MAR, S.A.
US
60/813606
28/02/2006
PCT/US/2007/062936
WO/2007/101235
29/07/2008
G01J )2009.01(
193086
‫טיפולים משופרים כנגד גידולים‬
A61M )2009.01(
193119
‫משאף‬
‫אלפרד זילברג‬
INHALER
ALEFRED ZILBERG
29/07/2008
APPARATUS AND METHOD FOR
HIGH EFFICIENCY ISOLATED
POWER CONVERTER
LUMENIS LTD.
US
11/882171
31/07/2007
29/07/2008
4489
‫התקן ושיטה למתמר כח מבודד בעל‬
‫יעילות גבוהה‬
‫לומניס בע"מ‬
G08G )2009.01(
193123
LAHAY BOX-LOCATE AND PREVENT
SYSTEM REDUCTION OF ROAD
ACCIDENTS
MOSHE LAHAT
IL
7
H01F )2009.01(
193120
‫קופסת להט– שיטה ומערכת איתור‬
‫ומניעה הפחתת תאונות הדרכים‬
‫משה להט‬
24/07/2008
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
29/07/2008
193124
‫התקן לברר זבל‬
‫רפאל אדלר‬
DEVICE FOR SORTING GARBAGE
RAFAEL ADLER
29/07/2008
193129
A TABLET WITH REMEDIAL
COMPOSITION AND METHODS FOR
TREATING MEDICAL DISORDERS
AND ALIMENTS
DR. KATZ DANIEL
US
60/935165
30/07/2007
08/02/2007
‫ד"ר דניאל כץ‬
A24B )2009.01(
–‫תוספים גמא–ציקלודקסטרינים משחררי‬
‫טעם‬
193165
PHARMACEUTICAL COMPOSTIONS
CONTAINING A VIRAL VECTOR
CONTAINING A TRANSGENE
ENCODING AN IMMUNOGEN TO A
MAMMAL'S LIVER TISSUE
GENZYME CORPORATION
US
60/771628
08/02/2006
60/772360
09/02/2006
US
PCT/US/2007/003388
WO/2007/092563
June 15,
A61K )2009.01(
‫טבלייה המכילה הרכב טבעי למניעת‬
‫מחלות ושיטה לייצורה‬
193158
GAMMA CYCLODEXTRIN
FLAVORING-RELEASE ADDITIVES
PHILIP MORRIS PRODUCTS S.A.
US
60/771462
09/02/2006
PCT/IB/2007/001770
WO/2007/091181
08/02/2007
B22C )2009.01(
A61K )2009.01(
‫תכשירי רוקחות המכילים וקטור נגיפי‬
‫המכיל טרנסגן המקודד אימונוגן לרקמת‬
‫כבד של יינק‬
– ‫כ"ג בסיוון התשס"ט‬
4490
2009
31/07/2008
DEVICE AND METHOD FOR
SHIELDING A VEHICLE
SHLOMO SHMUL
31/07/2008
‫התקן ושיטה כדי לסוכך על רכב‬
‫שלמה שמול‬
G09F )2009.01(
193167
AN APPARATUS AND METHOD FOR
DRAWING ATTENTION TO A
VIBRATING DEVICE
ELI PADAN
31/07/2008
B60S )2009.01(
193166
‫מערכת ושיטה למשיכת תשומת לב‬
‫למתקן רוטט‬
‫אלי פדן‬
A45D )2009.01(
193168
‫קוצץ ציפורניים‬
‫גולן דרורי‬
A NAIL CLIPPER
GOLAN DRORI
31/07/2008
‫אסלה לשימוש של פעוטות‬
‫יוסף עגיב‬
A TOILET FOR INFANT USE
josef agiv
31/07/2008
G02C )2009.01(
193193
METHOD OF MEASURING
DIFFRACTIVE LENSES
ALCON RESEARCH, LTD.
US
60/952913
31/07/2007
4491
A47K )2009.01(
193169
‫שיטה למדידת עדשות משתברות‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
05/02/2007
193198
LONG-ACTINE POLYPEPTIDES AND
METHODS OF PRODUCING AND
ADMINISTERING SAME
MODIGENE INC
US
60/764761
03/02/2006
PCT/US/2007/003014
WO/2007/094985
06/02/2007
04/08/2008
‫פוליפפטידים מיוצבים ושיטות שימוש‬
‫והכנה של פוליפפטידים מיוצבים‬
193220
METHODS AND DEVICES FOR
TREATING SLEEP APNEA AND
SNORING
LINGUAFLEX, LLC
US
60/765638
06/02/2006
PCT/US/2007/061721
WO/2007/092865
193226
A47J )2009.01(
‫ המופעלת‬,‫יחידת מאוורר ידנית למנגל‬
‫חשמלית‬
‫מיכאל אוסטינוב‬
193233
CUTTING TOOL HAVING A
BIDIRECTIONAL ADJUSTMENT
MECHANISM
ISCAR LTD.
June 15,
A61F )2009.01(
‫שיטות והתקן לטיפול בדום–שינה ונחירות‬
AN ELECTRICALLY OPERATED,
HAND HELD BARBECUE FAN UNIT
MICHAEL USTINOV
04/08/2008
C07K )2009.01(
B23F )2009.01(
‫כלי חיתוך עם מנגנון כוונון דו–כיווני‬
‫ישקר בע"מ‬
– ‫כ"ג בסיוון התשס"ט‬
4492
2009
04/08/2008
SHOE PNEUMATIC SIMULATOR
DISPLAY
SHAY ABUDI-PROMO ABUDI
05/08/2008
‫מתקן תצוגה פניאומאטי לנעל‬
‫שי עבודי חב' פרומו עבודי‬
B60S )2009.01(
193253
‫מנגנון הגבלת מהירות נסיעה ברכב‬
‫בהתנייה לחגירת חגורות בטיחות לנהג‬
‫ולנוסעים‬
‫עמית זאב‬
SAGETY-BALT SPEED LIMIT
MECHANISM
OFER ALON
05/08/2008
G09F )2009.01(
193235
A45D )2009.01(
193254
‫מעמד לפאה נוכרית‬
‫שמואל דרוק‬
A WIG STAND
YAKOV HAR-TZVI
05/08/2008
A METHOD AND DEVCIE FOR
ILLUMINATING A TOILET
DAN KATZ
05/08/2008
A47K )2009.01(
193256
‫שיטה ומיתקן להארת אסלה‬
‫עצמון דקל‬
A47K )2009.01(
193257
‫מכשיר מושב לאסלה‬
‫אסף שרון‬
A TOILET SEAT APPARATUS
ASAF SHARON
05/08/2008
ROCKING CHAIR WITH INVERSED
ARCS
ALON RAZGOUR
4493
A47C )2009.01(
193258
‫כיסא מתנדנד עם קשתות מהופכות‬
‫אלון רזגור‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
05/08/2008
193259
‫כיסא שאינו יציב עם רגליים משיקות‬
‫שאינן מחוברות בניהן‬
‫אלון רזגור‬
UNBALANCED CHAIR WITH
INTERLOCKING LEGS
ALON RAZGOUR
05/08/2008
193260
RECLINING CHAIR THAT ROTATES
180 DEGREES RELATIVE TO THE
HORIZONTAL
ALON RAZGOUR
05/08/2008
‫אלון רזגור‬
193271
C07K )2009.01(
‫מודולציה של היווצרות עצם‬
17/02/2006
13/09/2006
06/08/2008
193284
MILLING CUTTER AND CUTTING
INSERT THEREFOR
ISCAR LTD.
June 15,
A47C )2009.01(
‫כיסא בר בעל רגל אחת שמאפשר‬
‫להתנדנד עליו‬
‫אלון רזגור‬
BAR STOOL WITH ONE POLE THAT
ALLOWS FOR GLIDING
ALON RAZGOUR
MODULATION OF BONE
FORMATION
WYETH
US
60/774534
60/844239
US
PCT/US/2007/004510
WO/2007/098198
A47C )2009.01(
‫ מעלות ביחס‬180 ‫כיסא נוח שמסתובב‬
‫למישור אופקי‬
193261
16/02/2007
A47C )2009.01(
B23C )2009.01(
‫כלי כרסום ושימת חיתוך עבורו‬
‫ישקר בע"מ‬
– ‫כ"ג בסיוון התשס"ט‬
4494
2009
08/02/2007
COMPOSITIONS AND METHODS FOR
TREATING LYSOSOMAL STORAGE
DISEASES
DIATOS
EP
06290221.8 08/02/2006
PCT/IB/2007/000301
WO/2007/091159
07/08/2008
4495
‫שיטה ומערכת לניהול מידע‬
H04M )2009.01(
,‫שיטה ומערכת להגברת שיחות קוליות‬
‫כגון הגברת שיחות קוליות באמצעות‬
‫שירותי נתונים‬
E02B )2009.01(
193302
WATER DRAIN TANK OR CHANNEL
MODULE
BRENTWOOD INDUSTRIES ,INC
US
60/771417
08/02/2006
PCT/US/2007/061650
WO/2007/092828
07/08/2008
H04L )2009.01(
193292
A METHOD AND SYSTEM FOR
ENHANCING VOICE CALLS, SUCH AS
ENHANCING VOICE CALLS WITH
DATA SERVICES
SNAPIN SOFTWARE INC.
US
60/771514
07/02/2006
60/883609
05/01/2007
US
PCT/US/2007/061806
WO/2007/092908
06/02/2007
‫הרכבים ושיטות לטיפול במחלות אגירה‬
‫ליזומליות‬
193291
SYSTEM AND METHOD FOR
INFORMATION MANAGEMENT
ALSTOM TRANSPORT SA.
FR
0756975
07/08/2007
07/02/2007
C07K )2009.01(
193289
‫מיכל לניקוז מים מודול ערוצים‬
C11C )2009.01(
193303
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
PROCESS FOR PREPERATION OF
PHOSPHATIDES
DAVID RUTENBERG
07/08/2008
‫תהליך להכנת פוספוליפידים‬
‫דוד רוטנברג‬
193304
METHOD AND SYSTEM FOR
ENABLING A USER TO MOVE A
MOUSE CURSOR ON A MOBILE
DEVICE SCREEN WITHOUT A DELAY
VOLLEE LTD
07/08/2008
‫שיטה ומערכת המאפשרת למשתמש‬
‫להזיז סמן של עכבר על מסך של התקן‬
‫נייד ללא השהייה‬
‫ווליי בע"מ‬
193305
193311
METHOD FOR RUNNING STANDARD
PC APPLICATIONS ON MOBILE
HANDSETS
VOLLEE LTD
08/02/2007
June 15,
G06F )2009.01(
‫שיטה להרצת אפלקציות סטנדרטיות של‬
‫ על מכשירים ניידים‬PC
193313
‫ווליי בע"מ‬
A61K )2009.01(
‫ עוקבים חדשניים‬siRNA
NOVEL TANDEM siRNAs
QUARK PHARMACEUTICALS, INC.
US
60/771238
08/02/2006
PCT/IL/2007/000184
WO/2007/091269
09/02/2007
A44C )2009.01(
‫התקן דינמי לתכשיט‬
‫ליבני דיזיין בע"מ‬
A DYNAMIC ITEM OF JEWELRY
LIVNI DESIGN LTD
07/08/2008
G06F )2009.01(
193316
– ‫כ"ג בסיוון התשס"ט‬
G08B )2009.01(
4496
2009
PROXIMITY LOCATOR SYSTEM
CARD LOGISTICS PROPERTIES, LTD
US
60/771743
09/02/2006
PCT/US/2007/061930
WO/2007/092957
08/02/2007
‫מערכת לאיתור בסמיכות‬
C07H )2009.01(
193317
RNA ‫שיטות להפקת‬
METHODS OF EXTRACTING RNA
LUMIGEN, INC.
US
60/771510
08/02/2006
11/703459
07/02/2007
US
PCT/US/2007/061826
WO/2007/092916
07/08/2008
‫מערכת תצוגה עילית בעלת שדה ראייה‬
‫רחב‬
‫אלביט מערכות בע"מ‬
WIDE FIELD OF VIEW COVERAGE
HEAD-UP DISPLAY SYSTEM
ELBIT SYSTEMS LTD.
07/08/2008
G09B )2009.01(
193327
MUSICAL COMPOSITION USER
INTERFACE REPRESENTATION
NEOCRAFT LTD.
US
60/964107
09/08/2007
10/08/2008
G02B )2009.01(
193326
‫ממשק משתמש ליצירות מוסיקליות‬
‫ניאוקראפט בע"מ‬
F16K )2009.01(
193337
‫מכשיר למיתוג ברז‬
‫רמי זליקוביץ‬
TAP SWITCHING APPARATUS
RAMI ZELIKOVICH
10/08/2008
4497
B60K )2009.01(
193338
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
SECURITY APPARATUS FOR A TWO
WHEELED VEHICLE
MOSHE OR HIZKIAU
14/02/2007
‫מכשיר בטיחות עבור כלי רכב דו גלגלי‬
‫משה אור חזקיהו‬
METHODS AND COMPOSITIONS FOR
ENHANCING ENGRAFTMENT OF
HEMATOPOIETIC STEM CELLS
CELLERANT THERAPEUTICS, INC.
US
60/773405
14/02/2006
PCT/US/2007/062163
WO/2007/095594
10/08/2008
‫שיטות והרכבים להגברת יכולת הקליטה‬
‫של תאי גזע המאוטופוייטים‬
193350
193362
METHOD AND SYSTEM TO
CONTROL OPERATION OF A DEVICE
USING AN INTEGRATED
SIMULATION WITH A TIME SHIFT
OPTION
THE BOEING COMPANY
US
11/855717
14/09/2007
11/08/2008
June 15,
G06F )2009.01(
‫שיטה ומערכת לבקרה על תפעול התקן‬
‫באמצעות הדמייה משולבת עם אפשרות‬
‫להעתקת זמן‬
193370
– ‫כ"ג בסיוון התשס"ט‬
G06F )2009.01(
‫מערכת בדיקת אחר קביעת תאריך ללא‬
‫נייר‬
PAPERLESS POST-DATABLE CHECK
SYSTEM
VERIFONE, INC.
US
000000000000 24/07/2008
11/08/2008
C12N )2009.01(
193345
A47D )2009.01(
4498
2009
AN APPARATUS FOR ORGANIZING
CHAIRS
ZAMIR BARHUM
11/08/2008
‫מיתקן לארגון כיסאות‬
‫זמיר ברהום‬
‫ בזמן אמת‬GPS ‫הדמיית‬
‫שרון אליהו‬
GPS REAL-TIME IMAGING
SHARON ELIYAHU
12/08/2008
PROTECTION SYSTEM
MOWAG GMBH
CH
01282/07
13/02/2007
4499
‫מכשיר תקשורת בן שני חלקים לרשת‬
‫שידור אלחוטית‬
‫יצחק וגנר‬
G08B )2009.01(
193387
‫מערכת מיגון‬
13/08/2007
C12N )2009.01(
193390
PRODUCTION OF FOREIGN NUCLEIC
ACIDS AND POLYPEPTIDES IN
PLANT SYSTEMS
FRAUNHOFER USA, INC.
US
11/353905
13/02/2006
60/773255
13/02/2006
US
60/773374
13/02/2006
US
60/773378
13/02/2006
US
60/879450
09/01/2007
US
PCT/US/2007/003942
WO/2007/095304
13/02/2007
H04Q )2009.01(
193383
A WIRELESS TELECOMMUNICATION
BIPARTITE END DEVICE
ISAAC WAGNER
12/08/2008
G01S )2009.01(
193377
‫ייצור חומצות גרעין זרות ופוליפפטידים‬
‫במערכות צמח‬
C07K )2009.01(
193391
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
INFLUENZA ANTIGENS, VACCINE
COMPOSITIONS, AND RELATED
METHODS
FRAUNHOFER USA, INC.
US
60/813955
15/06/2002
60/773378
13/02/2006
US
PCT/US/2007/003969
WO/2007/095318
15/02/2007
,‫ תכשירי חיסון‬,‫אנטיגנים של שפעת‬
‫ושיטות קשורות‬
193407
FUNCTIONAL ANTIBODIES
IMCLONE SYSTEMS INCORPORATED
US
60/773994
15/02/2006
PCT/US/2007/004051
WO/2007/095338
15/02/2007
193408
ANTIBODY FORMULATION
IMCLONE SYSTEMS INCORPORATED
US
60/774101
15/02/2006
PCT/US/2007/004050
WO/2007/095337
13/08/2008
193419
SEA WAVES BASED ELECTRIC
ENERGY GENERATOR
DAVID COHEN
13/08/2008
June 15,
C12N )2009.01(
‫נוגדנים פונקציונאליים‬
A61K )2009.01(
‫תכשיר נוגדן‬
F03B )2009.01(
‫מתקן לייצור אנרגיה חשמלית מגלי ים‬
‫דוד כהן‬
193424
– ‫כ"ג בסיוון התשס"ט‬
B67B )2009.01(
4500
2009
PUSH BUTTON FLIP TOP WITH
ATTACHED SECOND CONTAINER
KRAFT FOODS GLOBAL BRANDS
LLC
US
11/840651
17/08/2007
13/08/2008
‫הסרת מכסה בלחיצה ממיכל בעל מיכל‬
‫נוסף הקשור אליו‬
B43K )2009.01(
193433
‫ראש טוש מפוצל‬
‫תומר פנחס‬
SPLITED SHOWER HEAD
TOMER PINHAS
13/08/2008
GRIP WITH BIPOD
FAB MANUFACTURING & IMPORT
OF INDUSTRIAL EQUIPMENT LTD.
US
60/955406
13/08/2007
14/02/2007
4501
‫ידית עם דורגל‬
‫פאב ייצור ויבוא ציוד תעשייתי בע"מ‬
C12Q )2009.01(
193439
MITOTIC PROGRESSION GENES AND
METHODS OF MODULATING
MITOSIS
SANOFI-AVENTIS
US
60/772987
14/02/2006
PCT/US/2007/003974
WO/2007/095321
12/03/2007
F41B )2009.01(
193437
‫גנים של קידום התחלקות התא ושיטות‬
‫לשינוי ההתחלקות‬
C12N )2009.01(
193444
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
ANTIBODIES THAT BIND BOTH IL17A AND IL-17F AND METHODS OF
USING THE SAME
ZYMOGENETICS INC.
US
60/781121
10/03/2006
60/828271
05/10/2006
US
60/862501
23/10/2006
US
PCT/US/2007/063787
WO/2007/106769
14/08/2008
F 17–IL ‫ והן‬A 17–IL ‫נוגדנים הקושרים הן‬
‫ושיטות לשימוש בהם‬
193453
‫מיכל רב–תאי‬
MULTI-COMPARTMENT CONTAINER
EYAL RESEARCH CONSULTANTS
LTD.
14/08/2008
20/02/2007
‫אייל יועצי מחקר בע"מ‬
193461
STABLE AMORPHOUS CALCIUM
CARBONATE COMPRISING
PHOSPHORYLATED AMINO ACIDS
AMORPHICAL LTD.
June 15,
C07H )2009.01(
‫סידן פחמתי אמורפי יציב המכיל חומצות‬
‫אמינו שעברו פוספורילציה‬
‫אמורפיקל בע"מ‬
193464
A METHOD FOR SERVING A
PLURALITY OF APPLICATIONS BY A
SECURITY TOKEN
ALADDIN KNOWLEDGE SYSTEMS
LTD
US
11/363058
28/02/2006
PCT/IL/2007/000228
WO/2007/099527
20/02/2007
B65D )2009.01(
193465
– ‫כ"ג בסיוון התשס"ט‬
H04L )2009.01(
‫שיטה לשרת מספר יישומים על ידי טוקן‬
‫בטחון‬
‫אלדין מערכות ידע בע"מ‬
G06F )2009.01(
4502
2009
A METHOD AND SYSTEM FOR
INCREASING SALES OF DIGITAL
PRODUCT MODULES
ALADDIN KNOWLEDGE SYSTEMS
LTD
US
11/363059
28/02/2006
PCT/IL/2007/000229
WO/2007/099528
14/08/2008
‫שלמה בבלוקי‬
‫התקן להקפאה ואספקת מנת משקה‬
‫קומרקס פתרונות דיגיטאליים‬
‫מערכת להמרת וניתוב שיחות‬
‫ואופטימזציות עלויות תקשורת‬
‫אליהו גבאי‬
F24J )2009.01(
193501
‫תחנת כוח סולרית מבוססת אויר‬
‫וולפצון לאוניד‬
SOLAR AIR ELECTRIC PLANT
WOLFTSUN LEONID
4503
H04L )2009.01(
193491
ELIYAHU GABAI
17/08/2008
A47J )2009.01(
193488
PSR- PRIVATE SMART ROUTER
17/08/2008
H04Q )2009.01(
‫ממשק אלחוטי לקו טלפון חוטי‬
APPARATUS FOR FREEZING AND
DISPENSING A BEVERAGE
COOLMAX LTD
17/08/2008
‫אלדין מערכות ידע בע"מ‬
193480
WIRELESS INTERFACE FOR
LANDLINE
SHLOMO BABLUKI
14/08/2008
‫שיטה ומערכת להגברת המכירות של‬
‫מודולי מוצר דיגיטליים‬
H01H )2009.01(
193502
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
POWER BOOSTER FOR CABLE
SYSTEMS
H.T. HULDA TRANSFORMERS
17/08/2008
‫מגבר כוח למערכת כבלים‬
‫ש"ח שנאי חולדה‬
193504
CODED SYSTEM FOR FADIO
FREQUENCY COMMUNICATION
PARELEC ISRAEL LTD
17/08/2008
RF–‫מערכת מקודדת לתקשורת ב‬
‫פארלק ישראל בע"מ‬
193506
193509
HEXOSE COMPOUNDS TO TREAT
CANCER
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM
US
60/776793
24/02/2006
60/795621
27/04/2006
US
60/796173
28/04/2006
US
PCT/US/2007/062789
WO/2007/101148
15/02/2007
June 15,
C07H )2009.01(
‫תרכובות הקסוז לטיפול בסרטן‬
193512
PLASMA FROM VITILIGO PATIENTS
FOR TREATMENT OF MELANOMA
GAMMACAN LTD.
US
60/773335
15/02/2006
PCT/US/2007/003919
WO/2007/095293
18/08/2008
H04B )2009.01(
‫מערכת הכנסת נתונים משופרת‬
‫בנימין פירוז גסביאן‬
IMPROVED DATA ENTRY SYSTEM
BENJAMIN FIROOZ GHASSABIAM
26/02/2007
G06F )2009.01(
A61K )2009.01(
‫פלסמה מחולי בהרת לטיפול במלנומה‬
193513
– ‫כ"ג בסיוון התשס"ט‬
D03D )2009.01(
4504
2009
‫שיטה לדוולקניזציה של אלסטומרים‬
‫מגופרים‬
‫ בע"מ‬.‫ל‬.‫אינוברט השקעות א‬
METHOD FOR DEVULCANIZATION
OF CURED ELASTOMER MATERIALS
INNOVERT INVESTMENTS A.L. LTD
16/03/2007
ANTIBODIES TO EGFL7 AND
METHODS FOR THEIR USE
GENENTECH, INC.
US
60/783686
16/03/2006
60/812569
09/06/2006
US
PCT/US/2007/064242
WO/2007/106915
18/08/2008
‫ ושיטות לשימוש בהם‬EGFL 7–‫נוגדנים ל‬
‫התקן לניקוי מעבה של מקרר‬
‫ניר גרוף‬
‫מערכת איתות אלקטרונית‬
‫יצחק כהן‬
4505
B23D )2009.01(
193527
PROCESS AND APPARATUS FOR
SCORING AND BREAKING INGOTS
SUPERIOR PRESS & AUTOMATION,
INC.
US
60/743322
20/02/2006
PCT/US/2007/062415
WO/2007/098439
18/08/2008
G08B )2009.01(
193521
ELECTRONIC SIGNALLING SYSTEM
YITZCHAK COHEN
20/02/2007
F28G )2009.01(
193520
APPARATUS FOR CLEANING A
REFRIGERATOR CONDENSER
GROFF, NIR
18/08/2008
C12N )2009.01(
193514
‫תהליך ומכשיר לחריצת ושבירת מטילים‬
G06F )2009.01(
193528
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
A SYSTEM AND METHOD OF REALTIME MANIPULATING OF 3D
GRAPHIC APPLICATIONS WITHOUT
ACCESS TO SOURCE CODE
VOLLEE LTD
19/08/2008
‫מערכת ושיטה לביצוע מניפולציה בזמן‬
‫אמת של יישומים גרפים תלת מימדיים‬
‫ללא גישה לקוד המקור‬
‫ווליי בע"מ‬
193531
IMPROVED ACTIVATION DEVICE
FOR A TOILET TANK WITH DUAL
QUANTITIES
YEHUDA CANAFF
19/08/2008
‫מנגנון הפעלה משופר למיכל הדחה‬
‫אסלתי דו–כמותי‬
‫יהודה כנף‬
193532
193533
LINER MAT FOR SHELVES AND
DRAWERS
PINHAS HASCALOVICH
19/08/2008
A47D )2009.01(
‫משטח כיסוי למדפים ומגירות‬
‫פנחס חסקלוביץ‬
193535
ROLLER ASSEMBLY FOR SLIDING
WINDOWS
YADID MERAL INDUSTRIES LTD.
June 15,
A47J )2009.01(
‫מדף נשלף למשקאות‬
‫אדוארד רוחברג‬
PULL-OUT DRINKING SHELF
EDUARD RUKHBERG
19/08/2008
A47K )2009.01(
E05C )2009.01(
‫מערכת גלגלים לחלונות הזזה‬
‫ידיד תעשיות מתכת בע"מ‬
– ‫כ"ג בסיוון התשס"ט‬
4506
2009
19/08/2008
INJECTABLE PHARMACEUTICAL
COMPOSITION
DAVID SEGAL
22/02/2007
‫תכשיר רוקחות הניתן להזרקה‬
‫דוד סגל‬
‫כלים לכריתת איברים ושיטות קשורות‬
‫שבכה מודולרית לפתח יציאת אויר‬
‫במערכות מיזוג‬
‫טויטופלסט בע"מ‬
‫מערכת הגנה לצילינדר‬
‫משה אהרון‬
G06Q )2009.01(
193557
M-COMMERCE VIRTUAL CASH
SYSTEM, METHOD, AND
APPARATUS
QUALCOMM INCORPORATED
US
11//376981
15/03/2006
PCT/US/2007/064108
WO/2007/106906
4507
E05B )2009.01(
193553
CYLINDER PROTECTIVE SYSTEM
MOSHE AHARON
IL
192010
05/06/2008
15/03/2007
F24F )2009.01(
193551
MODULAR GRILL FOR AIR OUTLET
SYSTEMS
TWITOPLAST LTD
19/08/2008
A61B )2009.01(
193545
ABLATION INSTRUMENTS AND
RELATED METHODS
CUSTOM MEDICAL APPLICATIONS,
INC.
US
60/775466
22/02/2006
PCT/US/2007/004665
WO/2007/100629
19/08/2008
A61K )2009.01(
193538
‫ שיטה ומתקן לסחר נייד במזומנים‬,‫מערכת‬
‫וירטואליים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
23/02/2007
193574
‫התקן נעילה עבור כסא‬
FASTENING BRACKET FOR A CHAIR
PETER OPSVIK AS
NO
20060920
24/02/2006
PCT/NO/2007/000071
WO/2007/097637
25/08/2006
193583
MANUALLY ACTUATED TONGS
FORCE MONITORING
HANS OETIKER AG MASCHINENUND APPARATEFABRIK
A47D )2009.01(
B25B )2009.01(
‫מלקחיים המופעלים ידנית בעלי פיקוח כח‬
PCT/EP/2006/008375
WO/2008/022649
28/02/2006
193584
METHODS AND APPARATUSES FOR
ASSISTED NAVINGATION SYSTEMS
NOKIA CORPORATION
G01S )2009.01(
‫שיטות ומכשירים למערכות עזר לניווט‬
PCT/FI/2006/050084
WO/2007/099196
21/08/2008
193585
ASSOCIATION BETWEEN AN ANTIATHEROTHROMBOTIC AND AN
ANGIOTENSIN-CONVERTING
ENZYME INHIBITOR
LES LABORATOIRES SERVIER
FR
07/06345
11/09/2007
June 15,
C07K )2009.01(
‫תסמיך בין נוגד פקקת מרובד ומעכב אנזים‬
‫ממיר אנגיוטנסין‬
– ‫כ"ג בסיוון התשס"ט‬
4508
2009
21/08/2008
1,2,4,5-TETRAHYDRO-3HBENZAZEPINE COMPOUNDS, A
PROCESS FOR THEIR PREPARATION
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THEM
LES LABORATOIRES SERVIER
FR
07.06346
11/09/2007
21/08/2008
DIAGNOSTIC METHODS AND
SYSTEMS BASED ON URINE
ANALYSIS
MED-I-DYNAMIX FLUID
MONITORING LTD.
4509
C07B )2009.01(
‫תהליך להפקת כלוריד מתכתי מתמיסה‬
‫מימית שלו‬
‫אייץ' ס' אל קלינטג בע"מ‬
B28B )2009.01(
193590
METHOD AND APPARATUS FOR
DEPOSITING A COATING ONTO A
SUBSTRATE
SANDVIK INTELLECTUAL
PROPERTY AB
SE
0702060.5
14/09/2007
21/08/2008
–H3–‫–טטרהידרו‬1,2,4,5 ‫תרכובות‬
‫ תהליך להכנתן ותכשירי‬,‫בנזאזפיניות‬
‫רוקחות המכילים אותן‬
193589
A PROCESS FOR THE RECOVERY OF
A METAL CHLORIDE FROM AN
AQUEOUS SOLUTION THEREOF
HCL CLEANTECH LTD.
21/08/2008
C07C )2009.01(
193586
‫שיטה ומכשיר להשקעת ציפוי על מצא‬
G01N )2009.01(
193591
‫שיטות ומערכות אבחון המבוססות על‬
‫בדיקות שתן‬
‫דינמיקס ניטור נוזלים בע"מ‬-‫י‬-‫מד‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
21/08/2008
193607
‫מכשיר חיתוך‬
SLICING DEVICE
PROGRESSIVE INTERNATIONAL
CORPORATION
US
61/042648
04/04/2008
US
PCT/US08/061453 24/04/2008
12/118620
09/05/2008
US
12/124969
21/05/2008
US
12/129550
29/05/2008
US
21/08/2008
193627
A METHOD FOR MANAGING A
TRANSITION PROGRAM BY THE
RISKS ASSOCIATED WITH THE
ACTIVITIES COMPRISED THEREIN
G.P.V. PROCESSES ANALYSIS &
SOLUTIONS LTD.
21/08/2008
193632
‫ ניתוח תהליכים ופתרונות בע"מ‬.‫וי‬.‫פי‬.‫ג'י‬
193633
B02C )2009.01(
‫התקן ושיטה להפרדת חלקיקים מוצקים‬
‫גדעון דרורי‬
193644
G06F )2009.01(
‫מערכת הכנסת נתונים משופרת‬
‫בנימין פירוז גסביאן‬
IMPROVED DATA ENTRY SYSTEM
BENJAMIN FIROOZ GHASSABIAM
June 15,
G07F )2009.01(
‫שיטה לניהול תוכנית לתקופת מעבר עפ"י‬
‫הסיכונים הכרוכים בפעילויות המרכיבות‬
‫אותה‬
DEVICE AND METHOD FOR
SEPARATING SOLID PARTICLES
OLEG GOLOBRODSKY
24/08/2008
A47G )2009.01(
‫בית מזוזה מעוטר‬
‫רפאל גיל קובי‬
A DECORATED MEZUZAH CASE
REFAEL GIL KOBY
21/08/2008
B23G )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4510
2009
25/08/2008
‫מדף למשקאות להרכבה‬
‫אדוארד רוחברג‬
MODULAR SHELF FOR DRINKS
EDUARD RUKHBERG
25/08/2008
A47J )2009.01(
193654
G07F )2009.01(
193655
‫גובוק‬
‫שני כהן‬
GOBOOK
SHANI COHEN
25/08/2008
INTERNAL COMMUNICATION
SYSTEM FOR CUSTOMERS USE IN A
SUPER-MARKET
GAVRIEL ASULIN
25/08/2008
‫גבריאל אסולין‬
B67B )2009.01(
‫ ופקק מודולארי‬,‫בקבוק מודולארי מתחבר‬
)‫כפאזל (לגו‬
‫הראל שוורץ‬
C12N )2009.01(
193684
CHIMERIC ADENOVIRAL VECTORS
VAXART, INC.
US
60/778026
28/02/2006
60/801645
19/05/2006
US
60/802992
22/05/2006
US
60/821492
04/08/2006
US
60/846658
22/09/2006
US
60/848195
28/09/2006
US
PCT/US/2007/005386
WO/2007/100908
4511
‫מערכת תקשורת פנימית לשימוש‬
‫הלקוחות בסופר–מרקט‬
193662
MODULAR PLUG IN BOTTLE
AND/OR MODULAR PLUG IN
BOTTLE TOP (LEGO)
HAREL SHWARTS
28/02/2007
H04Q )2009.01(
193656
‫וקטורים כימריים של אדנווירוס‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
26/08/2008
193689
SAFETY BEHAVIOR IN
EDUCATIONAL INSTITUTES
VICINITY
"EYESONROAD" ASSOCIATION
26/08/2008
‫מיזם לבטיחות בדרכים ששמו "התנהגות‬
"‫בטיחותית בסביבת מוסדות חינוך‬
"‫עמותת "עיניים בדרכים‬
193694
193702
A PHARMACEUTICAL COMPOSITION
CONTAINING HUMAN EMBRYONIC
STEM CELLS
GEETA SHROFF
IN
582/DEL/2006 07/03/2006
IN
DEL/2006/1500 26/06/2006
60/844350
14/09/2006
US
PCT/IB/2007/002292
WO/2007/141657
27/08/2008
193718
193719
‫תכשיר רוקחות המכיל תאי גבעול‬
‫עובריים אנושיים‬
A47J )2009.01(
B43L )2009.01(
‫צמיד תמיכה לפרק כף היד בשימוש‬
‫במחשב‬
‫אסף פכטר‬
COMPUTER USER WRIST SUPPORT
ASSAF PACHTER
June 15,
C12N )2009.01(
‫גביע אוחז לכוס קרח‬
‫תמר גרמיזו‬
HOLDER FOR ICE GLASS
TAMAR GARMIZO
27/08/2008
C01F )2009.01(
‫ספינלים מונוליטיים מרובי גבישים של‬
‫מגנזיום אלומינאט‬
POLYCRYSTALLINE MONOLITHIC
MAGNESIUM ALUMINATE SPINELS
ROHM AND HAAS ELECTRONIC
MATERIALS, LLC
US
60/966313
27/08/2007
06/03/2007
G09B )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4512
2009
27/08/2008
PUMPING DEVICE FOR LINEAR
MOTOR WITH CONSTANT BATTERY
POWER/CURRENT
SOREQ NUCLEAR RESEARCH
CENTER ISRAEL ATOMIC ENERGY
COMMISSION
US
60/968321
28/08/2007
27/02/2007
‫זרם‬/‫מניע משאבה למנוע לינארי בעל כח‬
‫סוללה קבוע‬
C12N )2009.01(
‫תרכובות ואוכלוסיות תאים המושגים‬
‫מחבל הטבור ושיטות יצור של ההן‬
G01N )2009.01(
193736
METHOD FOR DETERMINING THE
SURFACE QUALITY OF A
SUBSTRATE AND ASSOCIATED
MACHINE FOR CONVERTING THE
SUBSTRATE
BOBST S.A.
EP
07018586.3 21/09/2007
28/08/2008
‫המרכז למחקר גרעיני נחל שורק הועדה‬
‫לאנרגיה אטומית‬
193735
COMPOSITIONS AND POPULATIONS
OF CELLS OBTAINED FROM THE
UMBILICAL CORD AND METHODS
OF PRODUCING THE SAME
THE REGENERATIVE MEDICINE
INSTITUTE
US
60/777517
01/03/2006
PCT/IL/2007/000259
WO/2007/099534
27/08/2008
F25B )2009.01(
193730
‫שיטה לקביעת איכות פני השטח של‬
‫משטח ומכונה נלוות להפיכת המשטח‬
A47J )2009.01(
193744
‫נר שמן‬
‫ראובן חומרי‬
OIL CANDLE
REUVEN HOMRI
4513
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
28/08/2008
193745
‫שיטה משופרת להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
IMPROVED DATA ENTRY SYSTEM
BENJAMIN FIROOZ GHASSABIAM
28/08/2008
193750
193753
SLOTTING MILLING CUTTER FOR
MACHINING WITH A HIGH FEED
AND A LOW PASS DEPTH
SNECMA
FR
07/06073
30/08/2007
28/08/2008
193757
– ‫כ"ג בסיוון התשס"ט‬
B25C )2009.01(
‫מכשיר לאחיזת מסמר בעת שממסמרים‬
‫אותו באמצעות פטיש‬
193759
A BRAKE DEVICE FOR PRAMS
JANE, S.A.
ES
ES 200702482 U 30/11/2007
June 15,
B23B )2009.01(
‫כרסום חירוץ למכונות עם הזנה גבוהה‬
‫ועומק מעבר נמוך‬
APPARATUS FOR APPARATUS FOR
HOLDING A NAIL WHILE NAILING IT
BY A HAMMER
RAPHAEL NATAN DURST
28/08/2008
G08B )2009.01(
‫מיקרוקונטרולר סתגלני המבוסס על ניטור‬
‫אבטחה‬
ADAPTABLE MICROCONTROLLER
BASED SECURITY MONITOR
HARRIS CORPORATION
US
11/847484
30/08/2007
28/08/2008
G06F )2009.01(
‫רפאל נתן דורסט‬
B62B )2009.01(
‫התקן מעצור לעגלת תינוק‬
4514
2009
15/03/2007
AUTOMATABLE ARTIFICIAL
IMMUNE SYSTEM (AIS)
VAXDESIGN CORPORATION
US
11/375033
15/03/2006
PCT/US/2007/006571
WO/2007/106575
29/04/2007
‫מערכת חיסונית מלאכותית הניתנת‬
)AIS( ‫להפעלה אוטומטית‬
H04L )2009.01(
193763
UNINTERRUPTED TRANSMISSION
DURING A CHANGE IN CIPHERING
CONFIGURATION
QUALCOMM INCORPORATED
US
60/795775
28/04/2006
PCT/US/2007/067722
WO/2007/127972
13/03/2007
C12N )2009.01(
193761
‫תשדורת ללא הפרעות במהלך שינוי‬
‫בהצפנת תצורה‬
B81B )2009.01(
193769
THIN SILICON OR GERMANIUM
SHEETS AND PHOTOVOLTAICS
FORMED FROM THIN SHEETS
‫שכבות דקות של סיליקון או גרמניום‬
‫ותאים פוטו וולטאים שנוצרו משכבות‬
‫דקות‬
NANOGRAM CORPORATION
US
60/782115
13/03/2006
PCT/US/2007/006357
WO/2007/106502
4515
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
09/03/2007
193773
A PEPTIDE WHICH BINDS TO AN
ERYTHROPOIETIN RECEPTOR AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
APLAGEN GMBH
EP
06004833.7 09/03/2006
60/780568
09/03/2006
US
06010174.8
17/05/2006
EP
60/747515
17/05/2006
US
PCT/EP/2007/002068
WO/2007/101698
02/03/2007
‫פפטיד המתקשר לקולט אריתרופויטין‬
‫ותכשירי רוקחות המכילים אותו‬
193775
PHARMACEUTICAL COMPOSITIONS
CONTAINING NATALIZUMAB
ELAN PHARMACEUTICALS, INC.
US
60/779190
03/03/2006
PCT/US/2007/005265
WO/2007/103112
15/03/2007
A61K )2009.01(
‫תכשירי רוקחות המכילים נטאליזומאב‬
193777
MODIFIED BOTULINUM TOXINS
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
BIOTECON THERAPEUTICS GMBH
EP
06005300.6 15/03/2006
PCT/EP/2007/002296
WO/2007/104567
June 15,
C07K )2009.01(
C07K )2009.01(
‫טוקסינים של בוטולינום שעברו שינוי‬
‫ותכשירי רוקחות המכילים אותם‬
– ‫כ"ג בסיוון התשס"ט‬
4516
2009
31/08/2008
CUTTING TOOL AND ROUND
DOUBLE SIDED CUTTING INSERT
THEREFOR
ISCAR LTD.
06/03/2007
‫כלי חיתוך ושימת חיתוך עגולה דו–צדדית‬
‫עבורו‬
‫ישקר בע"מ‬
C08B )2009.01(
193780
HYDRAZIDO DERIVATIVES OF
HYALURONIC ACID
PROCHON BIOTECH LTD.
US
60/779423
07/03/2006
PCT/IL/2007/000284
WO/2007/102149
28/02/2007
B23C )2009.01(
193779
‫נגזרות הידרזידו של חומצה היאלורונית‬
‫פרוכון ביוטק בע"מ‬
G10L )2009.01(
193784
‫קידוד אותות מידע‬
INFORMATION SIGNAL ENCODING
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V.
DE
102006022346.2 12/05/2006
PCT/EP/2007/001730
WO/2007/131564
06/03/2007
IMAGE PROCESSING SYSTEMS FOR A
PRINTING PRESS
MANROLAND AG
DE
102006012513.4 18/03/2006
PCT/EP/2007/001884
WO/2007/107234
4517
B41F )2009.01(
193785
‫מערכות עבוד תמונות עבור מכבש‬
‫הדפסה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
23/10/2007
193786
APPARATUS AND METHOD FOR
GENERATING AUDIO SUBBAND
VALUES AND APPARATUS AND
METHOD FOR GENERATING TIMEDOMAIN SAMPLES
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V.
US
60/862954
25/10/2006
PCT/EP/2007/009200
WO/2008/049590
14/03/2007
‫התקן ושיטה ליצירת ערכי תת–פס של‬
‫אודיו והתקן ושיטה ליצירת דגימות אודיו‬
‫של תחום זמן‬
193788
193789
G02F )2009.01(
‫שיטה ואפנון של אור אופטי המופנה‬
‫מרחבית‬
OPTICALLY ADDRESSED SPATIAL
LIGHT MODULATOR AND METHOD
COMPOUND PHOTONICS
US
60/778704
02/03/2006
PCT/US/2007/005531
WO/2007/103274
June 15,
H01L )2009.01(
MEMS ‫אריזות של אמצעי‬
PACKAGING OF MEMS DEVICES
MICROCHEM CORP.
US
60/784071
17/03/2006
11/716771
12/03/2007
US
PCT/US/2007/006535
WO/2007/109090
02/03/2007
G10L )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4518
2009
16/02/2007
USE OF ADENOSINE A1 AND/OR DUAL
A1/A2B AGONISTS FOR PRODUCTION
OF MEDICAMENTS FOR TREATING
DISEASES
BAYER HEALTHCARE AG
DE
102006009813.7 01/03/2006
PCT/EP/2007/001342
WO/2007/101531
07/03/2007
C07D )2009.01(
‫שימוש בפטאלוציאנינים מותמרים באריל‬
‫או באלקילאוקסי כחומרי סימון עבור‬
‫נוזלים‬
G01N )2009.01(
193796
METHOD AND DEVICE FOR
DETERMINING THE TOTAL OXYGEN
CONTENT AND/OR THE TOTAL
CARBON CONTENT IN AMMONIA
BASF SE
DE
102006014278.0 28/03/2006
PCT/EP/2007/052752
WO/2007/110365
4519
‫או‬/‫ ו‬A1 ‫שימוש באגוניסטים של אדנוזין‬
‫ ליצור תרופות לטיפול במחלות‬B2A/1A
193795
USE OF ARYL-OR ALKYLOXYSUBSTITUTED PHTHALOCYANINES
AS MARKING SUBSTANCES FOR
LIQUIDS
BASF SE
EP
06111161.3 15/03/2006
PCT/EP/2007/052122
WO/2007/104685
22/03/2007
C07D )2009.01(
193794
‫שיטה והתקן לקביעת כמות החמצן‬
‫או כמות הפחמן הכוללת‬/‫הכוללת ו‬
‫באמוניה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
12/03/2007
A61K )2009.01(
193797
METHOD OF PREVENTING OR
REDUCING THE RISK OR INCIDENCE
OF CANCER USING NEURAL
THREAD PROTEIN BASED PEPTIDES
NYMOX CORPORATION
US
60/780829
10/03/2006
PCT/CA/2007/000402
WO/2007/104149
26/02/2007
‫שיטה למניעת או הורדת הסיכון או היקף‬
‫של סרטן ע"י שימוש בחלבון עצבי מבוסס‬
‫פפטידים‬
193801
SAFETY DEVICE FOR FIRE-ARM AND
REMOTE CONTROL SYSTEM OF ONE
OR MORE FIRE-ARMS PROVIDED WITH
SAID DEVICE
FAMIGLIA ANZELONI S.R.L.
IT
RM2006A000119 08/03/2006
PCT/IT/2007/000137
WO/2007/102181
20/03/2007
05/03/2007
193804
CANCER TREATMENTS
BOULIKAS, PARTHENIOS
GR
20060100144 03/03/2006
PCT/GR/2007/000015
WO/2007/099377
June 15,
‫התקן בטיחות עבור נשק ומערכת‬
‫שלט רחוק של כלי נשק אחד או יותר‬
‫המסופקים עם התקן זה‬
193802
DEVICE AND METHOD FOR THE
PRODUCTION OF COMPOUNDS BY
PRECIPITATION
H. C. STARCK GMBH
DE
102006015538.6 31/03/2006
PCT/EP/2007/052653
WO/2007/113102
– ‫כ"ג בסיוון התשס"ט‬
F41A )2009.01(
B01D )2009.01(
‫התקן ושיטה לייצור תרכובות באמצעות‬
‫שיקוע‬
A61K )2009.01(
‫טיפולים לסרטן‬
4520
2009
06/03/2007
METHODS AND COMPOSITIONS FOR
IDENTIFYING A CELL PHENOTYPE
ZETIQ TECHNOLOGIES LTD.
US
60/778839
06/03/2006
60/778944
06/03/2006
US
60/778900
06/03/2006
US
60/778902
06/03/2006
US
PCT/IL/2007/000281
WO/2007/102146
07/03/2007
‫שיטות ותכשירים לזיהוי פנוטיפ של תאים‬
‫זטיק טכנולוגיות בע"מ‬
‫שיטה ומערכת לסימולצית אמינות לצורך‬
‫תכנות מעגלים מודפסים‬
‫שיטת ציפוי לשם התנגדות מוגברת של‬
‫נחושת לאלקטרומיגרציה‬
H04M )2009.01(
193812
METHOD AND INTERFACE FOR
IDENTIFYING AND ROUTING CALLS
TO/FROM AN EXTENSION OF AN
EXCHANGE IN A CELLULAR
NETWORK
WEBNET LTD
4521
H01L )2009.01(
193811
COATING METHOD FOR ENHANCED
ELECTROMIGRATION RESISTANCE
OF COPPER
ALCHIMER
US
60/778923
06/03/2006
PCT/EP/2007/052091
WO/2007/101851
01/09/2008
G06F )2009.01(
193808
PCB DESIGN RELIABILITY
SIMULATION METHOD AND SYSTEM
EXPERT DYNAMICS LTD.
IL
174186
08/03/2006
PCT/IL/2007/000295
WO/2007/102155
06/03/2007
C12N )2009.01(
193805
‫שיטה וממשק לזיהוי וניתוב שיחות‬
,‫המבוצעות דרך שלוחה קווית של מרכזת‬
‫ברשת סלולארית‬
‫וובנט בע"מ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
12/04/2007
193815
BACK-ILLUMINATED PHOTOTRANSISTOR ARRAYS FOR
COMPUTED TOMOGRAPHY AND
OTHER IMAGING APPLICATIONS
SEMICOA
US
60/791333
12/04/2006
60/902986
23/02/2007
US
11/786385
10/04/2007
US
PCT/US/2007/009002
WO/2007/120748
09/03/2007
‫מערכים של פוטו–טרנזיסטורים מוארים‬
‫מאחור לטומוגרפיה ממוחשבת ויישומי‬
‫הדמיה אחרים‬
193817
MANUFACTURING OF NETS
CONSISTING OF SYNTHETIC YARNS
AND MONOFILAMENT YARNS
KARATZIS S.A.
GR
20060100154 09/03/2006
PCT/EP/2007/002101
WO/2007/101707
30/03/2007
193818
ABRASION RESISTANT COATING
COMPOSITIONS AND COATED
ARTICLES
PPG INDUSTRIES OHIO, INC.
US
60/789779
06/04/2006
11/693372
29/03/2007
US
PCT/US/2007/065575
WO/2007/118024
June 15,
H01L )2009.01(
D04B )2009.01(
‫ייצור של רשתות המורכבות מחוטי טווי‬
‫סינטתיים וחוט טווי יחיד גדול‬
C09D )2009.01(
‫תרכובות ציפוי עמיד לשריטות ופריטים‬
‫מצופים‬
– ‫כ"ג בסיוון התשס"ט‬
4522
2009
02/04/2007
CONCENTRATE OF CHIKUNGUNYASPECIFIC IMMUNOGLOBULINS AS
MEDICINE
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES
FR
0602802
31/03/2006
PCT/FR/2007/000561
WO/2007/118987
02/04/2007
A61K )2009.01(
FAB ‫או‬/‫ ו‬AB)F(2 ‫נגד ארבווירוס כתרופה‬
‫תרכיז של אימונוגלובולינים וקטעי קושר‬
‫אנטיגן‬
C07D )2009.01(
193822
CRYSTALLINE FORMS AND
PROCESSES FOR THE PREPARATION
OF PHENYL-PYRAZOLES USEFUL AS
MODULATORS OF THE 5-HT2A
SEROTONIN RECEPTOR
ARENA PHARMACEUTICALS, INC.
US
60/801789
18/05/2006
60/921318
02/04/2007
US
PCT/US/2007/011810
WO/2007/136689
4523
‫תרכיז של אימונוגלובולינים נגד צ'יקונגוניה‬
‫כתוצר רפואי‬
193820
CONCENTRATE OF
IMMUNOGLOBULINS AND F(AB)2
AND/OR FAB FRAGMENTS SPECIFIC
OF AN ARBOVIRUS AS MEDICINE
LABORATOIRE FRANCAIS DU
FRACTIONNEMENT ET DES
BIOTECHNOLOGIES
FR
0602803
31/03/2006
PCT/FR/2007/000560
WO/2007/118986
17/05/2007
A61K )2009.01(
193819
–‫צורות גבישים ותהליכים להכנת פניל‬
‫פיראזולים יעילים כאפנני קולטן סרטונין‬
A2HT–5
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
08/03/2007
193823
METHOD AND APPARATUS FOR
STABILISING STRIP DURING
WINDING
RIB LOC AUSTRALIA PTY LIMITED
AU
2006901189 09/03/2006
PCT/AU/2007/000296
WO/2007/101312
09/03/2007
‫שיטה ומערכת לייצוב פס במהלך ליפוף‬
193824
METHOD OF MAKING GaN
NANOWIRES AND A GROUP III-N
NANOWIRE ARRAY AND
SUBSTRATE FORMED THEREBY
STC.UNM
US
60/780833
10/03/2006
60/798337
08/05/2006
US
60/808153
25/05/2006
US
60/889363
12/02/2007
US
PCT/US/2007/063673
WO/2008/048704
02/09/2008
193826
193827
PHARMACEUTICAL AND
DIAGNOSTIC COMPOSITIONS
CONTAINING AT LEAST TWO
BLOOD GROUP ANTIGENS
ABSORBER AB
US
60/785700
23/03/2006
PCT/IB/2007/002530
WO/2007/135571
June 15,
H01L )2009.01(
‫שיטה ליצור חוטי ננומטר מגאליום‬
‫) ומערך חוט ננומטר‬GaN( ‫ארסנייד‬
‫ ומצא המיוצרים באמצעותה‬N–III ‫בקבוצת‬
A PROCESS FOR THE PRODUCTION
OF HCI GAS FROM CHLORIDE SALTS
HCL CLEANTECH LTD.
23/03/2007
B21C )2009.01(
C07B )2009.01(
‫תהליך להפקת חומצה הידרוכלורית גז‬
‫ממלחים כלורידיים‬
‫אייץ ס' אל קלינטג בע"מ‬
G01N )2009.01(
‫תכשירי רוקחות ואבחון המכילים‬
‫אנטיגניים לפחות לשתי קבוצות דם‬
– ‫כ"ג בסיוון התשס"ט‬
4524
2009
24/04/2007
BODILY FLUID ANALYZER, AND
SYSTEM INCLUDING SAME AND
METHOD FOR PROGRAMMING SAME
RICHARD FUISZ
US
60/794117
24/04/2006
PCT/US/2007/009878
WO/2007/127181
02/03/2007
‫ מערכת הכוללת‬,‫מכשיר בודק נוזלי גוף‬
‫מכשיר זה ושיטה לתכנות המערכת‬
G06K )2009.01(
193835
SINGLE LENS SPLITTER CAMERA
HONEYWELL INTERNATIONAL INC.
US
60/778770
03/03/2006
11/382373
09/05/2006
US
60/807046
11/07/2006
US
11/681505
02/03/2007
US
PCT/US/2007/063205
WO/2007/101276
19/03/2007
A61B )2009.01(
193833
‫מצלמה בעלת עדשה אחת מפוצלת‬
A61F )2009.01(
193836
‫מכלול מבליט תואם‬
COMPLIANT EMBOSSER ASSEMBLY
THE PROCTER & GAMBLE
COMPANY
US
11/384699
20/03/2006
PCT/IB/2007/050958
WO/2007/107953
01/03/2007
A SYSTEM FOR IRIS DETECTION,
TRACKING AND RECOGNITION AT A
DISTANCE
HONEYWELL INTERNATIONAL INC.
US
60/778770
03/03/2006
11/382373
09/05/2006
US
PCT/US/2007/063016
WO/2008/021584
4525
G06K )2009.01(
193837
‫ מעקב וגילוי‬,‫מערכת לזיהוי קשתית‬
‫מרחוק‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
26/02/2007
193838
SUPPORTING EMERGENCY CALLS
ON A WIRELESS LOCAL AREA
NETWORK
INTERDIGITAL TECHNOLOGY
CORPORATION
US
11/367125
03/03/2006
PCT/US/2007/005067
WO/2007/103055
16/03/2007
‫תמיכה בשיחות חירום ברשת מקומית‬
‫אלחוטית‬
193839
N-HYDROXYLSULFONAMIDE
DERIVATIVES AS NEW
PHYSIOLOGICALLY USEFUL
NITROXYL DONORS
JOHNS HOPKINS UNIVERSITY
SCHOOL OF MEDICINE
US
60/783556
17/03/2006
PCT/US/2007/006710
WO/2007/109175
21/03/2007
C07C )2009.01(
‫–הידרוקסילסולפונאמיד כתורמי‬N ‫תולדות‬
‫ניטרוקסיל חדשים שימושיים פיזיולוגית‬
193840
INTRANASAL INFLUENZA VACCINE
BASED ON VIROSOMES
SOLVAY BIOLOGICALS B.V.
EP
06111534.1 22/03/2006
60/784462
22/03/2006
US
PCT/EP/2007/052690
WO/2007/107585
June 15,
H04Q )2008.04(
– ‫כ"ג בסיוון התשס"ט‬
A61K )2009.01(
‫חיסון שפעת תוך–נחירי המבוסס על‬
‫וירוסומים‬
4526
2009
09/03/2007
NITROGENATED HETEROCYCLIC
DERIVATIVE, AND
PHARMACEUTICAL AGENT
COMPRISING THE DERIVATIVE AS
ACTIVE INGREDIENT
ONO PHARMACEUTICAL CO., LTD.
2006JP
10/03/2006
066451
PCT/JP/2007/054684
WO/2007/105637
30/07/2007
C07D )2009.01(
193843
‫נגזרת הטרוציקלית המכילה חנקן וגורם‬
‫רוקחי המכיל את הנגזרת כמרכיב פעיל‬
GREENHOUSE AND FORCED
GREENHOUSE CLIMATE CONTROL
SYSTEM AND METHOD
HOUWELING NURSERIES OXNARD,
INC.
US
60/817755
29/06/2006
11/824159
28/06/2007
US
PCT/US/2007/017083
WO/2008/002686
02/09/2008
‫חממה ומערכת ושיטה לבקרת אקלים‬
‫בחממה מאולצת‬
C07D )2009.01(
193845
METHOD FOR MANUFACTURE OF
ESCITALOPRAM
H. LUNDBECK A/S
DK
PA200401314 11/09/2007
4527
A01G )2009.01(
193844
‫שיטה לייצור אציטלופראם‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
06/03/2007
193846
METHODS FOR REGULATING
INFLAMMATORY MEDIATORS AND
PEPTIDES USEFUL THEREIN
NORTH CAROLINA STATE
UNIVERSITY
US
11/367449
06/03/2006
PCT/US/2007/005688
WO/2007/103368
14/03/2007
‫שיטות לויסות מתווכים דלקתיים ופפטידים‬
‫שימושיים לכך‬
193848
HYBRID AMORPHOUS METAL
ALLOY STENT
MEDINOL LTD.
US
11/377769
15/03/2006
PCT/IB/2007/000632
WO/2007/105088
14/03/2007
‫מדינול בע"מ‬
193849
A61K )2009.01(
‫מצמדי קלאטים עם גורם ארומטי מותמר‬
‫ונגזרות שלהם‬
193850
METAL COMPLEXES OF
TETRAAZAMACROCYCLE
DERIVATIVES
MALLINCKRODT INC.
US
60/782093
14/03/2006
PCT/US/2007/006514
WO/2007/106546
June 15,
A61K )2009.01(
‫סטנט היברידי מסגסוגת מתכת אמורפית‬
CHELATING CONJUGATES HAVING
A SUBSTITUTED AROMATIC
MOIETY AND DERIVATIVES
THEREOF
MALLINCKRODT INC.
US
60/782366
15/03/2006
PCT/US/2007/006512
WO/2007/106544
14/03/2007
A61K )2009.01(
C07D )2009.01(
‫קומפלקסים מתכתיים של נגזרות של‬
‫טטרהאזמקרוציקל‬
– ‫כ"ג בסיוון התשס"ט‬
4528
2009
14/03/2007
SYSTEM FOR PERCUTANEOUSLY
ADMINISTERING REDUCED
PRESSURE TREATMENT USING
BALLOON DISSECTION
KCI LICENSING, INC.
US
60/782171
14/03/2006
11/717892
13/03/2007
US
PCT/US/2007/006649
WO/2007/106592
14/03/2007
‫מערכת למתן טיפול דרך העור בלחץ‬
‫מופחת על ידי שימוש בביתור על ידי בלון‬
‫מערכת ושיטה למתן טיפול דרך העור‬
‫בלחץ מופחת על ידי שימוש בסעפת‬
‫מותאמת לזרימה‬
A61M )2009.01(
193853
SYSTEM FOR ADMINISTERING
REDUCED PRESSURE TREATMENT
HAVING A MANIFOLD WITH A
PRIMARY FLOW PASSAGE AND A
BLOCKAGE PREVENTION MEMBER
KCI LICENSING, INC.
US
60/782171
14/03/2006
11/724072
13/03/2007
US
PCT/US/2007/006647
WO/2007/106590
4529
A61F )2009.01(
193852
SYSTEM AND METHOD FOR
PERCUTANEOUSLY
ADMINISTERING REDUCED
PRESSURE TREATMENT USING A
FLOWABLE MANIFOLD
KCI LICENSING, INC.
US
60/782171
14/03/2006
11/724073
13/03/2007
US
PCT/US/2007/006652
WO/2007/106594
14/03/2007
A61H )2009.01(
193851
‫מערכת למתן טיפול בלחץ מופחת בעלת‬
‫סעפת עם מעבר זרימה עיקרי וחלק‬
‫למניעת סתימה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
14/03/2007
193854
METHOD FOR PERCUTANEOUSLY
ADMINISTERING REDUCED
PRESSURE TREATMENT USING
BALLOON DISSECTION
KCI LICENSING, INC.
US
60/782171
14/03/2006
11/717854
13/03/2007
US
PCT/US/2007/006646
WO/2007/106589
14/03/2007
16/03/2007
A61M )2009.01(
‫מערכת ושיטה לטיהור התקן לחץ מופחת‬
‫במשך מתן טיפול בלחץ מופחת‬
193856
CONTINUOUS DOSING REGIMENS
FOR NEUTRAL STEM CELL
PROLIFERATING AGENTS AND
NEURAL STEM CELL
DIFFERENTIATING AGENTS
STEM CELL THERAPEUTICS CORP
US
60/783500
17/03/2006
60/789132
05/04/2006
US
60/862669
24/10/2006
US
PCT/CA/2007/000427
WO/2007/106987
June 15,
‫שיטה למתן טיפול דרך העור בלחץ‬
‫מופחת על ידי שימוש בביתור על ידי בלון‬
193855
SYSTEM AND METHOD FOR
PURGING A REDUCED PRESSURE
APPARATUS DURING THE
ADMINISTRATION OF REDUCED
PRESSURE TREATMENT
KCI LICENSING, INC.
US
60/782171
14/03/2006
11/717893
13/03/2007
US
PCT/US/2007/006648
WO/2007/106591
A61M )2009.01(
A61K )2009.01(
‫נוהלי מינון ממושכים לגורמי התרבות תאי‬
‫גזע ניורליים וגורמי התמיינות תאי גזע‬
‫ניורליים‬
– ‫כ"ג בסיוון התשס"ט‬
4530
2009
16/03/2007
DOSING REGIMES FOR LH OR HCG
AND EPO FOR TREATMENT OF
NEUROLOGICAL DISORDERS
STEM CELL THERAPEUTICS CORP
US
60/783500
17/03/2006
60/789132
05/04/2006
US
60/862669
24/10/2006
US
PCT/CA/2007/000426
WO/2007/106986
06/03/2006
‫ לטיפול‬EPO–‫ ו‬HCG ‫ או‬LH–‫נוהלי מינון ל‬
‫בהפרעות ניורולוגיות‬
C07C )2009.01(
‫תהליך להוספת חנקן לאיסואורה‬
A23D )2009.01(
193862
A SOLID PRODUCT COMPRISING
OIL-DROPLETS
NESTEC S.A.
EP
06111524.2 22/03/2006
PCT/EP/2007/052404
WO/2007/107490
4531
‫מכונת מכנף בעלת חלקים גליליים‬
‫מסתובבים וקבועים‬
193861
PROCESS FOR NITRATING ISOUREAS
SUMITOMO CHEMICAL COMPANY,
LIMITED
2006JP
16/03/2006
072577
PCT/JP/2007/055206
WO/2007/105793
14/03/2007
F01C )2009.01(
193860
VANE MACHINE WITH STATIONARY AND
ROTATING CYLINDER PARTS
BOSKOVIC NEBOJSA
WO
PCT/HR2006/000002 06/03/2006
PCT/HR/2006/000002
WO/2007/102033
15/03/2007
A61K )2009.01(
193857
‫מוצר מוצק המכיל טיפונת של שמן‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
26/03/2007
193863
‫חלבוני מיסל של מי חלב‬
WHEY PROTEIN MICELLES
NESTEC S.A.
EP
06006295.7 27/03/2006
PCT/EP/2007/052877
WO/2007/110411
24/04/2007
193864
PLASTIC CLOSURE WITH A SLIDE
OPENING FOR A BOTTLE NECK OR A
CONTAINER SPOUT
NESTEC S.A.
CH
688/06
25/04/2006
PCT/EP/2007/003584
WO/2007/121982
02/03/2007
193865
193866
METHODS AND SYSTEMS FOR
GENERATING VIRTUAL RADAR
TARGETS
ISRAEL AEROSPACE INDUSTRIES
LTD.
IL
174746
03/04/2006
PCT/IL/2007/000266
June 15,
B65D )2009.01(
‫סגירה מפלסטיק עם פתיחה מתחלקת‬
‫לצוואר בקבוק צינור של מיכל‬
H04L )2009.01(
‫שיטה ומערכת להעברה מוגברת של‬
‫מערכת שירות בסיסית עבור מערכת‬
‫תקשורת מקומית אל–חוטית בעלת‬
‫תפוקה גבוהה‬
METHOD AND SYSTEM FOR
ENHANCED BASIC SERVICE SET
TRANSITION FOR A HIGH
THROUGHPUT WIRELESS LOCAL
AREA NETWORK
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/778767
03/03/2006
PCT/US/2007/005557
WO/2007/103291
01/03/2007
A23C )2009.01(
G01S )2009.01(
‫שיטות והתקנים ליצירת מטרות דמי‬
‫למכ"ם‬
‫התעשייה האוירית לישראל בע"מ‬
– ‫כ"ג בסיוון התשס"ט‬
4532
2009
WO/2007/113790
23/02/2007
SWIRL NOZZLE
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
102006010877.9
102006055661.5
DE
PCT/EP/2007/001558
WO/2007/101557
27/04/2007
‫זרבובית מערבלת‬
07/03/2006
23/11/2006
PLASTIC LED BULB
SUPERBULBS, INC.
US
60/797146
PCT/US/2007/010469
WO/2007/130358
27/04/2007
‫הסרת חם מנורות להט המכילות דיודות‬
‫פולטות אור‬
H01L )2009.01(
193869
‫נורה פלסטית המכילה דיודה פולטת אור‬
02/05/2006
H01L )2009.01(
193870
METHOD OF LIGHT DISPERSION
AND PREFERENTIAL SCATTERING
OF CERTAIN WAVELENGTHS OF
LIGHT FOR LIGHT-EMITTING
DIODES AND BULBS CONSTRUCTED
THEREFROM
SUPERBULBS, INC.
US
60/797118
02/05/2006
PCT/US/2007/010467
WO/2007/130357
4533
H01L )2009.01(
193868
HEAT REMOVAL DESIGN FOR LED
BULBS
SUPERBULBS, INC.
US
60/797187
02/05/2006
PCT/US/2007/010470
WO/2007/130359
27/04/2007
B05B )2009.01(
193867
‫שיטה לפיזור אור ופיזור מועדף של אורכי‬
‫גל מסויימים של אור עבור דיודות פולטות‬
‫אור ונורות להט המורכבות מהן‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
06/07/2006
193871
HUMANIZED ANTI-CD20 MONOCLONAL
ANTIBODY
OSAKA UNIVERSITY
JP
PCT/JP2006/304370 07/03/2006
PCT/JP/2006/313499
WO/2007/102230
23/02/2007
193872
193873
AQUEOUS MICROEMULSIONS
CONTAINING PYRETHROID
COMPOUNDS
BASF SE
EP
06006601.6 29/03/2006
PCT/EP/2007/052972
WO/2007/110435
14/03/2007
A61K )2009.01(
A01N )2009.01(
‫מיקרואמולסיות מימיות המכילות תרכובות‬
‫פירטרואידיות‬
193878
ORODISPERSIBLE DOMPERIDONE
TABLETS
PIERRE FABRE MEDICAMENT
FR
06/02253
15/03/2006
PCT/EP/2007/052388
WO/2007/104771
June 15,
‫ חד שיבוטי‬CD20–‫נוגדן אנושי אנטי‬
‫הרכבי תרופות המכילים‬
‫פלואורוקווינולונים‬
MEDICAMENT FORMULATIONS
COMPRISING FLUOROQUINOLONES
BAYER ANIMAL HEALTH GMBH
DE
102006010642.3 08/03/2006
PCT/EP/2007/001568
WO/2007/101560
28/03/2007
C12P )2009.01(
A61K )2009.01(
‫טבליות מתפזרות בפה של דומפרידון‬
– ‫כ"ג בסיוון התשס"ט‬
4534
2009
09/03/2007
‫תהליך שטוח לציפוי בתרופות עבור‬
‫סטנטים‬
‫מדינול בע"מ‬
FLAT PROCESS OF DRUG COATING
FOR STENTS
MEDINOL LTD.
US
11/376879
15/03/2006
PCT/IB/2007/000563
WO/2007/105060
06/03/2007
‫שיטה לזיהוי תאי גזע עובריים אנושיים עם‬
PODXL ‫ביטוי של‬
C07D )2009.01(
193891
PYRIDAZINONE COMPOUND AND
USE THEREOF
SUMITOMO CHEMICAL COMPANY,
LIMITED
2006JP
17/03/2006
074190
2006-289735 25/10/2006
JP
PCT/JP/2007/055579
WO/2007/119434
4535
C12N )2009.01(
193883
HUMAN EMBRYONIC STEM CELL
METHODS AND PODXL EXPRESSION
AGENCY FOR SCIENCE,
TECHNOLOGY AND RESEARCH
US
60/778913
06/03/2006
PCT/SG/2007/000064
WO/2007/102787
13/03/2007
A61L )2009.01(
193879
‫תרכובת פירידאזינון והשימוש מזה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
02/10/2006
193893
PHARMACEUTICAL COMPOSITIONS
FOR EXTERNAL USE CONTAINING
LULICONAZOLE
POLA PHARMA INC
2006JP
08/03/2006
062078
2006-215904 08/08/2006
JP
PCT/JP/2006/319705
WO/2007/102241
06/03/2006
A61K )2009.01(
‫תכשירי רוקחות לשימוש חצוני המכילים‬
‫לוליקונאזול‬
193895
VANE MACHINE WITH
STATIONARY AND ROTATING
CYLINDER PARTS
BOSKOVIC NEBOJSA
F01C )2009.01(
‫מכונת מכנף בעלת חלקים גליליים‬
‫מסתובבים וקבועים‬
PCT/HR/2006/000002
WO/2007/102033
04/09/2008
193896
METHOD FOR IMPROVING
UTILIZATION OF RADIO RESOURCES
ALVARION LTD.
08/03/2007
193899
ASYMMETRIC CATALYTIC
HYDROGENATION OF PROCHIRAL
KETONES AND ALDEHYDES
SOLVIAS AG
CH
00379/06
10/03/2006
PCT/EP/2007/052160
WO/2007/104690
June 15,
H04Q )2009.01(
‫שיטה לשיפור ניצולם של משאבי רדיו‬
‫אלווריון בע"מ‬
C07C )2009.01(
‫הידרוגנציה קטליטית ואסימטרית של‬
‫קטונים ואלדהידים פרוכיראליים‬
– ‫כ"ג בסיוון התשס"ט‬
4536
2009
12/03/2007
HSD–1–‫–בטא‬11–‫פיראזולים כ‬
PYRAZOLES AS 11-BETA-HSD-1
F. HOFFMANN-LA ROCHE AG
US
60/784831
22/03/2006
60/875274
15/12/2006
US
PCT/EP/2007/052269
WO/2007/107470
28/03/2007
‫סרטים ומטרות מסגסוגות משולשות של‬
‫חמרן‬
‫פורמולציה של נוגדן מונוקלונאלי אנושי‬
R1–IGF ‫המכוון כנגד‬
G06T )2009.01(
193906
METHODS AND SYSTEMS FOR
CREATING AN ALIGNED BANK OF
IMAGES WITH AN ITERATIVE SELF CORRECTION TECHNIQUE FOR
COORDINATE ACQUISITION AND
OBJECT DETECTION
PRO TRACK LTD
4537
C07K )2009.01(
193904
ANTI-IGF-1R HUMAN MONOCLONAL
ANTIBODY FORMULATION
F. HOFFMANN-LA ROCHE AG
EP
06111848.5 28/03/2006
PCT/EP/2007/052569
WO/2007/110339
04/09/2008
C23C )2009.01(
193902
TERNARY ALUMINUM ALLOY
FILMS AND TARGETS
PRAXAIR TECHNOLOGY, INC.
US
11/395360
03/04/2006
PCT/US/2007/007755
WO/2007/126943
19/03/2007
C07D )2009.01(
193900
‫שיטות ומערכות ליצירת מאגר תמונות‬
‫מתואמות הכולל טכניקה לתיקון עצמי‬
‫איטרטיבי לצורך הרכשת קוארדינאטות‬
‫וגילוי אובייקטים‬
‫פרו טראק בע"מ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
04/09/2008
193907
APPARATUS TO SIGNAL A CHILD'S
LOCATION
KANER HAGAI
‫מתקן לאיתות ואיתור ילדים‬
‫חגי קנר‬
01/03/2007
193909
HIGH-TEMPERATURE PRESSURE
SENSOR ELEMENT, PARTICULARLY
FOR MEASURING PRESSURES INSIDE
POWER UNITS, METHOD OF
PRODUCING IT AND COMPONENT FOR
POWER UNITS
ASTRIUM GMBH
DE
102006010804.3 07/03/2006
PCT/DE/2007/000382
WO/2007/101426
06/03/2007
A61P )2009.01(
‫שימוש בפטיטדים לבקרת בפגיעת הקרנה‬
193911
METHOD AND APPARATUS FOR
UNIVERSAL IMPROVEMENT OF
VISION
SCIENTIFIC OPTICS, INC.
US
60/780153
08/03/2006
PCT/US/2007/063572
WO/2007/104013
June 15,
G01L )2009.01(
‫חיישן לחץ טמפרטורה גבוהה בפרט‬
‫ שיטת‬,‫למדידת לחץ בתוך יחידת כח‬
‫ייצורו ורכיב עבור יחידת כח‬
193910
USE OF PEPTIDES FOR THE
CONTROL OF RADIATION INJURY
BIOTEMPT, B.V.
US
60/779896
07/03/2006
06076181.4
07/06/2006
EP
60/811878
07/06/2006
US
PCT/NL/2007/050092
WO/2007/102735
08/03/2007
G08B )2009.01(
A61F )2009.01(
‫שיטה והתקן לשיפור כללי בראייה‬
– ‫כ"ג בסיוון התשס"ט‬
4538
2009
09/03/2006
G06F )2009.01(
193912
AN APPARATUS, METHOD AND
COMPUTER PROGRAM PRODUCT
FOR GENERATING TRACE DATA
ARM LIMITED
‫ שיטה ותוכנת מחשב‬,‫מוצר שהוא מנגנון‬
‫לייצור בעקבות מידע‬
PCT/GB/2006/000831
WO/2007/101972
26/07/2006
G06N )2009.01(
193913
‫מאגר ידע‬
KNOWLEDGE REPOSITORY
TRUE KNOWLEDGE LTD.
US
60/781517
08/03/2006
PCT/GB/2006/050222
WO/2007/101973
20/03/2006
H02K )2009.01(
193915
LINEAR DRIVE WITH A MOVING
MASS-REDUCED AND LATERALLY
GUIDED PASSIVE UNIT
INA DRIVES & MECHATRONICS
GMBH & CO.OHG
‫הנעה לינארית עם יחידה נעה מופחתת‬
‫מסה ובעלת הולכה צידית פאסיבית‬
PCT/EP/2006/060891
WO/2007/107183
27/03/2007
BUPRENORPHINE DERIVATIVES
AND USES THEREOF
RECKITT BENCKISER HEALTHCARE
(UK) LIMITED
GB
0606124.6
28/03/2006
PCT/GB/2007/001120
WO/2007/110636
4539
C07D )2009.01(
193917
‫תולדות בופרנורפיין ושימושן‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
04/09/2008
POSITION DETECTING DEVICE AND
POSITION DETECTING METHOD
WACOM CO., LTD.
P2007JP
10/09/2007
234518
14/03/2007
‫מכשיר זיהוי מיקום ושיטת זיהוי מיקום‬
‫שיטה לטיפול בזאבת באמצעות שימוש‬
CD4 ‫בנוגדנים‬
193922
ANTI-TAT226 ANTIBODIES AND
IMMUNOCONJUGATES
GENENTECH, INC.
US
60/783746
17/03/2006
PCT/US/2007/064212
WO/2007/109567
07/03/2007
C07K )2009.01(
‫ ותצמידים חיסוניים‬TAT226 ‫נוגדנים אנטי‬
193923
SUBSTITUTED CHROMANOL
DERIVATIVES AND THEIR USE
BAYER HEALTHCARE AG
DE
102006012548.7 18/03/2006
PCT/EP/2007/001930
WO/2007/107243
June 15,
A61K )2009.01(
193920
METHODS OF TREATING LUPUS
USING CD4 ANTIBODIES
GENENTECH, INC.
US
60/783535
16/03/2006
60/873881
07/12/2006
US
PCT/US/2007/006443
WO/2007/109052
16/03/2007
G08C )2009.01(
193918
– ‫כ"ג בסיוון התשס"ט‬
C07D )2009.01(
‫תולדות מותמרות של כרומנול‬
‫ושימושם‬
4540
2009
19/03/2007
H04N )2009.01(
193924
‫סדר צילום תוף פנימי‬
INTERNAL-DRUM IMAGESETTER
XPOSE HOLDING AG
CH
438/06
21/03/2006
PCT/CH/2007/000151
WO/2007/107030
29/05/2007
NOVEL 1,4-DIAZABICYCLO[3.2.2]NONYL
OXADIAZOLYL DERIVATIVES AND
THEIR MEDICAL USE
NEUROSEARCH A/S
DK
PA200600731 30/05/2006
PCT/EP/2007/055169
WO/2007/138038
21/03/2007
C07D )2009.01(
193925
–‫–דיאזא‬4,1 ‫תולדות חדשות של‬
‫]נוניל אוקסאדיאזוליל‬2.2.3[‫ביציקלו‬
‫ושימושן הרפואי‬
C07K )2009.01(
193926
‫טיפול צירופי‬
COMBINATORIAL THERAPY
GENENTECH, INC.
US
60/784704
21/03/2006
60/785330
22/03/2006
US
60/871743
22/12/2006
US
PCT/US/2007/064572
WO/2008/060645
20/07/2006
AUTOMATIC SYSTEM FOR GUIDING,
RETAINING AND ADJUSTING
CABLES
MAERSK ESPANA S.A.
ES
P200600667 06/03/2006
PCT/ES/2006/000423
WO/2007/101893
4541
B66D )2009.01(
193927
‫ אחזקה ותיאום‬,‫מערכת אוטומטית לניתוב‬
‫כבלים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
07/09/2008
INSERTS FOR PARTING OR
GROOVING AND METHOD OF
MAKING
SANDVIK INTELLECTUAL
PROPERTY AB
SE
0702232.0
05/10/2007
‫שתלים לחילוק או חירוץ ושיטה ליצורם‬
28/02/2007
193932
193937
SPECIFIC AMPLIFICATION OF FETAL
DNA SEQUENCES FROM A MIXED,
FETAL-MATERNAL SOURCE
THE TRUSTEES OF COLUMBIA
UNIVERSITY IN THE CITY OF NEW
YORK
US
60/778911
06/03/2006
PCT/US/2007/063366
WO/2007/103910
June 15,
– ‫כ"ג בסיוון התשס"ט‬
B21D )2009.01(
‫התקן ושיטה לגלילת אלמנטים‬
‫מתכתיים‬
DEVICE AND METHOD FOR WIDENING
METAL ELEMENTS
PROTEKTORWERK FLORENZ MAISCH
GMBH & CO. KG
DE
102006010795.0 08/03/2006
PCT/EP/2007/001734
WO/2007/101594
06/03/2007
B23H )2009.01(
193928
C12Q )2009.01(
‫ עובריים‬DNA ‫הגדלה ספציפית של רצפי‬
‫ממקור עוברי–אמהי מעורב‬
4542
2009
25/01/2007
METHOD AND APPARATUS FOR
SUPPORTING ROUTING AREA
UPDATE PROCEDURES IN A SINGLE
TUNNEL GPRS-BASED WIRELESS
COMMUNICATION SYSTEM
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/780235
08/03/2006
60/886328
24/01/2007
US
PCT/US/2007/002233
WO/2007/102954
25/01/2007
H04L )2008.04(
‫שיטה ומערכת לתמיכה בתהליך להעברת‬
‫נתונים מערוץ אחד לשני ושרות הליכי‬
‫שינוי מקום בתת–מערכת של רשת רדיו‬
–‫במערכת תקשורת אלחוטית חד‬
GPRS ‫מנהרתית מבוססת‬
C07K )2009.01(
193940
CANCEROUS DISEASE MODIFYING
ANTIBODIES FOR DIAGNOSTIC AND
THERAPEUTIC USE IN BREAST AND
PROSTATE CANCER
ARIUS RESEARCH INC.
US
11/370203
07/03/2006
PCT/CA/2007/000343
WO/2007/101331
4543
‫שיטה ומערכת לתמיכה בניתוב הליכי‬
‫עדכון במערכת תקשורת אלחוטית‬
‫ חד–מינהרתית‬GPRS–‫מבוססת‬
193939
METHOD AND APPARATUS FOR
SUPPORTING HANDOFF AND
SERVING RADIO NETWORK
SUBSYSTEM RELOCATION
PROCEDURES IN A SINGLE TUNNEL
GPRS-BASED WIRELESS
COMMUNICATION SYSTEM
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/780233
08/03/2006
60/886372
24/01/2007
US
PCT/US/2007/002232
WO/2007/102953
05/03/2007
H04L )2008.04(
193938
‫נוגדנים המשנים המחלה סרטנית עבור‬
‫שימוש אבחוני וטיפולי בסרטן השד‬
‫והפרוסטטה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
09/06/2006
193941
PORTABLE PNEUMATIC POWER
SUPPLY AND COMPRESSOR
SYSTEMS AND METHODS THEREOF
ROBERT LEW TURAN, JR.
US
60/780236
08/03/2006
0000
09/06/2006
US
PCT/US/2006/022610
WO/2007/102837
09/06/2006
‫ספק כוח פניאומטי נייד ומערכות מדחס‬
‫ושיטות מזה‬
193942
193947
193949
A61B )2009.01(
‫לוחיות רדיוס דיסטאלית‬
DISTAL RADIUS PLATE
ORTHO-HELIX SURGICAL DESIGNS,
INC.
US
60/779865
07/03/2006
PCT/US/2007/005699
WO/2007/103376
June 15,
A61K )2009.01(
‫וויסות תאי גזע‬
REGULATING STEM CELLS
KWALATA TRADING LIMITED
US
60/780781
08/03/2006
PCT/IL/2007/000308
WO/2007/102162
06/03/2007
F04B )2009.01(
‫גז נייד‬/‫מדחס אוויר‬
PORTABLE AIR/GAS COMPRESSOR
ROBERT LEW TURAN, JR.
US
60/780236
08/03/2006
00000
09/06/2006
US
PCT/US/2006/022609
WO/2007/102836
08/03/2007
F04B )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4544
2009
06/03/2007
A61B )2009.01(
193950
‫לוחיות אורתופדית‬
ORTHOPEDIC PLATE
ORTHO-HELIX SURGICAL DESIGNS,
INC.
US
60/780027
07/03/2006
PCT/US/2007/005624
WO/2007/103333
16/03/2007
IAP BIR DOMAIN BINDING
COMPOUNDS
AEGERA THERAPEUTICS, INC.
US
60/782523
16/03/2006
60/876994
26/12/2006
US
PCT/CA/2007/000428
WO/2007/104162
08/09/2008
SOBOL DOV
A41B )2009.01(
‫המסך המגן על אשכי הגבר נגד קרנת חום‬
‫הגופו הנתפר במסגרת בגדים התחתוניים‬
‫לגברים‬
‫סובול דב‬
A61M )2009.01(
193953
FLUID TRANSFER DEVICES FOR USE
WITH CARTRIDGES
MEDIMOP MEDICAL PROJECTS LTD.
IL
174352
16/03/2006
PCT/IL/2007/000343
WO/2007/105221
4545
BIR IAP ‫תרכובות הקשורות אתר‬
193952
SCREEN DEFENDING MAN TESTICLE
FROM BODY HEAT TO BE SEWN THE
'POSTERIOR' VOR MENS
15/03/2007
C07D )2009.01(
193951
‫התקנים להעברת נוזלים לשימוש עם‬
‫מחסניות‬
‫מדימופ פרויקטים רפואיים בע"מ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
08/09/2008
193954
A VIDED PRESENTATION AND
METHOD FOR PRODUCING THE
SAME
ALEXANDER SPEKTOR
08/09/2008
‫מצגת וידאו ושיטה להפקתה‬
‫אלכסנדר ספקטור‬
193955
193956
METHOD FOR CYCLICALLY
PORTIONING LIQUIDS AND PASTES
BY COPPING REQUIRED VOLUME
FROM LONG DISTANCE
PACK LINE LTD.
08/09/2008
‫פאק ליין בע"מ‬
193957
G08B )2009.01(
‫מערכת ושיטה לגילוי חודר‬
‫יעקב פרוכט‬
193958
MECHANISM FOR POWER
AMPLIFIER MOTORIZED FORCE KEEP TIEME OF MOVEMENT
DISPOSITIV DE MECANISME DE
AMPLIFICATION DE PUISSANCE ET
SANS PERD DE TEMP EN
SHIMON BUCH
June 15,
B65B )2009.01(
‫שיטה למילוי מחזורי של נוזלים ומשחות‬
‫בעזרת העתקה של הנפח הנדרש ממרחק‬
‫הרחוק‬
SYSTEM AND METHOD FOR
INTRUDER DETECTION
YAACOV FRUCHT
08/09/2008
H02K )2009.01(
‫מנוע מגנטי‬
‫גיאת הלוי יעקב‬
MGNETIC MOTOR
GIAT HALEVI YAKOV
08/09/2008
G06F )2009.01(
F16D )2009.01(
‫מנגנון להגברת כוח ועצמה מכנית בתנועה‬
‫קווית ו–או סיבובית תוך כדי שימור זמן‬
‫התנועה בין כניסה ליציאה‬
)‫בוק שמעון (אצל שרה בוך‬
– ‫כ"ג בסיוון התשס"ט‬
4546
2009
05/03/2007
USE OF CASPASES FOR THE
PREPARATION OF MEDICAMENTS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
IL
174253
12/03/2006
PCT/IL/2007/000278
WO/2007/105199
09/03/2007
A61K )2009.01(
193959
‫שימוש בקספאזים להכנת תרופות‬
‫ידע חברה למחקר ופיתוח בע"מ‬
B01D )2009.01(
193960
‫מטהר מים‬
WATER PURIFIER
FKA DISTRIBUTING CO. D/B/A
HOMEDICS, INC.
US
60/780579
09/03/2006
PCT/US/2007/063705
WO/2007/133834
08/09/2008
DETECTOR DEVICE AND ITS
METHOD OF OPERATION
MICHAEL OPHIR
08/09/2008
G08B )2009.01(
193961
‫התקן גילוי ושיטת פעולתו‬
‫עידן זוטא‬
E03D )2009.01(
193962
‫מערכת לניצול מים‬
‫אלון קוה‬
WATER UTILIZATION SYSTEM
EITAN TAGAR
08/03/2007
REFRIGERATOR ILLUMINATION
SYSTEM
RAMI AVRAHAM KALFON
US
60/780934
10/03/2006
PCT/IL/2007/000302
WO/2007/105204
4547
A47F )2009.01(
193963
‫מערכת תאורה למקרר‬
‫רמי אברהם כלפון‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
14/03/2007
193964
METHOD FOR MAKING SILICON FOR
SOLAR CELLS AND OTHER
APPLICATIONS
RESC INVESTMENTS LLC
US
60/782361
15/03/2006
PCT/US/2007/063985
WO/2007/106860
09/03/2007
‫שיטה להכנת סיליקון לתאים סולריים‬
‫ויישומים אחרים‬
193965
PEPTIDES OF REGULATORY OR
ACCESSORY PROTEINS OF HIV,
COMPOSITIONS AND THE
UTILIZATION THEREOF
PEPTCELL LIMITED
GB
0604920.9
10/03/2006
0614260.8
18/07/2006
GB
PCT/GB/2007/000812
WO/2007/104932
07/03/2007
C07K )2009.01(
‫ מווסתים או‬HIV ‫פפטידים של חלבוני‬
‫ תכשירים וניצול שלהם‬,‫מסייעים‬
193967
WIRELESS COMMUNICATION
METHOD AND SYSTEM FOR
PERFORMING HANDOVER BETWEEN
TWO RADIO ACCESS
TECHNOLOGIES
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/780582
09/03/2006
PCT/US/2007/005922
WO/2007/103496
June 15,
C01B )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
H04Q )2008.04(
‫שיטה ומערכת לתקשורת אלחוטית‬
‫לביצוע העברה בין שתי טכנולוגיות גישה‬
‫לרדיו‬
4548
2009
12/03/2007
DEVICE FOR MEASURING
PERMEATE FLOW AND PERMEATE
CONDUCTIVITY OF INDIVIDUAL
REVERSE OSMOSIS MEMBRANE
ELEMENTS
HYDRANAUTICS
US
60/781858
13/03/2006
PCT/US/2007/006152
WO/2007/108977
12/03/2007
‫התקן למדידת התפשטות זרם והתפשטות‬
‫מוליכות ביסודות ממברניים פרטיים‬
‫באוסמוזה הפוכה‬
ENERGY EFFICIENT PYROLYTIC
PROCESSING OVEN
JERRY M. EDMONDSON
‫תולדות קווינוליניות ושימושן כקוטלי‬
‫מזיקים‬
F25B )2009.01(
193972
A SPLIT-THERMO-ELECTRIC
STRUCTURE FOR HEATING,
COOLING, AND POWER
GENERATION SYSTEMS
LAMOS INC.
10/03/2006
C07D )2009.01(
193969
QUINOLINE DERIVATIVES AND
THEIR USE AS PESTICIDES
BASF SE
US
60/782429
15/03/2006
PCT/EP/2007/052262
WO/2007/104726
08/09/2008
B01D )2009.01(
193968
‫מבנה תרמו–אלקטרי מפוצל לחימום‬
‫וקירור ולמערכות ליצירת אנרגיה‬
‫דוד מרון‬
F23G )2009.01(
193974
‫תנור עיבוד פירוליטי בעל יעילות אנרגיה‬
PCT/US/2006/008922
WO/2007/106084
4549
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
11/04/2007
193975
‫שיטה להענקת ביטחון עבור יישום ברשת‬
‫האינטרנט‬
METHOD FOR PROVIDING WEB
APPLICATION SECURITY
ART OF DEFENCE GMBH
EP
06007879.7 13/04/2006
PCT/EP/2007/003222
WO/2007/118657
06/03/2007
193976
193977
METHOD FOR MARKING
PHARMACEUTICAL ARTICLES
ARES TRADING S.A.
EP
06008144.5 20/04/2006
60/794565
24/04/2006
US
PCT/IB/2007/001016
WO/2007/122473
12/03/2007
A61J )2009.01(
‫שיטה לסימון מוצרים רוקחיים‬
193978
C08F )2009.01(
‫פולימרים‬
POLYMERS
WARWICK EFFECT POLYMERS LTD
GB
0604911.8
10/03/2006
60.809588
31/05/2006
US
0617918.8
11/09/2006
GB
PCT/GB/2007/000840
WO/2007/104948
June 15,
C09G )2009.01(
‫הרכבים ושיטות לליטוש כימי–מכני‬
‫מיוצבים נגד חמצון‬
OXIDATION-STABILIZED CMP
COMPOSITIONS AND METHODS
CABOT MICROELECTRONICS
CORPORATION
US
11/384538
20/03/2006
PCT/US/2007/005592
WO/2007/108925
19/04/2007
H04L )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4550
2009
11/03/2007
USE OF LIPID CONJUGATES FOR THE
COATING OF STENTS AND
CATHETERS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/780516
09/03/2006
PCT/IL/2007/000311
WO/2007/102164
08/03/2007
‫שימוש בתצמידים שומניים לציפוי‬
‫תומכנים (סטנטים) וצנתרים (קתטרים‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
09/03/2007
‫מערכת לאספקת דגימות במהירות גבוהה‬
C07D )2009.01(
193982
SUBSTITUTED IMIDAZO[2,1-B]
THIAZOLE COMPOUNDS AND THEIR
USE FOR PRODUCING DRUGS
GRUNENTHAL GMBH
DE
102006011574.0 10/03/2006
PCT/EP/2007/002067
WO/2007/104485
‫] תיאזול‬B– 1 ,2[‫תרכובות אימידזו‬
‫מותמרות ושימוש בהן להכנת תרופות‬
B29B )2009.01(
193983
PROCESS FOR PELLETIZING
POLYMER MELTS COMPRISING
LOW-BOILING SUBSTANCES
BASF SE
EP
06111527/5 22/03/2006
PCT/EP/2007/052681
WO/2007/107584
4551
G01N )2009.01(
193980
HIGH SPEED SAMPLE SUPPLY
DEVICE
SARYNA BIOTECHNOLOGIES LLC
US
60/781103
10/03/2006
PCT/US/2007/005992
WO/2007/106376
21/03/2007
A61F )2009.01(
193979
‫שיטה לגרעון פולימרים מותכים המכילים‬
‫חומרים בעלי נקודת רתיחה נמוכה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
20/03/2007
193985
‫הרכבים אגרוכימיים‬
AGROCHEMICAL FORMULATIONS
BASF SE
EP
06111672.9 24/03/2006
PCT/EP/2007/052651
WO/2007/110355
09/03/2007
193986
ANTI-5T4 ANTIBODIES AND USES
THEREOF
WYETH
US
60/781346
10/03/2006
60/891248
23/02/2007
US
PCT/US/2007/063685
WO/2007/106744
03/04/2007
193988
G05B )2009.01(
‫תיאום מיקום של מתקן רדיולוגי נייד‬
193989
11?-HYDROXYSTEROID
DEHYDROGENASE TYPE 1 ACTIVE
COMPOUNDS
HIGH POINT PHARMACEUTICALS,
LLC
EP
06112359.2 07/04/2006
PCT/EP/2007/052929
WO/2007/115935
June 15,
C07K )2009.01(
‫ ושימוש בהם‬T 54 ‫נוגדנים נוגדי‬
ADJUSTING THE POSITION OF A
MOBILE RADIOLOGY FACILITY
SERGIO SERAFINI
FR
06/02939
04/04/2006
PCT/FR/2007/000565
WO/2007/118990
27/03/2007
A01N )2009.01(
C07C )2009.01(
–11? ‫תרכובות פעילות המשפיעות על‬
1 ‫הדרוקסי סטרואיד דהידרוגנאז מסוג‬
– ‫כ"ג בסיוון התשס"ט‬
4552
2009
26/03/2007
MALATE SALTS, AND POLYMORPHS
OF (3S,5S)-7-[3-AMINO-5-METHYLPIPERIDINYL]-1- CYCLOPROPYL-1,4DIHYDRO-8-METHOXY-4-OXO-3QUINOLINECARBOXYLIC ACID
THE PROCTER & GAMBLE
COMPANY
US
60/786483
28/03/2006
PCT/IB/2007/051055
WO/2007/110834
26/03/2007
S , S53( ‫מלחי מאלאט וצורות מופע של‬
–1–]‫–מתיל–פיפרידיניל‬5–‫ –אמינו‬3]–7–ׂ,
–4–‫–מתוקסי‬8–‫–דיהידרו‬4 ,1–‫ציקלופרופיל‬
‫–קווינולין חומצה קרבוקסילית‬3–‫אוקסו‬
‫תהליך צימוד להכנת חומרי ביניים‬
‫קווינולונים‬
C07C )2009.01(
193992
A HYDRIDE REDUCTION PROCESS
FOR PREPARING QUINOLONE
INTERMEDIATES
THE PROCTER & GAMBLE
COMPANY
US
60/786450
28/03/2006
PCT/IB/2007/051057
WO/2007/110836
4553
C07D )2009.01(
193991
A COUPLING PROCESS FOR
PREPARING QUINOLONE
INTERMEDIATES
THE PROCTER & GAMBLE
COMPANY
US
60/786482
28/03/2006
PCT/IB/2007/051056
WO/2007/110835
26/03/2007
C07D )2009.01(
193990
‫תהליך לחיזור הידריד להכנת חומרי ביניים‬
‫קווינולונים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
29/03/2007
193993
‫להבים עבור סכין גילוח וסכיני גילוח‬
RAZOR BLADES AND RAZORS
THE GILLETTE COMPANY
US
11/392127
29/03/2006
PCT/IB/2007/051131
WO/2007/110848
21/06/2000
193994
THE HIGH BONE MASS GENE OF
11q13.3
OSCIENT PHARMACEUTICALS
CORPORATION
US
09/543771
05/04/2000
09/544398
05/04/2000
US
PCT/US/2000/016951
WO/2001/077327
26/03/2007
193995
C07D )2009.01(
‫אמינוטטרהידרופירנים כמעכבים של‬
‫ לטיפול או מניעה‬IV–‫דיפפטידיל פפטידאז‬
‫של סוכרת‬
193996
C07K )2009.01(
U ‫אגוניסטים של רצפטור נוירומדין‬
‫ושימושים שלהם‬
NEUROMEDIN U RECEPTOR
AGONISTS AND USES THEREOF
MERCK & CO., INC.
US
60/783933
20/03/2006
PCT/US/2007/006635
WO/2007/109135
June 15,
C12N )2009.01(
‫ האחראי למסת עצם גבוהה‬q11 .313 –‫גן‬
AMINOTETRAHYDROPYRANS AS
DIPEPTIDYL PEPTIDASE-IV
INHIBITORS FOR THE TREATMENT
OR PREVENTION OF DIABETES
MERCK & CO., INC.
US
60/786518
28/03/2006
60/838122
16/08/2006
US
PCT/US/2007/007434
WO/2007/126745
16/03/2007
B26B )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4554
2009
06/03/2007
METHOD TO REDUCE THE RISK
AND/OR SEVERITY OF ANTHRAX
INFECTION
IMMUNEREGEN BIOSCIENCES, INC.
US
60/780825
10/03/2006
60/781367
13/03/2006
US
60/828723
09/10/2006
US
60/899035
02/02/2007
US
PCT/US/2007/005668
WO/2008/054465
07/03/2006
A61K )2009.01(
193997
‫או ההחמרה‬/‫שיטה להפחתת הסיכון ו‬
‫בהדבקה של אנתרקס‬
H02K )2009.01(
193998
STATOR WINDING FOR A SLOTLESS
MOTOR
ALLIED MOTION TECHNOLOGIES
INC.
‫ליפופי סטטור למנוע בלי חריצים‬
PCT/US/2006/008260
WO/2007/102818
09/03/2007
8-HETEROARYLPURINE MNK2
INHIBITORS FOR TREATING
METABOLIC DISORDERS
PHARMACOPEIA, INC.
US
60/780800
09/03/2006
PCT/US/2007/063699
WO/2007/104053
4555
C07D )2009.01(
193999
‫ לטיפול‬MNK2 ‫–הטרוארילפורין כמעכבי‬8
‫בהפרעות מטבוליות‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
07/03/2007
194000
ENDOSCOPIC FULL THICKNESS
RESECTION USING SURGICAL
COMPRESSION CLIPS
NITI MEDICAL TECHNOLOGIES LTD.
US
60/780446
09/03/2006
11/647912
29/12/2006
US
PCT/IL/2007/000287
WO/2007/102151
07/03/2007
194001
SURGICAL COMPRESSION CLIPS
NITI MEDICAL TECHNOLOGIES LTD.
US
60/780446
09/03/2006
11/647913
29/12/2006
US
PCT/IL/2007/000288
WO/2007/102152
09/09/2008
194002
194003
TARGET RECOGNITION SYSTEM
AND METHOD
RAYTHEON COMPANY
US
11/650013
05/01/2007
PCT/US/2007/025344
WO/2008/082470
June 15,
‫הסרה כירורגית אנדוסקופית בעובי מלא‬
‫המשתמשת במהדקי דחיסה כירורגיים‬
‫ניטי טכנולוגיות רפואיות בע"מ‬
A61B )2009.01(
‫מהדקי דחיסה כירורגיים‬
‫ניטי טכנולוגיות רפואיות בע"מ‬
G06F )2009.01(
‫מערכת הכנסת נתונים משופרת‬
‫בנימין פירוז גסביאן‬
IMPROVED DATA ENTRY SYSTEM
BENJAMIN FIROOZ GHASSABIAM
11/12/2007
A61B )2009.01(
G06K )2009.01(
‫שיטה ומערכת לזיהוי מטרה‬
– ‫כ"ג בסיוון התשס"ט‬
4556
2009
10/03/2006
A61K )2009.01(
194004
ANTICANCER DRUGS CONJUGATED
TO ANTIBODY VIA AN ENZYME
CLEAVABLE LINKER
DIATOS
‫תרופות נגד סרטן המצומדות לנוגדן דרך‬
‫לינקר הניתן לחיתוך על ידי אנזים‬
PCT/IB/2006/001185
WO/2007/105027
12/03/2007
STABLE NANOCAPSULATE
SYSTEMS FOR THE
ADMINISTRATION OF ACTIVE
MOLECULES
ADVANCED IN VITRO CELL
TECHNOLOGIES, S.L.
EP
06380048.6 13/03/2006
PCT/EP/2007/052276
WO/2007/104732
06/03/2007
A61B )2009.01(
194005
‫מערכות יציבות ננונרתיקיות לנתינה של‬
‫מולקולות פעילות‬
A61B )2009.01(
194006
‫מתקן פוטוקוסמטי‬
PHOTOCOSMETIC DEVICE
PALOMAR MEDICAL
TECHNOLOGIES, INC.
US
60/781083
10/03/2006
11/415360
01/05/2006
US
11/415363
01/05/2006
US
11/415373
01/05/2006
US
11/415359
01/05/2006
US
11/415362
01/05/2006
US
PCT/US/2007/005576
WO/2007/106339
4557
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
30/03/2007
194007
PHARMACEUTICAL COMPOSITION
COMPRISING ANTI-MIRNA
ANTISENSE OLIGONUCLEOTIDES
SANTARIS PHARMA A/S
DK
PA200600478 03/04/2006
60/788995
03/04/2006
US
DK
PA200600615 01/05/2006
60/796813
01/05/2006
US
60/838710
18/08/2006
US
DK
PA200601401 30/10/2006
PCT/DK/2007/000168
WO/2007/112753
14/03/2007
194008
SYNTHESIS OF THROMBOPOIETIN
ACTIVITY MODULATING
COMPOUNDS
LIGAND PHARMACEUTICALS
INCORPORATED
US
60/782426
15/03/2006
PCT/US/2007/006547
WO/2007/106564
04/04/2007
MIRNA–‫תכשיר רוקחות המכיל אנטי‬
‫אנטי–סנס אוליגונוקליאוטידים‬
C07D )2009.01(
‫הכנת תרכובות המווסתות פעילות‬
‫תרמבופואיטין‬
194009
E02F )2009.01(
PI3 ‫אנטגוניסטים של קינאז‬
PI3 KINASE ANTAGONISTS
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/744269
04/04/2006
60/744270
04/04/2006
US
PCT/US/2007/008355
WO/2008/127226
June 15,
C12N )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4558
2009
04/04/2007
E02F )2009.01(
194010
‫אנטגוניסטים לקינאז‬
KINASE ANTAGONISTS
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/744269
04/04/2006
60/744270
04/04/2006
US
PCT/US/2007/008395
WO/2007/114926
30/06/2006
AUTONOMOUS STRATOSPHERE
PLATFORM
III-SOLUTIONS GMBH
CH
437/06
21/03/2006
PCT/CH/2006/000350
WO/2007/107018
09/03/2007
C07D )2009.01(
‫תהליך לייצור תרכובת כרומין אוקסיד‬
‫פעילה אופטית‬
A61M )2009.01(
194018
RUBIDIUM ELUTION SYSTEM
CONTROL
OTTAWA HEART INSTITUTE
RESEARCH CORPORATION
US
11/372149
10/03/2006
PCT/CA/2007/000295
WO/2007/104133
4559
‫משטח עצמאי לסטראטוספירה‬
194017
PROCESS FOR PRODUCING
OPTICALLY ACTIVE CHROMENE
OXIDE COMPOUND
NISSAN CHEMICAL INDUSTRIES
LTD.
2006JP
10/03/2006
066818
2006-084285 24/03/2006
JP
PCT/JP/2007/054730
WO/2007/105658
26/02/2007
B64C )2009.01(
194012
‫מערכת לבקרה על זרימה של רובידיום‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
10/09/2008
A61N )2009.01(
194020
APPARATUS FOR TREATMENT OF
DAMAGED TISSUE
HEALFUS LTD.
‫התקן לטיפול ברקמה פגועה‬
‫הילפוס בע"מ‬
07/03/2007
194021
MODIFIED WAXES, A PROCESS FOR
THEIR PREPARATION, AND THEIR USE
CLARIANT FINANCE (BVI) LIMITED
DE
102006011989.4 16/03/2006
102006011990.8
16/03/2006
DE
102006011991.6
16/03/2006
DE
PCT/EP/2007/052149
WO/2007/104689
14/03/2007
16/03/2007
‫ תהליך להכנתן ושימושן‬,‫שעוות שונות‬
194022
2-(CYCLIC AMINO)-PYRIMIDONE
DERIVATIVES AS TPK1 INHIBITORS
SANOFI-AVENTIS
2006JP
15/03/2006
110242
PCT/JP/2007/055787
WO/2007/119463
C07D )2009.01(
‫–(אמינו ציקלי)–פירימידון כמעכבי‬2 ‫תולדות‬
TPK1
194023
A01G )2009.01(
‫התקן השקיה‬
IRRIGATION DEVICE
DESIGN TECHNOLOGY AND
INNOVATION LIMITED
GB
0605322.7
16/03/2006
PCT/GB/2007/000953
WO/2007/105007
June 15,
C08F )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4560
2009
06/03/2007
SIGNAL JAMMING AVOIDANCE
METHOD FOR A FREQUENCY
HOPPING COMMUNICATION
SYSTEM
HARRIS CORPORATION
US
11/377529
16/03/2006
PCT/US/2007/005586
WO/2007/108922
11/09/2008
‫שיטה למניעת שיבוש אותות עבור מערכת‬
‫תקשורת המדלגת על תדרים‬
‫מכשירי בדיקה המסייעים במצבי תפעול‬
‫רבים עבור סידורי גלאי רבים‬
H02P )2009.01(
194026
DISCRETE FREQUENCY SOFT
STARTING METHOD AND ITS DEVICE
FOR AN ELECTRIC MACHINE
RONGXIN POWER ELECTRONIC CO.
LTD
CN
200610047311.9 26/07/2006
PCT/CN/2007/002244
WO/2008/014681
4561
G01N )2009.01(
194025
INSPECTION TOOLS SUPPORTING
MULTIPLE OPERATING STATES FOR
MULTIPLE DETECTOR
NEGEVTECH, LTD
US
61/027586
11/02/2008
12/142416
19/06/2008
US
24/07/2007
H04B )2009.01(
194024
‫שיטת אתחול בתדירות בלתי רציפה‬
‫והתקן עבור מכונה חשמלית‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
09/03/2007
194027
USE OF GHRELIN SPLICE VARIANT
FOR TREATING CACHEXIA AND/OR
ANOREXIA AND/OR ANOREXIACACHEXIA AND/OR MALNUTRITION
AND/OR LIPODYSTROPHY AND/OR
MUSCLE WASTING AND/OR
APPETITE STIMULATION
LIAT MINTZ
US
60/781860
13/03/2006
PCT/US/2007/006189
WO/2007/108990
11/09/2008
‫שימוש במשתנה איחוי גרליני לטיפול‬
–‫או אנוקרסיה‬/‫או אנורקסיה ו‬/‫בכיחשון ו‬
‫או הפרעת חילוף‬/‫או תת–תזונה ו‬/‫כיחשון ו‬
‫או גירוי‬/‫או דילול שרירי ו‬/‫חומרים שומניים ו‬
‫תיאבון‬
194029
SYSTEM AND METHOD FOR
IDENTIFICATION OF A DISTANT
SEABORNE OBJECT
KILOLAMBDA TECHNOLOGIES LTD.
11/09/2008
194030
CUTTING TOOL AND CUTTING
INSERT THEREFOR
ISCAR LTD.
21/03/2007
‫ליאת מינץ‬
G08B )2009.01(
‫מערכת ושיטה לזיהוי מטרה ימית‬
‫מרוחקת‬
‫קילולמבדה טכנולוגיות בע"מ‬
B23C )2009.01(
‫כלי חיתוך ושימת חיתוך עבורו‬
‫ישקר בע"מ‬
194031
CHUCK AND ARTICLE HAVING
MATING FEATURES TO PREVENT
AXIAL SLIPPAGE
ISCAR LTD.
IL
174722
02/04/2006
PCT/IL/2007/000367
WO/2007/113797
June 15,
A61K )2009.01(
B23B )2009.01(
‫אום מחזיק ופריט בעל מאפינים למניעת‬
‫תזוזה צירית‬
‫ישקר בע"מ‬
– ‫כ"ג בסיוון התשס"ט‬
4562
2009
11/09/2008
A METHOD AND DEVICE FOR A KEY
HOLDER
LIOR WERPOOLER
US
60/993371
13/09/2007
11/09/2008
‫שיטה ומתקן למחזיק מפתחות קבוע‬
‫ליאור ורפולר‬
‫זיהוי שינויים באובייקטים בין זוג תמונות‬
‫אופטיקה אלאופ‬-‫אלביט מערכות אלקטרו‬
‫בע"מ‬
‫–דסמתיל–ונלפקסין‬O ‫שיטה להכנה של‬
B05B )2009.01(
194035
ACTUATOR FOR A RECEPTACLE
HAVING A PRESSURIZED CONTENT
AND METHOD FOR SPRAYING A
PRESSURIZED CONTENT
PACKAGING TECHNOLOGY
PARTICIPATION SA
EP
06075598.0 14/03/2006
06076815.7
03/10/2006
EP
PCT/BE/2007/000024
WO/2007/104113
4563
C07C )2009.01(
194034
METHOD FOR PREPARING ODESMETHYLVENLAFAXINE
WYETH
US
60/334953
04/12/2001
PCT/US/2002/038403
WO/2003/048104
13/03/2007
G06T )2009.01(
194033
METHOD FOR IDENTIFYING
CHANGED SHAPED OBJECTS IN AN
IMAGE OF A SCENE COMPARED TO
A PREVIOUS IMAGE OF THE SAME
SCENE
ELBIT SYSTEMS ELECTRO-OPTICAL
ELOP LTD.
03/12/2002
A44B )2009.01(
194032
‫מפעיל עבור כלי קיבול המכיל תוכן בלחץ‬
‫ושיטה לריסוס תוכן בלחץ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
05/04/2001
HANDOFF METHOD FOR DIGITAL
BASE STATIONS WITH DIFFERENT
SPECTRAL CAPABILITIES
QUALCOMM INCORPORATED
US
09/546219
07/04/2000
PCT/US/2001/011370
WO/2001/078440
09/03/2007
‫שיטת העברה לתחנות בסיס דיגיטליים‬
‫בעלות יכולות ספקטראליות שונות‬
194038
A METHOD FOR MAKING A SECURE
RERSONAL CARD AND ITS WORKING
PROCESS
BORRACCI FABRIZIO
IT
UD2006A000075 27/03/2006
IT
UD2006A000046 01/03/2007
PCT/EP/2007/002083
WO/2007/110142
19/03/2007
194039
PYRIDINE AND PYRIMIDINE
DERIVATIVES AS mGluR2
ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
06111939.2 29/03/2006
PCT/EP/2007/052560
WO/2007/110337
June 15,
H04Q )2008.04(
194037
G07F )2009.01(
‫שיטה ליצירת כרטיס אבטחה אישי‬
‫ותהליך עבודתו‬
C07D )2009.01(
‫נגזרות של פירידין ופירימידין‬
mGluR2 ‫כאנטגוניסטים של‬
– ‫כ"ג בסיוון התשס"ט‬
4564
2009
15/03/2007
TREATMENT OF PAROXYSMAL
NOCTURNAL HEMOGLOBINURIA
PATIENTS BY AN INHIBITOR OF
COMPLEMENT
ALEXION PHARMACEUTICALS, INC.
US
60/783070
15/03/2006
PCT/US/2007/006606
WO/2007/106585
14/03/2007
‫טיפול בחולי המוגלובינוריה התקפית‬
‫לילית על ידי מעכב של משלים‬
‫בתא–אגוניסטים חדשים טהורים מבחינה‬
‫ שיטה לייצורם ושימושם‬,‫אננטיומרית‬
‫כתרופות‬
F03D )2009.01(
194045
METHOD, DEVICE AND SYSTEM FOR
CONVERTING ENERGY
KLAUS WOLTER
DE
10200615527.0
31/03/2006
10200616111.4
04/04/2006
DE
102006020752.1
03/05/2006
DE
102006045559.2
25/09/2006
DE
102006053180.9
09/11/2006
DE
EP
PCT/EP07/051940 01/03/2007
PCT/EP/2007/053015
WO/2007/113200
4565
C07D )2009.01(
194043
NOVEL ENANTIOMERICALLY PURE
BETA-AGONISTS, METHOD FOR
THEIR PRODUCTION AND THEIR
USE AS MEDICAMENTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
06111191.0 15/03/2006
06111338.7
17/03/2006
EP
06111342.9
17/03/2006
EP
PCT/EP/2007/052389
WO/2007/104772
29/03/2007
A61K )2009.01(
194041
‫ התקן ומערכת להמרת אנרגיה‬,‫שיטה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
12/03/2007
194046
METHOD FOR OPTIMIZING
TRANSMISSION RESOURCES BY
LOCAL LOOPBACK IN A MOBILE
RADIO COMMUNICATION
CELLULAR NETWORK, NETWORK
AND LOCAL ADAPTORS THEREOF
CELL & SAT
FR
0602222
14/03/2006
0602223
14/03/2006
FR
0611565
29/12/2006
FR
PCT/EP/2007/052305
WO/2007/104743
12/03/2007
10/04/2007
H04Q )2008.04(
‫שיטה לאופטימיזציה של חלוקת משאבים‬
‫במערכת תקשורת סלוללרית באמצעות‬
‫ מערכת‬,‫שימוש חיבור תקשורת רדיו‬
‫תקשורת ומתאמים לשם כך‬
194048
CONCURRENT MONITORING OF A
PLURALITY OF SAMPLES BY AN
ARRAY OF BIOSENSING ELEMENTS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/790545
10/04/2006
PCT/IL/2007/000449
WO/2007/116402
June 15,
‫שיטה לאופטימיזציה של העברת משאבים‬
‫באמצעות היזון חוזר מקומי במערכת‬
‫ מערכת‬,‫תקשורת רדיו אלחוטית סלולרית‬
‫תקשורת ומתאמים מקומיים לכך‬
194047
METHOD FOR OPTIMIZING
ALLOCATION OF RESOURCES IN A
CELLULAR NETWORK USING A
SHARED RADIO TRANSMISSION
LINK, NETWORK AND NETWORK
ADAPTORS THEREOF
CELL & SAT
FR
0602222
14/03/2006
PCT/EP/2007/052303
WO/2007/104741
H04Q )2008.04(
G01N )2009.01(
‫מעקב בו–זמני של מספר רב של דגימות‬
‫באמצעות מערך של גורמי חישה ביולוגיים‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
– ‫כ"ג בסיוון התשס"ט‬
4566
2009
16/04/2007
PROCESS FOR PREPARING
DORZOLAMIDE
ZACH SYSTEM S.P.A.
EP
06112883.1 21/04/2006
PCT/EP/2007/053691
WO/2007/122130
06/03/2007
‫שיטה עבור סינכרון רצף סיביות מקודדות‬
‫או מוצפנות‬
H04B )2009.01(
‫שיטה משופרת לפענוח מידע דיגיטלי‬
"‫במערכת תקשורת בעלת "תדירות קופצת‬
A61F )2009.01(
194052
EYEWEAR WITH MASK
ATTACHMENT FEATURES
KIMBERLY-CLARK WORLDWIDE,
INC.
US
11/413576
28/04/2006
PCT/IB/2007/051081
WO/2007/125436
4567
H03M )2009.01(
194051
IMPROVED METHOD FOR
DECODING DIGITAL DATA IN A
FREQUENCY HOPPING
COMMUNICATION SYSTEM
HARRIS CORPORATION
US
11/377491
16/03/2006
PCT/US/2007/005587
WO/2007/108923
27/03/2007
‫תהליך להכנת דורזולאמיד‬
194050
METHOD FOR ENCODED OR
ENCRYPTED BIT STREAM
SYNCHRONIZATION
HARRIS CORPORATION
US
11/377492
16/03/2006
PCT/US/2007/005588
WO/2007/108924
06/03/2007
C07D )2009.01(
194049
‫מגן לעיניים עם אמצעיי הידוק כמו מסכה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
08/03/2007
194053
X-RAY DETECTABLE ELEMENT FOR
ASSOCIATION WITH SURGICAL
ABSORBENT SUBSTRATES AND
METHOD OF MAKING
TYCO HEALTHCARE GROUP LP
US
60/782141
14/03/2006
PCT/US/2007/005986
WO/2007/106373
19/03/2007
194054
194055
PROCESS FOR PREPARING RETINOID
COMPOUNDS
F. HOFFMANN-LA ROCHE AG
US
60/787752
31/03/2006
PCT/EP/2007/052744
WO/2007/113122
19/03/2007
194056
COMPOUNDS WHICH POTENTIATE
AMPA RECEPTOR AND USES
THEREOF IN MEDICINE
GLAXO GROUP LIMITED
GB
0605589.1
20/03/2006
0621438.1
27/10/2006
GB
PCT/EP/2007/052568
WO/2007/107539
June 15,
‫ לחיבור‬X ‫גורם הניתן לזיהוי על ידי קרני‬
‫עם מצע סופג כירורגי ושיטה ליצורו‬
C07D )2009.01(
‫נגזרות של מאלונאמיד כמעכבים של‬
‫גאמא סקרטאז‬
MALONAMIDE DERIVATIVES AS
GAMMA SECRETASE INHIBITORS
F. HOFFMANN-LA ROCHE AG
EP
06111771.9 27/03/2006
PCT/EP/2007/052557
WO/2007/110335
22/03/2007
A61F )2009.01(
C07D )2009.01(
‫תהליך להכנת תרכובות של רטינואיד‬
C07D )2009.01(
AMPA ‫תרכובות המגבירות רצפטור‬
‫ושימושן ברפואה‬
– ‫כ"ג בסיוון התשס"ט‬
4568
2009
14/03/2007
CONVEYOR BELT WITH ATTACHED
STRIPS OF TEETH
THERMODRIVE LLC
US
60/743474
14/03/2006
PCT/US/2007/063952
WO/2007/106845
14/09/2008
B65G )2009.01(
194058
‫חגורת הסעה עם רצועות שיניים צמודות‬
H02J )2009.01(
194059
‫שקע אלחוטי‬
‫עידן מורדוב‬
WIRELESS SOCKET
IDAN MORADOV
28/02/2007
COMPRESSION MOULDING FLUFFY
CELLULOSIC MATERIAL
PAPER TECHNOLOGIES S.R.L.
IT
MI2006A000447 14/03/2006
PCT/EP/2007/001724
WO/2007/104431
14/09/2008
‫מכשיר לעיצוב חומר צלוליזה רך‬
F01B )2009.01(
194061
PISTON MOTOR, USE LEVER, THE
LEVER IS POSITINED BETWEEN
PISTON AND CRANKSHAFT, THE
LEVER USEING 2 CONNECTING ROD.
ONE FOR PISTON, AND ONE FOR
CRANKSHAF. THE LEVERS LENTH IS
ADJUSTABLE
SHIMON BUCH
4569
B29C )2009.01(
194060
‫מנוע בוכנה הפועל בעזרת מנוף בעל אורך‬
‫ המוצב בין הבוכנה ובין גל‬,‫מתכוונן‬
.‫ תוך שימוש בשני טלטלים‬,‫הארכובה‬
‫האחד מחובר לבוכנה והשני לגל הארכובה‬
‫שמעון בוק אצל שרה בוך‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
16/05/2006
194062
SOLID ORAL FORM OF A MEDICINAL
PREPARATION AND A METHOD FOR
THE PRODUCTION THEREOF
OLEG ILIICH, EPSHTEIN
RU
2006107580 13/03/2006
PCT/RU/2006/000237
WO/2007/105981
10/03/2007
‫צורה אוראלית סולידית של תכשיר רפואי‬
‫ושיטה לייצורה‬
194063
194064
ENHANCED METHOD FOR SIGNAL
SHAPING IN MULTI-CHANNEL
AUDIO RECONSTRUCTION
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V.
US
60/787096
28/03/2006
PCT/EP/2006/004732
WO/2007/110101
22/03/2007
H04S )2009.01(
‫שיטה משופרת לעיצוב אות בשחזור שמע‬
‫רב–ערוצית‬
194067
APPARATUS AND METHOD FOR
FEEDING CHICKS DURING THE
HATCHING PROCESS
MILOUOT CORPORATION FOR THE
DEVELOPMENT OF HAIFA BAY
SETTLEMENTS LTD.
US
60/786733
29/03/2006
PCT/IL/2007/000372
WO/2007/110861
June 15,
B41F )2009.01(
‫בדיקת גליונות עם משקולת‬
WEIGHTED SHEET INSPECTION
MANROLAND AG
DE
102006015828.8 03/04/2006
PCT/EP/2007/002315
WO/2007/115637
18/05/2006
A61K )2009.01(
A01K )2009.01(
‫מתקן ושיטה להאכלת אפרוחים בתהליך‬
‫הבקיעה‬
– ‫כ"ג בסיוון התשס"ט‬
4570
2009
22/03/2007
OCCLUSION DEVICE AND METHOD
FOR ITS MANUFACTURE
OCCLUTECH GMBH
DE
102006013770.1 24/03/2006
PCT/EP/2007/002563
WO/2007/110195
26/02/2007
CONSTRUCTION SYSTEM AND
METHOD FOR ITS USE
DANIEL SHLEZINGER
4571
‫ניר סניטרי טישיו וכיסוי כסא אסלה‬
‫דוד יששכר‬
E04B )2009.01(
‫מערכת ושיטה לבניה ושמושן‬
‫דניאל שלזינגר‬
E04B )2009.01(
194071
CONSTRUCTION SYSTEM AND
METHOD FOR ITS USE
DANIEL SHLEZINGER
IL
154792
06/03/2003
14/09/2008
A47K )2009.01(
194070
CONSTRUCTION SYSTEM AND
METHOD FOR ITS USE
DANIEL SHLEZINGER
14/09/2008
‫מתקן אוקלוזיה ושיטה ליצורו‬
194069
TISSUE AND TOILET SEAT-COVER
SANITARY PAPER
DAVID ISSACHAR
US
11/373189
13/03/2006
PCT/IL/2007/000249
WO/2007/105197
14/09/2008
A61B )2009.01(
194068
‫מערכת ושיטה לבניה ושמושן‬
‫דניאל שלזינגר‬
E04B )2009.01(
194072
‫מערכת ושיטה לבניה ושמושן‬
‫דניאל שלזינגר‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
14/09/2008
194073
CONSTRUCTION SYSTEM AND
METHOD FOR ITS USE
DANIEL SHLEZINGER
20/01/2003
‫מערכת ושיטה לבניה ושמושן‬
‫דניאל שלזינגר‬
194074
PIM-3 KINASE AS A TARGET FOR
TYPE 2 DIABETES MELLITUS
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
02001401.5 19/01/2002
PCT/EP/2003/000492
WO/2003/060130
14/09/2008
194077
A01H )2009.01(
‫ייצור חומצות שומן בלתי רוויות ארוכות‬
‫שרשרת באורגניזמים הטרולוגים‬
PUFA ‫באמצעות שימוש במערכות‬
‫פוליקטיד סינתאז‬
POLYUNSATURATED FATTY ACID
PRODUCTION IN HETEROLOGOUS
ORGANISMS USING PUFA
POLYKETIDE SYNTHASE SYSTEMS
June 15,
G01H )2009.01(
‫שיטה ומערכת להעצמה של מוזיקה‬
‫מתנגנת‬
‫ניאוקראפט בע"מ‬
METHOD AND SYSTEM FOR
ENHANCING MUSIC BEING PLAYED
NEOCRAFT LTD.
MARTEK BIOSCIENCES
CORPORATION
US
60/783205
60/784616
US
PCT/US/2007/064104
WO/2007/106903
G01N )2009.01(
‫–קינאז כמטרה לסוכרת נעורים סוג‬3–‫פימ‬
2
194075
15/03/2007
E04B )2009.01(
15/03/2006
21/03/2006
– ‫כ"ג בסיוון התשס"ט‬
4572
2009
15/03/2007
‫שמנים מזרעי צמחים המכילים חומצות‬
‫שומן בלתי רוויות ארוכות שרשרת‬
PLANT SEED OILS CONTAINING
POLYUNSATURATED FATTY ACIDS
MARTEK BIOSCIENCES
CORPORATION
US
60/783205
15/03/2006
60/784616
21/03/2006
US
PCT/US/2007/064105
WO/2007/106904
18/03/2007
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/782514
16/03/2006
PCT/IL/2007/000345
WO/2007/105223
A47J )2009.01(
‫תהליך בו מוצרי בשר נצלים על האש‬
‫נארזים במגשיות עמידות לחום ולמיקרוגל‬
‫מוקפאים בהקפאה עמוקה ומשווקים‬
.‫במקפיא בטמפרטורה נמוכה מאוד‬
‫ד"ר חיים עמרם בן שמחון‬
H04Q )2008.04(
194081
METHOD FOR COORDINATED
CONTROL OF RADIO RESOURCES IN
A DISTRIBUTED WIRLESS SYSTEM
LUCENT TECHNOLOGIES INC.
US
11/386065
21/03/2006
PCT/US/2007/006060
4573
‫שיטות לאבחון מחלות ליפידיות הקשורות‬
HDL – 1PON–‫ב‬
‫מכון רפפורט המכון למחקר במדעי‬
‫הרפואה ע"ש משפחת רפפורט‬
194080
A PROCESS IN WHICH MEAT
PRODUCTS ARE DAR-B-QUED ON
FIRE, PACKED IN MICROWARABLE
AND/OR HEAT RESISTANT PACKAGE
DEEP FROZEN AND MARKETED IN
DEEP FREEZERS.
DR. HAIM AMRAM BEN-SIMHON
09/03/2007
C12Q )2009.01(
194079
METHODS OF DIAGNOSING PON1HDL ASSOCIATED LIPID DISORDERS
15/09/2008
A01H )2009.01(
194078
‫שיטה עבור בקרה מתואמת של משאבי‬
‫רדיו במערכת אלחוטית מחולקת‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
WO/2007/108959
14/03/2007
194083
METHOD FOR PREPARING INDENE
DERIVATIVES, AND
INTERMEDIATES FOR PREPARATION
OF DERIVATIVES
MERCIAN CORPORATION
2006JP
15/03/2006
070248
PCT/JP/2007/055137
WO/2007/105773
09/03/2007
‫ וחומרי ביניים‬,‫שיטה להכנת תולדות אינדן‬
‫להכנת התולדות‬
194084
METHOD AND APPARATUS FOR
OPTICALLY READING INFORMATION
BAYER INNOVATION GMBH
DE
102006012991.1 22/03/2006
PCT/EP/2007/002060
WO/2007/107251
03/04/2007
194085
DEVICES AND METHODS FOR THE
ISOLATION AND CULTIVATION OF
MICROORGANISMS
NORTHEASTERN UNIVERSITY
US
60/789101
04/04/2006
PCT/US/2007/008127
WO/2007/114897
June 15,
C07C )2009.01(
G11B )2009.01(
‫שיטה ומערכת לקריאה אופטית של‬
‫מידע‬
G05B )2009.01(
‫התקנים ושיטות לבידוד וטיפוח של‬
‫מיקרואורגניזמים‬
– ‫כ"ג בסיוון התשס"ט‬
4574
2009
14/03/2007
QUINOLONE DERIVATIVE OR
PHARMACEUTICALLY ACCEPTABLE
SALT THEREOF
ASTELLAS PHARMA INC.
2006JP
16/03/2006
073045
PCT/JP/2007/055040
WO/2007/105751
29/03/2007
‫נגזרת קווינולונית או מלח רוקחי שלה‬
B26B )2009.01(
194087
MULTI-BLADE RAZORS AND
BLADES FOR SAME
THE GILLETTE COMPANY
US
11/392148
29/03/2006
PCT/IB/2007/051130
WO/2007/110847
22/03/2007
C07D )2009.01(
194086
‫סכיני גילוח רבי–להב ולהבים עבורם‬
B26B )2009.01(
194088
‫סכיני גילוח‬
RAZORS
THE GILLETTE COMPANY
US
11/391762
29/03/2006
PCT/IB/2007/051014
WO/2007/110821
15/09/2008
ENCLOSURE PROTECTING SYSTEM
AND METHOD
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
4575
G08B )2009.01(
194090
‫שיטה והתקן להגנת מתחמים‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
15/09/2008
194091
A SHORT-RANGE COMMUNICATION
DEVICE
REUBEN BERMAN
15/09/2008
‫מכשיר תקשורת קצרת טווח‬
‫ראובן ברמן‬
194092
194093
STRUCTURE OF IMPELLER WITH
ROTATE SHROUD
VLADIMIR KLIATZKIN
21/03/2007
‫ולדימיר קליאצקין‬
194096
A61K )2009.01(
‫פורמולצית שחרור מבוקר של טולטרודין‬
‫טבע תעשיות פרמצבטיות בע"מ‬
194097
OFDMA - BASED OPERATION OF A
WIRELESS SUBSCRIBER TERMINAL
IN A PLURALITY OF CELLS
ALVARION LTD.
June 15,
F04D )2009.01(
‫מבנה של אימפלור עם מעטפת מסתובבת‬
CONTROLLED RELEASE
FORMULATION OF TOLTERODINE
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/784573
21/03/2006
PCT/US/2007/007176
WO/2007/109357
15/09/2008
A47J )2009.01(
‫טרמודוד‬
‫ברוך לוי‬
TERMODOD
BARUCH LEVI
15/09/2008
H04B )2009.01(
G06F )2009.01(
‫הפעלת מסוף מנוי אלחוטי במספר תאים‬
OFDMA ‫המבוססת על‬
‫אלווריון בע"מ‬
– ‫כ"ג בסיוון התשס"ט‬
4576
2009
21/01/2007
COMBAT TRAINING SYSTEM AND
METHOD
ISRAEL AEROSPACE INDUSTRIES
LTD.
IL
174327
15/03/2006
177080
25/07/2006
IL
PCT/IL/2007/000076
WO/2007/105194
15/09/2008
‫מערכת ושיטה לאימון ניהול קרב‬
‫התעשייה האוירית לישראל בע"מ‬
G08B )2009.01(
194099
SYSTEM FOR MANAGING
ASSIGNMENT AND PLACEMENT OF
WORKERS
CV-VC LTD.
15/09/2008
F41G )2009.01(
194098
‫מערכת להשמת וקבלה לעבודה של כוח‬
‫אדם‬
.‫סי‬.‫וי‬.‫וי‬.‫סי‬
B66F )2009.01(
194100
‫מערבל בטון מתנייע‬
‫אסף דגון‬
VEHICULAL CONCRETE MIXER
ASSAF DAGON
15/03/2007
DEVICES AND METHODS FOR
DETECTING CELLS AND OTHER
ANALYTES
THE GENERAL HOSPITAL
CORPORATION
US
60/782470
15/03/2006
PCT/US/2007/006791
WO/2007/106598
4577
G01N )2009.01(
194101
‫התקן ושיטות לגילוי תאים ואנליטים‬
‫אחרים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
08/03/2007
194102
SUBSTITUTED 2-AMINO-4-PHENYLDIHYDROQUINOLINES, METHOD FOR
THE PRODUCTION THEREOF, USE
THEREOF AS MEDICAMENTS, AND
MEDICAMENTS CONTAINING THEM
SANOFI AVENTIS
DE
102006012545.2 18/03/2006
PCT/EP/2007/001983
WO/2007/107246
08/03/2007
19/03/2007
194104
HEXAGONAL ROADWAY SYSTEM
AND TRAFFIC CONTROL SYSTEM
THEREOF
YOUNG DAE KIM
10-2006KR
17/03/2006
0024968
PCT/KR/2007/001324
WO/2007/108623
June 15,
‫–פניל–דיהידרוקווינולינים‬4–‫–אמינו‬2
‫ שימוש‬,‫ שיטה לייצורם‬,‫מותמרים‬
‫כתרופות ותרופות המכילות אותן‬
194103
SUBSTITUTED 1-AMINO-4-PHENYLDIHYDROISOQUINOLINES, METHOD
FOR THE PRODUCTION THEREOF, USE
THEREOF AS A MEDICAMENT, AND
MEDICAMENTS CONTAINING THEM
SANOFI AVENTIS
DE
102006012544.4 18/03/2006
PCT/EP/2007/001982
WO/2007/107245
C07D )2009.01(
C07D )2009.01(
‫–פניל–דיהידרוקווינולינים‬4–‫–אמינו‬1
‫ שימוש‬,‫ שיטה לייצורם‬,‫מותמרים‬
‫כתרופות ותרופות המכילות אותן‬
E01C )2009.01(
‫מערכת כבישים משושה ומערכת בקרת‬
‫תנועה שלה‬
– ‫כ"ג בסיוון התשס"ט‬
4578
2009
21/02/2007
4-(PYRROLOPYRIDINYL)
PYRIMIDINYL-2-AMINE DERIVATIVES
MERCK PATENT GMBH
DE
102006012617.3 20/03/2006
PCT/EP/2007/001494
WO/2007/107221
14/03/2007
A61K )2009.01(
‫שימור האיזון הכימי במי כלור‬
‫ידע חברה למחקר ופיתוח בע"מ‬
C07D )2009.01(
194107
A PROCESS FOR PREPARING
TETRAHYDROQUINOLINE
DERIVATIVES
MITSUBISHI TANABE PHARMA
CORPORATION
2006JP
30/03/2006
092783
2006-322845 30/11/2006
JP
PCT/JP/2007/057610
WO/2007/116922
4579
–‫ (פירולופירידיניל) פירימידיניל‬4 ‫נגזרות‬
‫–אמין‬2
194106
METHODS, COMPOSITIONS AND
DEVICES FOR MAINTAINING
CHEMICAL BALANCE OF
CHLORINATED WATER
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/783028
17/03/2006
PCT/IL/2007/000336
WO/2007/107981
29/03/2007
C07D )2009.01(
194105
‫תהליך להכנת נגזרות של‬
‫טטרההידרוקווינולין‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
11/07/2003
HYBRIDOMA CELL LINE DSM
ACC2542, THE ANTIBODIES
PRODUCED THEREBY AND THE USE
OF THE ANTIBODIES
BLASTICON BIOTECHNOLOGISCHE
FORSCHUNG GMBH
DE
665.431102 12/07/2002
PCT/EP/2003/007551
WO/2004/007701
15/03/2007
,ACC DSM2542 ‫תא היברידומה קווי‬
‫הנוגדנים המופקים על ידי זה והשימוש‬
‫בנוגדנים‬
194109
ELECTROSTIMULATING APPARATUS
AND METHOD
LORENZ BIOTECH S.P.A.
IT
MO2006A000087 17/03/2006
PCT/IB/2007/000637
WO/2007/107831
03/05/2007
SUCTION PUMP UNIT
MEDELA HOLDING AG
CH
749/06
PCT/CH/2007/000220
WO/2007/128156
A61N )2009.01(
‫מתקן חשמלי ממריץ ושיטה‬
194110
A61M )2009.01(
‫יחידת משאבת יניקה‬
09/05/2006
15/09/2008
194111
DEEP FRYING POT APPARATUS AND
METHOD THEREWITH
PESACH MELAMED
June 15,
C12N )2009.01(
194108
– ‫כ"ג בסיוון התשס"ט‬
A47J )2009.01(
‫ ושיטה עבורו‬,‫מתקן לטיגון עמוק עם סיר‬
‫פסח מלמד‬
4580
2009
15/03/2007
C12Q )2009.01(
194112
DETECTION AND TREATMENT OF
CANCERS
UNIVERSITE DE GENEVE
EP
06290425.5 16/03/2006
PCT/IB/2007/001721
WO/2007/105114
16/03/2007
14/03/2007
‫טיפול במצבים של מערכת העצבים‬
‫המרכזית‬
17/03/2006
C07C )2009.01(
194115
PROCESSES AND INTERMEDIATES
FOR PREPARING STERIC
COMPOUNDS
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/782976
16/03/2006
60/844771
15/09/2006
US
PCT/US/2007/006320
WO/2007/109023
4581
C12N )2009.01(
194114
TREATMENT OF CNS CONDITIONS
SYLENTIS S.A.
GB
0605337.5
PCT/GB/2007/050128
WO/2007/107789
‫גילוי וטיפול בסרטנים‬
‫תהליכים ותוצרי ביניים להכנת תרכובות‬
‫סטריות‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
14/03/2007
194116
DEUTERATED HEPATITIS C
PROTEASE INHIBITORS
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/782788
16/03/2006
60/782976
16/03/2006
US
60/844771
15/09/2006
US
PCT/US/2007/006493
WO/2007/109080
17/12/1999
‫ שעברו דאוטרציה‬C ‫מעכבי פרוטאז צהבת‬
194117
POLYPEPTIDES CONTAINING
OVARIAN CARCINOMA PROTEINS
PHARMACEUTICAL COMPOSITIONS,
VACCINES AND DIAGNOSTIC KITS
CONTAINING THE SAME
CORIXA CORPORATION
US
09/215681
17/12/1998
09/216003
17/12/1998
US
09/338933
23/06/1999
US
09/404879
24/09/1999
US
PCT/US/1999/030270
WO/2000/036107
20/03/2007
C12N )2009.01(
‫פוליפפטידים המכילים חלבוני סרטן של‬
‫ תכשירי רוקחות וחיסונים וערכות‬,‫השחלה‬
‫איבחון המכילים אותם‬
194118
FLEXIBLE, COMPRESSED
INTRAVAGINAL RINGS, AND
METHODS OF MAKING THE SAME
DURAMED PHARMACEUTICALS,
INC.
US
60/783411
20/03/2006
PCT/US/2007/006850
WO/2007/109247
June 15,
C07C )2009.01(
A61K )2009.01(
‫טבעות גמישות דחוסות תוך–נרתיקיות‬
‫ושיטות להכנתן‬
– ‫כ"ג בסיוון התשס"ט‬
4582
2009
21/03/2007
FLAME RETARDANT COMPOSITIONS
CONTAINING ALKYL SUBSTITUTED
ARYL PHOSPHATE DERIVATIVES
FOR USE WITH A FLEXIBLE
POLYURETHANE FOAM
CHEMTURA CORPORATION
US
60/785002
22/03/2006
11/723539
20/03/2007
US
PCT/US/2007/007281
WO/2007/109361
19/03/2007
‫תכשירים מעכבי להבות המכילים תולדות‬
‫אריל פוספט המותמרות באלקיל לשימוש‬
‫בקצף פוליאורתן גמיש‬
‫תכשירים פוליפפטידים מיוצבים‬
G02F )2009.01(
194121
PALATABILITY ENHANCERS FOR
PET FOOD AND METHODS OF
MANUFACTURE
AFB INTERNATIONAL
US
60/784778
22/03/2006
11/639493
21/03/2007
US
PCT/US/2007/064649
WO/2007/109761
4583
A61K )2009.01(
194120
STABILIZED POLYPEPTIDE
COMPOSITIONS
BIOGEN IDEC MA INC.
US
60/783622
17/03/2006
60/812688
09/06/2006
US
60/873802
08/12/2006
US
60/873996
08/12/2006
US
PCT/US/2007/006883
WO/2007/109254
22/03/2007
C08K )2009.01(
194119
‫מגבירי טעימות למזון חיות מחמד ושיטות‬
‫לייצור‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
29/03/2007
194122
PROCESS FOR PREPARATION OF HIV
PROTEASE INHIBITORS
GILEAD SCIENCES, INC.
US
60/787126
29/03/2006
PCT/US/2007/007564
WO/2007/126812
19/03/2007
194123
METHODS FOR REDUCING PROTEIN
AGGREGATION
WYETH
US
60/784130
20/03/2006
PCT/US/2007/006787
WO/2007/109221
12/04/2007
194124
SLOT MOTOR AND CIRCUIT
BREAKER INCLUDING THE SAME
EATON CORPORATION
US
11/402789
12/04/2006
PCT/IB/2007/000962
WO/2007/116311
20/03/2007
‫תהליך להכנת מעכבי פרוטיאז לנגיף‬
‫האיידס‬
A61K )2009.01(
‫שיטות להקטנת הצטברות חלבון‬
H01H )2009.01(
‫מנוע ומתג הכולל אותו‬
194125
VOLTAGE CONTROL LOAD CENTER,
MODULAR VOLTAGE CONTROL
TRANSFORMER CIRCUIT, AND
METHOD OF MAKING AND USING
ACTIVE ES LIGHTING CONTROLS
INC.
US
60/784351
21/03/2006
PCT/US/2007/007041
WO/2007/109331
June 15,
C07D )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
H01J )2009.01(
‫ מעגל שנאי‬,‫מרכז לבקרת עומס מתח‬
‫ ושיטה להכנה‬,‫מודולרי לבקרת מתח‬
‫ושימוש‬
4584
2009
09/03/2007
INFUSION DEVICE CAPABLE OF
PROVIDING MULTIPLE LIQUID
MEDICAMENTS
CALIBRA MEDICAL, INC.
US
60/782941
16/03/2006
11/705813
12/02/2007
US
PCT/US/2007/006243
WO/2007/109006
16/03/2007
‫התקן אינפוזיה המסוגל לספק מספר רב‬
‫של תרופות נוזליות‬
‫שיטה להכנת מבנה לתנור ומבנה לתנור‬
A61M )2009.01(
194129
INFUSION DEVICE PUMP
CALIBRA MEDICAL, INC.
US
60/782941
16/03/2006
11/705811
12/02/2007
US
PCT/US/2007/006181
WO/2007/108987
4585
H05B )2009.01(
194127
A METHOD OF MAKING A HEATER
STRUCTURE AND A HEATER
STRUCTURE
GKN AEROSPACE SERVICES
LIMITED
GB
0605453.0
17/03/2006
PCT/GB/2007/000933
WO/2007/107713
09/03/2007
A61M )2009.01(
194126
‫משאבה עבור התקן אינפוזיה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
09/03/2007
194130
INFUSION DEVICE WITH
PRESSURIZABLE LIQUID
MEDICAMENT CHAMBER
CALIBRA MEDICAL, INC.
US
60/782941
16/03/2006
11/705815
12/02/2007
US
PCT/US/2007/006182
WO/2007/108988
09/03/2007
‫התקן אינפוזיה עם תא לתרופה נוזלית‬
‫העומדת בתנאי לחץ‬
194131
INFUSION DEVICE WITH DOSAGE
DIAL CONTROL
CALIBRA MEDICAL, INC.
US
60/782941
16/03/2006
11/705814
12/02/2007
US
PCT/US/2007/006115
WO/2007/108969
25/04/2007
A61M )2009.01(
‫התקן אינפוזיה עם בקרת מינון‬
194132
H04L )2009.01(
‫ משתנה‬OFDM ‫קידוד ערוץ–משנה‬
‫ומודולציה‬
VARIABLE OFDM SUBCHANNEL
CODING AND MODULATION
MICROSOFT CORPORATION
US
11/410409
25/04/2006
PCT/US/2007/010021
WO/2007/127251
June 15,
A61M )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4586
2009
12/04/2007
ELECTRICAL SWITCHING
APPARATUS AND CIRCUIT
BREAKER INCLUDING A MOLDED
ENCLOSURE AND MACHINE
SCREWS REINFORCING THE SAME
EATON CORPORATION
US
11/402732
12/04/2006
PCT/IB/2007/000943
WO/2007/116307
22/03/2007
‫מערכת מיתוג חשמלית ומתג המכיל סוגר‬
‫וברגים לחיזוקו‬
‫נוגדן טיפולי לאנטיגן תאי אנטי–גידולי‬
E01B )2009.01(
194138
FAST AND NON-EXPENSIVE
METHOD TO REPAIR CRATERS AND
PATCHES OF ABSCENCE OF
ASPHALT OR OTHER PAVING OF A
ROAD.
DR. HAIM AMRAM BEN-SIMHON
16/09/2008
C07K )2009.01(
194137
ANTI-TUMOR CELL ANTIGEN
ANTIBODY THERAPEUTICS
NOVARTIS AG
US
60/785704
23/03/2006
PCT/US/2007/007382
WO/2007/109376
16/09/2008
H01H )2009.01(
194135
‫או‬/‫שיטה מהירה ולא יקרה לתיקון בור ו‬
‫חסר אספלט או צפוי אחר בדרכים (כביש‬
.)‫דרך עפר או כל דרך אחרת‬
‫ד"ר חיים עמרם בן שמחון‬
B65D )2009.01(
194139
PROTECTIVE DEVICE FOR
INANIMATE OBJECTS
YISHAI BAABAD
4587
‫מתקן הגנה לחפצים‬
‫ישי באב"ד‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
17/04/2007
194140
ISOLATION OF TETRACYCLINE
DERIVATIVES
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/792814
17/04/2006
PCT/US/2007/009432
WO/2007/120913
19/03/2007
‫בידוד של נגזרות טטרהציקלין‬
‫טבע תעשיות פרמצבטיות בע"מ‬
194142
INSTRUMENT FOR INTRODUCING
SOLID FILLERS INTO THE INTERIOR
OF A BONE
AKROSS AG
EP
06111415.3 20/03/2006
PCT/EP/2007/052562
WO/2007/107538
15/03/2007
23/03/2007
C12N )2009.01(
‫רצפי נוקלאוטיד חדשים המקדדים‬
‫–קסילוזילטרנספראז‬2,1–‫לניקוטיאנה בטה‬
194145
ENGINEERED HETERODIMERIC
PROTEIN DOMAINS
MERCK PATENT GMBH
US
60/785474
24/03/2006
PCT/EP/2007/002590
WO/2007/110205
June 15,
A61B )2009.01(
‫מכשיר להחדרת מילויים מוצקים לתוך‬
‫החלק הפנימי של עצם‬
194144
NOVEL NUCLEOTIDE SEQUENCES
ENCODING NICOTIANA BETA-1,2XYLOSYLTRANSFERASE
BAYER BIOSCIENCE N.V.
EP
06075714.3 23/03/2006
60/787551
30/03/2006
US
PCT/EP/2007/002322
WO/2007/107296
C07C )2009.01(
C07K )2009.01(
‫אזורים מהונדסים של חלבון הטרודימרי‬
– ‫כ"ג בסיוון התשס"ט‬
4588
2009
27/03/2007
MONOCYCLIC AND BICYCLIC
HIMBACINE DERIVATIVES USEFUL
AS THROMBIN RECEPTOR
ANTAGONISTS
SCHERING CORPORATION
US
60/786961
29/03/2006
PCT/US/2007/007497
WO/2007/126771
12/03/2007
‫נגזרות מונוציקליות וביציקליות של‬
‫הימבאצין שימושיות כאנטגוניסטים‬
‫לרצפטור תרומבין‬
A61M )2009.01(
194147
INTRAVAGINAL MEDICAMENT
APPLICATORS
DRUGTECH CORPORATION
US
60/784900
22/03/2006
11/684009
09/03/2007
US
PCT/US/2007/063801
WO/2007/109450
19/03/2007
C07D )2009.01(
194146
‫אפליקטורים למתן תוך–וגינאלי של תרופה‬
C07D )2009.01(
194148
HETEROCYCLIC SUBSTITUTED
PYRIDINE COMPOUNDS WITH
CXCR3 ANTAGONIST ACTIVITY
‫תרכובות פירידין מותמרות בטבעות‬
–‫הטרוציקליות עם פעילות אנטגוניסטית ל‬
CXCR3
SCHERING CORPORATION
US
60/784504
21/03/2006
PCT/US/2007/006827
WO/2007/109238
4589
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
26/03/2007
194149
CUTTING TOOL AND METHOD OF
PRODUCING THE SAME
SUMITOMO METAL INDUSTRIES,
LTD.
2006JP
28/03/2006
086773
2006-097318 31/03/2006
JP
PCT/JP/2007/056185
WO/2007/111293
29/03/2007
‫מכשיר חיתוך ושיטה להפקתו‬
194151
METHODS OF PRODUCING
CARBOXYLIC ACID CHLORIDE
COMPOUNDS
AJINOMOTO CO., INC.
JP
2006-98389 31/03/2006
PCT/JP/2007/056775
WO/2007/119580
16/03/2006
B23B )2009.01(
C07C )2009.01(
‫שיטות ליצור תרכובות חומצות‬
‫קרבוקסיליות כלורידיות‬
194152
PORTABLE APPLICATOR FOR
COLLAGEN STIMULATION
RICHARD MARKOLL
A61N )2009.01(
‫מוליך נייד לסטימולציה של קולאגן‬
PCT/EP/2006/002421
WO/2007/104340
20/03/2007
194154
METHOD AND APPARATUS FOR
GENERATING NON-BINARY
BALANCED CODES
MARVELL WORLD TRADE LTD
US
60/783941
20/03/2006
11/649899
04/01/2007
US
PCT/US/2007/006900
WO/2007/109262
June 15,
H04L )2009.01(
‫שיטה ומערכת ליצירת צופנים מאוזנים‬
‫לא בינאריים‬
– ‫כ"ג בסיוון התשס"ט‬
4590
2009
17/09/2008
‫משטחי אויר‬
AEROFOILS
ISRAEL AEROSPACE INDUSTRIES
LTD.
19/03/2007
‫התעשייה האוירית לישראל בע"מ‬
C12N )2009.01(
‫טטראמריזציה של פוליפפטידים ושיטות‬
‫לשימוש‬
A61K )2009.01(
194162
HER-2/NEU MULTI-PEPTIDE
VACCINE
BIO LIFE SCIENCE FORSCHUNGS
UND
ENTWICKLUNGSGESELLSCHAFT
M.B.H.
EP
06007834.2 13/04/2006
PCT/EP/2007/003226
WO/2007/118660
4591
,‫פירול מותמר בפירידיל ובפירימידיניל‬
‫תולדות תיאופן ופוראן כמעכבי קינאז‬
194161
TETRAMERIZING POLYPEPTIDES
AND METHODS OF USE
ZYMOGENETICS INC.
US
60/791626
13/04/2006
PCT/US/2007/066607
WO/2007/124283
11/04/2007
C07D )2009.01(
194157
PYRIDYL AND PYRIMIDINYL
SUBSTITUTED PYRROLE,
THIOPHENE-AND FURANE
DERIVATIVES AS KINASE
INHIBITORS
NERVIANO MEDICAL SCIENCES
S.R.L.
EP
06111766.9 27/03/2006
PCT/EP/2007/052587
WO/2007/110344
13/04/2007
B64C )2009.01(
194155
NEU/2–HER ‫חיסון רב פפטידי‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
30/03/2007
194163
NOVEL DIPEPTIDYL PEPTIDASE IV
INHIBITORS AND PROCESSES FOR
THEIR PREPARATION AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM
MATRIX LABORATORIES LIMITED
IN
610/CHE/2006 03/04/2006
60/801437
18/05/2006
US
PCT/IB/2007/000830
WO/2007/113634
20/04/2007
194164
194165
E21B )2009.01(
C07K )2009.01(
‫נוגדנים שעברו תהליך גליקוזילציה‬
GLYCOSYLATED ANTIBODIES
F. HOFFMANN-LA ROCHE AG
EP
06007565.2 11/04/2006
06016203.9
03/08/2006
EP
PCT/EP/2007/003164
WO/2007/115813
June 15,
,‫ חדשים‬IV ‫מעכבי דיפפטידיל פפטידאז‬
‫תהליכים להכנתם ותכשירי רוקחות‬
‫המכילים אותם‬
‫סגסוגות בעלות חוזק רב‬
HIGH STRENGTH ALLOYS
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.
US
60/794298
21/04/2006
60/853096
20/10/2006
US
PCT/US/2007/067093
WO/2007/124426
10/04/2007
C07D )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4592
2009
14/03/2007
METHOD FOR ADAPTIVE
QUADRATURE AMPLITUDE
MODULATION SIGNAL
CONSTELLATION REMAPPING FOR
DATA PACKET AETRANSMISSIONS
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/783644
17/03/2006
PCT/US/2007/006397
WO/2007/109041
21/03/2007
‫שיטה להתאמת מודולציה אמפליטודית‬
‫קוורטורית למיפוי מחדש של מערך סיגנלי‬
‫עבור שידור חוזר של חבילת מידע‬
–H5–‫–טטרהידרו‬9,8,7,6 ‫נגזרות של‬
‫–איל]–אמין‬4–‫]אזפין‬D–5,4[‫פירימידו‬
TRPVL–‫המשמשות כמודולטורים ל‬
‫לטיפול בכאב‬
F16D )2009.01(
194172
LIQUID-COOLED DISC BRAKES
QINETIQ LIMITED
GB
0605769.9
23/03/2006
PCT/GB/2007/001037
WO/2007/107771
4593
C07D )2009.01(
194170
6,7,8,9-TETRAHYDRO-5H-PYRIMIDO
[4,5-D]AZEPIN-4-YL]-AMINE
DERIVATIVES AS MODULATORS OF
TRPVL FOR THE TREATMENT OF
PAIN
JANSSEN PHARMACEUTICA N.V.
US
60/785415
21/03/2006
PCT/US/2007/007166
WO/2007/109355
21/03/2007
H04L )2009.01(
194168
‫מעצורי דיסק מקוררים בנוזל‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
23/03/2007
194173
ICE-MAKING DEVICE FOR
REFRIGERATOR
LG ELECTRONICS INC.
10-2006KR
23/03/2006
0026660
10-200623/03/2006
KR
0026661
10-200623/03/2006
KR
0026663
10-200623/03/2006
KR
0026664
F25C )2009.01(
‫התקן למקרר להכנת קרח‬
PCT/KR/2007/001420
WO/2007/108662
20/03/2007
194175
METHODS TO MAINTAIN, IMPROVE
AND RESTORE THE CARTILAGE
PHENOTYPE OF CHONDROCYTES
TIGENIX N.V.
US
60/783986
20/03/2006
PCT/EP/2007/002452
WO/2007/107330
19/03/2007
‫ שיפור ושיקום פנוטיפ‬,‫שיטות לשמירה‬
‫סחוסי של תאי סחוס‬
194176
A61K )2009.01(
‫תכשירי רוקחות‬
PHARMACEUTICAL COMPOSITIONS
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/784275
20/03/2006
60/871692
22/12/2006
US
PCT/US/2007/064294
WO/2007/109605
June 15,
C12N )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4594
2009
27/03/2007
USE OF GHRELIN SPLICE VARIANT
FOR TREATING
HYPERCHOLESTEROLEMIA AND/OR
HIGH CHOLESTEROL AND/OR HIGH
CHOLESTEROL COMPLICATION
AND/OR LIPEMIA COMPLICATION
AND/OR CORONARY HEART
DISEASE AND/OR WEIGHT
MANAGEMENT AND/OR DIABETES
AND/OR HYPERGLYCEMIA
LIAT MINTZ
US
60/786616
28/03/2006
PCT/US/2007/007534
WO/2007/126792
20/03/2007
‫ליאת מינץ‬
B07C )2009.01(
‫מערכת לעיבוד כפפות שניתן לעשות בהן‬
‫שימוש חוזר‬
G06F )2009.01(
194181
FILTERED REPLICATION OF DATA
STORES
MICROSOFT CORPORATION
US
11/380579
27/04/2006
PCT/US/2007/002379
WO/2007/130178
4595
‫שימוש במשתנה איחוי גרליני לטיפול‬
‫או עודף כולסטרול‬/‫ביתר כולסטרול בדם ו‬
‫או‬/‫או סיבוך הנובע מעודף כולסטרול ו‬/‫ו‬
‫או סיבוך הנובע מעודף‬/‫יתר שומן בדם ו‬
‫או ניהול משקל‬/‫או התקף לב ו‬/‫שומן בדם ו‬
‫או יתר סוכר בדם‬/‫או סכרת ו‬/‫ו‬
194180
A SYSTEM FOR THE PROCESSING OF
REUSABLE GLOVES
TGT ENTERPRISE LTD.
SG
200601745-3 21/03/2006
PCT/SG/2007/000076
WO/2007/010877
29/01/2007
C07K )2009.01(
194177
‫העתקה מסוננת של מאגרי מידע‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
03/08/2007
194182
FORMULATIONS FOR PARENTERAL
DELIVERY OF COMPOUNDS AND
USES THEREOF
WYETH
US
60/835574
04/08/2006
PCT/US/2007/017430
WO/2008/019115
26/03/2007
‫הרכבי תרכובות למתן תוך ורידי‬
‫ושימושיהם‬
194186
G01N )2009.01(
‫הרכבה של תא מיקרופלואידי לתבחין של‬
‫מסטיטיס‬
MICROFLUIDIC CHAMBER
ASSEMBLY FOR MASTITIS ASSAY
ADVANCED ANIMAL DIAGNOSTICS
US
60/785877
24/03/2006
PCT/US/2007/064893
WO/2007/112332
22/03/2007
A61K )2009.01(
194188
C07D )2009.01(
TRIAZOLONE DERIVATIVE
EISAI R&D MANAGEMENT CO., LTD.
2006JP
24/03/2006
083486
60/786687
29/03/2006
US
2006-162594 12/06/2006
JP
60/804878
15/06/2006
US
2006-218819 10/08/2006
JP
60/838418
18/08/2006
US
PCT/JP/2007/055813
WO/2007/111212
‫נגזרת טריאזולון‬
03/04/2007
G06F )2009.01(
194190
MERGING MULTI-LINE LOG ENTRIES
ARCSIGHT, INC.
US
11/398863
05/04/2006
PCT/US/2007/065886
WO/2007/118096
June 15,
– ‫כ"ג בסיוון התשס"ט‬
‫מיזוג של רישומי יומן רבי שורות‬
4596
2009
01/04/2005
METHOD OF PRODUCTION OF MEAT
PRODUCTS FROM ENTIRE
MUSCULAR TISSUE, WITH DIRECT IN
CORPORATION OF OLIVE OIL
CRETA FARM ANONIMOS
VIOMICHANIKI & EMPORIKI
ETAIREIA,
GR
20040100113 01/04/2004
PCT/GR/2005/000009
WO/2005/094617
19/05/2004
H01L )2009.01(
‫שיטה לקישור קוולנטי בטמפרטורת חדר‬
F25C )2009.01(
194194
ICE-MAKING DEVICE FOR
REGRIGERATOR
LG ELECTRONICS INC.
10-2006KR
18/04/2006
0035107
10-200618/04/2006
KR
0035110
10-200618/04/2006
KR
0035122
PCT/KR/2007/001895
WO/2007/120015
4597
‫שיטה לייצור מוצרי בשר מרקמה שרירית‬
‫עם שילוב ישיר של שמן זית‬
194192
METHOD OF ROOM TEMPERATURE
COVALENT BONDING
ZIPTRONIX, INC.
US
10/440099
19/05/2003
PCT/US/2004/013306
WO/2004/105084
18/04/2007
A23L )2009.01(
194191
‫התקן למקרר להכנת קרח‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
13/03/2007
194195
MAGNESIUM HYDROXIDE WITH
IMPROVED COMPOUNDING AND
VISCOSITY PERFORMANCE
ALBEMARLE CORPORATION
US
60/787844
31/03/2006
PCT/US/2007/063889
WO/2007/117841
13/03/2007
‫מגנזיום הידרוקסיד בעל ביצועי התרכבות‬
‫וצמיגות משופרים‬
194196
MAGNESIUM HYDROXIDE WITH
IMPROVED COMPOUNDING AND
VISCOSITY PERFORMANCE
ALBEMARLE CORPORATION
US
60/788246
31/03/2006
PCT/US/2007/063886
WO/2007/117840
21/03/2006
C01F )2009.01(
C01F )2009.01(
‫מגנזיום הדירוקסיד בעל ביצועי התרכבות‬
‫וצמיגות משופרים‬
194199
TREATMENT OF POULTRY FOR
REDUCING THE FEED CONVERSION
RATE OR FOR REDUCING THE
INCIDENCE OF ASCITES
TAMINCO
A23K )2009.01(
‫טיפול בבעלי כנף להקטנת יחס המרת‬
‫הזנה או להקטנת ארוע מימת הבטן‬
PCT/EP/2006/060926
WO/2007/107184
21/03/2007
DENTAL IMPLANT
URI ARNI
US
60/784833
PCT/IL/2007/000369
WO/2007/107995
June 15,
194200
A61C )2009.01(
‫שתל דנטאלי‬
‫אורי ארני‬
21/03/2006
– ‫כ"ג בסיוון התשס"ט‬
4598
2009
18/10/2006
HIGH-CALORIE NUTRITIONAL
SUPPLEMENT
NESTEC S.A.
US
60/785070
23/03/2006
PCT/US/2006/040628
WO/2007/108827
21/03/2007
A23L )2009.01(
194201
‫תוסף תזונתי המכיל קלוריות רבות‬
H01H )2009.01(
194203
‫התקן מיתוג‬
A SWITCHING DEVICE
MOELLER GEBAUDEAUTOMATION
GMBH
AT
A675/2006
20/04/2006
PCT/AT/2007/000136
WO/2007/121492
28/03/2006
F24J )2009.01(
194204
PARABOLIC SOLAR TROUGH
SYSTEMS WITH ROTARY TRACKING
MEANS
CAPAN, RAHMI, OGUZ
‫מערכות פרבוליות באמצעות סולרית עם‬
‫אמצעי מעקב סיבוביים‬
PCT/IB/2006/050941
WO/2007/110713
03/04/2007
VENT GROOVE MODIFIED SPUTTER
TARGET ASSEMBLY
PRAXAIR TECHNOLOGY, INC.
US
60/788715
04/04/2006
11/731105
30/03/2007
US
PCT/US/2007/008130
WO/2007/114899
4599
C25B )2009.01(
194205
‫חריץ אוורור מותאם להרכבת מטרת פיזור‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
09/03/2007
194207
METHOD FOR VISUALIZING AND
COMPARING IMAGES OR VOLUMES OF
DATA OF PHYSICAL QUANTITIES
ENI S.P.A.
IT
MI2006A000505 21/03/2006
PCT/EP/2007/002122
WO/2007/107257
13/03/2007
12/04/2007
194210
194211
PIPERIDINE DERIVATIVES USEFUL
FOR TREATING OSTEOARTHRITIS
AND OSTEOARTROSIS
ASTRAZENECA AB
US
60/790303
06/04/2006
PCT/SE/2007/000321
WO/2007/114770
June 15,
A61K )2009.01(
‫נאנו חלקיקים פולילקטידים‬
C07D )2009.01(
‫נגזרות של תיאוקסאנתין ושימושן‬
MPO ‫כמעכבים של‬
THIOXANTHINE DERIVATIVES AND
THEIR USE AS INHIBITORS OF MPO
ASTRAZENECA AB
US
60/791667
13/04/2006
PCT/SE/2007/000349
WO/2007/120098
04/04/2007
‫שיטה לויזואליזציה והשוואת תמונות או‬
‫נפחי מידע של כמויות פיזיות‬
194209
POLYLACTIDE NANOPARTICLES
LTS LOHMANN THERAPIE-SYSTEME
AG
DE
102006013531.8 24/03/2006
PCT/EP/2007/002198
WO/2007/110152
G01V )2009.01(
C07D )2009.01(
‫נגזרות של פיפרידין השימושיות לטיפול‬
‫באוסטאוארתריטיס ואוסטאוארתרוזיס‬
– ‫כ"ג בסיוון התשס"ט‬
4600
2009
27/03/2007
‫זיכרון אפיק משנה מידע‬
DATA MODIFYING BUS BUFFER
RAYTHEON COMPANY
US
60/791544
11/04/2006
11/381081
01/05/2006
US
PCT/US/2007/007647
WO/2008/051281
10/04/2007
GPR 119–‫שיטות לשימוש ברצפטור ל‬
‫לזיהוי תרכובות שימושיות להעלאת מסת‬
‫העצמות בפרט‬
A61K )2009.01(
194216
ASYMMETRIC MEMBRANES FOR
DRUG DELIVERY DEVICES
PFIZER PRODUCTS INC.
US
60/794681
24/04/2006
PCT/IB/2007/001114
WO/2007/122510
4601
C12Q )2009.01(
194215
METHODS OF USING GPR119
RECEPTOR TO IDENTIFY
COMPOUNDS USEFUL FOR
INCREASING BONE MASS IN AN
INDIVIDUAL
ARENA PHARMACEUTICALS, INC.
US
60/791550
11/04/2006
PCT/US/2007/008902
WO/2007/120689
13/04/2007
G06F )2009.01(
194213
‫ממברנות אסימטריות לנתינת תרופות‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
11/04/2007
194217
SYNTHESIS OF
ACYLAMINOALKENYLENE AMIDES
USEFUL AS SUBSTANCE P
ANTAGONISTS
NOVARTIS AG
GB
0607532.9
13/04/2006
0610244.6
23/05/2006
GB
PCT/EP/2007/003213
WO/2007/118651
26/03/2007
‫סינתזה של אצילאמינואלקנילן אמידים‬
P ‫השימושיים כאנטגוניסטים של חומר‬
194218
PROCESS FOR PREPARING
LINEZOLID
PFIZER PRODUCTS INC.
US
60/790360
07/04/2006
60/816983
28/06/2006
US
PCT/IB/2007/000882
WO/2007/116284
26/03/2007
C07D )2009.01(
‫תהליך להכנת לינזוליד‬
194219
PROCESS FOR PREPARATION OF
ENANTIOMERICALLY ENRICHED
CYCLIC B- ARYL OR HETEROARYL
CARBOXYLIC ACIDS
F. HOFFMANN-LA ROCHE AG
EP
06112171.1 03/04/2006
PCT/EP/2007/052855
WO/2007/113155
June 15,
C07D )2009.01(
C07D )2009.01(
‫תהליך להכנת חומצות קרבוקסיליות של‬
‫–אריל ציקלי או הטרואריל המועשרות‬B
‫באופן אננתיומרי‬
– ‫כ"ג בסיוון התשס"ט‬
4602
2009
21/03/2007
PROCESS FOR THE MANUFACTURE
OF A SHAPED PART AND SHAPED
PART OBTAINABLE WITH SAID
PROCESS
DSM IP ASSETS B.V.
EP
06075677.2 21/03/2006
PCT/EP/2007/002515
WO/2007/107359
28/03/2007
‫תהליך לייצור חלק מעוצב וחלק מעוצב‬
‫הניתן להשגה על ידי התהליך האמור‬
‫נוגדנים חד שבטייים מאונשים נגד גורם‬
‫גידול הפטוציטי‬
‫תרכובות מיוצבות המכילות תרופות‬
‫רגישות לבסיס‬
G01J )2009.01(
194223
SPECTRUM-FORMING DEVICE ON
AN OPTICAL SENSOR WITH SPATIAL
REJECTION
SC SPIM
FR
06/02442
21/03/2006
4603
A61K )2009.01(
194222
STABILIZED COMPOSITIONS
CONTAINING ALKALINE LABILE
DRUGS
AUXILIUM PHARMACEUTICALS,
INC.
US
60/785505
24/03/2006
PCT/US/2007/064714
WO/2007/112286
07/02/2007
C11D )2009.01(
194221
HUMANIZED MONOCLONAL
ANTIBODIES TO HEPATOCYTE
GROWTH FACTOR
GALAXY BIOTECH, LLC
US
60/788243
01/04/2006
PCT/US/2007/065385
WO/2007/115049
22/03/2007
B29C )2009.01(
194220
‫מתקן היוצר ספקטרום בחיישן אופטי בעל‬
‫דחייה מרחבית‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
PCT/FR/2007/000220
WO/2007/107643
22/03/2007
194224
DEVICE FOR COMMUNICATIONS
VIA THE ELECTRICITY MAINS WITH
FILTERED AUXILIARY POWER
OUTLET
DISENO DE SISTEMAS EN SILICIO,
S.A.
ES
P200600743 23/03/2006
PCT/ES/2007/000159
WO/2007/107615
21/09/2008
‫מתקן לתקשורת דרך רשת חשמל עם‬
‫שקע עזר מסנן‬
194225
DRILL BIT AND CORE RETAINING
DEVICE
SIG-M DIAMOND BLADES
MANUFACTURING LTD.
19/03/2007
‫אם ייצור להבי יהלום בע"מ‬-‫סיג‬
194226
G02C )2009.01(
‫מערכת עינית המשלבת רכיבים עיניים עם‬
‫חסימה של אורך גל של אור כחול‬
‫ופונקציונאליות של איזון צבע‬
194227
LOW TOP BONE FIXATION SYSTEM
AND METHOD FOR USING THE
SAME
PIONEER SURGICAL TECHNOLOGY,
INC.
June 15,
B23B )2009.01(
‫מקדח ומתקן המחזיק את החומר הנחתך‬
OPHTHALMIC SYSTEM COMBINING
OPHTHALMIC COMPONENTS WITH
BLUE LIGHT WAVELENGTH
BLOCKING AND COLORBALANCING FUNCTIONALITIES
HIGH PERFORMANCE OPTICS, INC.
US
11/378317
20/03/2006
PCT/US/2007/006748
WO/2007/109202
22/03/2007
H04B )2009.01(
A61F )2009.01(
‫מערכת לקיבוע עצם עליונה תחתונה‬
‫ושיטה לשימוש בה‬
– ‫כ"ג בסיוון התשס"ט‬
4604
2009
US
60/784674
PCT/US/2007/007306
WO/2008/103150
22/03/2006
09/03/2007
HYDROPNEUMATIC BRAKING AND
RETURN SYSTEM FOR BARREL-RECOIL
GUNS
RHEINMETALL WAFFE MUNITION
GMBH
DE
102006014155.5 24/03/2006
PCT/EP/2007/002065
WO/2007/110140
21/09/2008
REDUCED DARK CURRENT
PHOTODETECTOR
SHIMON MAIMON
B01D )2009.01(
‫מיתוג אוטומטי להפרדת מים אפורים‬
‫עדי לב‬
C07K )2009.01(
194230
NOVEL STREPTOCOCCUS ANTIGENS
SHIRE CANADA, INC.
US
60/113800
23/12/1998
PCT/CA/1999/001218
WO/2000/039299
21/03/2006
‫מערכת בלימה והחזר הידרופנוימטית‬
‫לנשק דריכת קנה‬
194229
AUTO GRAY WATER SEPRATION
SWITCHER
ADI LEV
20/12/1999
F41A )2009.01(
194228
‫אנטיגנים חדשים של סטרפטוקוקוס‬
H01L )2009.01(
194231
) CURRENT DARK( ‫גלאי זרם חושך‬
‫מצומצם‬
‫שמעון מימון‬
PCT/IL/2006/000364
WO/2007/107973
4605
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
22/03/2007
194232
METHODS FOR CELL EXPANSION
AND USES OF CELLS AND
CONDITIONED MEDIA PRODUCED
THEREBY FOR THERAPY
PLURISTEM LTD
US
60/784769
23/03/2006
60/847088
26/09/2006
US
PCT/IL/2007/000380
WO/2007/108003
18/03/2007
‫שיטות לפרוליפרציה של תאים ושימושים‬
‫של התאים ונוזלי גידול בתראפיה‬
‫פלוריסטם בע"מ‬
194233
SYSTEM AND METHOD FOR REAL
TIME MONITORING OF A SUBJECT
AND VERIFICATION OF AN
EMERGENCY SITUATION
IANIV SEROR
US
60/784489
22/03/2006
PCT/IL/2007/000349
WO/2007/107984
09/03/2007
H04J )2009.01(
‫מערכת ושיטה לניטור בזמן אמת של‬
‫סובייקט וזיהוי של מצב חירום‬
‫יניב סרור‬
194234
RAS MUTATION AND
COMPOSITIONS AND METHODS
RELATED THERETO
GLOBEIMMUNE, INC.
US
60/786568
27/03/2006
PCT/US/2007/063711
WO/2007/133835
June 15,
C12N )2009.01(
A61F )2009.01(
‫ הרכבים ושיטות הקשורים‬,RAS ‫מוטציה‬
‫לכך‬
– ‫כ"ג בסיוון התשס"ט‬
4606
2009
04/04/2007
C07K )2009.01(
194236
‫זיקוק נוגדנים‬
ANTIBODY PURIFICATION
ABBOTT BIOTECHNOLOGY LTD.
US
60/789725
05/04/2006
60/790414
06/04/2006
US
PCT/US/2007/008359
WO/2007/117490
14/03/2007
ACCESSORY DEVICE FOR CONES FOR
THE EAR CARE
OTOSAN DI GIANARDI MASSIMILIANO
IT
RA2006A000018 22/03/2006
PCT/IB/2007/050871
WO/2007/107927
22/03/2007
‫אביזר לקונוסים עבור טיפול באוזן‬
–2–‫מלחים בעלי פעילות אנטאגוניסטית ב‬
CRTH
C07D )2009.01(
194241
AGENTS THAT DISRUPT CELLULAR
REPLICATION AND THEIR USE IN
INHIBITING PATHOLOGICAL CONDITIONS
THE EUROPEAN MOLECULAR BIOLOGY
LABORATORY
EP
PCT/EP2006/002604 21/03/2006
PCT/EP/2007/002504
WO/2007/107352
4607
C07D )2009.01(
194240
SALTS WITH CRTH2 ANTAGONIST
ACTIVITY
OXAGEN LIMITED
GB
0605743.4
22/03/2006
PCT/GB/2007/001038
WO/2007/107772
21/03/2007
A61F )2009.01(
194239
‫סוכנים המפריעים לשכפול תאי‬
‫ושימושם בעיכוב מצבים פתולוגיים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
27/03/2007
194243
PROCESS FOR PRODUCTION OF
ETHYLENEDIAMINE DERIVATIVES
HAVING A HALOGENATED
CARBAMATE GROUP AND AN ACYL
GROUP AND INTERMEDIATES FOR
USE THEREIN
MITSUI CHEMICALS, INC.
2006JP
29/03/2006
090705
PCT/JP/2007/000307
WO/2007/111024
10/05/2007
‫תהליך להכנת תולדות אתילנדיאמין עם‬
‫קבוצת קרבאמאט המותמרת בהלוגן ועם‬
‫קבוצת אציל וחומרי ביניים לשימוש‬
‫בתהליך זה‬
194244
AQUEOUS PHARMACEUTICAL
SUSPENSION
NORBROOK LABORATORIES
LIMITED
GB
0610058.0
19/05/2006
0610246.1
23/05/2006
GB
0708375.1
30/04/2007
GB
PCT/GB/2007/001700
WO/2007/135362
22/09/2008
194245
F15D )2009.01(
‫מערכת אוטומטית לעצירת דליפת מים‬
‫חיים אהרונוביץ‬
194246
INTEGRATED SYSTEM FOR SEA
WATER DESALINATION AND
ELECTRIC POWER GENERATION
June 15,
A61K )2009.01(
‫תרחיף רוקחי מימי‬
AN AUTOMATIC SYSTEM TO STOP
WATER LEAKAGE
HAIM AHARONOVIS
22/09/2008
C07C )2009.01(
C02F )2009.01(
‫מערכת משולבת להתפלת מי ים והפקת‬
‫חשמל‬
– ‫כ"ג בסיוון התשס"ט‬
4608
2009
‫חיים פורת‬
CHAIM PORAT
26/03/2007
IMIDIAZOPYRIDIN-2-ONE
DERVIVATIVES AS INHIBITORS OF
ENDOTHELIAL LIPASE
SANOFI AVENTIS
DE
102006014685.9 28/03/2006
PCT/EP/2007/002637
WO/2007/110215
22/03/2007
‫–און כמעכבי‬2–‫נגזרות אימידזופירידין‬
‫אנדותליאל ליפאז‬
‫התקן סגירה עם מסך בעל שוליים גמישים‬
GENTLE-ACTING SKINDISINFECTANTS AND
HYDROALCOHOLIC GEL
FORMULATIONS
4609
C07D )2009.01(
194249
AZOLOPYRIDIN-3-ONE DERIVATIVES
AS INHIBITORS OF ENDOTHELIAL
LIPASE
SANOFI AVENTIS
DE
102006014688.3 28/03/2006
PCT/EP/2007/002649
WO/2007/110216
23/10/2002
E06B )2009.01(
194248
CLOSURE DEVICE WITH A CURTAIN
HAVING FLEXIBLELATERAL EDGES
DYNACO INTERNATIONAL S.A.
EP
06111956.6 29/03/2006
PCT/EP/2007/052777
WO/2007/110381
26/03/2007
C07D )2009.01(
194247
‫–און כמעכבים של‬3–‫נגזרות אזולופירידין‬
‫אנדותליאל ליפאז‬
A61K )2009.01(
194250
‫חומרי חיטוי לעור ותכשירי ג'ל‬
‫הידרואלכוהוליים בעלי פעילות עדינה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
THE TRUSTEES OF COLUMBIA
UNIVERSITY IN THE CITY OF NEW
YORK
US
10/047631
23/10/2001
PCT/US/2002/033865
WO/2003/034994
30/03/2007
194251
AZOLOPYRIMIDINES AS INHIBITORS
OF CANNABINOID 1 ACTIVITY
IRM LLC
US
60/788310
30/03/2006
PCT/US/2007/007989
WO/2007/120454
21/11/2006
‫אזולופירימידינים כמעכבים של פעילות של‬
1 ‫קאנאבינואיד‬
194252
MODIFIED SURFACES FOR
ATTACHMENT OF BIOLOGICAL
MATERIALS
CHAMELEON SCIENTIFIC
CORPORATION
US
60/786118
27/03/2006
11/603436
20/11/2006
US
PCT/US/2006/045314
WO/2008/054408
07/06/2002
A61L )2009.01(
‫משטחים מותאמים לחיבור חומרים‬
‫ביולוגיים‬
194253
BENZO 1,4 - DIAZEPINE, 2 - OXO
DERIVATIVES AS CYCLIC
NUCLEOTIDE PHOSPHODIESTERASE
INHIBITORS, THEIR PREPARATION
AND USE
VIA PHARMACEUTICALS, INC.
FR
01/07458
07/06/2001
PCT/FR/2002/001952
WO/2002/098865
June 15,
C07D )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
C07D )2009.01(
‫ – אוקסו‬2 ,‫ – דיאזפין‬1,4 – ‫נגזרות של בנזו‬
‫כמעכבים של פוספודיאסטראז של‬
‫ הכנתם ושימושם‬,‫נוקלאוטיד טבעתי‬
4610
2009
28/03/2007
PROCESS FOR THE PREPARATION OF
WATER-IN-OIL AND OIL-IN-WATER
NANOEMULSIONS
POLIMERI EUROPA S.P.A.
IT
MI2006A000618 31/03/2006
PCT/EP/2007/002863
WO/2007/112967
29/03/2007
4611
C09D )2009.01(
‫קופסאות שימורים מצופות בהרכב‬
‫המורכב מפולימור אקרילי‬
B64C )2009.01(
194259
AERODYNAMIC OR
HYDRODYNAMIC PROFILE WHICH
CAN BE DEFORMED IN A
CONTINUOUS AND CONTROLLED
MANNER
CETIM CERMAT (ASSOCIATION)
FR
0651048
27/03/2006
PCT/FR/2007/050866
WO/2007/110518
22/09/2008
‫תהליך להכנת ננו–תחליב של מים‬
‫בשמן ושמן במים‬
194258
FOOD CANS COATED WITH A
COMPOSITION COMPRISING AN
ACRYLIC POLYMER
PPG INDUSTRIES OHIO, INC.
US
11/399227
06/04/2006
PCT/US/2007/007880
WO/2007/123659
01/03/2007
C10L )2009.01(
194255
‫פרופיל אירודינמי או הידרודינמי היכול‬
‫להשתנות בצורה מתמשכת ומבוקרת‬
A61K )2009.01(
194260
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
METHODS AND COMPOSITIONS FOR
TREATING HAIR
K.K.L. PHARMACEUTICALS LTD.
30/03/2007
‫שיטות והרכבים לטיפול בשיער‬
‫ פרמצודיקלס בע"מ‬.‫אל‬.‫קי‬.‫קי‬
194262
CYCLIC NATRIURETIC PEPTIDE
CONSTRUCTS
PALATIN TECHNOLOGIES, INC.
US
60/743960
30/03/2006
60/743961
30/03/2006
US
PCT/US/2007/065645
WO/2007/115175
‫מבנים פפטידים ציקלים נתריאורתים‬
29/03/2007
194264
OPTICAL DATA BUS SYSTEM
ROHDE & SCHWARZ GMBH & CO. KG
DE
102006014848.7 30/03/2006
PCT/EP/2007/002848
WO/2007/112960
30/03/2007
194265
194266
ANTI-IGF-IR ANTIBODIES AND USES
THEREOF
June 15,
H04B )2009.01(
‫מערכת אפיקי נתונים אופטית‬
B23B )2009.01(
‫תחליפים של חומצה אמינית למבנים‬
‫פפטידיים‬
AMINO ACID SURROGATES FOR
PEPTIDIC CONSTRUCTS
PALATIN TECHNOLOGIES, INC.
US
60/743963
30/03/2006
60/743964
30/03/2006
US
60/743960
30/03/2006
US
PCT/US/2007/065632
WO/2007/115164
28/03/2007
A61K )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
A61K )2009.01(
‫ ושימושיהם‬IR–IGF ‫נוגדנים אנטי‬
4612
2009
BIOGEN IDEC MA INC.
US
60/786347
60/876554
US
PCT/US/2007/007664
WO/2007/126876
28/03/2006
22/12/2006
04/04/2007
A PROCESS FOR CONCENTRATION OF
A POLYPEPTIDE
ZYMENEX A/S
DK
PA200600488 04/04/2006
DK
PA200600922 05/07/2006
PCT/DK/2007/000177
WO/2007/112757
02/04/2007
‫מטוס עם התקן ליצירת תנופה‬
‫אוירודינאמית‬
A61L )2009.01(
‫חבישה לפצעים הכוללת גורמים נוגדי‬
‫חיידקים וגורמי קילציה‬
A61L )2009.01(
194271
MULTI-LAYER WOUND DRESSINGS
TYCO HEALTHCARE GROUP LP
4613
B64C )2009.01(
194270
WOUND DERSSINGS WITH ANTIMICROBIAL AND CHELATING
AGENTS
TYCO HEALTHCARE GROUP LP
US
60/790813
11/04/2006
PCT/US/2007/008755
WO/2007/120608
11/04/2007
‫תהליך לריכוז פוליפפטיד‬
194268
AIRCRAFT WITH AERODYNAMIC
LIFT GENERATING DEVICE
FANWING LIMITED
GB
0606518.9
31/03/2006
PCT/GB/2007/001186
WO/2007/113525
11/04/2007
C07K )2009.01(
194267
‫חבישה לפצעים מרובת שכבות‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
US
60/790813
60/790814
US
11/716008
US
PCT/US/2007/008772
WO/2007/120617
11/04/2006
11/04/2006
09/03/2007
28/03/2007
STACKS OF PRE-MOISTENED WIPES
WITH UNIQUE FLUID RETENTION
CHARACTERISTICS
THE PROCTER & GAMBLE
COMPANY
US
60/787467
30/03/2006
PCT/US/2007/007794
WO/2007/126974
07/04/2006
A47L )2009.01(
194272
‫ערימות מגבונים טרום–לחים עם תכונות‬
‫מיוחדות לשמירת נוזלים‬
C07K )2009.01(
194274
‫ סינתטי עבור טיפול‬MECP2 ‫רצף‬
‫בהחלפת חלבון‬
SYNTHETIC MECP2 SEQUENCE FOR
PROTEIN SUBSTITUTION THERAPY
GEORG AUGUST-UNIVERSITAT
GOTTINGEN STIFTUNG
OFFENETLLICHEN RECHTS
PCT/EP/2006/003203
WO/2007/115578
04/08/2006
194276
DEVICE AND METHOD FOR THE
DILUTION AND PREPARATION OF
ANTIBLASTIC DRUGS
BIODUCT S.R.L
IT
MO2006A000097 24/03/2006
PCT/IB/2006/002134
WO/2007/110684
June 15,
– ‫כ"ג בסיוון התשס"ט‬
A61J )2009.01(
‫התקן ושיטה לדילול והכנה של סמים‬
‫אנטיבלסטיים‬
4614
2009
26/03/2007
DOSAGE AEROSOLS FOR THE
ADMINISTRATION OF
PHARMACEUTICAL PREPARATIONS
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
DE
102006014433.3 27/03/2006
PCT/EP/2007/052857
WO/2007/110403
14/03/2007
H04Q )2008.04(
‫שיטה להקצאת יחידה ניידת לאזור מעקב‬
‫המבוססת על תדירות איזורית מעודכנת‬
A61M )2009.01(
194280
PACKAGING MEANS FOR MULTI-DOSE
POWDER INHALERS WITH OPTIMIZED
DISCHARGING PROPERTIES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
102006014434.1 27/03/2006
PCT/EP/2007/052854
WO/2007/110402
4615
‫תרסיסי מינון למתן תכשירי רוקחות‬
194279
METHOD OF ASSIGNING A MOBILE
UNIT OF A TRACKING AREA BASED
ON A LOCATION UPDATE
FREQUENCY
LUCENT TECHNOLOGIES INC.
US
11/390995
28/03/2006
PCT/US/2007/006505
WO/2007/126595
26/03/2007
B05B )2009.01(
194278
–‫אמצעי אריזה עבור משאפי אבקה רבי‬
‫מנות עם תכונות פריקה אופטימליים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
23/03/2007
194281
BIOMARKERS USEFUL FOR
DIAGNOSING PROSTATE CANCER,
AND METHODS THEREOF
PHENOMENOME DISCOVERIES INC.
US
60/785480
24/03/2006
PCT/CA/2007/000469
WO/2007/109881
22/03/2007
‫סמנים ביולוגיים המשמשים לאבחון סרטן‬
‫הפרוסטטה ושיטות לכך‬
194282
CARRIER BODY FOR COMPONENTS OR
CIRCUITS
CERAMTEC AG
DE
102006013873.2 23/03/2006
102006055965.7
24/11/2006
DE
102006058417.1
08/12/2006
DE
PCT/EP/2007/052726
WO/2007/107601
05/04/2007
194283
QUINAZOLINES FOR PDK1
INHIBITION
NOVARTIS VACCINES AND
DIAGNOSTICS, INC.
US
60/790304
06/04/2006
PCT/US/2007/008592
WO/2007/117607
13/03/2007
June 15,
C07F )2009.01(
H01L )2009.01(
‫גוף נושא עבור רכיבים או מעגלים‬
C07D )2009.01(
PDK1 ‫קווינאזולינים לעכוב‬
194284
– ‫כ"ג בסיוון התשס"ט‬
A01C )2009.01(
4616
2009
SUBSURFACE SOIL INJECTION
APPARATUS WITH IMPROVED
DELIVERY DEVICE
ARYSTA LIFESCIENCE NORTH
AMERICA, LLC.
US
11/389054
27/03/2006
PCT/US/2007/063839
WO/2007/117833
23/03/2007
‫מערכת להזרקה תת–קרקעית עם התקן‬
‫נתינה משופר‬
OXIDATION-STABLE GRANULATE
CONTAINING UNSATURATED
FATTY ACIDS
UNILEVER PLC
EP
06075938.8 21/04/2006
PCT/EP/2007/052810
WO/2007/122053
11/04/2007
‫גרנולאט העמיד לחמצון המכיל חומצות‬
‫שומניות בלתי רוויות‬
‫כיסוי לפצעים המכיל גורמים נוגדי חיידקים‬
‫וגורמים המכילים אבץ‬
4617
C12N )2009.01(
194290
SMALL INTERNALLY SEGMENTED
INTERFERING RNA
SANTARIS PHARMA A/S
DK
PA200600433 23/03/2006
DK
PA200601254 28/09/2006
PCT/DK/2007/000146
WO/2007/107162
23/03/2007
A61L )2009.01(
194288
WOUND DRESSINGS WITH ANTIMICROBIAL AND ZINC-CONTAINING
AGENTS
TYCO HEALTHCARE GROUP LP
US
60/790814
11/04/2006
PCT/US/2007/008771
WO/2007/120616
23/03/2007
A23L )2009.01(
194287
RNA ‫מקטעים פנימיים קטנים של‬
G01N )2009.01(
194294
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
A METHOD OF OBTAINING A
PROFILE OF AT LEAST ONE
APOLIPOPROTEIN BIOMARKER IN A
BIOLOGICAL SAMPLE
MARY K ROBINSON
US
60/743678
23/03/2006
PCT/US/2007/007359
WO/2007/112055
26/03/2007
‫שיטה לקבלת פרופיל של לפחות סימון מן‬
‫החי אפוליפופרוטאין אחד בדגימה ביולוגית‬
194295
BIOMASS FUEL SYNTHESIS
METHODS FOR INCREASED ENERGY
EFFICIENCY
ALTERVIA ENERGY LLC
US
60/767403
25/03/2006
PCT/US/2007/007430
WO/2007/112090
23/09/2008
‫שיטות לסינתוז דלק ביומס לשם יעילות‬
‫כוח מוגברת‬
194296
194297
MONOLITHIC HIGH ASPECT RATIO
NANO-SIZE SCANNING PROBE
MICROSCOPE (SPM) TIP FORMED BY
NANOWIRE GROWTH
IBM CORPORATION
US
11/388132
23/03/2006
PCT/US/2007/005743
WO/2008/054467
23/09/2008
June 15,
G01N )2009.01(
‫אלקטרודת קצה זעירה של מיקרוסקופ‬
‫ העשויה מחוט ננו–מטרי‬,‫מכני סורק‬
‫) המגודל על שבב סיליקון‬WIRE NANO(
194298
– ‫כ"ג בסיוון התשס"ט‬
F24J )2009.01(
‫או מכשיר למערכת עקיבה‬/‫שיטה ו‬
‫סולארית‬
‫אורן אהרון‬
A METHOD AND APPARATUS FOR A
SOLAR TRACKER DEVICE
OREN AHARON
08/03/2007
C12P )2009.01(
G06F )2009.01(
4618
2009
METHOD, SYSTEM AND COMPUTER
PROGRAM PROGRAM PRODUCT FOR
REFERENCE INFORMATION BASED
EVALUATION
CAMTEK LTD.
28/03/2007
–‫שיטות וערכות לקביעת סיכון לעמידות ל‬
WARFARIN
‫תשתית ושירותים‬, ‫מחקרים‬-‫תל השומר‬
‫רפואיים בע"מ‬
F25D )2009.01(
‫מיכל עם יחידה לחימום או קירור תכולתו‬
C07D )2009.01(
194301
ANTAGONISTS OF THE VANILLOID
RECEPTOR SUBTYPE 1 (VR1) AND
USES THEREOF
ABBOTT LABORATORIES
US
60/792699
18/04/2006
PCT/US/2007/066515
WO/2007/121299
4619
C12Q )2009.01(
194300
CONTAINER WITH MODULE FOR
HEATING OR COOLING THE
CONTENTS
ONTECH OPERATIONS, INC.
US
11/388913
23/03/2006
PCT/US/2007/064856
WO/2007/109811
12/04/2007
‫קמטק בע"מ‬
194299
METHODS AND KITS FOR
DETERMINING PREDISPOSITION TO
WARFARIN RESISTANCE
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE AND
SERVICES LTD
US
60/786350
28/03/2006
60/834559
01/08/2006
US
PCT/IL/2007/000405
WO/2007/110869
23/03/2007
‫ התקן ומוצר תוכנה להערכה‬,‫שיטה‬
‫מבוססת מידע ייחוס‬
1 ‫אנטגוניסטים לקולטן ונילואיד תת–סוג‬
‫) ושימושים שלהם‬VR1(
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
27/06/2007
194302
PYRROLE DERIVATIVES AND THEIR
METHODS OF USE
ABBOTT LABORATORIES
US
60/816813
27/06/2006
PCT/US/2007/072228
WO/2008/002974
13/04/2007
194303
PROCESS FOR THE PREPARATION
OF INDAZOLYL UREAS THAT
INHIBIT VANILLOID SUBTYPE 1
(VR1) RECEPTORS
ABBOTT LABORATORIES
US
60/792099
14/04/2006
PCT/US/2007/066605
WO/2007/121339
10/04/2007
194304
June 15,
C07D )2009.01(
C07D )2009.01(
‫תרכובות פרמצבטיות חדשות‬
194305
A TISSUE DISPENSER AND A
METHOD THEREFOR
NAOMI ARRAM
22/03/2007
‫נגזרות פירול ושיטות לשימוש בהן‬
‫תהליך להכנת אוריאות אינדזוליל‬
‫ של‬1 ‫המעכבות קולטנים של תת–סוג‬
)VR1(‫ונילואיד‬
NEW PHARMACEUTICAL
COMPOUNDS
BIAL-PORTELA & CA, S.A.
EP
06007534.8 10/04/2006
PCT/PT/2007/000016
WO/2007/117165
24/09/2008
C07D )2009.01(
A47K )2009.01(
‫מנפק מגבונים ושיטה עבורו‬
‫נעמי ארם‬
194306
– ‫כ"ג בסיוון התשס"ט‬
F41H )2009.01(
4620
2009
IMPROVED CERAMIC BALLISTIC
PANEL CONSTRUCTION
HONEYWELL INTERNATIONAL INC.
US
11/388422
24/03/2006
PCT/US/2007/064586
WO/2008/054843
21/03/2007
B32B )2009.01(
194307
CERAMIC FACED BALLISTIC PANEL
CONSTRUCTION
HONEYWELL INTERNATIONAL INC.
US
11/388904
24/03/2006
PCT/US/2007/064502
WO/2008/014020
24/09/2008
‫מבנה פנל בליסטי קירמי משופר‬
‫מבנה פנל בליסטי עם פני שטח קירמיים‬
G09F )2009.01(
194309
‫התקן פניית פרסה‬
‫סלי מרדכי‬
U-TURN DEVICE
SALI MORDECHAY
11/04/2007
FLUID MANAGER INCLUDING
ELECTRICAL CONTACTS AND A
BATTERY INCLUDING THE SAME
EVEREADY BATTERY COMPANY,
INC.
US
60/817199
28/06/2006
60/860175
20/11/2006
US
PCT/US/2007/066464
WO/2007/121266
08/05/2007
H01M )2009.01(
194310
‫מבקר נוזלים הכולל מגעים חשמליים‬
‫וסוללה המכילה אותו‬
A61K )2009.01(
194312
‫נגזרת אינסולינית‬
INSULIN DERIVATIVE
4621
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
NOVO NORDISK A/S
EP
06113709.7
06118260.6
EP
PCT/EP/2007/054444
WO/2007/128817
09/05/2006
01/08/2006
20/04/2007
194313
ADJUSTING ALLOY COMPOSITIONS
FOR SELECTED PROPERTIES IN
TEMPERATURE LIMITED HEATERS
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.
US
60/794298
21/04/2006
60/853096
20/10/2006
US
PCT/US/2007/067055
WO/2007/124405
20/03/2007
‫התאמת תכשירי סגסוגות לתכונות‬
‫נבחרות בתנורים מוגבלי טמפרטורה‬
194314
CASUAL ANALYSIS IN COMPLEX
BIOLOGICAL SYSTEMS
GENSTRUCT, INC.
US
11/390496
27/03/2006
PCT/US/2007/006877
WO/2007/126631
12/03/2007
G06F )2009.01(
‫ניתוח מידע במערכות ביולוגיות מורכבות‬
194315
PROCESS FOR THE ISOLATION AND
STABILIZATION OF LOW
MOLECULAR WEIGHT
AMINOGLYCANS FROM WASTE EGG
SHELLS
ROMANO DEVELOPMENT INC.
US
11/277489
25/03/2006
PCT/IB/2007/050806
June 15,
E21B )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
C08B )2009.01(
‫תהליך לבידוד ולייצוב אמינוגלייקנים בעלי‬
‫משקל מולקולארי נמוך מפסולת קליפות‬
‫ביצים‬
4622
2009
WO/2007/110789
27/03/2007
C07C )2009.01(
194316
IMPROVED CRYSTALLINE
MATERIAL
KARO BIO AB
GB
0606201.2
28/03/2006
PCT/EP/2007/002687
WO/2007/110225
27/03/2007
‫חומר גבישי משופר‬
STABLE ORAL PHARMACEUTICAL
COMPOSITION CONTAINING
THYROID HORMONE RECEPTOR
AGONISTS
KARO BIO AB
GB
0606212.9
28/03/2006
PCT/EP/2007/002688
WO/2007/110226
27/03/2007
A61K )2009.01(
194317
‫תכשיר רוקחות יציב למתן דרך הפה‬
‫המכיל אגוניסטים לקולטי הורמון תריסי‬
BETA-GALACTOSIDASE WITH
TRANSGALACTOSYLATING
ACTIVITY
CLASADO INC.
GB
0606112.1
28/03/2006
PCT/GB/2007/001081
WO/2007/110619
26/03/2007
C12N )2009.01(
194318
‫ביתא–גלקטוזידאז בעל פעילות של‬
‫טרנסגלקטוזילאציה‬
B64C )2009.01(
194319
‫כלי טיס בר–הסבה‬
CONVERTIBLE AIRCRAFT
INTERNATIONAL AVIATION SUPPLY I.
A.S.S.R.L
IT
BR2006A000004 24/03/2006
PCT/IB/2007/051049
WO/2007/110833
4623
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
23/03/2007
POSITION ENCODER
SAGENTIA LIMITED
UA
0606055.2
0625428.8
UA
PCT/GB/2007/001057
WO/2007/110603
194320
‫מקודד עמדה‬
25/03/2006
20/12/2006
29/03/2007
194321
MICRO-REACTOR SYSTEM
ASSEMBLY
LONZA AG
EP
06006939.0 31/03/2006
06009574.2
09/05/2006
EP
PCT/EP/2007/002831
WO/2007/112945
01/12/2006
23/03/2007
B01J )2009.01(
‫מערכת הרכבה מיקרו ריאקטורית‬
194322
G01P )2009.01(
‫דיסק גל אקוסטי ג'ירוסקופי בעל קיבול‬
‫גדול‬
CAPACITIVE BULK ACOUSTIC
WAVE DISK GYROSCOPES
GEORGIA TECH RESEARCH
CORPORATION
US
60/786304
27/03/2006
11/601956
20/11/2006
US
PCT/US/2006/045931
WO/2007/126423
194323
SELF-EXPANDABLE
ENDOVASCULAR DEVICE FOR
ANEURYSM OCCLUSION
BIOMERIX CORPORATION
US
60/785901
24/03/2006
PCT/US/2007/007320
June 15,
G01D )2009.01(
A61F )2009.01(
‫התקן אנדווסקולארי המתרחב מעצמו‬
‫לסתימה של מפרצת‬
– ‫כ"ג בסיוון התשס"ט‬
4624
2009
WO/2008/051279
28/03/2007
FLOATING GASTROINTESTINAL
ANCHOR
SPATZ-FGIA INC
US
60/787124
28/03/2006
60/815624
21/06/2006
US
PCT/IL/2007/000398
WO/2007/110866
06/04/2007
‫עוגן גסטרואינטסטינאלי צף‬
‫תרכובת פפטידית בעלת פעילות‬
‫ הכנתה ויישומה‬,‫ביולוגית‬
‫מעגל מוטה לאחזקת ערך קבוע של‬
‫הולכי–דרך מחולק בקיבול מעמסה‬
C07C )2009.01(
194327
IMPROVEMENTS IN THE
PREPARATION OF INTERMEDIATES
LEADING TO [4-(5-AMINOMETHYL-2FLUORO-PHENYL)-PIPERIDIN-1-YL](4-BROMO-3-METHYL-5-PROPOXYTHIOPHEN-2YL)-METHANONE HYDROCHLORIDE
4625
H03F )2009.01(
194326
BIAS CIRCUIT FOR MAINTAINING A
CONSTANT VALUE OF
TRANSCONDUCTANCE DIVIDED BY
LOAD CAPACITANCE
QUALCOMM INCORPORATED
US
/09773404
31/01/2001
PCT/US/2002/003012
WO/2002/061519
28/03/2007
C07K )2009.01(
194325
PEPTIDE COMPOUND WITH
BIOLOGICAL ACTIVITY, ITS
PREPARATION AND ITS APPLICATION
SANOFI-AVENTIS SPA
IT
MI2006A000678 06/04/2006
PCT/IB/2007/002003
WO/2007/113691
31/01/2002
A61M )2009.01(
194324
‫שיפורים בהכנה של חומרי ביניים‬
–2–‫–אמינומתיל‬5(–4[–‫המובילים ל‬
–]‫–איל‬1–‫פלואורו–פניל)–פיפרידין‬
–‫–פרופוקסי–תיאופן‬5–‫–מתיל‬3–‫–ברומו‬4(
‫–איל)–מתאנון הידרוכלוריד‬2
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
SANOFI AVENTIS
US
60/743908
PCT/US/2007/065339
WO/2007/118010
29/03/2006
30/03/2007
194328
USE OF RASAGILINE FOR THE
TREATMENT OF RESTLESS LEGS
SYNDROME
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/788617
03/04/2006
PCT/US/2007/008261
WO/2007/117431
24/04/2007
‫טיפול בתסמונת רגליים חסרות מנוח‬
‫באמצעות רסג'ילין‬
‫טבע תעשיות פרמצבטיות בע"מ‬
194329
TIGEYCLINE CRYSTALLINE FORMS
AND PROCESSES FOR PREPARATION
THEREOF
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/794763
24/04/2006
60/796800
01/05/2006
US
PCT/US/2007/010108
WO/2007/127292
25/04/2007
C07C )2009.01(
‫צורות קריסטליניות של טיגציקלין‬
‫ותהליכים להכנתן‬
‫טבע תעשיות פרמצבטיות בע"מ‬
194331
CRYSTALLINE FORMS OF
IBANDRONIC ACID AND PROCESSES
FOR PREPARATION THEREOF
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
June 15,
A61K )2009.01(
C07F )2009.01(
‫צורות קריסטליניות של חומצה איבנדרונית‬
‫ותהליכים להכנתן‬
– ‫כ"ג בסיוון התשס"ט‬
‫טבע תעשיות פרמצבטיות בע"מ‬
4626
2009
US
60/794515
PCT/US/2007/010016
WO/2007/127249
25/04/2006
25/09/2008
MODULAR CLOTHE AND METHOD
OF CONNECTION
ELENA KURBATOV
25/09/2008
‫בגד מודולארי ושיטת חיבור‬
‫ילנה קורבטוב‬
‫התקן בעל דחיפה עצמית‬
‫גיוון אימג'ינג בע"מ‬
‫שיטה להפעלת תהליך לאיסוף תמונות‬
‫גיוון אימג'ינג בע"מ‬
ANTISENSE MODULATION OF
INSULIN-LIKE GROWTH FACTOR
BINDING PROTEIN 5 EXPRESSION
4627
C12N )2009.01(
194382
ANTISENSE MODULATION OF
INSULIN-LIKE GROWTH FACTOR
BINDING PROTEIN 5 EXPRESSION
ISIS PHARMACEUTICALS, INC.
US
09/975123
09/10/2001
PCT/US/2002/032060
WO/2003/030826
07/10/2002
A61B )2009.01(
194359
METHOD FOR ACTIVATING AN
IMAGE COLLECTING PROCESS
GIVEN IMAGING LTD.
07/10/2002
A61B )2009.01(
194358
SELF PROPELLED DEVICE
GIVEN IMAGING LTD.
US
60/354925
11/02/2002
15/11/1999
A41D )2009.01(
194332
5 ‫אפנון מול–קריא של ביטויי חלבון קושר‬
‫דמוי אינסולין של הורמון גדילה‬
C12N )2009.01(
194383
5 ‫אפנון מול–קריא של ביטויי חלבון קושר‬
‫דמוי אינסולין של הורמון גדילה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
ISIS PHARMACEUTICALS, INC.
US
09/975123
09/10/2001
PCT/US/2002/032060
WO/2003/030826
28/09/2008
194399
‫מקור מוארך של פלזמת לייזר‬
‫פלזמת לייזר קשתית עבור ביצוע‬/‫מסוננת‬
‫הציפוי‬
‫ בע"מ‬.‫א‬.‫ט‬.‫לומיקס פ‬
EXTENDED LASER/LASER-ARC
FILTERED PLASMA SOURCE FOR
COATING DEPOSITION
LUMIKS P.T.I. LTD
28/09/2008
194400
UNIVERSAL COMBINED FILTERED
PLASMA FLUX AND NEUTRAL
ATOM SOURCE
LUMIKS P.T.I. LTD
28/09/2008
‫ בע"מ‬.‫א‬.‫ט‬.‫לומיקס פ‬
194401
H01J )2009.01(
‫מקור לייזר קשתי אימפולסיבי של פלזמת‬
‫מתכת הומוגנית מסוננת‬/‫פחמן‬
‫ בע"מ‬.‫א‬.‫ט‬.‫לומיקס פ‬
194402
G01F )2009.01(
‫מד מים ביתי‬
‫הראל צ'רניס‬
DOMESTIC WATER METER
HAREL CHARNIS
June 15,
H01J )2009.01(
‫מקור אוניברסלי משולב של זרם הפלזמה‬
‫המסוננת ואטומים נייטרליים‬
PULSED LASER-ARC SOURCE OF
UNIFORM FILTERED
CARBON/METAL PLASMA
LUMIKS P.T.I. LTD
28/09/2008
H01J )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4628
2009
28/09/2008
INFESTATION TESTER FOR SMALL
INSECTS
DR. SHIMON ZILBERSHLAG
12/02/2003
‫מכשיר לבדיקת הימצאות חרקים קטנים‬
‫ד"ר שמעון זילברשלג‬
‫צורת מינון פומית לשיחרור תרופה מבוקר‬
A61K )2009.01(
194439
PHARMACEUTICAL COMPOSITIONS
CONTAINING POLYPEPTIDES
COVALENTLY ATTACHED TO
ACTIVE AGENTS AND METHODS
FOR MAKING AND USING SAME
SHIRE LLC
US
60/247917
14/11/2000
60/247919
14/11/2000
US
60/247982
14/11/2000
US
60/247892
14/11/2000
US
60/247899
14/11/2000
US
60/247916
14/11/2000
US
60/247809
14/11/2000
US
60/247826
14/11/2000
US
60/247878
14/11/2000
US
60/247791
14/11/2000
US
60/247793
14/11/2000
US
60/247798
14/11/2000
US
60/247727
14/11/2000
US
4629
A61K )2009.01(
194433
ORAL DOSAGE FORM FOR
CONTROLLED DRUG RELEASE
GLAXO GROUP LIMITED
GB
0203298.5
12/02/2002
0203296.9
12/02/2002
GB
0203297.7
12/02/2002
GB
PCT/GB/2003/000594
WO/2003/068195
14/11/2001
A01D )2009.01(
194413
‫תכשירי רוקחות המכילים פוליפפטידים‬
‫הקשורים לחומרים פעילים ושיטות‬
‫להכנתם ולשימוש בהם‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
60/247728
US
60/247730
US
60/247707
US
60/247723
US
60/247724
US
60/247694
US
60/247701
US
60/247702
US
60/247679
US
60/247684
US
60/247685
US
60/247594
US
60/247615
US
60/247632
US
60/247561
US
PCT/US/2001/043089
WO/2003/034980
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
14/11/2000
02/10/2008
194456
BAG AND A METHOD FOR
ACCOMMODATION AND TAKING
OUT PHYLACTERIES ACCORDING
TO THE HALACHA
AMNON BEN MOSHE
02/10/2008
‫תיק ושיטה לאכסון ולהוצאת תפילין‬
‫כהלכה‬
‫אמנון בן משה‬
194457
A SYSTEM AND METHOD FOR
CARRYING OUT A PURCHASE IN A
NON-VIRTUAL STORE
INDOOR LIVE
02/10/2008
G09F )2009.01(
‫מערכת ושיטה לביצוע רכישה בחנות לא‬
‫מקוונת‬
‫אינדור לייב‬
194458
A SYSTEM FOR ASCERTAINING
SAFE ENTRANCE OF A MAIL ITEM
INTO A POSTBOX
REUBEN BERMAN
June 15,
B65D )2009.01(
A47G )2009.01(
‫מערכת לאימות כניסה של דבר דואר אל‬
‫תיבת מכתבים‬
‫ראובן ברמן‬
– ‫כ"ג בסיוון התשס"ט‬
4630
2009
02/10/2008
‫שיכלולים במערכות התרעה‬
‫פימא מערכות אלקטרוניות בע"מ‬
IMPROVED ALARM SYSTEM
PIMA ELECTRONIC SYSTEMS LTD.
02/10/2008
G08B )2009.01(
194470
A47K )2009.01(
194477
‫התקן ליצב כיסא‬
‫דוד זמט‬
CHAIR STABILIZING DEVICE
DAVID ZAMET
20/11/2003
MODIFIED BIOLOGICAL
SUBSTANCE, PROCESS FOR
PRODUCING THE SAME, AND
INTERMEDIATE
NOF CORPORATION
2002JP
20/11/2002
337113
PCT/JP/2003/014844
WO/2004/046222
05/10/2008
4631
‫ תהליך לייצורו וחומר‬,‫מוצר ביולוגי משופר‬
‫ביניים‬
F41H )2009.01(
194517
REACTIVE ARMOR FOR A TANK,
APC(ARMOURED PERSONNEL
CARRIER) OR A VEHICLE, AGAINST
SHELLS OR MISSILES WITH
HOLLOW EXPLOSIVE CHARGE
(ARMOR PENETRATING
AMUNITION).
DR. HAIM AMRAM BEN-SIMHON
05/10/2008
C08G )2009.01(
194501
,‫ נגמ"ש או רכב‬,‫שריון ריאקטיבי לטנק‬
‫כנגד פגזים או טילים בעלי מטען חלול (או‬
)‫חודרי שריון‬
‫ד"ר חיים עמרם בן שמחון‬
B66F )2009.01(
194518
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
FRONTWARD PARKING AND
STRUCFURES THAT ALLOW IT,
FORMING A SAFE BICYCLE AND
MINOR TRAFFIC LANE
DR. HAIM AMRAM BEN-SIMHON
05/10/2008
,‫חניה קדימנית ומבנים המאפשרים אותה‬
‫ויוצרים מסלול בטוח לאופניים ולרכבים‬
‫קטנים‬
‫ד"ר חיים עמרם בן שמחון‬
194519
A NEEDLE FOR SURGICAL
THREADING AND METHOD FOR
USING THE SAME
MENEHEM NEUMAN M.D.
05/10/2008
‫מחט לתפירה כירורגית ושיטה לשימוש‬
‫עבורה‬
‫ד"ר מנחם נוימן‬
194520
194527
194534
ANTHRANILAMIDES AND METHODS
USING THEM FOR CONTROLLING
ANTHROPODS
E.I. DUPONT DE NEMOURS AND
COMPANY
US
60/191242
22/03/2000
60/220232
24/07/2000
US
60/254635
11/12/2000
US
60/262015
17/01/2001
US
PCT/US/2001/009338
June 15,
E01F )2009.01(
‫התקן לעיצרת כלי רכב‬
VEHICLE ARRESTING DEVICE
QINETIQ LIMITED
GB
0303119.2
12/02/2003
PCT/GB/2004/000048
WO/2004/072382
20/03/2001
B60J )2009.01(
‫כיסוי חיצוני לכלי רכב‬
‫קרן סוג'אץ‬
EXTERNAL COVER FOR VEHICLE
KOBI SOJAS
08/01/2004
A61F )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
A01N )2009.01(
‫אנתרנילאמידים ושיטות שמשתמשות‬
‫בהם להדברת פרוקי רגליים‬
4632
2009
WO/2001/070671
06/10/2008
A VEHICULAR COVERING SYSTEM
AND METHOD
YOTAM LEVY
20/09/2002
‫מערכת ושיטה לכיסוי רכב‬
‫רועי שרף‬
‫מערכת לדיכוי אש ומחולל אירוסול מוצק‬
‫לשימוש במערכת זו‬
4633
H04J )2009.01(
194548
INITIAL CELL SEARCH ALGORITHM
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/271642
27/02/2001
09/918611
31/07/2001
US
PCT/US/2002/003217
WO/2002/069551
12/04/2007
A62C )2009.01(
194547
FIRE SUPPRESSION SYSTEM AND
SOLID PROPELLANT AEROSOL
GENERATOR FOR USE THEREIN
UNIVERSAL PROPULSION
COMPANY, INC.
US
60/323824
21/09/2001
10/193448
11/07/2002
US
PCT/US/2002/030031
WO/2003/024534
04/02/2002
B60J )2009.01(
194545
‫אלגוריתם עבור תא חיפוש ראשוני‬
A61N )2009.01(
194553
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
TRANSDERMAL METHODS AND
SYSTEMS FOR THE DELIVERY OF
ANTI-MIGRAINE COMPOUNDS
NUPATHE INC.
US
60/791819
13/04/2006
60/814131
16/06/2006
US
PCT/US/2007/009000
WO/2007/120747
06/04/2007
–‫שיטות ומערכות למתן תרכובות אנטי‬
‫מיגרנה דרך העור‬
194558
VERSATILE COMPACT
TRANSMITTER FOR GENERATION
OF ADVANCED MODULATION
FORMATS
FINISAR CORPORATION
US
60/789863
06/04/2006
11/441944
26/05/2006
US
60/853867
24/10/2006
US
11/702436
05/02/2007
US
PCT/US/2007/008729
WO/2007/117678
06/10/2008
‫משדר קומפקטי רב–גוני ליצירה של‬
‫תבניות מודולציה מתקדמות‬
194562
ANTI-THEFT DEVICES FOR
PORTABLE OBJECTS SUCH AS
LAPTOPS
MEIR AVGANIM
16/01/2002
June 15,
G02B )2009.01(
E05B )2009.01(
‫מתקן הגנה עבור מכשירים ניידים כגון‬
‫מחשב נייד‬
‫מאיר אבגנים‬
194574
– ‫כ"ג בסיוון התשס"ט‬
H04J )2009.01(
4634
2009
METHOD AND APPARATUS FOR
ALLOCATING DATA STREAMS
GIVEN TRANSMISSION TIME
INTERVAL (TTI) CONSTRAINTS
QUALCOMM INCORPORATED
US
09/764788
17/01/2001
PCT/US/2002/001973
WO/2002/065675
18/04/2007
NOVEL COMPOUNDS
GLAXO GROUP LIMITED
GB
0607840.6
0620382.2
GB
0706516.2
GB
0706515.4
GB
PCT/EP/2007/053795
WO/2007/122165
‫שיטה ומכשור להקצות לזרמי מידע‬
‫הגבלות פסקי זמן העברה נתונים‬
‫תרכובות חדשות‬
20/04/2006
13/10/2006
03/04/2007
03/04/2007
13/07/2007
26/04/2007
COMPOSITION AND METHOD FOR
IMPROVING PLANT HEALTH
BASF SE
A01N )2009.01(
194588
METHOD OF APPLYING A DISPERSION
EVONIK DEGUSSA GMBH
DE
102006037822.9 12/08/2006
PCT/EP/2007/057220
WO/2007/019918
4635
C07D )2009.01(
194587
‫שיטה ליישום דיספרסיה‬
A01N )2009.01(
194589
‫תכשיר ושיטה לשיפור בריאות הצמח‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
EP
06113166.0
PCT/EP/2007/054111
WO/2007/122264
26/04/2006
18/04/2007
194590
2-SUBSTITUTED 4BENZYLPHTHALAZINONE
DERIVATIVES AS HISTAMINE HL
AND H3 ANTAGONISTS
GLAXO GROUP LIMITED
GB
0607839.8
20/04/2006
0706160.9
29/03/2007
GB
0706176.5
29/03/2007
GB
PCT/EP/2007/053773
WO/2007/122156
10/04/2007
‫–בנזילפתאלאזינון–מותמרות‬4 ‫תולדות‬
HL ‫ כאנטגוניסטים של היסטמין‬2 ‫בעמדה‬
H3–‫ו‬
194591
194592
NOVEL CRYSTALLINE COMPOUNDS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
102006017827.0 13/04/2006
PCT/EP/2007/053488
WO/2007/118819
17/04/2007
June 15,
C07D )2009.01(
‫]פיראזינונים‬B–4,3[ ‫פירידין‬
PYRIDINE[3,4-B]PYRAZINONES
PFIZER PRODUCTS INC.
US
60/793971
21/04/2006
PCT/IB/2007/001001
WO/2007/122466
11/04/2007
C07D )2009.01(
194594
– ‫כ"ג בסיוון התשס"ט‬
C07D )2009.01(
‫תרכובות גבישיות חדשות‬
C07J )2009.01(
4636
2009
–?17–‫?–מתוקסי‬17]–4 ‫שיטה להכנת‬
–9,4–‫–אוקסואסטרא‬3–‫מתוקסימתיל‬
–)E( ‫?–איל]בנזאלאלדהיד‬11–‫דיאן‬
)‫אוקסים(אסופריסניל‬
METHOD FOR PREPARING 4-[17?METHOXY-17?-METHOXYMETHYL-3OXOESTRA-4,9-DIEN-11?YL]BENZALDEHYDE (E)-OXIME
(ASOPRISNIL)
BAYER SCHERING PHARMA AG
DE
102006018888.8 18/04/2006
PCT/EP/2007/003723
WO/2007/118717
18/04/2007
PYRIDONE SULFONAMIDES AND
PYRIDONE SULFAMIDES AS MEK
INHIBITORS
ARDEA BIOSCIENCES, INC.
US
60/793129
18/04/2006
PCT/US/2007/066894
WO/2007/121481
23/05/2007
‫פירידון סולפונאמידים ופירידון סולפאמידים‬
MEK ‫כמעכבי‬
‫תרכובות הטרוציקליות שעברו ניטרציה‬
‫כאנטגוניסטים של קולטן אנדותיאלין‬
B65H )2009.01(
194597
GRIPPER FOR HOLDING AND
CONVEYING FLAT OBJECTS
FERAG AG
CH
610/06
12/04/2006
PCT/CH/2007/000172
WO/2007/115421
4637
C07D )2009.01(
194596
NITRATED HETEROCYCLIC
COMPOUNDS AS ENDOTHELIN
RECEPTOR ANTAGONIST
NICOX SA
EP
06114617.1 29/05/2006
PCT/EP/2007/055012
WO/2007/137980
07/04/2007
C07D )2009.01(
194595
‫תופסן להחזקת והעברת פריטים שטוחים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
18/05/2007
194603
DEVICE FOR FASTENING AND
HOLDING A CREEPING PLANT
ALONG A CARRYING WIRE
A. RAYMOND ET CIE
FR
06/05348
15/06/2006
PCT/EP/2007/004450
WO/2007/144059
10/04/2006
A01G )2009.01(
‫התקן להידוק והחזקת צמח לאורך תיל‬
‫נושא‬
194604
A REINFORCED ABSORBABLE
MULTILAYERED HEMOSTATIC
WOUND DRESSING AND METHOD
OF MAKING
OMRIX BIOPHARMACEUTICALS S.A
A61L )2009.01(
‫תחבושת רב–שכבתית סופגת לחבישת‬
‫פצעים העוצרת דימום ושיטה להכנתה‬
PCT/US/2006/013282
WO/2007/117237
16/03/2007
194605
‫ווידוא מוצר‬
PRODUCT AUTHENTICATION
UNIVERSITY OF MARYLAND,
BALTIMORE
US
11/399600
07/04/2006
PCT/US/2007/064193
WO/2007/117867
10/04/2006
G06F )2009.01(
194608
A REINFORCED ABSORBABLE
MULTILAYERED FABRIC FOR USE IN
MEDICAL DEVICES AND METHOD
OF MANUFACTURE
ETHICON, INC.
D04H )2009.01(
‫אריג סופג רב–שכבתי מחוזק לשימוש‬
‫בהתקנים רפואיים ושיטה ליצורו‬
PCT/US/2006/013284
WO/2007/117238
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4638
2009
31/05/2007
‫סיליקה בצורת חלקיקים זעירים‬
PELLETIZED SILICA
DEGUSSA NOVARA TECHNOLOGY S.P.A
EP
PCT/EP06/062883 02/06/2006
PCT/EP/2007/055365
WO/2007/141196
12/04/2007
A61N )2009.01(
194612
SYSTEM FOR CONDITIONING
SURFACES IN VIVO
ATS MEDICAL INC.
US
11/402463
12/04/2006
PCT/US/2007/066486
WO/2007/121281
03/05/2007
‫מערכת למצב שטחים בחי‬
A PROCESS FOR MINIMIZING THE
EMISSION OF PARTICULATE
MATTER FROM A GAS EMISSION
STREAM
VORTEX ECOLOGICAL
TECHNOLOGIES LTD.
4639
C07H )2009.01(
194613
CRYSTALLINE ISOMALTULOSE
COMPOSITION
SUDZUCKER AKTIENGESELLSCHAFT
MANNHEIM/OCHSENFURT
DE
102006022506.6 08/05/2006
PCT/EP/2007/003883
WO/2007/128483
07/10/2008
C01B )2009.01(
194611
‫תכשיר איזומלטולוז גבישי‬
B01D )2009.01(
194614
‫תהליך להפחתת פליטת חומר חלקקי‬
‫מזרימת גס פליטה‬
‫וורטקס טכנולוגיות אקולוגיות בע"מ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
11/04/2007
194615
IMPROVED VACCINES COMPRISING
MULTIMERIC HSP60 PEPTIDE
CARRIERS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/790782
11/04/2006
PCT/IL/2007/000468
WO/2007/116409
11/04/2007
‫חיסונים משופרים המכילים נשאים‬
HSP60 ‫פפטידיים מולטימריים של‬
‫ידע חברה למחקר ופיתוח בע"מ‬
194616
LIVESTOCK MANAGEMENT FOR
IMPROVED REPRODUCTIVE
EFFICIENCY
THE STATE OF ISRAEL, MINISTRY
OF AGRICULTURE AND RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION,
VOLCANI CENTER
US
60/790784
11/04/2006
PCT/IL/2007/000469
WO/2007/116410
28/03/2007
June 15,
A61K )2009.01(
‫ממשק לשיפור יעילות הרבייה בעדרים‬
‫מילאוטיס בע"מ‬
194618
WEIGHTED DETERMINATION IN
CONFIGURATION MANAGEMENT
SYSTEM
IBM CORPORATION
US
11/279299
11/04/2006
A61K )2009.01(
H04L )2009.01(
‫החלטה מבוססת משקל במערכות לניהול‬
‫תצורות‬
– ‫כ"ג בסיוון התשס"ט‬
4640
2009
PCT/EP/2007/052975
WO/2007/115940
15/09/2006
‫הרכב עבור ראות ורושם של‬
‫חומרים מתורחפים‬
COMPOSITION FOR VISIBILITY AND
IMPACT OF SUSPENDED MATERIALS
COLGATE-PALMOLIVE COMPANY
WO
PCT/US2006/015108 21/04/2006
PCT/US/2006/035923
WO/2007/123566
07/10/2008
A47D )2009.01(
194620
MEANS FOR CONNECTING A LIGHT
FIXTURE TO A WALL
TSAFRIR BARMUCHA
04/04/2007
‫אמצעי לחיבור גוף תאורה אל קיר‬
‫צפריר ברמוחה‬
‫מכשיר ושיטה למדידת כמות הדלק על‬
‫סיפונה של חללית‬
C07D )2009.01(
194622
2,6-SUBSTITUTED-4MONOSUBSTITUTED AMINOPYRIMIDINE AS PROSTAGLANDIN
D2 RECEPTOR ANTAGONISTS
SANOFI AVENTIS
US
60/744676
12/04/2006
PCT/US/2007/066481
WO/2007/121280
4641
F02K )2009.01(
194621
APPARATUS AND METHOD FOR
MEASURING THE AMOUNT OF FUEL
ABOARD A SPACECRAFT
ASTRIUM GMBH
DE
102006017811.4 13/04/2006
PCT/DE/2007/000612
WO/2007/118453
12/04/2007
C11D )2009.01(
194619
‫–אמינו–מונומותמר‬4 ,‫–מותמר‬2,6 ‫פירימידין‬
D2 ‫כאנטאגוניסטים לרצפטור‬
‫פרוסטאגלנדני‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
07/10/2008
194624
NOVEL TOPICAL MOISTURIZING
AND RESTRUCTURIZING
COMPOSITIONS
CARELINE (PHARMAGIS) LTD
11/04/2007
‫תכשירים חדשניים להענקת לחות וחידוש‬
‫העור בשימוש חיצוני‬
‫קרליין (פרמאגיס) בע"מ‬
194626
FOOD PRODUCTS COMPRISING
LONG CHAIN POLYUNSATURATED
FATTY ACIDS AND METHODS FOR
PREPARING THE SAME
MARTEK BIOSCIENCES
CORPORATION
US
60/791358
11/04/2006
PCT/US/2007/066471
WO/2007/121273
01/05/2007
194627
194629
PURIFICATION PROCESSES FOR
ISOLATING PURIFIED VESICULAR
STOMATITIS VIRUS FROM CELL
CULTURE
WYETH
US
60/793376
20/04/2006
June 15,
A23D )2009.01(
‫מוצרי מזון המורכבים מחומצות שומן בלתי‬
‫רוויות ארוכות שרשרת ושיטות להכנתם‬
IMPROVED FUNCTIONAL ELECTRICAL
STIMULATION SYSTEMS
BIONESS NEUROMODULATION LTD
US
60/746060
01/05/2006
60/805359
21/06/2006
US
WO
PCT/IL2006/001326 16/11/2006
PCT/IL/2007/000531
WO/2007/125534
19/04/2007
A61K )2009.01(
A61B )2009.01(
‫מערכות גירוי חשמלי משופרות‬
‫ופונקציונליות‬
C12N )2009.01(
‫תהליכי טיהור עבור בידוד של וירוס‬
‫סטומטיטיס וסיקולרי טהור מתרבית תאים‬
– ‫כ"ג בסיוון התשס"ט‬
4642
2009
PCT/US/2007/009510
WO/2007/123961
10/04/2007
B60Q )2009.01(
194631
‫פלס‬
A SPIRIT LEVEL
PAUL ANDREW SPARROW
GB
0606924.9
07/04/2006
0617796.8
11/09/2006
GB
PCT/GB/2007/001324
WO/2007/128992
13/04/2007
COLONIC DRUG DELIVERY
FORMULATION
SCHOOL OF PHARMACY,
UNIVERSITY OF LONDON
GB
0607534.5
13/04/2006
PCT/GB/2007/001354
WO/2007/122374
10/04/2007
‫תרכובת למתן תרופה דרך מעי הגס‬
‫תרכובות חדשות נגד חיידקים‬
B60J )2009.01(
194636
VEHICLE, SUSPENSION SYSTEM,
SUSPENDED OBJECTS, AND
METHOD OF USE THEREOF
PLASAN SASA LTD.
IL
191807
29/05/2008
4643
A61K )2009.01(
194634
NOVEL ANTIBACTERIAL COMPOUNDS
PIRAMAL LIFE SCIENCES LIMITED
IN
607/MUM/2006 18/04/2006
60/809674
31/05/2006
US
PCT/IB/2007/051268
WO/2007/119201
07/10/2008
A61K )2009.01(
194632
‫ אלמנטים תלויים‬,‫ מערכת תליה‬,‫רכב‬
‫ושיטה לשימוש בהם‬
‫פלסן סאסא בע"מ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
07/10/2008
194637
COMPOUND AND USE IN
TREATMENT
BIOXELL SPA
GB
0322395.5
24/09/2003
0325598.1
03/11/2003
GB
13/04/2007
‫תרכובות ושימוש בטיפול‬
194638
PHARMACEUTICAL COMPOSITIONS
OF HGLP-1, EXENDIN-4 AND
ANALOGS THEREOF
SOCIETE DE CONSEILS DE
RECHERCHES ET D'APPLICATIONS
SCIENTIFIQUES (S.C.R.A.S.)
US
60/791701
13/04/2006
PCT/US/2007/009292
WO/2007/120899
19/04/2007
DIVIDED SPINDLE
ABLOY OY
FI
20065302
PCT/FI/2007/050205
WO/2007/128868
A61K )2009.01(
HGLP, 4––1 ‫תכשירי רוקחות של‬
‫ ואנלוגים שלהם‬EXENDIN
194639
E05B )2009.01(
‫ציר מפולג‬
09/05/2006
05/04/2007
194640
RIMLESS SPECTACLES WITH SIDES
OF ESSENTIALLY FILAMENTARY
STRUCTURE
MINIMA
FR
0603493
20/04/2006
PCT/FR/2007/000577
WO/2007/125184
June 15,
C07C )2009.01(
G02C )2009.01(
‫משקפיים נטולי מסגרת עם איזורים צידיים‬
‫בעלי מבנה משלים‬
– ‫כ"ג בסיוון התשס"ט‬
4644
2009
17/04/2007
PROCESS ANALYSIS SYSTEM WITH
STERILE SAMPLING OF
MECHANICALLY-SENSITIVE
MATERIAL FROM A BIOREACTOR
BAYER TECHNOLOGY SERVICES
GMBH
DE
102006019242.7 21/04/2006
PCT/EP/2007/003341
WO/2007/121887
24/04/2007
‫מערכת לניתוח תהליך עם דגימה‬
‫סטרילית מביו–ריאקטור של חומר‬
‫הרגיש באופן מכני‬
‫תפעול ערוץ בעל הספק יציאה גבוה‬
–‫במערכת תקשורת מרושתת איזורית אל‬
‫חוטית‬
‫הרכבים תחליביים יציבים‬
C12Q )2009.01(
194646
STEROID RESPONSIVE NUCLEIC
ACID EXPRESSION AND PREDICTION
OF DISEASE ACTIVITY
XDX, INC.
US
60/790474
07/04/2006
PCT/US/2007/008909
WO/2008/051290
4645
A61K )2009.01(
194645
STABLE EMULSION FORMULATIONS
AMGEN INC.
US
60/793825
20/04/2006
PCT/US/2007/067155
WO/2007/124465
09/04/2007
H04L )2009.01(
194644
HIGH-THROUGHPUT CHANNEL
OPERATION IN A MESH WIRELESS
LOCAL AREA NETWORK
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/794604
25/04/2006
PCT/US/2007/010149
WO/2007/127312
20/04/2007
C12M )2009.01(
194643
‫ביטוי חומצת גרעין המגיב לסטרואיד וניבוי‬
‫פעילות מחלה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
09/04/2007
194647
METHOD FOR TESTING EMBEDDED
WIRELESS TRANSCEIVER WITH
MINIMAL INTERACTION BETWEEN
WIRELESS TRANSCEIVER AND HOST
PROCESSOR DURING TESTING
LITEPOINT CORPORATION
US
11/279778
14/04/2006
PCT/US/2007/066211
WO/2007/121127
04/04/2007
10/04/2007
‫שיטה לבחינת משדר–מקלט אלחוטי‬
‫משובץ עם אינטראקציה מינימאלית בין‬
‫משדר–מקלט אלחוטי ומעבד אורח במהלך‬
‫הבחינה‬
194648
NIGHT VISION ATTACHMENT
MOUNTABLE ON A FIREARM AND
INTENDED FOR A SIGHTING
TELESCOPE
VECTRONIX AG
EP
06112406.1 10/04/2006
11/401192
10/04/2006
US
PCT/EP/2007/003053
WO/2007/115770
F41G )2009.01(
‫התקן לראיית לילה הניתן להרכבה על גבי‬
‫נשק המיועד לכוונת טלסקופ‬
194649
G01S )2009.01(
‫מערכת שיבוש מבוזרת‬
‫אלתא מערכות בע"מ‬
DISTRIBUTED JAMMER SYSTEM
OPTIGO SYSTEMS LTD
IL
174888
10/04/2006
182382
01/04/2007
IL
June 15,
H04B )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4646
2009
PCT/IL/2007/000451
WO/2007/116403
10/04/2007
MONO AND DI-SUBSTITUTED
OXYCODONE COMPOUNDS AND
COMPOSITIONS
SHIRE LLC
US
60/790524
10/04/2006
60/796352
01/05/2006
US
60/849775
06/10/2006
US
PCT/US/2007/008821
WO/2007/120648
27/03/2007
‫קישור התקבצות דו כיווני‬
‫קוריג'נט מערכות בע"מ‬
G06F )2009.01(
‫שיטה ומערכת לשליטה על חלוקת‬
‫משאבי מחשוב‬
‫ בע"מ‬.‫טי‬.‫מור משאבי אי‬
A61K )2009.01(
194656
NICOTINE-CARRIER VACCINE
FORMULATION
CYTOS BIOTECHNOLOGY AG
EP
06113895.4 12/05/2006
PCT/EP/2007/054604
WO/2007/131972
4647
H04J )2009.01(
194654
METHOD AND SYSTEM FOR
TRANSACTION RESOURCE
CONTROL
MORE IT RESOURCES LTD
US
60/871994
27/12/2006
PCT/IL/2007/001621
WO/2008/078329
11/05/2007
–‫תרכובות ותכשירים של אוקסיקודון חד‬
‫ודו–מותמר‬
194652
TWO-WAY LINK AGGREGATION
CORRIGENT SYSTEMS LTD.
US
11/279045
07/04/2006
PCT/IL/2007/000394
WO/2007/116391
27/12/2007
A61K )2009.01(
194650
‫פורמולציה לחיסון של נשא ניקוטין‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
27/04/2007
194657
COMPOUNDS THAT ARE AGONISTS
OF MUSCARINIC RECEPTORS AND
THAT MAY BE EFFECTIVE IN
TREATING PAIN, ALZHEIMER'S
DISEASE AND/OR SCHIZOPHRENIA
ASTRAZENECA AB
US
60/746187
02/05/2006
PCT/SE/2007/000409
WO/2007/126362
07/05/2007
‫תרכובות שהן אגוניסטים לקולטנים‬
‫מוסקרינים ושיכולות להיות יעילות בטיפול‬
‫או בסכיזופרניה‬/‫ באלצהיימר ו‬,‫בכאב‬
194658
PARENTERAL FORMULATION
COMPRISING PROTON PUMP
INHIBITOR STERILIZED IN ITS FINAL
CONTAINER BY IONIZING
RADIATION
ASTRAZENECA AB
US
60/799058
09/05/2006
PCT/SE/2007/000440
WO/2007/129961
10/12/2007
194660
A61K )2009.01(
‫פורמולציה פרנטרלית המכילה מעכב‬
‫משאבת פרוטון מעוקרת במיכלה הסופי‬
‫על ידי קרינה מייננת‬
A23L )2009.01(
‫תחליף מלח טבעי‬
‫גן שמואל מזון בע"מ‬
NATURAL SALT SUBSTITUTE
GAN SHMUEL FOODS LTD
IL
180308
25/12/2006
PCT/IL/2007/001522
June 15,
C07D )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4648
2009
WO/2008/078315
07/10/2008
WASTE WATER QUALITY
ENHANCEMENT FOR USE IN HOME
AND GARDEN
MOSHE ELAZAR ERNEST
12/10/2008
‫הגברת איכות של מי ביוב לשימוש בבית‬
‫וגן‬
‫משה אלעזר ארנסט‬
B05D )2009.01(
194665
DESIGN AND METHOD OF
MANUFACTURING OF
PHOTOVOLTAIC SOLAR CELLS
UTILIGHT LTD.
13/04/2006
E03B )2009.01(
194661
–‫מבנה ושיטת ייצור של תאי שמש פוטו‬
‫וולטאים‬
‫יוטילייט בע"מ‬
A01N )2009.01(
194667
PHARMACEUTICAL COMPOSITIONS
CONTAINING ALLOGENEIC CELLS
IMMUNOVATIVE THERAPIES, LTD
‫תכשירי רוקחות המכילים תאים אלוגניים‬
‫אימיונובייטיב טרפיס בע"מ‬
PCT/US/2006/014088
WO/2007/120128
29/03/2007
SYSTEM AND METHOD FOR
CREATING MICROABLATED
CHANNELS IN SKIN
LUMENIS LTD.
US
60/791194
12/04/2006
60/832964
25/07/2006
US
60/850628
11/10/2006
US
PCT/US/2007/007829
4649
A61B )2009.01(
194668
‫מערכת ושיטה ליצירת תעלות קטועות‬
‫זעירות בעור‬
‫לומניס בע"מ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
WO/2007/126999
11/04/2007
C07C )2009.01(
194669
BENZAMIDE DERIVATIVES AND
PHARMACEUTICAL COMPOSTIONS
CONTAINING THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/791079
11/04/2006
PCT/US/2007/008818
WO/2007/120647
12/04/2007
‫תולדות בנזאמיד ותכשירי רוקחות‬
‫המכילים אותן‬
AQUEOUS HYDROGEN PEROXIDECONTAINING COMPOSITION AND
ITS USE FOR CLEANING SURFACES
AKZO NOBEL N.V.
US
60/791444
13/04/2006
06114297.2
22/05/2006
EP
PCT/EP/2007/053540
WO/2007/118835
12/04/2007
‫תכשיר מימי המכיל מי חמצן ושימוש בו‬
‫לניקוי משטחים‬
194671
ENDOTHELIN RECEPTOR ANTAGONISTS
FOR EARLY STAGE IDIOPATHIC
PULMONARY FIBROSIS
ACTELION PHARMACEUTICALS LTD.
WO
PCT/IB06/051170 13/04/2006
June 15,
C11D )2009.01(
194670
– ‫כ"ג בסיוון התשס"ט‬
A61K )2009.01(
‫אנטגוניסטים לקולטן אנדותלין לשלב‬
‫מוקדם של לייפת ריאות אידיופתית‬
4650
2009
WO
PCT/IB06/051610
PCT/IB/2007/051328
WO/2007/119214
19/05/2006
11/04/2007
STABILIZATION OF DICARBONATE
DIESTERS WITH PROTONIC ACIDS
LANXESS DEUTSCHLAND GMBH
DE
102006018845.4 22/04/2006
PCT/EP/2007/003202
WO/2007/121859
21/05/2007
A61K )2009.01(
‫טיפול בקיפול לא נכון של חלבונים‬
C07D )2009.01(
194674
ROSUVASTATIN ZINC SALT
EGIS GYOGYSZERGYAR Nyilvanosan
Mukodo Reszvenytarsasag
HU
P0600293
13/04/2006
PCT/HU/2007/000030
WO/2007/119085
4651
‫ייצוב דיאסטרים דיקרבונאטים‬
‫באמצעות חומצות פרוטוניות‬
194673
TREATMENT OF PROTEIN
MISFOLDING
THE SCRIPPS RESEARCH INSTITUTE
US
60/801840
19/05/2006
60/815494
21/06/2006
US
60/859890
17/11/2006
US
PCT/US/2007/069394
WO/2007/137237
12/04/2007
C07C )2009.01(
194672
‫מלח אבץ של רוזווסטטין‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
23/04/2007
194675
OXADIAZOLIDINEDIONE
COMPOUND
ASTELLAS PHARMA INC.
2006JP
24/04/2006
118630
PCT/JP/2007/058694
WO/2007/123225
10/04/2007
‫תרכובת אוקסדיאזולידינדיאונית‬
194676
APPLICATOR WITH EXCHANGEABLE
RESERVOIR
BAYER ANIMAL HEALTH GMBH
DE
102006018827.6 22/04/2006
PCT/EP/2007/003166
WO/2007/121854
08/05/2007
194677
ACETYLENIC HETEROARYL
COMPOUNDS
ARIAD PHARMACEUTICALS, INC.
US
60/798472
08/05/2006
60/833191
25/07/2006
US
60/920688
29/03/2007
US
PCT/US/2007/011134
WO/2007/133560
08/05/2007
G01F )2009.01(
‫מתקן מוליך עם מיכל אחסון הניתן‬
‫להחלפה‬
E06C )2009.01(
‫תרכובות הטרואריליות אצטילניות‬
194678
MONOCYCLIC HETEROARYL
COMPOUNDS
ARIAD PHARMACEUTICALS, INC.
US
60/798472
08/05/2006
60/833191
25/07/2006
US
June 15,
C07D )2009.01(
E06B )2009.01(
‫תרכובות הטרואריליות מונוציקליות‬
– ‫כ"ג בסיוון התשס"ט‬
4652
2009
60/920687
US
PCT/US/2007/011136
WO/2007/133562
08/03/2007
29/03/2007
CONVERTING MACHINES TO
VIRTUAL MACHINES
MICROSOFT CORPORATION
US
11/430676
08/05/2006
PCT/US/2007/006021
WO/2007/130209
24/04/2007
4653
B32B )2009.01(
‫רשת סיבית המכילה חלקיקים‬
C07D )2009.01(
194681
3-(1,3-BENZODIOXOL-5-YL)-6-(4CYCLOPROPYLPIPERAZIN-1-YL)PYRIDAZINE, ITS SALTS AND
SOLVATES AND ITS USE AS
HISTAMINE H3 RECEPTOR
ANTAGONIST
HIGH POINT PHARMACEUTICALS,
LLC
EP
06114615.5 29/05/2006
06120117.4
05/09/2006
EP
PCT/EP/2007/054940
WO/2007/137968
13/04/2007
‫הפיכת מכונה למכונה וירטואלית‬
194680
PARTICLE-CONTAINING FIBROUS
WEB
3M INNOVATIVE PROPERTIES
COMPANY
US
11/431152
08/05/2006
PCT/US/2007/067283
WO/2007/133903
22/05/2007
G06F )2009.01(
194679
–4(–6–)‫–יל‬5–‫–בנזודיאוקסול‬3,1(–3
,‫–יל)–פירידאזין‬1–‫ציקלופרופילפיפראזין‬
‫מלחיו ופאזה מוצקה שלו המכילה‬
‫מוליקולות ממס ושימוש בו כאנטגוניסט‬
H3 ‫לקולטן היסטמין‬
A61K )2009.01(
194683
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
METHOD OF TREATMENT OF AGERELATED MACULAR
DEGENERATION (AMD)
PRANA BIOTECHNOLOGY LIMITED
US
60/792278
14/04/2006
PCT/AU/2007/000490
WO/2007/118276
10/04/2007
‫שיטה לטיפול בהתנוונות כתמית הקשורה‬
)AMD( ‫לגיל‬
METHOD FOR RADIO RESOURCE
CONTROL REQUESTED CODEC RATE
CONTROL FOR VOIP
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/791361
12/04/2006
60/829686
17/10/2006
US
PCT/US/2007/066303
WO/2007/121163
11/04/2007
‫שיטה לבקרת משאב שידור המשתמש‬
VOIP ‫ עבור‬CODEC ‫בבקרת קצב‬
194687
MULTILAYERED FILM AND METHOD
FOR MANUFACTURING SAME
BIO-TEC BIOLOGISCHE
NATURVERPACKUNGEN GMBH & CO.
KG
DE
102006018060.7 14/04/2006
PCT/EP/2007/053518
WO/2007/118828
11/04/2007
194688
RAPID ACTING AND LONG ACTING
INSULIN COMBINATION
FORMULATIONS
June 15,
H04L )2009.01(
194685
B32B )2009.01(
‫פילם רב–שכבתי ושיטה לייצורו‬
A61K )2009.01(
‫הרכבים של צירופי אינסולין הפועלים‬
‫במהירות ולאורך זמן‬
– ‫כ"ג בסיוון התשס"ט‬
4654
2009
BIODEL, INC.
US
60/744687
11/537335
US
11/695562
US
PCT/US/2007/066452
WO/2007/121256
12/04/2006
29/09/2006
02/04/2007
11/04/2007
C07K )2009.01(
194689
AGENT, COMPOSITION AND
METHOD
BIOINVENT INTERNATIONAL AB
GB
0607354.8
12/04/2006
PCT/EP/2007/003216
WO/2007/115829
12/10/2008
‫ הרכב ושיטה‬,‫חומר‬
A47F )2009.01(
194690
BED WITH CIRCUMFERENTIAL
WALL
AMINACH LTD.
12/10/2008
BED WITH SELECTABLY
POSITIONABLE SUPPORT
APPENDAGE
AMINACH LTD.
12/10/2008
‫מיטה עם דופן מקיף‬
‫עמינח בע"מ‬
‫מיטה עם תוספת מתכווננת על פי בחירה‬
‫עמינח בע"מ‬
4655
A47F )2009.01(
194692
MULTIPLE AXIS PIVOTABLY
RAISABLE BED
AMINACH LTD.
19/04/2007
A47F )2009.01(
194691
‫מיטה רבת צירים הניתנת להרמה‬
‫עמינח בע"מ‬
A23C )2009.01(
194693
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
CASEIN MICELLES FOR
NANOENCAPSULATION OF
HYDROPHOBIC COMPOUNDS
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
60/793302
20/04/2006
PCT/IL/2007/000496
WO/2007/122613
26/04/2007
‫מיצלות קזאין לננו–אינקפסולציה של‬
‫חומרים הידרופוביים‬
‫מוסד הטכניון למחקר ופתוח בע"מ‬
194695
POTASSIUM FLUORIDE DISPERSION
AND PROCESS FOR PRODUCING
FLUORIDE-CONTAINING ORGANIC
COMPOUND USING THE SAME
SUMITOMO CHEMICAL COMPANY,
LIMITED
2006JP
27/04/2006
123126
2006-186334 06/07/2006
JP
PCT/JP/2007/059439
WO/2007/126142
23/04/2007
‫תפזורת של פלוריד פוטסיום והליך לייצור‬
‫פלוריד המכיל תרכובת אורגנית והשימוש‬
‫בה‬
194696
NOVEL METHOD FOR PRODUCING
PYRIMIDINE COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2006JP
24/04/2006
118803
2006-270442 02/10/2006
JP
PCT/JP/2007/059277
WO/2007/123277
11/04/2007
C07D )2009.01(
‫שיטת חדשנית לייצור תרכובת פירימידין‬
194697
IMPROVED DISPENSING
APPARATUS
RAWLPLUG LIMITED
June 15,
C01D )2009.01(
B65D )2009.01(
‫התקן חלוקה משופר‬
– ‫כ"ג בסיוון התשס"ט‬
4656
2009
GB
0607273.0
PCT/GB/2007/001333
WO/2007/128996
11/04/2006
12/10/2008
METHOD AND SYSTEM FOR
DISPLAYING A PANORAMIC VIEW
TO AN OPERATOR
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
12/04/2007
G08B )2009.01(
194701
‫שיטה ומערכת להצגת מראה נופי למפעיל‬
‫רפא"ל מערכות לחימה מתקדמות בע"מ‬
A61K )2009.01(
194702
METHODS OF TREATING,
DIAGNOSING OR DETECTING
CANCER
NOVARTIS VACCINES AND
DIAGNOSTICS, INC.
US
60/791871
13/04/2006
PCT/US/2007/009063
WO/2007/120787
12/04/2007
‫ אבחון או גילוי סרטן‬,‫שיטות טיפול‬
NANOPARTICLES, METHODS OF
MAKING, AND APPLICATIONS
USING SAME
NANOMAS TECHNOLOGIES, INC.
US
60/791325
12/04/2006
PCT/US/2007/009013
WO/2007/120756
13/04/2007
‫ שיטות להכנתם וניצולם‬,‫ננו–חלקיקים‬
‫ליישומים‬
H04N )2009.01(
194704
SYSTEM FOR TRIGGERING TERMINALS
AJAMES GMBH
DE
102006018245.6 13/04/2006
PCT/EP/2007/003288
WO/2007/118686
4657
B22F )2009.01(
194703
‫מערכת להפעלת נקודת חיבור‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
12/04/2007
POP-UP SPRINKLER
HAIM SHAHAK
US
60/792316
PCT/IL/2007/000472
WO/2007/119235
194705
‫ממטיר גיחה‬
‫חיים שחק‬
17/04/2006
16/11/2006
194706
DISSOCIATED DISCHARGE EHD
SPRAYER WITH ELECTRIC FIELD
SHIELD
VENTAIRA PHARMACEUTICALS,
INC.
US
60/773239
14/02/2006
PCT/US/2006/044626
WO/2007/094835
12/10/2008
17/02/2005
194708
G06F )2009.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
194709
PROCESS FOR PREPARING
INTERMEDIATES FOR COMPOUNDS
WHICH POSSESS ENDOTHELIN
RECEPTOR ANTAGONIST ACTIVITY
ASTRAZENECA AB
GB
0403744.6
20/02/2004
PCT/GB/2005/000567
WO/2005/080403
B05B )2009.01(
‫ עם הגנת‬EHD ‫מרסס חומר נתיק מסוג‬
‫שדה חשמלי‬
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAM
June 15,
B05D )2009.01(
C07F )2009.01(
‫תהליך להכנת חומרי ביניים עבור תרכובות‬
‫בעלות פעילות כנגד רצפטור אנדותל‬
– ‫כ"ג בסיוון התשס"ט‬
4658
2009
28/06/2002
PREIMPLANTATION FACTOR
PEPTIDE
BIOINCEPT, INC.
US
60/302607
02/07/2001
PCT/US/2002/020599
WO/2003/004601
26/04/2007
‫פפטיד לטרום השתלה‬
‫מתקן התעמלות אוניברסלי הניתן לתכנות‬
‫מערכת גילוי התקפה זדונית ושיטת‬
‫שימוש בה‬
C07K )2009.01(
194714
RECOMBINANT ATTENUATED
CLOSTRIDIUM ORGANISMS AND
VACCINE
SCHERING-PLOUGH LTD.
US
60/792553
17/04/2006
4659
G06F )2009.01(
194712
MALICIOUS ATTACK DETECTION
SYSTEM AND AN ASSOCIATED
METHOD OF USE
CONNECT TECHNOLOGIES
CORPORATION
US
11/279979
17/04/2006
PCT/US/2007/066645
WO/2007/121361
12/04/2007
A63B )2009.01(
194711
PROGRAMMABLE UNIVERSAL
EXERCISE DEVICE
LPT TECHNOLOGIES LTD
IL
175234
26/04/2006
PCT/IL/2007/000516
WO/2007/122627
13/04/2007
C07K )2009.01(
194710
‫אורגניזמים רקומביננטים מכוונים של‬
‫ וחיסון‬CLOSTRIDIUM
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
PCT/US/2007/009135
WO/2007/123850
19/04/2007
194715
PROCESS FOR THE PREPARATION
OF [(1R),2S]-2-AMINOPROPIONIC
ACID 2-[4-(4-FLUORO-2-METHYL-1HINDOL-5-YLOXY)-5METHYLPYRROLO[2,1F][1,2,4]TRIAZIN-6-YLOXY]-1METHYLETHYL ESTER
BRISTOL-MYERS SQUIBB COMPANY
US
60/745300
21/04/2006
PCT/US/2007/066911
WO/2007/124332
18/04/2007
12/10/2008
‫–חומצה‬R1),S2]–2([ ‫תהליך להכנת‬
–2–‫–פלואורו‬4(–4[–2 ‫אמינופרופיונית‬
–5–)‫–אילאוקסי‬5–‫–אינדול‬H1–‫מתיל‬
–6–‫]טריאזין‬F][4,2,1–1,2[‫מתילפירולו‬
‫–מתילאתיל אסטר‬1–]‫אילוקסי‬
194716
HETEROCYCLIC ARYLSULPHONES
SUITABLE FOR TREATING
DISORDERS THAT RESPOND TO
MODULATION OF THE SEROTONIN
5HT6 RECEPTOR
ABBOTT GMBH & CO. KG
US
60/793139
19/04/2006
PCT/EP/2007/053807
WO/2007/118899
C07D )2009.01(
‫ארילסולפונים הטרוציקליים מתאימים‬
‫לטיפול בהפרעות המגיבות למודולציה של‬
HT56 ‫קולטן סרוטונין‬
194717
A METHOD, SYSTEM AND MEANS
FOR PROVIDING THREEDIMENSIONAL IMAGES
June 15,
C07D )2009.01(
G06T )2009.01(
‫שיטה התקנים ומערכת לייצור תמונות‬
‫תלת מימדיות‬
– ‫כ"ג בסיוון התשס"ט‬
4660
2009
‫גאומיין בע"מ‬
GEOMINE LTD
22/10/2008
INDICATOR OF LINE-TO-LINE AND
LINE-TO-GROUND NETWORK FAULT
22/10/2008
A63C )2009.01(
‫דמות עם אנימציה המיועדת לקישוט של‬
‫פרטי לבוש וחפצים אישיים‬
‫הולהלה פיתוח שעשועים בע"מ‬
H02H )2009.01(
194724
‫שנאי אלקטרוני אוניוורסלי דו–כיווני‬
)REVERSIBLE(
‫סינוטרל בע"מ‬
THE UNIVERSAL REVERSIBLE
ELECTRONIC TRANSFORMER
SINOTREL LTD
22/10/2008
‫אינדיקטור של קו–לקו וקו–לאדמה קצר‬
‫של מערכת חשמלי‬
194723
AN ANIMATION FIGURE FOR
DECORATION OF CLOTHING AND
PERSONAL ACCESSORIES
HULLAHALA FUN DEVELOPMENTS
LTD
22/10/2008
G01R )2009.01(
194721
B60N )2009.01(
194725
PROTECTION FOR CHILDREN IN
CARS
JONATAN ZITONY
22/10/2008
‫מגן לילדים לרכב‬
‫יונתן זיתוני‬
B60L )2009.01(
194727
TECHNOLOGICAL SCHEME OF THE
ELECTRIC CAR WITH CENTRAL
LOCATION DRIVING AGGREGATES
AND ELECTRONIC CONTROL
‫מתווה טכנולוגי של רכב חשמלי עם‬
‫אגרגטים מובילים ממוקמים בזיר מרכזי‬
‫של הרכב ועם בקרה אלקטרונית‬
‫שליאחו גריגורי‬
4661
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
22/10/2008
194728
DEVICE (SYSTEM)OF SEAT BELTS IN
CARS WITH TOP LOCATION
(FASTENING)
GONTMACHER ALEXANDER
22/10/2008
‫מערכת חגורות בטיחות במכונית עם‬
‫הרכבה עליונה‬
‫גונטמאכר אלכסנדר‬
194729
PARLAMENT SYSTEM - MANAGING
DISCOURSE BETWEEN
ORGANIZATION AND
STAKEHOLDERS
NOAM NIR
22/10/2008
‫נועם ניר‬
194730
‫ד"ר חיים עמרם בן שמחון‬
194731
G06F )2009.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
194764
CLOSURE SYSTEM FOR A VIAL,
VIAL, METHOD OF CLOSING AND
FILLING A VIAL AND STAND FOR A
VIAL
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0219152.6
16/08/2002
0304268.6
25/02/2003
GB
PCT/EP/2003/009151
June 15,
A61C )2009.01(
‫אמצעים לסמון הגבלת החדירה של‬
.‫איברים גלוליים‬
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAM
15/08/2003
G09B )2009.01(
‫מערכת "פרלמנט"– ניהול שיח בין ארגון‬
‫למחזיקי העניין‬
MEANS TO MARK THE LIMIT OF
PENETRATION OF CIRCULAR
ORGANS.
DR. HAIM AMRAM BEN-SIMHON
22/10/2008
B60R )2009.01(
B65D )2009.01(
‫ שיטה‬,‫מערכת סגירה לבקבוקון בקבוקון‬
‫לסגירה ומילוי הבקבוקון ומעמד לבקבוקון‬
– ‫כ"ג בסיוון התשס"ט‬
4662
2009
WO/2004/018317
15/08/2003
CLOSURE SYSTEM FOR A VIAL,
VIAL, METHOD OF CLOSING AND
FILLING A VIAL AND STAND FOR A
VIAL
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0219152.6
16/08/2002
0304268.6
25/02/2003
GB
PCT/EP/2003/009151
WO/2004/018317
30/04/2001
SYSTEM AND METHOD FOR FAST
DYNAMIC LINK ADAPTATION
INTERDIGITAL TECHNOLOGY
CORPORATION
4663
‫ שיטה‬,‫ בקבוקון‬,‫מערכת סגירה לבקבוקון‬
‫לסגירה ומילוי הבקבוקון ומעמד לבקבוקון‬
H04B )2009.01(
194766
DOWNLINK POWER CONTROL FOR
MULTIPLE DOWNLINK TIME SLOTS
IN TDD COMMUNICATION SYSTEMS
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/200756
01/05/2000
PCT/US/2001/013720
WO/2001/084740
18/10/2002
B65D )2009.01(
194765
‫בקר כוח לאות משודר מלווין עבור מספר‬
‫רב של אותות משודרים בחריצי זמן‬
TDD ‫במערכת תקשורת‬
H04B )2009.01(
194767
‫מערכת ושיטה לסיגנל קישור דינמי מהיר‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
US
60/344693
PCT/US/2002/033587
WO/2003/041317
19/10/2001
17/08/1999
194772
METHOD FOR DETECTION OF
BIOLOGICAL FACTORS IN
EPIDERMIS
DERMTECH INTERNATIONAL
US
60/097025
18/08/1998
PCT/US/1999/019012
WO/2000/010579
22/10/2008
‫שיטה לזיהוי גורמים ביולוגיים באפידרמיס‬
194816
A SYSTEM AND METHOD FOR
DETERMINING AN ANONYMOUS
USER-CENTRIC CROSS COMMUNITY
REPUTATION
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
194817
STREPTOMYCES AVERMITILIS GENE
DIRECTING THE RATION OF B2:B1
AVERMECTINS
PFIZER PRODUCTS, INC.
US
60/148645
12/08/1999
PCT/IB/2000/001017
WO/2001/012821
24/10/2001
C12N )2009.01(
‫גן של סטרפטומיסס אברמיטיליס המכוון‬
‫ אברמקטינים‬B:2B1 ‫את היחס של‬
194827
METHOD AND APPARATUS FOR
HIGH RATE PACKET DATA AND
LOW DELAY DATA
TRANSMISSIONS
June 15,
G06F )2009.01(
‫מערכת ושיטה לקביעת משתמש–מרכזי‬
‫אנונימי המנוגד למוניטין קהילה‬
DEUTSCHE TELEKOM AG
24/07/2000
C12N )2009.01(
H04Q )2008.04(
‫שיטה והתקן לשידורי נתונים מארז בקצב‬
‫גבוה והשהיה נמוכה‬
– ‫כ"ג בסיוון התשס"ט‬
4664
2009
QUALCOMM INCORPORATED
US
09/697375
25/10/2000
PCT/US/2001/050892
WO/2002/041509
20/11/2001
DATA RECORDER
SONY CORPORATION
JP
2001-65074
PCT/JP/2001/010146
WO/2002/075739
23/10/2008
‫מקליט מידע‬
08/03/2001
4665
B07C )2009.01(
194856
MACHINE, APPARETUS AND
SYSTEM FOR SORTING, WEIGHING
BUNDLING DIFFERENT KINDS OF
FRASH LEAF AGRICULTURAL
GOODS SUCH AS FRASH LEAF
HERBS OR COMMERCIAL
DECORATIVE PLANTS OR ALIKE BY
ELECTRO-MECHANICAL, OPTROMECHANICAL MEANS INCLUDING
ROBOTIS
UZI MOR
23/10/2008
G11B )2009.01(
194836
‫ מנגנון מכשור ומערכת למיון‬,‫מכונה‬
‫שקילה אגידה ואריזה של מוצרים עלים‬
‫חקלאיים טריים שונים כגון צמחי תבלין‬
‫טריים או צמחי נוי קטופים באמצעות‬
–‫ אלקטרו‬,‫מערכות אלקטרו–מכאניות‬
‫אופטיות כולל רובוטיקה‬
‫עוזי מור‬
B65D )2009.01(
194857
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
EARS PLUG CONTAINER STORAGE
FLUID (MEDICINE)
YEHOSHOUA TABOR
23/10/2008
)‫פקק אוזניים מיכל לאפסון נוזלים (תרופות‬
‫יהושע תבור‬
194860
‫דפיברילטור בטוח למבקש‬
‫פואמס בע"מ‬
CAREGIVER SAFE DEFIBRILLATOR
POEMS LTD
25/05/2004
194872
C07D )2009.01(
‫–מותמרים על–ידי‬3 ‫אינדולים חדשים‬
‫גופרית‬
NOVEL SUBSTITUTED 3-SULFUR
INDOLES
ASTRAZENECA AB
SE
0301569-0
27/05/2003
0302305-8
27/08/2003
SE
PCT/SE/2004/000808
WO/2004/106302
June 15,
A61C )2009.01(
– ‫כ"ג בסיוון התשס"ט‬
4666
2009
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note: As from Patents and Designs Journal
No.1/06, patent applications are classified
according to the Eighth Edition of the
International Patent Classification (2006)
4667
- ‫ לחוק הפטנטים תשכ"ז‬26 ‫הודעה לפי סעיף‬
1976
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬17 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬30 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬57 ‫הפטנטים בדרך הקבועה בתקנה‬
.1968 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי – מהדורה שביעית‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
'‫ החל מיומן הפטנטים והמדגמים מס‬:‫*הערה‬
‫ ניתן ציון לבקשות פטנטים הסיווג לפי‬1/06
‫המהדורה השמינית של הסיווג הבינלאומי‬
)2006 ‫של פטנטים (משנה‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
128720
‫שיטה לאישור פעולות הנעשות דרך הטלפון‬
]54[
METHOD FOR CERTIFICATION
OF OVER THE PHONE
TRANSACTIONS
]22[
]51[
]71[
]74[
25.02.1999
Int. Cl.(2008.04) G10L 17/00, H04L 29/06, 9/00
CIDWAY TECHNOLOGIES LTD.
‫ בית שמש‬,
CIDWAY TECHNOLOGIES LTD.,
,
BEIT SHEMESH
‫ בית‬,205 .‫ד‬.‫אצל סידווי פיתוח בע"מ ת‬
‫שמש‬
[57] A method for identifying the owner
of a portable device, comprising the steps
of: computing a dynamic identification
code at the portable device; encoding the
identification code into an acoustic
signature at the portable device; causing
the portable device to transmit the acoustic
signature over a voice line to a service
provider; decoding the acoustic signature
into the identification code at the service
provider; transmitting the identification
code from the service provider to a
certification service; generating indicia of
the identification code at the certification
service; comparing the indicia of the
identification code to a plurality of
possible owners; producing a true owner
from the comparison; and causing the
certification service to transmit to the
service provider a digital certificate
corresponding to a digital signature of the
true owner.
________
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4668
2009
]11[]21[
129354
‫ להכנת‬ErbB2 ‫שימוש בנוגדנים נגד‬
‫תרופות להשריית אפופטרוזיס בתאים‬
‫ באופן מוגבר‬ErbB2 ‫המבטאים‬
]54[
USE OF ANTI – ERBB2
ANTIBODIES FOR THE
PREPARATION OF
MEDICAMENTS FOR INDUCING
APOPTOSIS IN CELLS
OVEREXPRESSING ERBB2
]22[
]31[
]51[
]71[
09.10.1997
731794
]32[ 18.10.1996
]33[ US
Int. Cl.(2008.04) A61K 393/95, C07K 16/32, C12N 15/13
GENENTECH, INC., U.S.A.
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM,
U.S.A.
WO/1998/017797
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
[57] Use of an effective amount of an
isolated first antibody that binds epitope
7C2/f7F3 (SEQ ID NO:2) of ErbB2 for the
preparation of a medicament for exposing
a cell that overexpresses ErbB2 to the
antibody, wherein said binding induces
apoptosis of the cell.
_______
]11[]21[
129497
‫תצמידי ליגנד רנא לגורם גדילה לציפוי‬
)VEGF(‫פנימי של כלי דם‬
]54[
VASCULAR ENDOTHELIAL
GROWTH FACTOR (VEGF)
NUCLEIC ACID LIGAND
]22[
]31[
17.10.2007
08/739109
]32[ 25.10.1996
]33[ US
08/870930
06.06.1997
US
08/897351
31.07.1997
US
Int. Cl.(2008.04) A61K 317/088, 47/48, A61P 17/06, 19/02, 27/02, 35/00, C07H
21/02, 21/04, C12P 19/34
GILEAD SCIENCES, INC., U.S.A.
WO/1998/018480
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]51[
]71[
]87[
]74[
4669
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
[57] An RNA ligand to VEGF
comprising the sequence:
fCmGmGrArAfUfCmAmGfUmGmAmAf
UmGfCfUfUmAfUmAfCmAfUfCfCmG3' 3'-dT.
_______
]11[]21[
129620
‫תכשיר רוקחות המכיל תצמיד פעיל‬
‫לחלבון ההדג'הוג וחלבון ותהליך ליצורו‬
]54[
PHARMACEUTICAL
COMPOSITION COMPRISING A
HEDGEHOG PROTEIN
CONJUGATE AND A PROTEIN
AND A PROCESS FOR ITS
PRODUCTION
]22[
]31[
27.04.1999
98107911.4
]32[ 30.04.1998
]33[ EP
98116733.1
03.09.1998
EP
Int. Cl.(2008.04) A61K 38/18, 38/22, 47/02, 47/08, 47/28, 47/42, 47/44, 47/48, C07K
14/47, 19/00
CURIS, INC., U.S.A.
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]51[
]71[
]74[
[57] Pharmaceutical composition
comprising
(a) a hedgehog conjugate, comprising from
1 to 4 moieties covalently bound to a
protein comprising a hedgehog N-terminal
domain; wherein each moiety is:
(i) a polypeptide composed of 10 to 30
hydrophobic amino acids or of amino acids
which form transmembrane helices and are
positively charged,
(ii) an aliphatic, saturated or unsaturated
hydrocarbon residue with a chain length of
8 to 24 C atoms and with a hydrophobic
character, or
(iii) a hydrophobic thio group and
(b) a protein selected from a bone
morphogenetic protein or a parathyroid
hormone.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4670
2009
]11[]21[
132030
‫תהליך להכנת פפטיד על ידי שימוש‬
‫בפפטיד עזר‬
]54[
PROCESS FOR PRODUCING
PEPTIDE WITH THE USE OF
ACCESSORY PEPTIDE
]22[
]31[
]51[
29.01.1999
10-32272
]32[ 30.01.1998
]33[ JP
Int. Cl.(2009.01) A61K 38//28, C07K 14//605, C12N 01//21, 05//10, 15//62, C12P
21//02, 21//06
ASUBIO PHARMA CO., LTD.,
JAPAN
WO/1999/038984
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]71[
]87[
]74[
[57] A process for producing a peptide
having a desired biological activity,
comprising the steps of:
(1) culturing cells transformed with an
expression vector having a nucleotide
sequence encoding a fusion protein, said
fusion protein comprising a peptide of
interest of not greater than 200 amino
acids, a protective peptide which is
heterologous to the peptide of interest and
protects the peptide of interest from
degradation by intra-cellular proteases, and
a helper peptide, wherein said fusion
protein has cleavage sites between the
protective peptide, the helper peptide and
the peptide of interest so that said fusion
protein comprises two cleavage sites;
(2) harvesting said fusion protein from said
culture;
(3) cleaving said fusion protein so as to
liberate said protective peptide and thereby
obtain said peptide of interest with said
helper peptide attached;
(4) purifying said peptide of interest with
said helper peptide attached;
(5) optionally subjecting said peptide of
interest with said helper peptide attached
to a modification reaction;
(6) cleaving said peptide of interest with
said helper peptide attached so as to
liberate said helper peptide and thereby
obtain said peptide of interest; and
(7) purifying said peptide of interest;
wherein said helper peptide alters the
physicochemical properties of the peptide
of interest, in order to circumvent
problems in the purification and/or
modification of the peptide of interest that
derive from the physicochemical
properties of the peptide of interest.
_______
4671
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
134498
– 2 – ‫ – אלקיל‬5 ‫חומצות‬
‫ארילאמינופנילאצטיות מסויימות‬
‫ תכשירים‬,‫ שיטה להכנתן‬,‫ונגזרותיהן‬
‫רפואיים המכילים אותן ושימושן להכנת‬
– ‫תרופות לעיכוב פעילות ציקלואוקסיגנאז‬
2
]54[
CERTAIN 5 – ALKYL – 2 –
ARYLAMINOPHENYLACETIC
ACIDS AND DERIVATIVES,
METHOD FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF FOR
THE PREPARATION OF
MEDICAMENTS FOR INHIBITING
CYCLOOXYGENASE-2 ACTIVITY
]22[
]31[
26.08.1998
60/057803
]32[ 28.08.1997
]33[ US
60/069837
28.08.1997
US
Int. Cl.(2008.04) A61K 311/95, 312/16, A61P 43/00, C07C 229/42
NOVARTIS AG, SWITZERLAND
WO/1999/011605
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
[57] A compound of the formula
wherein R is methyl or ethyl;
R1 is chloro or fluoro;
R2 is hydrogen or fluoro;
R3 is hydrogen, fluoro, chloro, methyl,
ethyl, methoxy, ethoxy or hydroxy;
R4 is hydrogen or fluoro; and
June 15,
R5 is chloro, fluoro, trifluoromethyl or
methyl;
or a pharmaceutically acceptable salt
thereof;
or a pharmaceutically acceptable prodrug
ester thereof.
_______
– ‫כ"ג בסיוון התשס"ט‬
4672
2009
]11[]21[
134905
‫תרכובות ביניים לנגזרות פירולידין נוגדות‬
‫ והרכבים רקחיים‬,‫ הכנתן‬,‫אנדותלין‬
‫המכילים אותן‬
]54[
INTERMEDIATES FOR
ENDOTHELIN ANTAGONISTIC
PYRROLIDINE DERIVATIVES,
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]22[
]31[
10.08.1995
293349
]32[ 19.08.1994
]33[ US
334717
04.11.1994
US
442575
30.05.1995
US
497998
02.08.1995
US
Int. Cl.(2008.04) A61K 31/40, C07D 211/00
DIVISION FROM 114894
ABBOTT LABORATORIES, U.S.A.
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]51[
]62[
]71[
]74[
[57] A compound of the formula:
)
wherein
Z is –C(R18)(R19)- or –C(O)- wherein R18
and R19 are independently selected from
hydrogen and loweralkyl; n is l: R is –
(CH2)m-W wherein m is an integer from 0
to 6 and W is
(a) –C(O)2-G wherein G is hydrogen or a
carboxy protecting group
(b) –PO3H2,
(c) –P(O)(OH)E wherein E is hydrogen,
loweralkyl or arylalkyl
(d) –CN,
4673
(e) –C(O)NHR17 wherein R17 is
loweralkyl,
(f) alkylaminocarbonyl,
(g) dialkylaminocarbonyl,
(h) tetrazolyl,
(i) hydroxy,
(j) alkoxy,
(k) sulfonamido,
(l) –C(O)NHS(O)2R16 wherein R16 is
loweralkyl, haloalkyl, phenyl or
dialkylamino,
(m) –S(O)2NHC(O)R16,
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
R1 and R2 are independently selected from
hydrogen, loweralkyl, alkenyl, alkynyl,
alkoxyalkyl, alkoxycarbonylalkyl,
hydroxyalkyl, alkoxyalkoxyalkyl,
thioalkoxyalkoxyalkyl, cycloalkyl,
aminocarbonylalkyl,
alkylaminocarbonylalkyl,
dialkylaminocarbonylalkyl,
aminocarbonylalkenyl,
alkylaminocarbonylalkenyl,
dialkylaminocarbonylalkenyl,
hydroxyalkenyl, aryl, arylalkoxyalkyl,
heterocyclic and
(Raa)(Rbb)N-Rcc- wherein Raa is aryl or
arylalkyl, Rbb is hydrogen or alkanoyl and
Rcc is alkylene, with the proviso that one of
R1 and R2 is other than hydrogen; R3 is (a)
R4-C(O)-R5-, R6-S(O)2-R7- or R26-S(O)R27- wherein R5 is (i) a covalent bond, (ii)
alkylene, (iii) alkenylene, (iv) –N(R20)-R8or –R8a-N(R20)-R8- wherein R8 and R8a are
independently selected from alkylene and
R20 is hydrogen, loweralkyl, alkenyl,
cycloalkyl or cycloalkylalkyl or (v) –O-R9or –R9a-O-R9- wherein R9 and R9a are
June 15,
independently selected from alkylene; R7
is (i) a covalent bond, (ii) alkylene, (iii)
alkenylene or (iv) –N(R21)-R10- wherein
R10 is alkylene and R21 is hydrogen or
loweralkyl;
R4 and R6 are independently selected from
the group consisting of
(i) (R11)(R12)N-wherein R11 and R12 are
independently selected from
(1) hydrogen,
(2) loweralkyl,
(3) alkoxyalkyl,
(4) alkenyl,
(5) alkynyl,
(6) cycloalkyl,
(7) cycloalkylalkyl,
(8) aryl,
(9) heterocyclic,
(10) arylalkyl, and
(11) (heterocyclic) alkyl,
(ii) loweralkyl,
(iii) alkenyl,
(iv) alkynyl,
(v) cycloalkyl,
(vi) cycloalkylalkyl,
– ‫כ"ג בסיוון התשס"ט‬
4674
2009
(vii) aryl,
(vii) arylalkyl,
(ix) heterocyclic,
(x) (heterocyclic) alkyl and
(xi) alkoxyalkyl;
R26 (i) loweralkyl, (ii) haloalkyl, (iii)
alkenyl, (iv) alkynyl,
(v) cycloalkyl, (vi) cycloalkylalkyl, (vii)
aryl,
(viii) arylalkyl, (ix) heterocyclic,
(x) (heterocyclic) alkyl, (xi) alkoxyalkyl or
(xii) alkoxy-subsituted haloalkyl; and
R27 is alkylene or alkenylene;
(b) R22-O-C(O)-R23 – wherein R22 is a
carboxy protecting group or heterocyclic
and R23 is (i) a covalent bond,
(ii) alkylene, (iii) alkenylene or (iv) –
N(R24)-R25- wherein R25 is alkylene and
R24 is hydrogen or loweralkyl;
(c) loweralkyl,
(d) alkenyl,
(e) alkynyl,
(f) cycloalkyl,
(g) cycloalkylalkyl,
(h) aryl,
(i) arylalkyl,
(j) aryloxyalkyl,
(k) heterocyclic,
(l) (heterocyclic) alkyl,
(m) alkoxyalkyl,
(n) alkoxyalkoxyalkyl, or
(o) R13-C(O)-CH(R14)-wherein R13 is
amino, alkylamino or dialkylamino and
R14 is aryl R15-C(O)-wherein R15 is amino,
alkylamino or dialkylamino; or a
pharmaceutically acceptable salt thereof
and with the further proviso that the
compound of formula 1 is not l-methyl-3cyano-pyrrolidine, l-propyl-2-methyl-3carbethoxy-pyrrolidine, l-ethyl-3fluoropyrrolidine, l-methyl-3chloromethylpyrrolidine, 1.5-dimethyl-3acetyl-pyrrolidine, l-phenyl-3vinylpyrrolidine, 1,2-dimethyl-3cyanopyrrolidine, l-benzyl-3acetoxypyrrolidine, l-hexyl-3dimethylaminopyrrolidine or l-ethyl-3methylsulfonyl-pyrrolidine.
_______
]11[]21[
]54[
SYSTEM AND METHOD FOR
ELECTRONIC INVENTORY
]22[
]31[
]51[
]71[
20.11.1998
08/975969
]32[ 21.11.1997
Int. Cl.(2008.04) G06K 7/00
SYMBOL TECHNOLOGIES, INC.,
U.S.A.
WO/1999/026462
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] A radio frequency identification tag
(102), comprising: means (306) for
receiving a first signal from a tag reader,
wherein the tag is identified by a plurality
of bits and wherein the tag is configured to
respond to the tag reader with
identification data during one of a plurality
4675
136220
‫מערכת ושיטה למצאי אלקטרוני‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
of time slots; and means (320) for
transmitting a second signal to the tag
reader including said identification data in
response to receiving said first signal from
the tag reader, characterized in that: said
identification data is a first subset of said
plurality of bits during a first read and said
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
identification data is a second subset of
said plurality of bits during a second read
from the tag reader, and in that said first
subset of said plurality of bits corresponds
to different bit positions in said plurality of
bits than said second subset of said
plurality of bits and wherein the number of
bits in said first subset of said plurality of
bits is less than the number of bits in said
plurality of bits.
_______
]11[]21[
137552
– 6 ‫צורה גבישית של הידרוכלוריד‬
– 1 – ‫ –(פיפרידין‬2 [– 4 ( – 3 – ‫הידרוקסי‬
– 4( – 2 – )‫איל) אתוקסי [פנוקסי‬
‫ הכנתו‬,‫] תיופן‬b[ ‫מתוקסיפניל) בנזו‬
‫ותכשירים רפואיים המכילים אותו‬
]54[
CRYSTALLINE FORM OF 6 –
HYDROXY – 3 – (4 – [2 –
(PIPERIDIN – 1 – YL)
ETHOXY]PHENOXY) – 2 – (4 –
METHOXYPHENYL) BENZO [B]
THIOPHENE HYDROCHLORIDE,
ITS PREPARATION AND
PHARMACEUTICAL
COMPOSIITONS COMPRISING IT
]22[
]31[
27.07.2000
60/146184
]32[ 29.07.1999
]33[ US
60/147642
06.08.1999
US
60/149820
19.08.1999
US
Int. Cl.(2008.04) A61K 314/45, C07D 409/00, 409/12
ELI LILLY AND COMPANY, U.S.A.
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]74[
[57] Crystalline 6-hydroxy-3-(4-[2(piperidin-1-yl) ethoxy] phenoxy)-2-(4methoxyphenyl) benzo [b] thiophene
hydrochloride hydrate (F-III) having an Xray diffraction pattern which comprises the
following peaks: 4.6 ±0.2, 7.8 ±0.2, 9.3
June 15,
±0.2, 14.0 ±0.2, 17.6 ±0.2, 20.8 ±0.2, and
24.3 ±0.2o in 2θ; when obtained at 25 ±
2oC and 35 ± 10% relative humidity from a
copper radiation source (CuKα; λ =
1.54056 Å).
– ‫כ"ג בסיוון התשס"ט‬
4676
2009
_______
]11[]21[
137820
‫תכשיר רוקחי למתן טופיקלי הכולל פפטיד‬
‫נגד כאב‬
]54[
PHARMACEUTICAL
COMPOSITION FOR TOPICAL
ADMINISTRATION
COMPRISING AN ANALGESIC
PEPTIDE
]22[
]51[
10.08.2000
Int. Cl.(2008.04) A61K 38/06, 38/07, A61P 23/00, 23/02, 29/00, 29/02, C07K 5/00,
5/08, 5/10
S.I.S. SHULOV INSTITUTE FOR
‫ רחובות‬,‫אס מכון שולוב למדע בע"מ‬.‫איי‬.‫אס‬
SCIENCE LTD.
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]71[
]74[
[57] Pharmaceutical composition for
topical administration comprising:
(a) an analgesic effective amount of a
peptide comprising L-amino acids of the
formula.
pGLU-X-Y-Z
wherein X is an amino acid selected from
the group consisting of GLY, VAL, GLU,
ASP, SER, ALA, ASN, GLN, ILE, LEU,
PRO, LYS and ARG, Y is TRP or THR,
and Z is any L-amino acid, or Z is absent,
and wherein when Z is any L-amino acid,
one but not both of Y and Z is TRP, and
when Z is absent, Y=TRP, or
(b) alkyl esters or alkyl amides of the
peptide of (a), wherein the alkyl group is
selected from the group consisting of C5C30, and a pharmaceutically acceptable
excipient.
________
4677
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
138339
‫אלרגנים רקומביננטים של מוטנטים לא‬
‫ שיטה להכנתם ותכשירים‬,‫טבעיים‬
‫רפואיים המכילים אותם‬
]54[
NON NATURALLY OCCURRING
MUTANT RECOMBINANT
ALLERGENS, METHODS FOR
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]22[
]31[
]51[
]71[
]87[
]74[
16.03.1999
0364/98
]32[ 16.03.1998
]33[ DK
Int. Cl.(2008.04) A61K 39/35, 39/36, C07K 144/15, 144/35, C12N 15/12, 15/29
ALK-ABELLO A/S, DENMARK
WO/1999/047680
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
[57] Recombinant allergen, characterised
in that it is a non-naturally occurring
mutant derived from a naturally occurring
allergen, wherein at least one surfaceexposed, conserved amino acid residue of
at least one patch of conserved amino acid
residues being coherently connected over
at least 400 Å2 of the surface of the threedimensional structure of the allergen
molecule as defined by having a solvent
accessibility of at least 20%, said patch
comprising at least one B cell epitope, is
substituted by another residue which does
not occur in the same position in the amino
acid sequence of any known homologous
protein within the taxonomic order from
which said naturally occurring allergen
originates, said mutant allergen having
essentially the same α-carbon backbone
tertiary structure as said naturally
occurring allergen, and the specific IgE
binding to the mutated allergen being
reduced as compared to the binding to said
naturally occurring allergen.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4678
2009
]11[]21[
139733
IL– 18 –‫תכשירי רוקחות המורכבים מ‬
‫בצירוף עם חומרים כימותרפיים‬
]54[
PHARMACEUTICAL
COMPOSITIONS COMPRISING
IL-18 IN COMBINATION
WITH CHEMOTHERAPEUTIC
AGENTS
]22[
]31[
]51[
]71[
20.05.1999
60/086560
]32[ 21.05.1998
]33[ US
Int. Cl.(2008.04) A61K 31/47, 38/19, 38/20, A61P 35/00
SMITHKLINE BEECHAM
CORPORATION, U.S.A.
WO/1999/059565
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] A pharmaceutical composition
comprising the polypeptide having the
amino acid sequence of SEQ ID NO:1, in
combination with topotecan.
_______
]11[]21[
139735
‫גנים לביוסינתזה של אפותילונים‬
]54[
GENES FOR THE BIOSYNTHESIS
OF EPOTHILONES
]22[
]31[
16.06.1999
09/099504
]32[ 18.06.1998
]33[ US
60/101631
24.09.1998
US
60/118906
05.02.1999
US
Int. Cl.(2008.04) C07K 141/95, C12N 15/52, 15/53, 9/00, 9/02, C12R 1/32
NOVARTIS AG, SWITZERLAND
WO/1999/066028
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
[57] An isolated nucleic acid molecule
comprising a nucleotide sequence that
encodes at least one polypeptide involved
in the biosynthesis of epothilone, wherein
the complement of said nucleotide
sequence hybridizes to a nucleotide
4679
sequence selected from the group
consisting of: nucleotides 16251-21749 of
SEQ ID NO:1 (encoding EpoB),
nucleotides 16251-43519 of SEQ ID NO:1
(encoding EpoB + EpoC) and nucleotides
16251-54920 of SEQ ID NO:1 (encoding
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
1mM EDTA at 50oC and washing with
2xSSC, 1%SDS at 50oC.
EpoB + EpoC+ EpoD), under conditions
of hybridization at 7% sodium dodecyl
sulphate (SDS), 0.5M NaPO4, pH7.0,
The applications for division
from this application have
not yet been published
,190391
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
______
]11[]21[
]54[
CIRCUMFERENCE ELECTRIC
LINEAR INDUCTION MOTOR
]22[
]51[
]71[
]74[
07.07.2004
Int. Cl.(2008.04) H01H 19/48
ABES DALY
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
139824
‫מנוע השראה חשמלית היקפי קווי‬
‫ ראשל"צ‬,‫אבס דאלי‬
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] An induction motor comprising a
rotatable component having a substantially
planar outer surface and being adapted to
be rotatably mounted onto an appliance;
said induction motor further comprising a
stationary component including at least
two electromagnetic coils adapted to be
fixedly attached to the appliance so that, in
use, the electromagnetic coils are adapted
to direct magnetic flux through the planar
outer surface of the rotatable component
near a periphery thereof and are spatially
June 15,
separated therefrom for allowing the
rotatable component to rotate with respect
thereto when an alternating magnetic field
is induced in the at least two
electromagnetic coils; wherein: the
rotatable component is an annular ring
configured for mounting within a
circumferential guide of the electrical
appliance whereby the appliance does not
require a spindle for supporting the rotor or
an accessory tool.
– ‫כ"ג בסיוון התשס"ט‬
4680
2009
_______
]11[]21[
139950
‫; או‬I ‫ מסוג‬HLA ‫תצמיד המכיל מולקולת‬
‫מקטע ממנה המציג פפטיד לזיהוי על ידי‬
‫ המגושרים ביניהם באורח יציב ע"י‬, T ‫תאי‬
‫קישורן של מולקולות קטנות‬
]54[
COMPLEX COMPRISING AN HLA
CLASS I MOLECULE OR
FRAGMENT THEREOF,
PRESENTING PEPTIDE FOR T
CELL RECOGNITION, STABLY
BRIDGED VIA SMALL
MOLECULES
]22[
]31[
04.06.1999
9812227.8
]32[ 05.06.1998
]33[ GB
9908333.9
12.04.1999
GB
Int. Cl.(2008.04) A61K 393/85, 47/48, A61P 31/04, 31/12, 33/06, 35/00, 35/02, C07K
14/74, 140/05, 147/05
ALEXIS BIOTECH LIMITED,
UNITED KINGDOM
WO/1999/064464
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
[57] A complex comprising an HLA class
I molecule or fragment thereof, the HLA
class I molecule or fragment thereof
comprising:
(i) a T cell binding portion: and
4681
(ii) attachment means for selectively
attaching the HLA class I molecule or
fragment thereof to a target cell;
wherein the HLA class I molecule or
fragment thereof binds or is attached to a
recognition peptide, wherein the
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
recognition peptide is arranged to be
presented by said HLA class I molecule or
fragment thereof for T cell recognition,
wherein the attachment means comprises:
(a) a linking polypeptide with specific
affinity for a molecule on the surface of a
target cell; and
(b) a coupling system for coupling the
linking polypeptide to the HLA class I
molecule or fragment thereof, wherein a
coupling system comprises: a first small
molecule joined to the linking polypeptide;
and a second small molecule joined to the
HLA class I molecule, wherein interaction
of the small molecules forms a stable
bridge between the linking polypeptide and
the HLA class I molecule.
_______
]11[]21[
‫תחבושת המכילה אסטראדיול עבור‬
‫שימוש טרנסדרמלי של הורמונים‬
]54[
ESTRADIOL-CONTAINING
PATCH FOR TRANSDERMAL
ADMINISTRATION OF
HORMONES
]22[
]31[
]51[
]71[
16.07.1999
19834007.9
]32[ 29.07.1998
Int. Cl.(2008.04) A61K 9/00
LTS LOHMANN THERAPIESYSTEME AG, GERMANY
WO/2000/006131
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]87[
]74[
141033
[57] Active substance-containing patch
for controlled release of estradiol or its
pharmaceutically acceptable derivatives,
alone or in combination with gestagens, to
the human or animal skin, consisting of a
backing layer, an active substancecontaining reservoir connected thereto
]33[
DE
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
which is suitable for combined active
substance release and which has been
produced using pressure-sensitive
adhesives, and a detachable protective
layer, characterized in that the pressuresensitive adhesive contains wool wax or
components thereof and zinc oxide.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4682
2009
]11[]21[
142216
‫פוליפפטיד המכיל חלק אימונוגני של‬
‫ טבעי ותכשיר רוקחות המכילים אותו‬WTI
]54[
POLYPEPTIDE CONTAINING AN
IMMUNOGENIC PORTION OF A
NATIVE WTI AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]22[
]31[
30.09.1999
09/164223
]32[ 30.09.1998
]33[ US
09/276484
25.03.1999
US
Int. Cl.(2008.04) A61K 38/17, A61P 35/00, C07K 14/00, 14/47, 16/30, C12N 15/12,
G01N 33/50
CORIXA CORPORATION, U.S.A.
ALEXANDER GAIGER, U.S.A.
]51[
]71[
]87[
]74[
WO/2000/018795
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A polypeptide wherein the
polypeptide is an immunogenic portion of
a native WT1 polypeptide and consists
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
essentially of a sequence selected from
SEQ ID NO:2 or SEQ ID NO:144.
_______
]11[]21[
142910
‫שימוש בשילוב חומרים להכנת תכשירים‬
B ‫רוקחיים לטיפול בוירוס צהבת מסוג‬
]54[
USE OF COMBINATIONS OF
AGENTS FOR THE
PREPARATION OF
MEDICAMENTS FOR
TREATMENT OF HEPATITIS B
VIRUS
]22[
]31[
]51[
]71[
]87[
]74[
02.11.1999
60/106664
]32[ 02.11.1998
]33[ US
Int. Cl.(2008.04) A61K 31/52, 315/13, 316/75, C07D 473/16
GILEAD SCIENCES, INC., U.S.A.
WO/2000/025797
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
4683
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
[57] Use of a synergistically effective
amount of β-2-hydroxymethyl-5-(5fluorocytosin-1-yl)-1,3-oxathiolane (βFTC) or a pharmaceutically acceptable
salt, ester or prodrug thereof with an
effective amount of a second anti-hepatitis
B agent selected from the group consisting
of penciclovir, famciclovir and Bis-POMPMEA in the manufacture of a
medicament for simultaneous, separate or
sequential administration in the treatment
of hepatitis B virus in a human.
,193148
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
]11[]21[
143036
‫ריבונוקלאז ציטוטוקסי מהונדס‬
]54[
ENGINEERED CYTOTOXIC
RIBONUCLEASE
]22[
]31[
]51[
]71[
22.11.1999
09/199242
]32[ 24.11.1998
]33[
Int. Cl.(2008.04) C12N 15/52, 15/55, 9/22
WISCONSIN ALUMNI RESEARCH
FOUNDATION, U.S.A.
WO/2000/031242
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
[57] An engineered cytotoxic
ribonuclease comprising an amino acid
sequence for a ribonuclease of the RNase
A superfamily and a steric hindrance
moiety covalently attached to an amino
acid in the ribonuclease in a loop region
functionally equivalent to the region of
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
amino acid residues 85-94 of bovine
pancreatic Rnase A, the engineered
ribonuclease having reduced binding
affinity for ribonuclease inhibitor due to
steric hindrance by the steric hindrance
moiety, the modified ribounclease
retaining ribonucleolytic activity.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4684
2009
]11[]21[
143599
‫מגוף בקרה‬
]54[
CONTROL VALVE
]22[
]51[
]71[
]72[
]74[
06.06.2001
Int. Cl.(2008.04) F16K 15/18, 21/10, 311/26, 37/00
BERMAD, LIMITED PARTNESHIP
‫ שותפות מוגבלת‬,‫ברמד‬
ZVI WEINGARTEN
‫צבי ויינגרטן‬
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
[57] A control valve (200) for regulating
flow of fluids passing through the valve,
the control valve comprising: (a) a body
having an inlet (14), an outlet (16) and a
passageway (40) through which the fluid
passes from said inlet to said outlet; (b) an
actuator (122) located in a chamber
connected to said body; (c) a displaceable
column (108, 122) deployed so as to be
displaced along an axis by said actuator
over a range of motion from a most
retracted position to a most extended
position, said displaceable column
including a hollow stem; (d) a check valve
assembly associated with said displaceable
column so as to be slidingly displaceable
parallel to said axis relative to said
displaceable column, said check valve
assembly including a damping piston (208)
4685
deployed within said hollow stem so as to
limit travel speed of said check valve
assembly relative to said displaceable
column; and (e) a valve closure (204)
associated with said check valve assembly,
such that, when said displaceable column
is displaced to said most extended position,
said displaceable column forces said check
valve assembly and said valve closure to a
sealing position in which said valve
closure blocks the passage of fluid from
said inlet to said outlet and, when said
displaceable column is displaced towards
said most retracted position, said check
valve assembly allows displacement of
said valve closure between said sealing
position and an open position in which said
inlet is in fluid communication with said
outlet.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
143806
,‫ תהליכים להכנתן‬,‫נגזרות פירימידין‬
‫תכשירים רוקחות המכילים אותן והשימוש‬
–‫בהן להכנת תרופות ליצירת אפקט אנטי‬
‫סרטני בחיה בעלת דם חם‬
]54[
PYRIMIDINE DERIVATIVES,
PROCESSES FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS FOR THE
PRODUCTION OF AN ANTICANCER EFFECT IN A WARMBLOODED ANIMAL
]22[
]31[
]51[
20.12.1999
9828511.7
]32[ 24.12.1998
]33[ GB
Int. Cl.(2008.04) A61K 315/05, A61P 35/00, C07D 239/46, 401/12, 401/14, 403/12,
405/04, 409/12, 413/12, 417/12
ASTRAZENECA AB, SWEDEN
WO/2000/039101
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
ZION HOUSE,
‫ תל‬,41-45 ‫ שדרות רוטשילד‬,‫בית ציון‬
41-45 ROTHSCHILD BLVD.,
‫אביב‬
TEL AVIV 65784
]71[
]87[
]74[
[57] A pyrimidine derivative of the formula
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4686
2009
wherein:
R1 is selected from hydrogen, C1-6 alkyl
[optionally substituted by one or two
substituents independently selected from
halo, amino, C1-4 alkylamino, di-(C1-4
alkyl) amino, hydroxyl, cyano, C1-4 alkoxy,
C1-4 alkoxycarbonyl, carbamoyl, NHCOC1-4 alkyl, trifluoromethyl,
phenylthio, phenoxy, pyridyl, morpholino],
benzyl, 2-phenylethyl, C3-5 alkenyl
[optionally substituted by up to three halo
substituents, or by one trifluoromethyl
substituent, or one phenyl substituent], Nphthalimido-C1-4 alkyl, C3-5 alkynyl
[optionally substituted by one phenyl
substituent] and C3-6 cycloalkyl-C1-6 alkyl;
wherein any phenyl or benzyl group in R1
is optionally substituted by up to three
substituents independently selected from
halo, hydroxy, nitro, amino, C1-3
alkylamino, di-(C1-3 alkyl) amino, cyano,
trifluoromethyl, C1-3 alkyl [optionally
substituted by 1 or 2 substituents
independently selected from halo, cyano,
amino, C1-3 alkylamino, di-(C1-3 alkyl)
amino, hydroxy and trifluoromethyl], C 3-5
alkenyl [optionally substituted by up to
three halo substituents, or by one
trifluoromethyl substituent], C3-5 alkynyl,
C1-3 alkoxy, mercapto, C1-3 alkylthio,
carboxy, C1-3 alkoxycarbonyl; Rx is
selected from halo, hydroxy, nitro, amino,
cyano, mercapto, carboxy, sulphamoyl,
formamido, ureido or carbamoyl or a
group of formula (Ib):
A-B-C(Ib)
wherein:
A is C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl,
C3-8 cycloalkyl, phenyl, a monocyclic ring
4687
containing 5 or 6 atoms or a bicyclic ring
containing 9 or 10 atoms, at least one of
which ring atoms is selected from nitrogen,
sulphur or oxygen, or an aromatic
monocyclic ring containing 5 or 6 atoms or
an aromatic bicyclic ring containing 9 or
10 carbon atoms, at least one of which ring
atoms is selected from nitrogen, sulphur or
oxygen, wherein said C1-6 alkyl, C3-6
alkenyl and C3-6 alkynyl are optionally
substituted by or more substituents
selected from halo, nitro, cyano, amino,
hydroxy, mercapto, carboxy, formamido,
ureido, C1-3 alkylamino, di-(C1-3 alkyl)
amino, C1-3 alkoxy, trifluoromethyl, C3-8
cycloalkyl, phenyl, a monocyclic ring
containing 5 or 6 atoms or a bicyclic ring
containing 9 or 10 atoms, at least one of
which is selected from nitrogen, oxygen or
sulphur, or an aromatic monocyclic ring
containing 5 or 6 atoms or an aromatic
bicyclic ring containing 9 or 10 carbon
atoms, at least one of which ring atoms is
selected from nitrogen, sulphur or oxygen;
wherein any phenyl, C3-8 cycloalkyl, or
heterocyclic ring may be optionally
substituted by one or more halo, nitro,
cyano, hydroxyl, trifluoromethyl,
trifluoromethoxy, amino, carboxy,
carbamoyl, mercapto, formamido, ureido,
sulphamoyl, C1-4 alkyl, C2-4 alkenyl, C2-4
alkynyl, C1-4 alkoxy, C1-4 alkanoyl, C1-4
alkanoylamino, N-C1-4 alkylcarbamoyl,
N,N-di-(C1-4 alkyl) carbamoyl, C1-4
alkylthio, C1-4 alkylsulphinyl, C1-4
alkylsulphonyl and C1-4 alkoxycarbonyl; B
is –O-, -S-, -C(O)-, -NH-, -N(C1-4 alkyl)-, C(O)NH-, -C(O)N(C1-4 alkyl)-, -NHC(O)-,
-N(C1-4 alkyl)C(O)- or B is a direct bond;
C is C1-4 alkylene or a direct bond; Q1 and
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
Q2 are independently selected form aryl, a
5- or 6-membered monocyclic moiety
(linked via a ring carbon atom and
containing one to three heteroatoms
independently selected from nitrogen,
oxygen and sulphur); and a 9- or 10membered bicyclic heterocyclic moiety
(linked via a ring carbon atom and
containing one or two nitrogen
heteroatoms and optionally containing a
further one or two heteroatoms selected
from nitrogen, oxygen and sulphur); and
one or both of Q1 and Q2 bears on any
available carbon atom one substitutent of
the formula (Ia) and Q2 may optionally
bear on any available carbon atom further
substituents of the formula (Ia):
[provided that when present in Q1 the
substituent of formula (Ia) is not adjacent
to the –NH-link]; wherein: X is –CH2-, -O, -NH-, -NRy- or –S-[wherein Ry is C1-4
alkyl, optionally substituted by one
substituent selected from halo, amino,
cyano, C1-4 alkoxy or hydroxyl];
Y1 is H, C1-4 alkyl or as defined for Z;
Y2 is H or C1-4 alkyl;
Z is RaO-, RbRcN-, RdS-, ReRfNNRg-, a
nitrogen linked aromatic monocyclic ring
containing 5 or 6 atoms or aromatic
bicyclic ring containing 9 or 10 atoms, at
least one of which ring atoms is selected
from nitrogen and optionally containing a
further 1 to 3 heteroatoms selected from
nitrogen, oxygen and sulphur, a nitrogen
linked monocyclic heterocycle ring
containing 5 or 6 atoms or bicyclic
heterocycle ring containing 9 or 10 atoms,
at least one of which ring atoms is selected
from nitrogen and optionally containing a
further 1 to 3 heteroatoms selected from
nitrogen, oxygen and sulphur [wherein
said heterocycle is optionally substituted
on a ring carbon or a ring nitrogen by C1-4
alkyl or C1-4 alkanoyl] wherein Ra, Rb, Rc,
Rd, Re, Rf and Rg are independently
selected from hydrogen, C1-4 alkyl, C2-4
alkenyl, C3-8 cycloalkyl, and wherein said
C1-4 alkyl and C2-4 alkenyl are optionally
substituted by one or more phenyl;
n is 1, 2 or 3;
m is 1, 2 or 3;
and Q1 may optionally bear on any
available carbon atom up to four
substituents independently selected from
halo, thio, nitro, carboxy, cyano, C2-4
alkenyl [optionally substituted by up to
three halo substituents, or by one
trifluoromethyl substituent], C2-4 alkynyl,
C1-5 alkanoyl, C1-4 alkoxycarbonyl, C1-6
alkyl, hydroxyl-C1-3 alkyl, fluoro-C1-4
alkyl, amino-C1-3 alkyl, C1-4 alkylaminoC1-3 alkyl, di-(C1-4 alkyl) amino-C1-3 alkyl,
cyano-C1-4 alkyl, C2-4 alkanoyloxy-C1-4alkoxy-C1-3 alkyl, carboxy-C1-4 alkyl, C1-4
alkoxycarbonyl-C1-4 alkyl, carbamoyl-C1-4
alkyl, N-C1-4 alkylcarbamoyl-C1-4 alkyl,
N,N-di-(C1-4 alkyl)-carbamoyl-C1-4 alkyl,
pyrrolidin-l-yl-C1-3 alkyl, piperidino-C1-3
alkyl, piperazin-l-yl-C1-3 alkyl,
morpholino-C1-3 alkyl, thiomorpholino-C13 alkyl, imidazo-l-yl-C1-3 alkyl, piperazin-lyl, morpholino, thiomorpholino, C1-4
alkylthio, C1-4 alkylsulphinyl, C1-4
alkylsulphonyl, hydroxy C2-4 alkylthio,
hydroxy C2-4 alkylsulphinyl, hydroxy C2-4
alkylsulphonyl, ureido, N'-(C1-4 alkyl)
ureido, N', N'-di-(C1-4 alkyl) ureido, N'-(C14 alkyl)-N-(C1-4 alkyl) ureido, N', N -di-(C1-
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4688
2009
4 alkyl)-N-(C1-4
alkyl) ureido, carbamoyl,
N-(C1-4 alkyl) carbamoyl, N, N-di-(C1-4
alkyl) carbamoyl, amino, C1-4 alkylamino,
di-(C1-4 alkyl) amino, C2-4 alkanoylamino,
sulphamoyl, N-(C1-4 alkyl) sulphamoyl,
N,N-di-(C1-4 alkyl) sulphamoyl; and also
independently, or where appropriate in
addition to the above substituents, Q1 may
optionally bear on any available carbon
atom up to two further substituents
independently selected from C3-8
cycloalkyl, phenyl-C1-4 alkyl, phenyl-C1-4
alkoxy, phenylthio, phenyl, naphthyl,
benzoyl, benzimidazol-2-yl, phenoxy and a
5-or 6-membered aromatic heterocycle
(linked via a ring carbon atom and
containing one to three heteroatoms
independently selected from oxygen,
sulphur and nitrogen); wherein said
naphthyl, phenyl, benzoyl, phenoxy, 5-or
6-membered aromatic heterocyclic
substituents and the phenyl group in said
phenyl-C1-4 alkyl, phenylthio and phenylC1-4 alkoxy substituents may optionally
bear up to five substituents independently
selected from halo, C1-4 alkyl and C1-4
alkoxy; and Q2 may optionally bear on any
available carbon atom up to four
substituents independently selected from
halo, hydroxy, thio, nitro, carboxy, cyano,
C2-4 alkenyl [optionally substituted by up
to three halo substituents, or by one
trifluoromethyl substituent], C2-4 alkynyl,
C1-5 alkanoyl, C1-4 alkoxycarbonyl, C1-6
alkyl, hydroxy-C1-3 alkyl, fluoro-C1-4 alkyl,
amino-C1-3 alkyl, C1-4 alkylamino-C1-3
alkyl, di-(C1-4 alkyl) amino-C1-3 alkyl,
cyano-C1-4 alkyl, C2-4 alkanoyloxy-C1-4 –
alkyl, C1-4 alkoxy-C1-3 alkyl, carboxy-C1-4
alkyl, C1-4 alkoxycarbonyl-C1-4 alkyl,
carbamoyl-C1-4 alkyl, N-C1-4
alkylcarbamoyl-C1-4 alkyl, N,N-di-(C1-4
alkyl)-carbamoyl-C1-4 alkyl, pyrrolidin-lyl-C1-3 alkyl, piperidino-C1-3 alkyl,
piperazin-l-yl-C1-3 alkyl, morpholino-C1-3
alkyl, thiomorpholino-C1-3 alkyl, imidazol-yl-C1-3 alkyl, piperazin-l-yl, morpholino,
4689
thiomorpholino, C1-4 alkoxy, cyano-C1-4
alkoxy, carbamoyl-C1-4 alkoxy, N-C1-4
alkylcarbamoyl-C1-4 alkoxy, N, N-di-(C1-4
alkyl)-carbamoyl-C1-4 alkoxy, 2aminoethoxy, 2-C1-4 alkylaminoethoxy,-C14 alkoxy, halo -C1-4 alkoxy, 2hydroxyethoxy, C2-4 alkanoyloxy-C2-4
alkoxy, 2-C1-4 alkoxyethoxy, carboxy-C1-4
alkoxy, 2-pyrrolidin-l-yl-ethoxy, 2piperidino-ethoxy, 2-piperazin-1-ylethoxy, 2-morpholino-ethoxy, 2thiomorpholino-ethoxy, 2-imidazo-l-ylethoxy, C3-5 alkenyloxy, C3-5 alkynyloxy,
C1-4 alkylthio, C1-4 alkylsulphinyl, C1-4
alkylsulphonyl, hydroxy C2-4 alkylthio,
hydroxy C2-4 alkylsulphinyl, hydroxy C2-4
alkylsulphonyl, ureido, N'-(C1-4 alkyl)
ureido, N-(C1-4 alkyl) ureido, N'N'-di-(C1-4
alkyl) ureido, N'-(C1-4 alkyl)-N-(C1-4 alkyl)
ureido, N',N'-di-(C1-4 alkyl)-N-(C1-4 alkyl)
ureido, carbamoyl, N-(C1-4 alkyl)
carbamoyl, N,N-di-(C1-4 alkyl) carbamoyl,
amino, C1-4 alkylamino, di-(C1-4 alkyl)
amino, C2-4 alkanoylamino, sulphamoyl,
N-(C1-4 alkyl) sulphamoyl, N,N-di-(C1-4
alkyl) sulphamoyl, and also independently,
or where appropriate in addition to the
above optional substituents, Q2 may
optionally bear on any available carbon
atom up to two further substituents
independently selected from C3-8
cycloalkyl, phenyl-C1-4alkoxy, phenylthio,
phenyl, naphthyl, benzoyl, phenoxy,
benzimidazol-2-yl, and a 5-or 6-membered
aromatic heterocycle (linked via a ring
carbon atom and containing one to three
heteroatoms independently selected from
oxygen, sulphur and nitrogen); wherein
said naphthyl, phenyl, benzoyl, phenoxy,
5- or 6-membered aromatic heterocyclic
substituents and the phenyl group in said
phenyl-C1-4 alkyl, phenylthio and phenylC1-4 alkoxy substituents may optionally
bear one or two substituents independently
selected from halo, C1-4 alkyl and C1-4
alkoxy; or a pharmaceutically acceptable
salt or in vivo hydrolysable ester thereof.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
]54[
KIDNEY DISEASE DETECTION
]22[
]31[
20.12.1999
PP7843
]32[ 21.12.1998
415217
12.10.1999
Int. Cl.(2008.04) G01N 33/68
MONASH UNIVERSITY,
AUSTRALIA
WO/2000/037944
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]51[
]71[
]87[
]74[
143892
‫זיהוי מחלת כליה‬
]33[
AU
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A method of diagnosing an early
stage of renal disease and/or renal
complications of a disease, comprising: (a)
separating all of the proteins in a urine
sample; and (b) detecting an intact
modified form of a protein in the sample,
wherein detection of the intact modified
protein is indicative of an early stage of the
renal disease and/or renal complications of
a disease.
_______
]11[]21[
143994
‫הורמון גדילה אנושי להמרצת הגיוס של‬
‫תאי גזע המאטופואטיים פלוריפוטנטיים‬
]54[
HUMAN GROWTH HORMONE TO
STIMULATE MOBILIZATION OF
PLURIPOTENT
HEMATOPOIETIC STEM CELLS
]22[
]31[
]51[
]71[
30.12.1999
98124834.7
]32[ 30.12.1998
]33[ EP
Int. Cl.(2008.04) A61K 38/27, C12N 5/06, 5/08
LABORATOIRES SERONO SA,
SWITZERLAND
WO/2000/040260
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD., NESS ZIONA
‫ מחלקת‬-‫פארק לתעשיות עתירות מדע‬
]87[
]74[
‫ציונה‬-‫ נס‬,‫קניין רוחקריית ויצמן‬
[57] Use of human growth hormone or
one of its derivatives to prepare a
medicament which increases, in a patient,
the number of CD34+ circulating cells
June 15, – ‫כ"ג בסיוון התשס"ט‬
capable of regenerating hematopoeisis in
vivo, wherein said cells are to be used to
treat, by re-infusion, transplantation or
engraftment, the same patient for
4690
2009
reconstitution of the hematopoeitic and
immune system following myeloablative
or antiblastic therapies.
_______
]11[]21[
144228
‫שימוש בגורמים המשרים אפופטוזיס‬
)‫להכנת תרופה לטיפול במחלות (אוטו‬
‫אימוניות‬
]54[
USE OF APOPTOSIS INDUCING
AGENTS IN THE PREPARATION
OF A MEDICAMENT FOR THE
TREATMENT OF (AUTO)
IMMUNE DISEASES
]22[
]31[
]51[
]71[
]87[
]74[
10.01.2000
99200056.2
]32[ 11.01.1999
]33[ EP
Int. Cl.(2008.04) A61K 38/16, 38/17, A61P 29/00, 37/00, G01N 33/50
LEADD B.V., THE NETHERLANDS
WO/2000/041497
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
[57] Use of an apoptosis inducing agent,
which exhibits its effect in aberrant cells
involved with or related to (auto) immune
diseases, in the preparation of a
medicament for the treatment of
inflammatory disorders, wherein said
apoptosis inducing agent is the apoptosis
inducing protein apoptin or other proteins
with apoptin-like activity.
_______
]11[]21[
144259
‫שיטות ליצירת חלבונים המכילים הרכבים‬
‫של ציסטאין חופשי‬
]54[
METHODS FOR MAKING
PROTEINS CONTAINING FREE
CYSTEINE RESIDUES
]22[
]31[
]51[
14.01.2000
60/116041
]32[ 14.01.1999
]33[ US
Int. Cl.(2008.04) A61K 47/48, C07K 11/13, 14/56, 14/61, 14/72, 145/05, 17/08,
C12N 1/15, 1/19, 1/21, 15/00, 5/10, C12P 21/02
BOLDER BIOTECHNOLOGY, INC.,
U.S.A.
WO/2000/042175
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]71[
]87[
]74[
[57] A method for obtaining a soluble
protein having at least one added free
cysteine residue comprising the steps of:
4691
(a) obtaining an isolated host cell
expressing a soluble protein, wherein the
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
soluble protein contains at least one added
free cysteine;
(b) exposing the host cell to a cysteine
blocking agent prior to step (c), wherein
the cysteine blocking agent forms a stable,
The applications for division
from this application have
not yet been published
mixed disulfide with at least one cysteine
residue in the soluble protein; and
(c) isolating the soluble protein from the
host cell.
,194483
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
]11[]21[
]54[
SECURE COMMUNICATION
SYSTEM AND METHOD USING
SHARED RANDOM SOURCE
FOR KEY CHANGING
]22[
]51[
]71[
]72[
]74[
17.07.2001
Int. Cl.(2008.04) H04L 9/08, 9/28
KING GREEN LTD.
ELI YANOVSKY
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
144369
‫מערכת ושיטה לאבטחת תקשורת על ידי‬
‫שימוש במקור אקראי משותף להחלפת‬
‫מפתח‬
‫ מושבה יוקנעם‬,‫קינג גרין בע"מ‬
‫אלי ינובסקי‬
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
[57] Apparatus for use by a first party for
key management for secure
communication with a second party,
having a same apparatus, said key
management being to provide at each
party, simultaneously remotely, ever
changing identical keys for said secure
communication without transferring said
keys over any communication link, the
apparatus comprising: a datastream
extractor, for obtaining from data
exchanged between said parties a
June 15,
bitstream, a random selector for selecting,
from said bitstream, a series of bits in
accordance with a randomization seeded
by said data exchanged between said
parties and randomness within said random
selector, said random selector changing for
next phase/selection based on said series of
bits, a key generator for generating a key
for encryption/decryption, said key
generator changing based on said series of
bits, thereby to manage key generation in a
manner repeatable at said parties.
– ‫כ"ג בסיוון התשס"ט‬
4692
2009
_______
]11[]21[
]54[
DOPANT PASTES FOR THE
PRODUCTION OF P,P+AND N, N+
REGIONS IN SEMICONDUCTORS
]22[
]31[
]51[
]71[
]87[
]74[
29.02.2000
19910816.1
]32[ 11.03.1999
Int. Cl.(2008.04) H01L 310/68
BASF SE, GERMANY
WO/2000/054341
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] Dopant pastes for the selective and
extensive printing of Si wafers by screen,
roller, pad, stencil printing or other
printing techniques customary in
semiconductor technology for the
production of p, p+, p++, n, n+, n++
regions in the Si wafer, containing
(a) one or more components with dopant
action,
145333
N – ‫ ו‬,P , +P ‫יצירת כתמי דבק לייצור אזורי‬
‫ בחצאי מוליכים‬+N
]33[
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
(b) one or more SiO2 precursors, which
can form an SiO2 matrix when heated to
temperatures of 200oC to 600oC,
(c) solvents,
(d) optionally an acid and water,
and optionally
(e) additives such as thickening agents or
wetting agents, the total composition
having impurities in the form of metal ions
in respective concentrations of less than
500 ppb, preferably less than 200 ppb.
_______
4693
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
145503
‫קומפלקס של ליפאז–חומר פעיל שטח‬
‫המעוגן על מטריצה בלתי מסיסה‬
]54[
SURFACTANT-LIPASE COMPLEX
IMMOBILIZED ON INSOLUBLE
MATRIX
]22[
]31[
]51[
]71[
]87[
]74[
16.03.2000
129086
]32[ 22.03.1999
]33[ IL
Int. Cl.(2008.04) A61K 9/20, C12N 11/08, 11/14, 9/18, 9/20, 9/96, C12P 7/64
ENZYMOTEC LTD.
‫ מגדל העמק‬,‫אנזימוטק בע"מ‬
WO/2000/056869
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
[57] Lipase preparation comprising an
insoluble matrix and a surfactant-coated
lipase complex immobilized onto said
insoluble matrix.
_______
]11[]21[
‫רקמת משתית בעלת שלושה מימדים‬
]54[
THREE-DIMENSIONAL
STROMAL TISSUE
]22[
]31[
12.04.2000
60/128838
]32[ 12.04.1999
411585
01.10.1999
Int. Cl.(2008.04) A61L 27/38
ADVANCED TISSUE SCIENCES,
INC., U.S.A.
WO/2000/061204
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
145892
[57] Use of a three-dimensional stromal
tissue for the preparation of a medicament
for promoting angiogenesis in ischemic
heart tissue, wherein said ischemic heart
tissue is to be contacted with a threedimensional stromal tissue comprising
stromal cells and connective tissue proteins
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
naturally secreted by the stromal cells said
cells being attached to and substantially
enveloping a framework composed of a
biocompatible, non-living material formed
into a three-dimensional structure having
interstitial spaces bridged by the stromal
cells.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4694
2009
]11[]21[
]54[
RECOMBINANT ANTI-CD40
ANTIBODY AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING IT
]22[
]31[
]51[
]71[
]87[
]74[
08.06.2000
328296
]32[ 08.06.1999
Int. Cl.(2008.04) C12N 15/13
SEATTLE GENETICS, INC., U.S.A.
WO/2000/075348
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
[57] A protein, which protein (a)
competes for binding to CD40 with
monoclonal antibody S2C6 as secreted by
the hybridoma deposited with the ATCC
and assigned accession number PTA-110,
146950
‫ רקומביננטי‬CD40 ‫נוגדן רקומביננטי נגד‬
‫ותכשירי רוקחות המכילים אותו‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
(b) increases the binding of CD40 ligand to
cell surface CD40 on B cells by at least
45%, and (c) comprises a human
immunoglobulin constant domain.
_______
]11[]21[
147038
‫שיטה מהירה לבדיקת דוגמה ביולוגית‬
‫מורכבת עבור נוכחות סוגים רבים של‬
‫יצורים חיים‬
]54[
RAPID METHOD FOR TESTING
A COMPLEX BIOLOGICAL
SAMPLE FOR THE PRESENCE OF
MANY TYPES OF ORGANISMS
]22[
]31[
]51[
]71[
15.06.2000
333110
]32[ 15.06.1999
]33[ US
Int. Cl.(2008.04) C12N 15/09, C12Q 1/68, G01N 33/53, 335/66
GENOMIC PROFILING SYSTEMS,
INC., U.S.A.
WO/2000/077260
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬
P.O.B. 1426,
TEL AVIV 61013
]87[
]74[
[57] A method for detecting target
nucleic acid molecules potentially present
in a sample comprising test nucleic acids
molecules, wherein each of said target
nucleic acid molecules corresponds to a
4695
member of an ensemble of ID sequences,
wherein said ID sequences comprise
greater than five families and have a
minimum genomic derivation of greater
than five, said method comprising
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
simultaneously contacting or comparing a
detection ensemble comprising ID
sequences and/or ID probes with said test
nucleic acid molecules that are:
(i) target nucleic acid molecules in said
sample,
(ii) probes that hybridize to said target
nucleic acid molecules in said sample,
(iii) amplification products of (i) or (ii), or
(iv) a genomic representation of (i),
wherein said detection ensemble and said
ensemble of ID sequences are congruent,
and each of said ID sequences and/or ID
probes of said detection ensemble
corresponds to a member of said ensemble
of ID sequences, whereby said target
nucleic acid molecules are detected.
_______
]11[]21[
147563
‫מולקולת פולינוקלאוטידית המכילה אלל‬
‫ של סטרפטומיסיס אברמיטיליס‬AveC
‫שעבר מוטציה ושמכוון את יחס של‬
‫ ושיטה לייצורם‬B:2B1 ‫אברמקטינים‬
]54[
POLYNUCLEOTIDE MOLECULE
COMPRISING A STREPTOMYCES
AVERMITILIS MUTATED AVEC
ALLELE DIRECTING THE RATIO
OF B2:B1 AVERMECTINS AND
METHOD OF PRODUCING THE
SAME
]22[
]31[
]51[
]71[
]87[
]74[
24.07.2000
60/148645
]32[ 12.08.1999
]33[ US
Int. Cl.(2008.04) C12N 1/21, 15/76, 5/06, 5/08, 5/16
PFIZER PRODUCTS, INC., U.S.A.
WO/2001/012821
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] A polynucleotide molecule
comprising a nucleotide sequence that is
the same as,
(a) the Streptomyces avermitilis aveC
allele,
(b) the S. avermitilis AveC gene product
encoding sequence of plasmid pSE186
(ATCC 209604),
(c) the nucleotide sequence of the aveC
ORF of S. avermitilis as presented in
FIGURE 1 (as shown in the specification)
(SEQ ID NO: 1), or
(d) a variant of any of (a) to (c) which
includes one more silent changes to the
nucleotide sequence according to the
degeneracy of the genetic code, wherein
June 15,
the nucleotide sequence further comprises
one or more mutations encoding an amino
acid substitution at one or more amino acid
residues corresponding to amino acid
position 38, 48, 89, 99, 111, 136, 154, 179,
228, 238, 289, or 298 of SEQ ID NO: 2,
such that cells of S. avermitilis strain
ATCC 53692 in which the wild type aveC
allele has been inactivated and that express
the polynucleotide molecule comprising
the mutated nucleotide sequences produce
a class 2:1 ratio of avermectins that is
reduced from the ratio produced by cells of
S. avermitilis strain ATCC 53692 that
instead express only the wild-type aveC
allele.
– ‫כ"ג בסיוון התשס"ט‬
4696
2009
,194817
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
]11[]21[
147992
–‫מולקולות של נוגדנים בעלי ספציפיות ל‬
‫ תרכובות והרכבים‬,‫ של אדם‬α TNF
‫ רצף דנ"א המקודד‬,‫המכילים אותן‬
‫לשרשרת כבדה וקלה של הנוגדן האמור‬
‫ותהליכים לייצור הנוגדן האמור‬
]54[
ANTIBODY MOLECULES
HAVING SPECIFICITY FOR
HUMAN TNF ALPHA
COMPOUNDS AND
COMPOSITION COMPRISING
THEM, DNA SEQUENCE
ENCODING HEAVY AND LIGHT
CHAIN OF SAID ANTIBODY AND
PROCESS FOR THE
PRODUCTION OF SAID
ANTIBODY
]22[
]31[
]51[
]71[
05.06.2001
0013810.7
]32[ 06.06.2000
]33[ GB
Int. Cl.(2008.04) A61K 393/95, C07K 16/24, 16/46, C12N 1/21, 15/13, 15/70
CELLTECH R&D LTD., UNITED
KINGDOM
WO/2001/094585
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]87[
]74[
[57] An antibody molecule comprising a
heavy chain wherein the variable domain
comprises a CDR consisting of the
sequence given in SEQ ID NO:1 for
CDRH1, SEQ ID NO:2 or SEQ ID NO:7,
for CDRH2 or SEQ ID NO:7, for CDRH2
or SEQ ID NO:3 for CDRH3 or a light
The applications for division
from this application have
not yet been published
chain wherein the variable domain
comprises a CDR having the sequence
given in SEQ ID NO:4 for CDRL1, SEQ
ID NO:5 for CDRL2 or SEQ ID NO:6 for
CDRL3, or a combination thereof of said
heavy and light chains.
,195085
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
4697
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
148384
‫תולדות גלוקופירנוזילאוקסיפירזול‬
‫ותכשירים רפואיים המכילים אותם‬
]54[
GLUCOPYRANOSYLOXYPYRAZOLE
DERIVATIVES AND MEDICINAL
COMPOSITIONS CONTAINING THE
SAME
]22[
]31[
]51[
]71[
24.08.2000
11/246800
]32[
31.08.1999
]33[ JP
Int. Cl.(2008.04) A61K 317/056, A61P 3/04, 31/10, C07D 231/20, C07H 17/02, 5/06
KISSEI PHARMACEUTICAL CO., LTD.,
JAPAN
WO/2001/016147
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]87[
]74[
[57] A glucopyranosyloxypyrazole
derivative of the formula:
wherein R1 represents a hydrogen atom or
a lower alkyl group wherein the lower
alkyl group is a straight-chain or branched
alkyl group having 1 to 6 carbon atoms;
one of Q1 and T1 represents a group of the
formula:
while the other represents a lower alkyl
group as hereinbefore described on a halo
(lower alkyl) group wherein the halo
(lower alkyl) group is a lower alkyl group
as hereinbefore defined substituted by
different or same 1 to 3 halogen atoms as
hereinbefore defined; R2 represents a
hydrogen atom, a lower alkyl group as
hereinbefore defined, a lower alkoxy group
wherein the lower alkoxy group is a
straight-chain or branched alkoxy group
having 1 to 6 carbon atoms, a lower
alkylthio group wherein the lowr alkylthio
group is a straight-chain or branched
alkylthio group having 1 to 6 carbon
atoms, a halo (lower alkyl) group as
hereinbefore defined or a halogen atom
wherein the halogen atom is fluorine atom,
a chlorine atom, a bromine atom or an
iodine atom, or a pharmaceutically
acceptable salt thereof.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4698
2009
]11[]21[
]54[
ANTIBODY DYE CONJUGATES
FOR BINDING TO TARGET
STRUCTURES OF
ANGIOGENESIS IN ORDER TO
INTRAOPERATIVELY DEPICT
TUMOR PERIPHERY
]22[
]31[
]51[
]71[
19.08.2000
19947559.8
]32[ 24.09.1999
Int. Cl.(2008.04) A61K 49/00
BAYER SCHERING PHARMA AG,
GERMANY
WO/2001/023005
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
[57] Antibody-dye conjugates that
preferably accumulate in the edge area of
the cell tissue of a focus of disease and
thus make the edge area of the focus of
disease optically detectable, characterized
in that the dye is a compound of the
formula
148405
‫תצמיד צבע–נוגדן לקישור למבני מטרה‬
‫של היווצרות כלי דם על מנת לסמן תוך כדי‬
‫קישור את גבולות הגידול‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
Ab–(F)n
(I),
in which
Ab stands for an antibody or an antibody
fragment with high binding to ED-BFN,
F stands for a cyanine dye of the formula
in which
D stands for the radicals
whereby the position labeled with a star
means the interface site with radical B, and
4699
B can stand for group V, VI, VII, VIII or
IX
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
in which
R1 and R2 mean C1-C4 sulfoalkyl, a
saturated or unsaturated, branched or linear
C1-C50 alkyl chain, which optionally can
be substituted with up to 15 oxygen atoms,
and/or with up to 3 carbonyl groups, R3
stands for group –COOE1, -CONE1E2, NHCOE1, -NHCONHE1, -NE1E2, -OE1, OSO3E1, -SO3E1,
-SO3E1, -SO2NHE1 or –E1, whereby E1 and
E2, independently of one another, stand for
a hydrogen atom, C1-C4 sulfoalkyl,
saturated or unsaturated, branched or
straight-chain C1-C50 alkyl, which
optionally is interrupted with up to 15
oxygen atoms, and/or up to 3 carbonyl
groups, and/or can be substituted with up
to 5 hydroxy groups, R4 stands for a
hydrogen atom or a fluorine, chlorine,
bromine or iodine atom, b stands for 2 or
3, X and Y stand for oxygen, sulfur or the
group =C(CH3) or –(CH=CH)-, and L
stands for a direct bond or a linker, which
is a straight-chain or branched carbon
chain with up to 20 carbon atoms, which
can be substituted with one or more –OH, COOH, or SO3 groups and/or optionally
can be interrupted in one or more places by
an –O-, -S-, -CO-, -CS-, -CONH-, NHCO-, -NHCSNH-, -SO2-, PO4- or an –
NH group or an aryl ring; and n stands for
1 to 5.
_______
]11[]21[
148564
‫שיטה להגדלת תכולת חומצות האמינו‬
‫בצמחים‬
]54[
METHOD FOR INCREASING THE
TOTAL FREE AMINO ACID
CONTENT IN PLANTS
]22[
]31[
]51[
]71[
05.08.2000
19944212.6
]32[ 15.09.1999
]33[ DE
Int. Cl.(2008.04) A01H 1/04, A23K 1/14, C12N 15/29, 15/82
BASF PLANT SCIENCE GMBH,
GERMANY
WO/2001/020009
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]87[
]74[
[57] A method for increasing the total
free amino acid content of a plant or
transformed progeny thereof, comprising:
transforming a plant with a plant
transformation vector comprising an
isolated polynucleotide encoding a
plastidial ATP/ADP translocator,
determining the free amino acid content of
the transformed plant compared to an
untransformed control plant and selecting
for an increase in the free amino acid
content; wherein the total amino acid
content is increased compared to a
untransformed control plant.
______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4700
2009
]11[]21[
]54[
DENTAL APPARATUS WITH A
FLUID RESERVOIR
]22[
]31[
]51[
]71[
17.03.2002
10114331.1
]32[ 23.03.2001
Int. Cl.(2008.04) A61C 17/00
FERTON HOLDING S.A.,
SWITZERLAND
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]74[
[57] Fluid reservoir (15, 16) containing a
fluid, which is used in a dental apparatus to
supply a handset used for a dental
treatment, characterised in that on a
connecting part of the fluid container two
check valves are disposed, of which a
valve body of the one check valve on an
outlet aperture of the fluid reservoir is
pressable by a counter-member (1)
148724
‫התקן לטיפול בשיניים בעל מיכל ניגרים‬
]33[
DE
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
disposed on the dental apparatus against
the force of a closing spring and into an
open position, and a valve body of the
second check valve on an aeration aperture
(30) of the fluid reservoir can compensate
for any low pressure which develops in the
fluid reservoir upon drawing off of the
fluid in the open position of the valve body
of the one check valve.
_______
4701
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
150196
‫תכשירים המכילים אוליגונוקלאוטידים‬
‫פוספודיאסטריים סינטטיים לריפוי וגורם‬
‫כמותרפיה‬
]54[
COMPOSITIONS COMPRISING
THERAPEUTIC SYNTHETIC
PHOSPHODIESTER
OLIGONUCLEOTIDES AND
CHEMOTHERAPEUTIC AGENT
]22[
]31[
12.12.2000
60/170325
]32[ 13.12.1999
]33[ US
60/228925
29.08.2000
US
Int. Cl.(2008.04) A61K 317/11, A61P 35/00, C07H 21/04
BIONICHE LIFE SCIENCES INC.,
CANADA
WO/2001/044465
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]51[
]71[
]87[
]74[
[57] A composition comprising a 3'-OH,
5'-OH synthetic phosphodiester nucleotide
sequence, a chemotherapeutic agent, and a
pharmaceutically acceptable carrier,
wherein the synthetic phosphodiester
nucleotide sequence is selected from the
group consisting of SEQ ID NOs:8 – 10,
25, 26, 41 – 43, 45 and 46.
_______
]11[]21[
150372
‫מכלול נר ושיטת ייצורו‬
]54[
CANDLE ASSEMBLY AND
METHOD OF
MANUFACTURING IT
]22[
]51[
]71[
]74[
23.06.2002
Int. Cl.(2008.04) F21V 35/00, F23D 3/16, 3/24
RESHEF YEKUTIELY
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
[57] A method for manufacturing a
candle assembly (10) comprising: feeding
a portion of a roll of wick (14) into a
candle mold; cold compressing a candle
material into said mold about said portion
of said wick to form a receptacle candle
(12); trimming said portion of said wick to
have a length that protrudes beyond a first
June 15,
‫רשף יקותיאלי‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,27 ‫חדר‬, 18 ‫מנוחה ונחלה‬
surface of said candle material, and
another length that protrudes beyond a
second surface of said candle material; and
forming one of the lengths of said wick
that protrudes beyond one of the surfaces
of said candle material into a base (18)
angled with respect to a longitudinal axis
of said portion of said wick, and
– ‫כ"ג בסיוון התשס"ט‬
4702
2009
embedding said base into said candle
material.
_______
]11[]21[
150606
‫לולאת מעקב תדרים מתואמת דופלר‬
‫בעלת ריבוי נתיבים‬
]54[
MULTIPATH DOPPLER
ADJUSTED FREQUENCY
TRACKING LOOP
]22[
]31[
]51[
]71[
26.01.2001
09/491349
]32[ 26.01.2000
]33[ US
Int. Cl.(2008.04) H04B 17/07, H04L 27/00
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/059937
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] A RAKE receiver comprising: a
plurality of fingers for receiving a signal,
each finger comprising: a frequency error
calculator for computing a frequency error
and a timing adjustor for adjusting the
timing of said received signal in response
to said frequency error for use in said
finger; a weighted average calculator for
computing a weighted average of said
plurality of frequency errors, wherein the
weight of each finger's frequency error is
calculated in proportion to a strength of
each finger's pilot; and a timing adjustor
for adjusting the timing of said received
signals in response to said weighted
average for use in said plurality of fingers.
_______
4703
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
]54[
PSEUDOPOLYMORPH OF (-)-CIS2-(2-CHLOROPHENYL)-5,7DIHYDROXY-8[4R- (3S HYDROXY-1METHYL)PIPERIDINYL]- 4H-1BENZOPYRAN - 4 - ONE, ITS
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING IT
]22[
]31[
]51[
]71[
08.01.2001
09/484717
]32[ 18.01.2000
Int. Cl.(2008.04) C07D 405/00
AVENTIS PHARMACEUTICALS
INC., U.S.A.
WO/2001/053293
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
150638
–( – 2 – ‫פסאודופולימורף של (–) – ציס‬
R4 – [ 8 – ‫ – דיהידרוקסי‬7 ,5 – )‫כלורופניל‬
H – 4‫ – מתיל(פיפרידיניל‬1 – ‫( הידרוקסי‬3S
‫ הכנתו ותכשירים‬,‫ – און‬4 – ‫ –[ – בנזופיר‬1
‫רפואיים המכילים אותו‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] Pseudopolypmorph Form l having an
x-ray powder diffraction pattern expressed
in terms of "D" spacing:
D space – Å
12.708
4.323
5.594
5.349
3.590.
_______
]11[]21[
]54[
STRAPLESS LOCKING ACTION
HOLSTER
]22[
]31[
]51[
]71[
]87[
]74[
12.01.2001
60/175659
]32[ 12.01.2000
Int. Cl.(2008.04) F41C 33/00
JOHN N. RASSIAS, U.S.A.
WO/2001/051876
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
June 15,
– ‫כ"ג בסיוון התשס"ט‬
150695
‫נרתיק חסר רצועה ובעל מנגנון נעילה‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
4704
2009
[57] A holster, comprising: a hip plate
(2); at least one adjustable mount (1)
removably connected to the hip plate, said
adjustable mount having shroud mounting
means thereon, with a safety pin storage
bore located on said adjustable mount;
means for mounting a hip plate on a
wearer's article of clothing (3); and a
shroud for removably receiving a firearm
(10), said shroud secured to the adjustable
mount via the shroud mounting means,
said adjustable mount being an elongated
strip with at least one bore and being
removably connected to the hip plate via a
bolt received in the bore of the hip plate
and the elongated strip.
________
]11[]21[
150707
‫ייצור רקומבוננטי של תת סוגים של‬
‫ אנושי‬1–‫היסטון‬
]54[
RECOMBINANT PRODUCTION
OF HUMAN HISTONE-1
SUBTYPES
]22[
]31[
]51[
11.01.2001
10001113.6
]32[ 13.01.2000
]33[ DE
Int. Cl.(2008.04) A61K 38/17, A61P 31/00, 35/00, 37/00, 5/00, C07K 14/47, C12P
21/02
STRATHMANN GMBH & CO.KG,
GERMANY
WO/2001/051511
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
P.O.B. 6451,
TEL AVIV 61063
]71[
]87[
]74[
[57] Method of producing recombinant
human protein histone-1, comprising the
following steps:
(a) expression of a nucleic acid sequence
coding for human protein histone-1 in
prokaryotic cells, and
(b) extraction and purification of the
recombinant human protein histone-1 from
the prokaryotic cells.
_______
4705
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
‫שיטה לעיבוד רקמת כבד תורם לקבל‬
‫תאים קדמונים‬
]54[
METHOD OF PROCESSING
DONOR LIVER TO OBTAIN
PROGENITOR CELLS
]22[
]31[
]51[
]71[
19.01.2001
60/176798
]32[ 19.01.2000
Int. Cl.(2008.04) C12N 5/06, 5/08
UNIVERSITY OF NORTH
CAROLINA AT CHAPEL HILL,
U.S.A.
WO/2001/053462
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
150819
[57] A method of processing ischemically
damaged non-fetal donor liver tissue to
obtain an enriched population of
progenitor cells comprising:
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
(a) providing non-fetal liver donor tissue
between about two hours and thirty hours
postmortem; and
(b) processing said non-fetal donor tissue
to obtain an enriched population of
progenitor cells.
_______
]11[]21[
151031
‫תכשירים קוסמטיים או לטיפוח הגוף‬
‫למניעת ריחות גוף המכילים גורם‬
‫קומפלקסציה‬
]54[
COSMETIC / PERSONAL CARE
COMPOSITIONS COMPRISING A
COMPLEXING AGENT FOR
INHIBITING BODY ODORS
]22[
]31[
]51[
14.02.2001
09/510134
]32[ 22.02.2000
]33[ US
Int. Cl.(2008.04) A61K 08/30, 311/32, 316/75, 6/00, A61P 31/04, A61Q 11/00, 15/00,
C07C 211/13, 215/02, 217/02, 323/23, C07D 255/02, 257/02, 401/02, 403/02, 405/02,
487/02, C07F 9/02
CHELATOR LLC, U.S.A.
WO/2001/062262
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]71[
]87[
]74[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4706
2009
[57] Cosmetic or personal care
compositions for inhibiting body odors in a
subject, wherein into said composition a
complexing agent having the formula (I) is
being incorporated
wherein,
p and q are independently integers of from
2 to 3; r is an integer of from 1 to 4; R2, R3,
and R4 are each independently selected
from the group consisting of H, alkyl,
alkenyl, aryl, arylalkyl, alkoxy, alkylthio,
alkenoxy, alkenylthio, aryloxy, arylthio,
alkyl interrupted by oxa, alkenyl
interrupted by oxa, alkyl interrupted by
thia, alkenyl interrupted by thia,
aryloxyalkyl, alkoxyaryl, aminoalkyl,
aminoalkenyl, aminoaryl, aminoarylalkyl,
hydroxyalkyl, hydroxyalkenyl,
hydroxyaryl, hydroxyarylalkyl, and
halogen-substituted versions thereof;
R1 is a radical of the formula:
wherein, R41, R42, R43, R44, n and X are as
defined in the specification
and wherein, optionally, any two of R1, R2,
R3 and R4 are combined to form a ring
structure; and dimers of Formula I, said
dimers being formed by the covalent
attachment of two complexing agents of
Formula I through a linking group having
from 1 to 6 carbon atoms; and
physiological salts thereof; with the
proviso that the molecular weight of said
complexing agent does not exceed 2000.
_______
4707
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
151088
‫שיטה והתקן לייצור חומרים מרוכבים לא‬
‫ארוגים באמצעות תפירה הידרודינמית‬
]54[
METHOD AND DEVICE FOR
PRODUCING COMPOSITE
NONWOVENS BY MEANS OF
HYDRODYNAMIC NEEDLING
]22[
]31[
]51[
]71[
13.01.2001
10008746.9
]32[ 24.02.2000
]33[ DE
Int. Cl.(2008.04) D04H 1/46, 13/00, 3/10, 5/02
FLEISSNER GMBH & CO.
MASCHINENFABRIK, GERMANY
ORLANDI SPA, ITALY
WO/2001/063032
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] Method for producing a composite
non-woven fabric (12) for absorbing and
storing liquids or the like, said fabric
comprising a carded non-woven fabric (10)
which is treated for strengthening
purposes, and a pulp layer, such as one
formed from wood pulp fibres, which is
applied to the strengthened carded nonwoven fabric and is brought into
permanent contact with the carded non-
woven fabric, characterised in that the
carded non-woven fabric is
prestrengthened when dry, prior to being
coated with the superabsorbent material,
then the layer of pulp fibres is applied to
this presetrengthened carded non-woven
fabric, and interconnecting the layer of
pulp fibers and the prestrengthened carded
non-woven fabric.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4708
2009
]11[]21[
]54[
FOOD INTAKE RESTRICTION
WITH WIRELESS ENERGY
SUPPLY
]22[
]31[
]51[
]71[
08.02.2001
09/502774
]32[ 11.02.2000
Int. Cl.(2008.04) A61F 2/02
OBTECH MEDICAL AG,
SWITZERLAND
WO/2001/058391
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
[57] A food intake restriction apparatus
for an obese patient, comprising: an
operable restriction device (4) adapted to
be implanted in the patient to engage the
stomach or the esophagus to form a
restricted stoma opening in the stomach or
esophagus, an energy transmission device
(10) for wireless transmission of energy of
a first form from outside the patient's body,
an energy transfer device (6) adapted to be
implanted in the patient for transferring
151138
‫הגבלת צריכת מזון עם מקור אנרגיה‬
‫אלחוטי‬
]33[
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
energy of the first form transmitted by said
energy transmission device into energy of
a second form, different than the first form
energy, and an operation device adapted to
be implanted in the patient for operating
said restriction device, wherein the second
form energy is used for powering said
operation device to operate said restriction
device to vary the restricted stoma
opening.
_______
4709
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
151165
‫שימוש בסיטידין דיפוספאט כולין להכנת‬
‫תרופה לטיפול כמונע מחלת איסכמיה של‬
‫המח הקטן‬
]54[
USE OF CDP-CHOLINE FOR THE
MANUFACTURE OF A
MEDICAMENT FOR THE
PROPHYLACTIC TREATMENT
OF CEREBRAL ISCHEMIA
]22[
]31[
]51[
]71[
13.03.2001
P200000610
]32[ 14.03.2000
]33[ ES
Int. Cl.(2008.04) A61K 317/068, A61P 43/00, 9/10, C07H 19/00, 19/10
FERRER INTERNACIONAL, S.A.,
SPAIN
WO/2001/068064
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]87[
]74[
[57] The use of CDP-Choline or of a
pharmaceutically acceptable salt thereof
for the manufacture of a medicament for
the prophylactic treatment of cerebral
ischemia, wherein CDP-Choline or the
pharmaceutically acceptable salt are to be
administered to a human subject being at
high risk of suffering an acute ischemic
event before the eventual onset of an
ischemic episode, wherein the acute
ischemic event is stroke and the high risk
is due to a risk factor selected from a
history of previous transient ischemic
episodes, arterial hypertension,
hypercholesterolemia, smoking, auricular
fibrillation and other embolic heart
disease.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4710
2009
]11[]21[
151267
‫אנתרליאמידים ושיטות שמשתמשות בהם‬
‫להדברת פרוקי רגליים‬
]54[
ANTHRANILAMIDES AND
METHODS USING THEM FOR
CONTROLLING ARTHROPODS
]22[
]31[
20.03.2001
60/191242
]32[ 22.03.2000
]33[ US
60/220232
24.07.2000
US
60/254635
11.12.2000
US
60/262015
17.01.2001
US
Int. Cl.(2008.04) A01N 43/00, 47/02, 55/10, C07C 237/30, 327/48, C07D 207/34,
213/78, 231/14, 239/28, 261/08, 263/34, 277/56, 333/38, 401/12, 513/04, C07F 7/18
E.I. DUPONT DE NEMOURS AND
COMPANY, U.S.A.
WO/2001/070671
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] A method for controlling arthropods
comprising contacting the arthropods or
their environment with an
arthropodicidally effective amount of a
compound of Formula 1, its N-oxide or
agriculturally suitable salts
wherein
A and B are independently O or S; each J
is independently a phenyl or naphthyl
group substituted with 1 to 2 R5 and
optionally substituted with 1 to 3 R6; or
each J is independently a 5- or 6membered heteroaromatic ring or an
aromatic 8-, 9- or 10-membered fused
heterobicyclic ring system wherein each
ring or ring system is optionally
substituted with 1 to 4 R7; n is 1 to 4; R1 is
H; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6
alkynyl or C3-C6 cycloalkyl each
optionally substituted with one or more
substituents selected from the group
consisting of halogen, CN, NO2, hydroxy,
C1-C4 alkoxy, C1-C4 alkylthio, C1-C4
alkylsulfinyl, C1-C4 alkylsulfonyl, C2-C4
alkoxycarbonyl, C1-C4 alkylamino, C2-C8
dialkylamino and C3-C6 cycloalkylamino;
or R1 is C2-C6 alkylcarbonyl, C2-C6
alkoxycarbonyl, C2-C6
alkylaminocarbonyl, C3-C8
dialkylaminocarbonyl or C(=A)J; n, R2,
R3, R4, are defined in the specification
provided that J is other than an optionally
substituted 1,2,3-thiadiazole.
The applications for division
4711
,194534
‫בקשות חלוקה מבקשה זו‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
.‫שטרם פורסמו‬
from this application have
not yet been published
______
]11[]21[
151287
‫שיטה להמרצת וריכוז תאים‬
]54[
METHOD FOR STIMULATING
AND CONCENTRATING CELLS
]22[
]31[
26.02.2001
60/184788
]32[ 24.02.2000
]33[ US
60/249902
17.11.2000
US
Int. Cl.(2008.04) B03C 1/00, C12N 15/06, 5/00, G01N 33/53
XCYTE THERAPIES, INC., U.S.A.
WO/2001/062895
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
[57] An in-vitro method for stimulating a
population of T-cells in vitro by
simultaneous T-cell concentration and cell
surface moiety ligation, comprising: (a)
providing a population of cells wherein at
least a portion thereof comprises T-cells;
(b) contacting said population of cells with
a surface, wherein said surface is a surface
of a paramagnetic particle and wherein
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
said surface has attached thereto one or
more agents that ligate a cell surface
moiety of at least a portion of said T-cells
and stimulates at least said portion of Tcells; (c) applying a magnetic force that
predominantly drives T-cell concentration
and T-cell surface moiety ligation, thereby
inducing T-cell stimulation.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4712
2009
]11[]21[
151428
‫ הכנתן ותכשירי‬,‫נגזרות של אזטידין‬
‫רוקחות המכילים אותם‬
]54[
AZETIDINE DERIVATIVES,
PREPARATION THEREOF AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
SAME
]22[
]31[
]51[
01.03.2001
00/02775
]32[ 03.03.2000
]33[ FR
Int. Cl.(2008.04) A61K 313/97, A61P 25/00, 3/04, C07D 205/04, 205/06, 401/00,
403/00, 405/00, 409/00, 413/00, 417/00
AVENTIS PHARMA S.A., FRANCE
WO/2001/064632
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]71[
]87[
]74[
[57] Compounds of the formula
in which
R represents a radical selected from CR1
R2, C=C(R5)SO2 R6 and C=C(R7)SO2 alk,
either R1 represents a hydrogen atom and
R2 represents a radical selected from –
C(R8)(R9)(R10), -C(R8)(R11)(R12), -CONR13R14, -CH2-CO-NR13, -CH2-CO-R6, CO-R6, -CO-cycloalkyl, -SO-R6, -SO2-R6,
-C(OH)(R12)(R6), -C(OH)(R6)(alkyl), C(=NOalk)R6, -C(=NO-CH2-CH=CH2)R6,
-CH2-CH(R6)NR31R32, -CH2C(=NOalk)R6, -CH(R6)NR31R32, CH(R6)NHSO2 alk,-CH(R6)NHCONHalk
and-CH(R6)NHCOalk, or R1 represents an
alkyl, NH-R15, cyano, -S-alk-NR16R17, CH2-NR18R19, or –NR20R21 radical and R2
represents a –C(R6)(R11)(R12) radical, R3
and R4, which may be identical or
different, phenyl or indenyl, these aromatic
radicals being unsubstituted or substituted
with one or more radicals selected from
4713
halogen, alkyl, alkoxy, formyl, hydroxyl,
trifluoromethyl, trifluoromethoxy, -COalk, cyano, -COOH, -COOalk, CONR22R23, -CO-NH-NR24R25,
alkylsulfanyl, alkylsulfinyl, alkylsulfonyl,
alkylsulfanylalkyl, alkylsulfinylalkyl,
alkylsulfonylalkyl, hydroxyalkyl and –alkNR24R25 radicals; or a heteroaromatic
radical selected from the benzofuryl,
benzothiazolyl, benzothienyl,
benzoxazolyl, chromanyl, 2, 3dihydrobenzofuryl, 2,3dihydrobenzothienyl, furyl, imidazolyl,
isochromanyl, isoquinolyl, pyrrolyl,
pyridyl, pyrimidinyl, quinolyl, 1,2,3,4tetrahydroisoquinolyl, thiazolyl and thienyl
rings, these heteroaromatic radicals being
unsubstituted or substituted with one or
more radicals selected from halogen, alkyl,
alkoxy, hydroxyl, trifluoromethyl,
trifluoromethoxy, cyano, -COOH, June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
COOalk, -CO-NH-NR24 R25, -CONR22R23,
-alk-NR24R25, alkylsulfanyl, alkylsufinyl,
alkylsulfonyl, alkylsulfanylalkyl,
alkylsulfinylalkyl, alkylsulfonyalkyl and
hydroxyalkyl radicals, R5 represents a
hydrogen or alkyl radical, R6 represents Ar
or Het radical, R7 represents a cycloalkyl,
heterocycloalkyl or heterocyclenyl radical,
optionally substituted by a-CSO-phenyl
radical, R8 represents a hydrogen or alkyl
radical, R9 represents a radical selected
from –CO-NR26R27, -COOH, -COOalk, CH2OH, -NH-CO-NH-alk, -CH2-NHR28
and –NHCOOalk, R10 represents an Ar or
Het radical, R11 represents a radical
selected from –SO2-alk, -SO2-Ar and –
SO2-Het, R12 represents a hydrogen, Ar or
Het radical, R13 represents a hydrogen or
alkyl radical, R14 represents an Ar, Het, alk-Ar or-alk-Het radical, R15 represents an
alkyl, cycloalkyl or –alk-NR29 R30 radical,
R16 and R17, which may be identical or
different, represent a hydrogen or alkyl
radical or, alternatively, R16 and R17, taken
together with the nitrogen atom to which
they are attached, form a 3-to 10membered unsaturated or saturated monoor bicyclic heterocycle ring, optionally
containing one or more other heteroatoms
selected from oxygen, sulfur and nitrogen
and optionally substituted with one or
more alkyl radicals, R18 represents a
hydrogen or alkyl radical, R19 represents a
hydrogen, alkyl, cycloalkyl,
cycloalkylalkyl, cycloalkylcarbonyl, -SO2
alk, -CO-NHalk or –CO-alk radical, or
alternatively, R18 and R19, taken together
with the nitrogen atom to which they are
attached, form a 3- to 10-membered
unsaturated or saturated mono-or bicyclic
heterocycle ring, optionally containing one
or more heteroatoms selected from
oxygen, sulfur and nitrogen and optionally
substituted with one or more alkyl radicals,
-NR20 R21 represents a 3- to 8-membered
saturated or unsaturated monocyclic
heterocycle ring, optionally containing
June 15,
another heteroatom selected from oxygen,
nitrogen and sulfur, R22 and R23, which
may be identical or different, represent a
hydrogen or alkyl radical or, alternatively,
R22 and R23, taken together with the
nitrogen atom to which they are attached,
form a 3-to 10-membered saturated monoor bicyclic heterocycle, optionally
containing another heteroatom selected
from oxygen, sulfur and nitrogen and
being optionally substituted with one or
more alkyl radicals, R24 and R25, which
may be identical or different, represent a
hydrogen, alkyl, -COOalk, cycloalkyl,
alkylcycloalkyl, -alk-O-alk or
hydroxyalkyl radical or, alternatively, R24
and R25, taken together with the nitrogen
atom to which they are attached, form a 3to 10-membered saturated or unsaturated
mono-or bicyclic heterocycle, optionally
containing another heteroatom selected
from oxygen, sulfur and nitrogen and
being optionally substituted with one or
more alkyl, -COalk, -COOalk, -CONHalk, -CS-NHalk, oxo, hydroxyalkyl, alk-O-alk or –CO-NH2 radicals, R26 and
R27, which may be identical or different,
represent a hydrogen, alkyl, hydroxyalkyl,
cycloalkyl, cycloalkylalkyl, -alk-COOalk,
-alk-Ar, -alk-Het, Het or –alk-N(alk)2
radical, or, alternatively, R26 and R27 taken
together with the nitrogen atom to which
they are attached, may form a 3-to 10membered unsaturated or saturated monoor bicyclic heterocycle, optionally
containing one or more other heteroatoms
selected from oxygen, sulfur and nitrogen,
and optionally substituted with one or
more halogen, alkyl or alkoxy radicals, R28
represents a –CH2-alk, benzyl-SO2 alk, COalk, cycloalkylalkylcarbonyl,
cycloalkylcarbonyl or –CO-(CH2)nOH
radical, n is equal to 1, 2 or 3, R29 and R30,
which may be identical or different,
represent a hydrogen or alkyl radical or,
alternatively, R29 and R30, taken together
with the nitrogen atom to which they are
– ‫כ"ג בסיוון התשס"ט‬
4714
2009
attached, form a 3- to 10-membered
saturated mono-or bicyclic heterocycle,
optionally containing another heteroatom
selected from oxygen, sulfur and nitrogen,
and being optionally substituted with one
or more alkyl radicals, R31 and R32, which
may be identical or different, represent a
hydrogen, alkyl, Ar or –alk-Ar radical or,
alternatively, R31 and R32, taken together
with the nitrogen atom to which they are
attached, form a heterocycle selected from
aziridinyl, azetidinyl, pyrrolidinyl and
piperidinyl, alk represents an alkyl or
alkylene radical, Ar represents a phenyl or
naphthyl radical optionally substituted
with one or more substituents selected
from halogen, alkyl, alkoxy, -CO-alk,
cyano, -COOH, -COOalk, -CONR22 R23, CO-NH-NR24R25, alkylsulfanyl,
alkylsulfinyl, alkylsulfonyl,
alkylsulfanylalkyl, alkylsulfinylalkyl,
alkylsulfonylalkyl, hydroxyalkyl, -alkNR24 R25, -NR24 R25, alkylthioalkyl,
formyl, hydroxyl, CF3, OCF3, Het, -O-alkNH-cycloalkyl and SO2NH2 radicals, Het
represents a 3-to 10-membered unsaturated
or saturated mono- or bicyclic heterocycle
containing one or more heteroatoms
selected from oxygen, sulfur and itrogen
and optionally substituted with one or
more halogen, alkyl, alkoxy,
alkoxycarbonyl, -CONR22R23, hydroxyl,
hydroxyalkyl, oxo or SO2NH2 radicals, the
alkyl, alkylene and alkoxy radicals are in
the form of a straight or branched chain
and contain 1 to 6 carbon atoms, the
cycloalkyl radicals contain 3 to 10 carbon
atoms and the heterocycloalkyl and
heterocyclenyl radicals contain 3 to 10
carbon atoms, their optical isomers and
their salts with an inorganic or organic
acid.
________
]11[]21[
]54[
MORTISE LOCK
]22[
]51[
]71[
09.09.2002
Int. Cl.(2008.04) E05B 59/00, E05C 9/06
MUL-T-LOCK TECHNOLOGIES
LTD.
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
]74[
[57] A lock comprising: a lock housing; a
lock located within said lock housing; a
bolt throw element, rotatably mounted
with respect to said lock housing about a
rotation axis, said bolt throw element
defining a plurality of link mounting
locations including link mounting
locations located at a plurality of different
distances from said rotation axis; a
plurality of link elements pivotably
mounted onto said bolt throw element at
some but not all of said plurality of link
mounting locations; a plurality of bolts,
4715
151656
‫מנעול חבוי‬
‫ יבנה‬,‫מולטילוק טכנולוגיות בע"מ‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,27 ‫חדר‬, 18 ‫מנוחה ונחלה‬
each pivotably coupled to one of said
plurality of link elements and being
arranged to be driven thereby in generally
linear motion; and wherein said plurality
of link elements are selectably pivotably
mountable onto ones of said plurality of
link mounting locations, such that the
distance of a mounting location of a given
link pivotably connected to a given bolt
may be selected, thereby selecting an outer
extent of generally linear bolt travel
thereof.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
151674
‫שיטה לגילוי אנליט באמצעות קרינה‬
‫פלואורסצנטית‬
]54[
METHOD FOR DETECTING AN
ANALYTE BY FLUORESCENCE
]22[
]31[
]51[
]71[
20.03.2001
60/190091
]32[ 20.03.2000
]33[ US
Int. Cl.(2008.04) G01N 21/00, 33/00, 33/58, 335/43, 335/44
ANALYTICAL BIOLOGICAL
SERVICES, INC., U.S.A.
WO/2001/071317
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
ZION HOUSE,
‫ תל‬,41-45 ‫ שדרות רוטשילד‬,‫בית ציון‬
41-45 ROTHSCHILD BLVD.,
‫אביב‬
TEL AVIV 65784
]87[
]74[
[57] A method for the detection of an
analyte in a sample, which comprises
contacting the sample to be tested with a
three-dimensional array comprising a
polydiacetylene backbone and a substrate,
wherein the substrate has direct affinity for
an analyte or is capable of binding to an
analyte or is capable of reacting with an
analyte; and wherein a change, if any, in
fluorescence of said polydiacetylene
backbone is in response to analyte present
in said sample; and detecting the change in
fluorescence to indicate the presence of an
analyte.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4716
2009
]11[]21[
]54[
SURFACE INSPECTION SYSTEM
]22[
]31[
24.09.2002
2001-370639 ]32[ 04.12.2001
2001-370640
04.12.2001
2001-370638
04.12.2001
Int. Cl.(2008.04) G01N 21/95
KABUSHIKI KAISHA TOPCON,
JAPAN
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]51[
]71[
]74[
[57] A surface inspection system for
projecting a laser beam to a surface of a
substrate and for detecting a foreign object
by detecting scattered reflection light of
the laser beam, comprising a light source
unit having a plurality of light emitting
sources (1a, 1b) for emitting the laser
beams (2a, 2b) via individual optical paths,
4717
151898
‫מערכת לבדיקת פני שטח‬
]33[
JP
JP
JP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
an optical path switching means (24a, b;
25a, b) on said optical paths and a
projecting optical system (4) for projecting
the laser beam from each of the light
emitting sources to the surface of the
substrate so that reflection characteristics
on the substrate surface differ from each
other.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
151982
‫סיב בעל מודולוס גבוה ובעל כושר לפיתה‬
‫גבוה‬
]54[
HIGH TENACITY, HIGH
MODULUS FILAMENT
]22[
]31[
]51[
]71[
27.03.2001
537461
]32[ 27.03.2000
]33[
Int. Cl.(2008.04) B32B 27/12, D01F 6/04
HONEYWELL INTERNATIONAL
INC., U.S.A.
WO/2001/073173
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
[57] A method of preparing a high
tenacity, high modulus multi-filament yarn
comprising: extruding solution of
polyethylene having an intrinsic viscosity
(measured in decalin at 135oC) between
about 4 dl/g and 40 dl/g through a
multipeorifice spinneret into a cross-flow
gas stream to form a fluid product;
stretching the fluid product at an extension
rate of more than about 500 min-1 above
the temperature at which a gel will form at
a stretch ratio of at least 5:1 over a length
of less than about 25 mm and with the
June 15,
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
cross-flow gas stream velocity at less than
about 3 m/min; quenching the fluid
product in a quench bath consisting of an
immiscible liquid to form a gel product;
stretching the gel product; removing the
solvent from the gel product to form a
xerogel product substantially free of
solvent; and, stretching the xerogel
product, the total stretch ratio being
sufficient to produce a polyethylene yarn
characterized by a tenacity of at least 35
g/d, a modulus of at least 1600 g/d, and a
work-to-break of at least 65 J/g.
– ‫כ"ג בסיוון התשס"ט‬
4718
2009
_______
]11[]21[
152179
3,5 ‫תרכובות פרמצבטיות יציבות המכילות‬
‫דיהדרוקסי חומצות הפטאנואיות או‬
7 ‫הפטנואיות המותמרות בעמדה‬
]54[
STABLE PHARMACEUTICAL
COMPOSITIONS CONTAINING 7SUBSTITUTED-3,5DIHYDROXYHEPTANOIC ACIDS
OR 7-SUBSTITUTED-3,5DIHYDROXYHEPTENOIC ACIDS
]22[
]31[
]51[
09.04.2001
60/195916
]32[ 10.04.2000
]33[ US
Int. Cl.(2008.04) A61K 31/22, 31/40, 47/30, 9/16, 9/20, 9/26, 9/48, A61P 3/06, C07C
69/33, C07D 207/34
TEVA PHARMACEUTICAL
‫ פתח‬,‫טבע תעשיות פרמצבטיות בע"מ‬
INDUSTRIES LTD.
‫תקווה‬
WO/2001/076566
TEVA PHARMACEUTICAL
,‫טבע תעשיות פרמצבטיות בע"מ‬
INDUSTRIES LTD.,
‫ פתח תקוה‬,3190 .‫ד‬.‫ ת‬, 5 ‫בזל‬
5 BASEL ST., P.O.B. 3190,
PETAH TIQVA 49131
]71[
]87[
]74[
[57] A stabilized pharmaceutical
composition for the treatment of
dyslipidemia, comprising an active
component consisting essentially of one or
more compounds selected from the group
consisting of (i) an HMG-CoA reductase
inhibiting ring-opened 7-substituted-3,5dihydroxyheptanoic acid or a
pharmaceutically acceptable acid salt
thereof, and (ii) an HMG-CoA reductase
inhibiting ring-opened 7-substituted-3,5-
dihydroxyheptenoic acid or a
pharmaceutically acceptable acid salt
thereof, and a stabilizing effective amount
of at least one amido-group containing
polymeric compound or at least one
amino-group containing polymeric
compound, or combination thereof,
wherein said stabilized pharmaceutical
composition does not contain a stabilizing
effective amount of another stabilizer or a
combination of other stabilizers.
_______
4719
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
152297
‫שיטה להשראת עמידות ויראלית בצמחים‬
]54[
METHOD FOR INDUCING VIRAL
RESISTANCE IN PLANTS
]22[
]31[
]51[
30.04.2001
10021190.9
]32[ 03.05.2000
]33[ DE
Int. Cl.(2008.04) A01N 37/36, 37/50, 43/40, 43/54, 43/56, 436/53, 47/20, C07C
251/48, 251/60, 255/54, 255/64, 271/28, 317/22, 317/32, 323/40, 327/48, 696/18,
697/36, C07D 213/63, 231/14, 239/52, 249/12
BASF SE, GERMANY
WO/2001/082701
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]71[
]87[
]74[
[57] A method of inducing the virus
resistance of plants which comprises
treating the plants, the soil or seeds with an
effective amount of a compound of the
formula
in which
X is halogen, C1-C4-alkyl or
trifluoromethyl;
m is 0 or 1;
Q is C(=CH-CH3)-COOCH3, C(=CHOCH3) –COOCH3, C(=N-OCH3)CONHCH3, C(=N-OCH3)-COOCH3 or N(OCH3) –COOCH3;
A is –O-B, -CH2O-B, -OCH2-B, -CH=CHB, -C=C-B, -CH2O-N=C(R1)-C(R2)=NOR3, where
B is phenyl, naphthyl, 5-membered or 6membered hetaryl or 5-membered or 6membered heterocyclyl, containing one to
three N atoms and/or one O or S atom or
one or two O and/or S atoms, the ring
systems being unsubstituted or substituted
by one to three radicals Ra:
Ra is cyano, nitro, amino, aminocarbonyl,
aminothiocarbonyl, halogen, C1-C4-alkyl,
June 15, – ‫כ"ג בסיוון התשס"ט‬
C1-C6-haloalkyl, C1-C6alkylcarbonyl, C1C6-alkylsulfonyl, C1-C6-alkylsufinyl, C3C6- cycloalkyl, C1-C6-alkoxy, C1-C6haloalkoxy, C1-C6-alkyloxycarbonyl, C1C6-alkylthio, C1-C6-alkylamino, di- C1-C6alkylamino, C1-C6-alkylaminocarbonyl, diC1-C6-alkylamino-carbonyl, C1-C6alkylaminothiocarbonyl, di- C1-C6alkylaminothiocarbonyl, C2-C6-alkenyl,
C2-C6-alkenyloxy, phenyl, phenoxy,
benzyl, benzyloxy, 5-or 6-membered
heterocyclyl, 5- or 6-membered hetaryl, 5or 6-membered hetaryloxy, C(=NORα)ORβ or OC (Rα)2-C(Rβ)=NORβ, the cyclic
radicals, in turn, being unsubsituted or
substituted by one to three radicals Rb;
Rb is cyano, nitro, halogen, amino, aminocarbonyl, aminothiocarbonyl, C1-C6-alkyl,
C1-C6-haloalkyl, C1-C6-alkylsulfonyl, C1C6-alkylsulfinyl, C3-C6-cycloalkyl,
4720
2009
C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6alkoxy-carbonyl, C1-C6-alkylthio, C1-C6alkylamino, di- C1-C6-alkylamino, C1-C6alkylamino-carbonyl, di- C1-C6alkylaminocarbonyl, C1-C6alkylaminothiocarbonyl, di- C1-C6-alkylaminothiocarbonyl, C2-C6-alkenyl, C2-C6alkenyloxy, C3-C6-cycloalkyl, C3-C6cycloalkenyl, C3-C6-cycloalkenyl, phenyl,
phenoxy, phenylthio, benzyl, benzyloxy,
5-or 6-membered heterocyclyl, 5-or 6membered hetaryl, 5-or 6-membered
hetaryloxy or C(=NORα)-ORβ;
Rα, Rβ are hydrogen or C1-C6-alkyl;
R1 is hydrogen, cyano, C1-C4-alkyl, C1-C4haloalkyl, C3-C6-cycloalkyl, C1-C4-alkoxy;
R2 is phenyl, phenylcarbonyl,
phenylsulfonyl, 5- or 6-membered hetaryl,
5-or 6-membered hetarylcarbonyl or 5-or
6-membered hetarylsulfonyl, the ring
systems being unsubstituted or substituted
by one to three radicals Ra, C1-C10-alkyl,
C3-C6-cycloalkyl, C2-C10-alkenyl, C2-C10alkynyl, C1-C10-alkylcarbonyl, C2-C10alkenyl-carbonyl, C3-C10-alkynylcarbonyl,
C1-C10-alkyl-sulfonyl, or C(=NORα)-ORβ,
the hydrocarbon radicals of these groups
being unsubstituted or substituted by one
to three radicals Rc:
Rc is cyano, nitro, amino, aminocarbonyl,
halogen, C1-C6-alkyl, C1-C6-haloalkyl, C1C6-alkylsulfonyl, C1-C6-alkylsulfinyl, C1C6-alkoxy, C1-C6-haloalkoxy, C1-C6alkoxycarbonyl, C1-C6-alkylthio, C1-C6alkylaminocarbonyl, di-C1-C6alkylaminocarbonyl, C1-C6-alkylaminothiocarbonyl, di-C1-C6alkylaminothiocarbonyl, C2-C6-alkenyl,
C2-C6-alkenyloxy, C3-C6-cycloalkyl, C3C6-cycloalkoxy, 5- or 6-membered
heterocyclyl, 5- to 6-membered
heterocycloxy, benzyl, benzyloxy, phenyl,
phenoxy, phenylthio, 5- or 6-membered
hetaryl, 5- or 6-membered hetaryloxy and
hetarylthio, it being possible for the cyclic
groups, in turn, to be partially or fully
halogenated or to have attached to them
one to three radicals Ra; and R3 is
hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2C6-alkynyl, the hydrocarbon radicals of
these groups being unsubstituted or
substituted by one to three radicals Rc;
which compound is taken up by the plants
or seeds.
_______
]11[]21[
152379
‫מבנים מודולרים וחומרים המשמשים‬
‫לבנייתם‬
]54[
MODULAR BUILDINGS AND
MATERIALS USED IN THEIR
CONSTRUCTION
]22[
]31[
]51[
]71[
18.04.2001
0009521.6
]32[ 18.04.2000
]33[ GB
Int. Cl.(2008.04) E04B 1/14, 7/20, E04D 3/35
ABERSHAM TECHNOLOGIES
LIMITED, GIBRALTAR
MALCOLM PARRISH
WO/2001/079619
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
]72[
]87[
]74[
4721
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
[57] A modular building comprising: a
foundation floor having secured therein a
plurality of anchor elements; a plurality of
wall-retaining track elements (82) adapted
to engage wall panels (80, 81) of the
building, the track elements being
securable to the foundation floor so as to
define the position of at least the load
bearing walls of the building; wall panels
locatable with respect to the track
elements, the internal material of the panel
defining at least one channel or duct (91A)
formed within the panel, parallel to a
longitudinal axis thereof and at least one
channel or duct (92A) formed therein
disposed perpendicularly to and laterally of
the longitudinal axis; and a plurality of
securing members (84, 93A, 93A, 93C)
adapted to pass through and locatable
within said channels or ducts, the securing
members being anchored at each end
thereof so as to maintain the panels in
fixed relationship to one another.
_______
]11[]21[
]54[
TRANSACTION TRACKING,
MANAGING, ASSESSMENT AND
AUDITING DATA PROCESSING
SYSTEM AND NETWORK
]22[
]31[
]51[
]71[
20.03.2001
09/558356
]32[ 26.04.2000
Int. Cl.(2008.04) G06Q 20/00
LINKSHARE CORPORATION,
U.S.A.
WO/2001/080846
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
152446
,‫ ניהול‬,‫מערכת ורשת לעקיבה אחר תנועה‬
‫הערכה ומעקב אחר עיבודנתונים‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
4722
2009
[57] A data processing system for
supporting web-based commerce and
commission tracking on a multi-node
network, comprising:
(a) one or more Content Providers with
web pages wherein said web pages include
linking instructions associated with
selected promotions;
(b) a Clearinghouse server for
automatically tracking USER interactions
The applications for division
from this application have
not yet been published
with said promotions, said Clearinghouse
server further comprising programming for
detecting fraudulent activity relating to
said promotions, and
(c) Merchant sites interconnected to said
network and available for providing goods
and/or services to USERs referred to said
Merchant site by said linking instructions.
,196338
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
4723
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
152484
‫מלחים של נגזרות טטרוזוליום כחומרי‬
‫גיבוש לאיברונים ולשלדי תאים ותכשירים‬
‫המכילים אותם עבור הריגת תאי גידול‬
]54[
SALTS OF TETRAZOLIUM
DERIVATIVES AS ORGANELLE
AND CYTOSKELETON
CRYSTALLIZING AGENTS AND
COMPOSITIONS CONTAINING
THEM FOR KILLING TUMOR
CELLS
]22[
]31[
27.04.2001
0111092.6
]32[ 29.04.2000
]33[ CA
09/663559
15.09.2000
US
09/687342
12.10.2000
US
00129316.8
13.11.2000
CA
Int. Cl.(2008.04) A61K 31/38, 31/41, A61P 35/00, C07D 257/00, 257/04, 417/04
QINGZHONG KONG, U.S.A.
WO/2001/082780
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] Use of an organelle and cytoskeleton
crystallizing agent for the preparation of a
medicament for killing tumor cells suited
for administering to a mammalian patient
having a cancer wherein the crystallizing
agent is selected from the group consisting
of tetrazolium salts and derivatives thereof,
and wherein said crystallizing agent forms
crystals in an organelle and the
cytoskeleton of tumor cells in said patient
through a reaction catalyzed by cellular
enzymes.
_______
]11[]21[
152516
‫רדידים פעילים רב–שכבתיים חופשיים‬
]54[
FREESTANDING REACTIVE
MULTILAYER FOILS
]22[
]31[
]51[
]71[
01.05.2001
60/201292
]32[ 02.05.2000
]33[
Int. Cl.(2008.04) C06B 45/12, C23C 14/14
THE JOHNS HOPKINS
UNIVERSITY, U.S.A.
WO/2001/083182
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
4724
2009
[57] A method of making a freestanding
reactive multilayer foil composed of a
plurality of alternating layers that can react
exothermically, comprising the steps of:
providing a substrate; vapor depositing the
alternating layers on the alternating layers
on the substrate to form a reactive
multilayer foil having a thickness in the
range of about 10 micrometers to about 1
cm, the vapor deposition conditions chosen
for low stress so that the product of stress
in the film and the film thickness is kept
below 1000 N/m; and separating the
multilayer foil from the substrate to
provide the freestanding reactive
multilayer foil.
_______
]11[]21[
152527
‫וקטורים רטרוויראליים המכילים סיום‬
‫(טרמינצית) שעתוק ביעילות מוגברת‬
]54[
RETROVIRAL VECTORS
COMPRISING AN ENHANCED
TRANSCRIPTION TERMINATION
EFFICIENCY
]22[
]31[
]51[
]71[
14.05.2001
60/203884
]32[ 12.05.2000
]33[ US
Int. Cl.(2008.04) A61K 48/00, C12N 158/61, 5/10, 7/01
UNIVERSITY OF SOUTHERN
CALIFORNIA, U.S.A.
WO/2001/085974
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] A retroviral vector comprising:
(a) a 5' LTR;
(b) a 3' LTR comprising a polyadenylation
signal; and
(c) (i) one or several heterologous
upstream enhancer (UE) sequences, or (ii)
one or several additional copies of
endogenous UE sequences operatively
associated with said polyadenylation
signal, wherein the transcriptional
termination efficiency is enchanced or
higher vector titers are produced.
_______
4725
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
152556
‫בקר כוח לאות משודר מלווין עבור מספר‬
‫רב של אותות משודרים בחריצי זמן‬
TDD ‫במערכת תקשורת‬
]54[
DOWNLINK POWER CONTROL
FOR MULTIPLE DOWNLINK
TIME SLOTS IN TDD
COMMUNICATION SYSTEMS
]22[
]31[
]51[
]71[
30.04.2001
60/200756
]32[ 01.05.2000
]33[ US
Int. Cl.(2008.04) H04B 7/26, 70/05, H04J 13/00, 3/00, H04L 1/00, H04Q 7/38
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2001/084740
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]87[
]74[
[57] A spread spectrum time division user
equipment using time slots for
communication comprising: an antenna
configured to receive data in a command
per coded composite transport channel
(CCTrCH) transmitted over a plurality of
time slots; an interference power
measurement device configured to
measure an interference power for each
time slot of the plurality of time slots; the
antenna configured to transmit a single
The applications for division
from this application have
not yet been published
power command in response to a signal to
interference ratio of the received CCTrCH
and the measured interference power
measurement for each time slot; and the
antenna configured to receive a subsequent
data in the CCTrCH communication
having a transmission power level for each
downlink communication time slot set
individually in response to the interference
power measurement or that time slot and
the single power command.
,194766
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4726
2009
]11[]21[
152771
‫] פירימידין‬d–3,2[ ‫תרכובות של פירולו‬
‫כחומרים מדכאי חיסון‬
]54[
PYRROLO[2,3-D] PYRIMIDINE
COMPOUNDS AS
IMMUNOSUPPRESSIVE AGENTS
]22[
]31[
]51[
]71[
]87[
]74[
05.06.2001
60/214287
]32[ 26.06.2000
]33[ US
Int. Cl.(2008.04) A61K 315/05, C07D 487/04
PFIZER PRODUCTS, INC., U.S.A.
WO/2002/000661
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] A compound of the formula
or the pharmaceutically acceptable salt
thereof; wherein R1 is a group of the
formula
wherein y is 0, 1 or 2,
R4 is selected from the group consisting of
hydrogen, (C1-C6) alkyl, (C1-C6)
alkylsulfonyl, (C2-C6) alkenyl, (C2-C6)
alkynyl wherein the alkyl, alkenyl and
alkynyl groups are optionally substituted
by deuterium, hydroxy, amino,
trifluoromethyl, (C1-C4) alkoxy, (C1-C6)
acyloxy, (C1-C6) alkylamino, ((C1-C6)
alkyl)2 amino, cyano, nitro, (C2-C6)
alkenyl, (C2-C6) alkynyl or (C1-C6)
acylamino; or R4 is (C3-C10) cycloalkyl
wherein the cycloalkyl group is optionally
substituted by deuterium, hydroxy, amino,
trifluoromethyl, (C1-C4) acyloxy, (C1-C6)
4727
acylamino, (C1-C6) alkylamino, ((C1-C6)
alkyl)2 amino, cyano, nitro, (C2-C6)
alkenyl, (C2-C6) alkynyl or (C1-C6)
acylamino; or R4 is (C3-C10) cycloalkyl
wherein the cycloalkyl group is optionally
substituted by deuterium, hydroxy, amino,
trifluoromethyl, (C1-C6) acyloxy, (C1-C6)
acylamino, (C1-C6) alkylamino, ((C1-C6)
alkyl)2 amino, cyano, cyano (C1-C6) alkyl,
trifluoromethyl (C1-C6) alkyl, nitro, nitro
(C1-C6) alkyl or (C1-C6) acylamino; R5 is
(C2-C9) heterocycloalkyl wherein the
heterocyclalkyl groups must be substituted
by one to five groups consisting of
carboxy, cyano, amino, deuterium,
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
hydroxy, (C1-C6) alkyl, (C1-C6) alkoxy,
halo, (C1-C6) acyl, (C1-C6) alkylamino,
amino (C1-C6) alkyl, (C1-C6) alkoxy-CONH, (C1-C6) alkylamino,-CO-, (C2-C6)
alkenyl, (C2-C6) alkynyl, (C1-C6)
alkylamino, amino (C1-C6) alkyl, hydroxy
(C1-C6) alkyl, (C1-C6) alkoxy (C1-C6)
alkyl, (C1-C6) acyloxy (C1-C6) alkyl, nitro,
cyano (C1-C6) alkyl, halo (C1-C6) alkyl,
nitro (C1-C6) alkyl, trifluoromethyl,
trifluoromethyl (C1-C6) alkyl, (C1-C6)
acylamino, (C1-C6) acylamino (C1-C6)
alkyl, (C1-C6) alkoxy (C1-C6) acylamino,
amino (C1-C6) acyl, amino (C1-C6) acyl
(C1-C6) alkyl, (C1-C6) alkylamino (C1-C6)
acyl, ((C1-C6) alkyl)2 amino (C1-C6) acyl,
R15R16N-CO-O-, R15R16N-CO-O—(C1-C6)
alkyl, (C1-C6) alkyl-S(O)m, R15R16NS(O)m,
R15R16NS(O)m (C1-C6) alkyl, R15S(O)m
R16N, R15S(O)mR16N(C1-C6) alkyl wherein
m is 0, 1 or 2 and R15 and R16 are each
independently selected from hydrogen or
(C1-C6) alkyl or by a substituent of the
formula
wherein a is 0, 1, 2, 3 or 4;
b, c, e, f and g are each independently 0 or
1;
d is 0, 1, 2, or 3;
X is S(O)n wherein n is 0, 1 or 2; oxygen,
carbonyl or –C(=N-cyano)-;
Y is S(O)n wherein n is 0, 1 or 2; carbonyl;
and
Z is carbonyl, C(O)O-, C(O)NR- wherein
R is hydrogen or (C1-C6) alkyl; or Z is
S(O)n wherein n is 0, 1 or 2;
R6, R7, R8, R9, R10 and R11 are each
independently selected from the group
consisting of hydrogen or (C1-C6) alkyl
optionally substituted by deuterium,
hydroxy, amino, trifluoromethyl, (C1-C6)
acyloxy, (C1-C6) acylamino, (C1-C6)
alkylamino, ((C1-C6) alkyl)2 amino, cyano,
cyano (C1-C6) alkyl, nitro (C1-C6) alkyl or
(C1-C6) acylamino; R12 is (C6-C10) aryl,
(C2-C9) heteroaryl, (C3-C10) cycloalkyl or
(C2-C9) heterocycloalkyl, wherein the aryl,
heteroaryl, cycloalkyl and heterocycloalkyl
groups are optionally substituted by one to
four groups consisting of hydrogen,
deuterium, amino, halo, oxo, hydroxy,
nitro, carboxy, (C2-C6) alkenyl, (C2-C6)
alkynyl, trifluoromethyl, trifluoromethoxy,
(C1-C6) alkyl, (C1-C6) alkoxy, (C3-C10)
cycloalkyl, (C1-C6) alkyl-CO-NH-, (C1-C6)
alkoxy-CO-NH-, (C1-C6) alkyl-CO-NH(C1-C8) alkyl, (C1-C6) alkoxy-CO-NH-(C1C8) alkyl, (C1-C6) alkoxy-CO-NH-(C1-C6)
alkyl, (C1-C6) alkoxy-CO-NH-(C1-C6)
alkoxy, carboxy, carboxy (C1-C6) alkyl,
carboxy (C1-C6) alkoxy,
benzyloxycarbonyl (C1-C6) alkoxy, (C1-C6)
alkoxycarbonyl (C1-C6) alkoxy, (C6-C10)
aryl, amino, amino (C1-C6) alkyl, (C1-C6)
alkoxycarbonylamino, (C6-C10) aryl (C1C6) alkoxycarbonylamino, (C1-C6)
alkylamino, ((C1-C6) alkyl)2 amino, (C1C6) alkylamino (C1-C6) alkyl, ((C1-C6)
alkyl)2 amino (C1-C6) alkyl, hydroxy, (C1C6) alkoxy, carboxy, carboxy (C1-C6)
alkyl, (C1-C6) alkoxycarbonyl, (C1-C6)
alkoxycarbonyl (C1-C6) alkyl, (C1-C6)
alkoxy-CO-NH-, (C1-C6) alkyl-CO-NH-,
cyano, (C5-C9) heterocycloalkyl, amino CO-NH-, (C1-C6) alkylamino-CO-NH,
((C1-C6) alkyl)2 amino-CO-NH-, (C6-C10)
arylamino-CO-NH-, (C5-C9)
heteroarylamino-CO-NH-, (C1-C6)
alkylamino-CO-NH-(C1-C6) alkyl, ((C1C6) alkyl)2 amino-CO-NH-(C1-C6) alkyl,
(C6-C10) arylamino-CO-NH-(C1-C6) alkyl,
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4728
2009
(C5-C9) heteroarylamino-CO-NH-(C1-C6)
alkyl, (C1-C6) alkylcyano, (C1-C6)
alkylcarboxy (C1-C6) alkoxy, (C1-C6)
alkylcarboxy, sulfonylamino,
aminosulfonyl, sulfonylamino (C1-C6)
alkyl, sulfonylaminocarboxy (C1-C6) alkyl,
(C1-C6) alkylsulfonyl, (C1-C6)
alkylsulfonylamino, (C1-C6)
alkylsulfonylamino (C1-C6) alkyl, (C6-C10)
arylsulfonyl, (C6-C10) arylsulfonylamino,
(C6-C10) arylsulfonylamino (C1-C6) alkyl,
(C1-C6) alkylsulfonylamino, (C1-C6)
alkylsulfonylamino (C1-C6) alkyl, (C3-C10)
cycloalkyl, (C3-C10) cycloalkoxy, (C1-C6)
alkylamino, ((C1-C6 alkyl)2 amino, (C6C10) arylamino, (C1-C6) alkylthio, (C6-C10)
arylthio, (C1-C6) alkylsufinyl, (C1-C6)
alkylsulfonyl, (C6-C10) arylsulfonyl, (C1C6) acyl, (C1-C6) alkoxy-CO-NH-, (C1-C6)
alkylamino-CO-, (C5-C9) heteroaryl, (C2C9) heterocycloalkyl or (C6-C10) aryl
wherein the heteroaryl, heterocycloalkyl
and aryl groups which are optionally
substituted or R12 may be further
substituted by one to three groups
consisting of halo, (C1-C6) alkyl, (C1-C6)
alkyl-CO-NH-, (C1-C6) alkoxy-CO-NH-,
(C1-C6) alkyl-CO-NH-(C1-C6) alkyl, (C1C6) alkoxy-CO-NH-(C1-C6) alkyl, (C1-C6)
alkoxy-CO-NH-(C1-C6) alkoxy, carboxy,
carboxy (C1-C6) alkyl, carboxy (C1-C6)
alkoxy, benzyloxycarbonyl (C1-C6) alkoxy,
(C1-C6) alkoxycarbonyl (C1-C6) alkoxy,
(C6-C10) aryl, amino, amino (C1-C6) alkyl,
(C1-C6) alkoxycarbonylamino, (C6-C10)
aryl (C1-C6) alkoxycarbonylamino, (C1-C6)
alkylamino ((C1-C6) alkyl)2 amino, (C1-C6)
alkylamino (C1-C6) alkyl, ((C1-C6) alkyl)2
amino (C1-C6) alkyl, hydroxy, (C1-C6)
alkoxy, carboxy, carbxoy (C1-C6) alkyl,
(C1-C6) alkoxycarbonyl, (C1-C6)
alkoxycarbonyl (C1-C6) alkyl, (C1-C6)
alkoxy-CO-NH-, (C1-C6) alkyl-CO-NH-,
cyano, (C5-C9) heterocycloalkyl, amino CO-NH-, (C1-C6) alkylamino-CO-NH-,
((C1-C6) alkyl)2 amino-CO-NH-, (C6-C10)
arylamino-CO-NH-, (C5-C9)
heteroarylamino-CO-NH-, (C1-C6)
4729
alkylamino-CO-NH-(C1-C6) alkyl, ((C1C6) alkyl)2 amino-CO-NH-(C1-C6) alkyl,
(C6-C10) arylamino-CO-NH-(C1-C6) alkyl,
(C5-C9) heteroarylamino-CO-NH-(C1-C6)
alkyl, (C1-C6) alkylsulfonyl, (C1-C6)
alkylsulfonylamino, (C1-C6)
alkylsulfonylamino (C1-C6) alkyl, (C6-C10)
arylsulfonyl, (C6-C10) arylsulfonylamino,
(C6-C10) arylsulfonylamino (C1-C6) alkyl,
(C1-C6) alkylsulfonylamino, (C1-C6)
alkylsulfonylamino (C1-C6) alkyl, (C5-C9)
heteroaryl and (C2-C9) heterocycloalkyl;
R2 and R3 are each independently selected
from the group consisting of hydrogen,
deuterium, amino, halo, hydroxy, nitro,
carboxy, (C2-C6) alkenyl, (C2-C6) alkynyl,
trifluoromethyl, trifluoromethoxy, (C1-C6)
alkyl, (C1-C6) alkoxy, (C3-C10) cycloalkyl
wherein the alkyl, alkoxy or cycloalkyl
groups are optionally substituted by one to
three groups selected from halo, hydroxy,
carboxy, amino (C1-C6) alkylthio, (C1-C6)
alkylamino, ((C1-C6) alkyl)2 amino, (C5C9) heteroaryl, (C2-C9) heterocycloalkyl,
(C3-C9) cycloalkyl or (C6-C10) aryl; or R2
and R3 are each independently (C3-C10)
cycloalkyl, (C3-C10) cycloalkoxy, (C1-C6)
alkylamino, ((C1-C6)2 amino, (C6-C10)
arylamino, (C1-C6) alkylthio, (C6-C10)
alkylsulfonyl, (C6-C10) arylsulfonyl, (C1C6) acyl, (C1-C6) alkoxy-CO-NH-, (C1-C6)
alkyamino-CO-, (C5-C9) heteroaryl, (C2C9) heterocycloalkyl or (C6-C10) aryl
wherein the heteroaryl, heterocycloalkyl
and aryl groups are optionally substituted
by one to three halo, (C1-C6) alkyl, (C1-C6)
alkyl-CO-NH-, (C1-C6) alkoxy-CO-NH-,
(C1-C6) alkyl-CO-NH-(C1-C6) alkyl, (C1C6) alkoxy-CO-NH-(C1-C6) alkyl, (C1-C6)
alkoxy-CO-NH-(C1-C6) alkoxy, carboxy,
carboxy (C1-C6) alkyl, carboxy (C1-C6)
alkoxy, benzyloxycarbonyl (C1-C6) alkoxy,
(C1-C6) alkoxycarbonyl (C1-C6) alkoxy,
(C6-C10) aryl, amino, amino (C1-C6) alkyl,
(C1-C6) alkoxycarbonylamino, (C6-C10)
aryl (C1-C6) alkoxycarbonylamino, (C1-C6)
alkylamino, ((C1-C6) alkyl)2 amino, (C1C6) alkylamino (C1-C6) alkyl, ((C1-C6)
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
alkyl)2 amino (C1-C6) alkyl, hydroxy, (C1C6) alkoxy, carboxy, carboxy (C1-C6)
alkyl, (C1-C6) alkoxycarbonyl, (C1-C6)
alkoxycarbonyl (C1-C6) alkyl, ((C1-C6)
alkoxy-CO-NH-, (C1-C6) alkyl-CO-NH-,
cyano, (C5-C9) heterocycloalkyl, amino CO-NH-, (C1-C6) alkylamino-CO-NH-,
((C1-C6) alkyl)2 amino-CO-NH, (C6-C10)
arylamino-CO-NH-, (C5-C9)
heteroarylamino-CO-NH-, (C1-C6)
alkylamino-CO-NH-(C1-C6) alkyl, ((C1C6) alkyl)2 amino-CO-NH-(C1-C6) alkyl,
(C6-C10) arylamino-CO-NH-(C1-C6) alkyl,
(C5-C9) heteroarylamino-CO-NH-(C1-C6)
alkyl, (C1-C6) alkylsulfonyl, (C1-C6)
alkylsulfonylamino, (C1-C6)
alkylsulfonylamino (C1-C6) alkyl, (C6-C10)
arylsulfonyl, (C6-C10) arylsulfonylamino,
(C6-C10) arylsulfonylamino (C1-C6) alkyl,
(C1-C6) alkylsulfonylamino, (C1-C6)
alkylsulfonylamino (C1-C6) alkyl, (C5-C9)
heteroaryl or (C2-C9) heterocycloalkyl;
with the proviso that R5 must be
substituted by the group of formula II, and
with the proviso that R5 cannot be 4piperidinyl substituted with benzyl.
_______
]11[]21[
153167
‫ תכשירי‬,‫ תהליך להכנתן‬,‫תולדות פניל‬
‫רוקחות המכילים אותן ושימושם בהכנת‬
‫תרופות לטיפול רפואי‬
]54[
PHENYL DERIVATIVES, A
PROCESS FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND USE THEREOF IN
THE MANUFACTURE OF
MEDICAMENTS FOR THERAPY
]22[
]31[
14.06.2001
0002331-7
]32[ 20.06.2000
]33[ SE
0004480-0
05.12.2000
SE
Int. Cl.(2008.04) A61K 313/95, A61P 11/00, 19/02, 29/00, 9/10, C07D 207/14,
211/58, 223/12, 401/12, 403/12, 405/12, 409/12, 413/12, 417/12
ASTRAZENECA AB, SWEDEN
TOMAS ERIKSSON, TOMAS
KLINGSTEDT, TESFALEDET
MUSSIE
WO/2001/098273
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]72[
]87[
]74[
[57] Compounds of the formula
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4730
2009
wherein
m is 0, 1, 2 or 3;
each R1 independently represents halogen,
cyano, nitro, carboxyl, hydroxyl, C3-C6
cycloalkyl, C1-C6 alkoxy, C1-C6
alkoxycarbonyl, C1-C6 haloalkyl, C1-C6
haloalkoxy, -NR9R10, C3-C6
cycloalkylamino, C1-C6 alkylthio, C1-C6
alkylcarbonyl, C1-C6 alkylcarbonylamino,
sulphonamido, C1-C6 alkylsulphonyl, C(O)NR11R12, -NR13C(O)-(NH)pR14,
phenyl, or C1-C6 alkyl optionally
substituted by carboxyl or C1-C6
alkoxycarbonyl; p is 0 or 1;
Z1 represents a bond or a group (CH2)q
where q is 1 or 2;
Z2 represents a bond or a group CH2, with
the proviso that Z1 and Z2 do not both
simultaneously represent a bond; Q
represents an oxygen or sulphur atom or a
group CH2 or NH; R2 represents a group
n is 0, 1 or 2;
each R3 independently represents a C1-C6
alkyl, C1-C6 alkoxycarbonyl, -CH2OH or
carboxyl group;
R4, R5, R6 and R7 each independently
represent a hydrogen atom or a C1-C6 alkyl
group, or R4, R5, R6 and R7 together
represent a C1-C4 alkylene chain linking
the two carbon atoms to which they are
attached to form a 4- to 7-membered
saturated carbocycle, or R5, R6 and R7 each
represent a hydrogen atom and R4 and R8
together with the carbon atoms to which
they are attached form a 5- to 6-membered
saturated carbocycle; R8 represents a
hydrogen atom, a C1-C6 alkyl group or is
linked to R4 as defined above; R9 and R10
each independently represent a hydrogen
atom or a C1-C6 alkyl group, or R9 and R10
together with the nitrogen atom to which
they are attached form a 4- to 7-membered
saturated heterocycle; R11 and R12 each
independently represent a hydrogen atom
or a C1-C6 alkyl group optionally
substituted by C1-C6 alkoxycarbonyl; R13
represents a hydrogen atom or a C1-C6
alkyl group; R14 represents a hydrogen
atom, or a C1-C6 alkyl group optionally
substituted by carboxyl, C1-C6 alkoxy or
C1-C6 alkoxycarbonyl; R15 represents
carboxyl, C1-C6 alkoxy, C1-C6
alkylcarbonyl, C1-C6 alkoxycarbonyl, C1C6 alkoxycarbonyl C1-C6 or a group –
NR17R18, -NHSO2CH3, -C(O)NR17R18, NHC(O)NR17R18, -OC(O)NR17R18, OCH2C(O)NR17R18, -NHC(O)OR19 or –
NHC(O)R20; t is 0, 1, 2 or 3; each R16
independently represents halogen, cyano,
nitro, carboxyl, hydroxyl, C3-C6
cycloalkyl, C1-C6 alkoxy, C1-C6
alkoxycarbonyl, C1-C6 haloalkyl, C1-C6
haloalkoxy, -NR21R22, C3-C6
cycloalkylamino, C1-C6 alkylthio, C1-C6
alkylcarbonyl, C1-C6 alkylcarbonylamino,
sulphonamido, C1-C6 alkylsulphonyl, C(O)NR23R24, -NR25C(O)(NH)vR26,
phenyl, or C1-C6 alkyl optionally
substituted by carboxyl or C1-C6
alkoxycarbonyl; R17 and R18 each
independently represent a hydrogen atom,
4731
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
or a C1-C6 alkyl group optionally
substituted by carboxyl or C1-C6
alkoxcyarbonyl, or R17 and R18 together
with the nitrogen atom to which they are
attached form a 4- to 7-membered
saturated heterocycle; R19 represents a
hydrogen atom, or a C1-C6 alkyl group
optionally substituted by carboxyl or C1-C6
alkoxycarbonyl; R20 represents a group C1C6 alkyl, C2-C6 alkenyl, C3-C6 cycloalkyl,
adamantyl, C5-C6 cycloalkenyl, phenyl or a
saturated or unsaturated 5- to 10membered heterocyclic ring system
comprising at least one heteroatom
selected from nitrogen, oxygen and
sulphur, each of which may be optionally
substituted by one or more substituents
independently selected from nitro,
hydroxy, oxo, halogen, carboxyl, C1-C6
alkyl, C1-C6 alkylthio, C1-C6 alkylcarbonyl,
C1-C6 alkoxycarbonyl, phenyl and –
NHC(O)-R27; R21 and R22 each
independently represent a hydrogen atom
or a C1-C6 alkyl group, or R21 and R22
together with the nitrogen atom to which
they are attached form a 4- to 7-membered
saturated heterocycle; R23 and R24 each
independently represent a hydrogen atom
or a C1-C6 alkyl group optionally
substituted by C1-C6 alkoxycarbonyl; v is 0
or 1; R25 represents a hydrogen atom or a
C1-C6 alkyl group; R26 represents a
hydrogen atom, or a C1-C6 alkyl group
optionally substituted by carboxyl, C1-C6
alkoxy or C1-C6 alkoxycarbonyl; and R27
represents a C1-C6 alkyl, amino (-NH2) or
phenyl group; or pharmaceutically
acceptable salts or solvates thereof.
_______
]11[]21[
153375
C – ‫נוגדנים חד–שבטיים לאגוניסט אנטי‬
TRK
]54[
AGONIST ANTI-TRK-C
MONOCLONAL ANTIBODIES
]22[
]31[
22.06.2001
60/213141
]32[ 22.06.2000
]33[ US
60/238319
05.10.2000
US
Int. Cl.(2008.04) A61K 393/95, C07K 16/28, C12N 15/02
GENENTECH, INC., U.S.A.
WO/2001/098361
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
[57] An agonist anti-trkC monoclonal
antibody which
(a) shows no significant cross-reactivity
with trkA or trkB; and
(b) recognizes an epitope in domain 5 of
trkC.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4732
2009
]11[]21[
153447
,‫פתלוציאנינים–מתכתיים מותמרים‬
‫הכנתם והשמוש בהם‬
]54[
SUBSTITUTED METALPHTHALOCYANINES, THEIR
PREPARATION AND THE USE
THEREOF
]22[
]31[
]51[
]71[
11.06.2001
00112654.9
]32[ 15.06.2000
]33[ EP
Int. Cl.(2008.04) A61K 31/40, 315/55, A61P 17/06, C07D 487/22, C07F 19/00, 3/06
L. MOLTENI & C. DEI FRATELLI
ALITTI-SOCIETA'DI ESERCIZIO
S.P.A., ITALY
WO/2001/096343
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
[57] Compounds of the formula:
in which:
M is chosen in the group consisting of Zn,
Si(OR8)2, Ge(OR8)2, Ge(OR8)2 and AlOR8;
R is H or a group selected from alkyl,
alkenyl and alkyloxy group, linear or
branched, having from 1 to 10 carbon
atoms provided that, when R is different
4733
from H, the positions 8, 11, 15, 18, 22, 25
or 9, 10, 16, 17, 23, 24 are substituted; and
R1 and R2, equal or different from one
another, are H or a group (X)pR3, wherein
X is chosen in the group consisting of O,
S, -NR6 and –CH2; and R3 is
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
where:
Y is chosen in the group consisting of C110 alkyl and phenyl, possibly substituted,
or it forms with the Z group, to which it is
bound, a saturated or unsaturated
heterocycle, possibly substituted, which
may contain up to two heteroatoms chosen
in the group consisting of N, O and S; Z is
chosen in the group consisting of –N, CH2N and –CONHCH2CH2N; R4 and R5,
equal or different from one another, are
chosen in the group consisting of C1-15
alkyl and phenyl, or form with the Z
group, to which they are bound, a saturated
or unsaturated heterocycle, possibly
substituted, which may contain up to two
heteroatoms chosen in the group consisting
of N, O and S; R6 and R7, equal or
different from one another, are chosen in
the group consisting of H and C1-C15
alkyl; m, n, w, t and u, independently from
one another, are 0 or 1; and v is an integer
comprised between 1 and 3, provided that
when R1 and R2 are the same, they are not
H and are in the positions 1, 4 or 2, 3,
whereas, when only one between R1 and
R2 is different from H, the position 1 or 2
is substituted, or R1 and R2, taken together,
form a saturated or unsaturated
heterocycle, possibly substituted, which
may contain up to two heteroatoms chosen
in the group consisting of N, O and S; R8 is
chosen from between H and C1-C15 alkyl.
_______
]11[]21[
‫תכשיר חיסוני רב ערכי‬
]54[
MULTIVALENT VACCINE
COMPOSITION
]22[
]31[
27.06.2001
0015999.6
]32[ 29.06.2000
0108363.3
03.04.2001
0108364.1
03.04.2001
Int. Cl.(2008.04) A61K 39/00
GLAXOSMITHKLINE
BIOLOGICALS S.A., BELGIUM
WO/2002/000249
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
[57] A multi-valent immunogenic
composition comprising a conjugate of a
carrier protein and the capsular
June 15,
153506
]33[
GB
GB
GB
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
polysaccharide or oligosaccharide of H.
influenzae type B at a dose of 1-5µg of
polysaccharide or oligosaccharide, with
– ‫כ"ג בסיוון התשס"ט‬
4734
2009
TT,DT or CRM197 as carrier protein,
wherein said composition additionally
comprises two or more further bacterial
polysaccharides or oligosaccharides
capable of conferring protection to a host
against infection by the bacteria from
which they are derived, and wherein the H.
influenzae type B capsular polysaccharide
or oligosaccharide conjugate and all the
further polysaccharide or oligosaccharides
are not adsorbed onto an aluminium
adjuvant salt.
_______
]11[]21[
153663
,‫מתקן הפעלה שקט להזנת מים למיכל‬
‫במיוחד למילוי מיכל שטיפה של שרותים‬
]54[
SILENT-OPERATING DEVICE FOR
FEEDING WATER INTO A TANK, IN
PARTICULAR FOR FILLING A
LAVATORY FLUSH TANK
]22[
]31[
]51[
]71[
25.12.2002
MI2001A002831 ]32[ 28.12.2001
]33[ IT
Int. Cl.(2008.04) E03D 1/32, 9/14, F16K 47/02
OLIVEIRA & IRMAO, S.A.,
PORTUGAL
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]74[
[57] A silent-operating device (1) for
feeding water into a tank, in particular for
filling a lavatory flush tank, comprising a
chamber (20) for the passage of a flow of
water and housing flow deflecting
members (25); an inlet (21) and an outlet
(22) defining a flow direction (23); and
4735
connecting members (31, 33) adapted to
circumferentially lock said deflecting
members to be chambers; wherein said
deflecting members are perforated
members arranged successively and spaced
apart substantially in said flow direction.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
153968
‫שיטה ומערכת לתאימות ספקטראלית‬
‫לאחורבתקשורת‬
]54[
METHOD AND SYSTEM FOR
COMMUNICATION SPECTRAL
BACKWARD COMPATIBILITY
]22[
]31[
15.01.2003
10/055197
]32[ 21.01.2002
]33[ US
10/119421
09.04.2002
US
Int. Cl.(2008.04) H03C 1/00, 1/52, H04B 1/00
COPPERGATE COMMUNICATIONS
‫ תל אביב‬,‫קופרגייט תקשורת בע"מ‬
LTD.
BOROCHOV, KORAKH & CO.,
,'‫בורוכוב קורח ושות‬
15TH FLOOR, ATIDIM TOWER,
‫אביב‬-‫ תל‬,58100 .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
]51[
]71[
]74[
[57] Communications method comprising
the procedure of: mixing a first generation
bandwidth Baseband signal with a second
generation carrier signal, to produce a
mixed first generation bandwidth
Baseband signal, having a first generation
June 15,
Baseband bandwidth, wherein, before
mixing, said first generation bandwidth
Baseband signal is spectrally shifted, by a
factor based on the difference between a
frequency of a first generation carrier
signal and a frequency of the second
– ‫כ"ג בסיוון התשס"ט‬
4736
2009
generation carrier signal, divided by said
first generation Baseband bandwidth, when
transmitting to first generation devices by
second generation devices to provide
backwards compatibility of second
generation devices to first generation
devices, transmitting said mixed first
generation bandwidth Baseband signal to
first generation devices by a second
generation device.
_______
]11[]21[
154077
‫ תכשירי‬,‫ תהליך להכנתן‬,‫תרכובות אמידינו‬
‫ השימוש בהן‬,‫רוקחות המכילים אותן‬
‫להכנת תרופות לטיפול במצבים בהם‬
‫נדרש עיכוב של תרומבין וחומרי ביניים‬
‫עבורן‬
]54[
AMIDINO COMPOUNDS,
PROCESS FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM, USE THEREOF IN THE
PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF CONDITIONS
WHERE INHIBITION OF
THROMBIN IS REQUIRED AND
INTERMEDIATES THEREFOR
]22[
]31[
13.08.2001
0002922-3
]32[ 16.08.2000
]33[ SE
0002921-5
16.08.2000
SE
09/900903
10.07.2001
US
Int. Cl.(2008.04) A61K 313/95, A61P 7/02, C07C 229/42, 233/53, C07D 205/04,
207/16, 401/12, 413/12, 417/12
ASTRAZENECA AB, SWEDEN
TORD INGHARDT, ARNE
SVENSSON
WO/2002/014270
]51[
]71[
]72[
]87[
4737
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]74[
,'‫ הורוביץ ושות‬.‫ש‬
‫ תל‬,41-45 ‫ שדרות רוטשילד‬,‫בית ציון‬
‫אביב‬
S. HOROWITZ & CO.,
ZION HOUSE,
41-45 ROTHSCHILD BLVD.,
TEL AVIV 65784
[57] Compounds of the formula
wherein
R1 represents C(O)CH3 or C1-3 alkyl; and
Y represents –CH2 – or –(CH2)2, or a
pharmaceutical-acceptable salt or prodrug
thereof. Claimed as novek are intermediate
compounds of the formula.
________
]11[]21[
]54[
PROCESS FOR PREPARING
SUBSTITUTED
DIMETHYLIMIDAZOPYRIDINE
COMPOUNDS
]22[
]31[
]51[
]71[
]72[
05.09.2001
0003186-4
]32[ 07.09.2000
Int. Cl.(2008.04) C07D 471/04
ASTRAZENECA AB, SWEDEN
BJORN ELMAN, SILKE ERBACK,
ERIC THIEMERMANN
WO/2002/020523
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
154466
‫תהליך להכנת תרכובות מותמרות של‬
‫דימתילאימידאזופירידין‬
]33[
SE
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A process for preparing a substituted
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4738
2009
imidazopyridine compound of the formula
wherein R1 is C1-C6 alkoxy or NH2,
comprising the step of reacting a
compound of the formula
with a 3-halo-2-butanone compound in
cyclohexanone.
_______
]11[]21[
]54[
APPARATUS FOR PERFORMING
ENDOLUMINAL
FUNDOPLICATION
]22[
]31[
]51[
]71[
21.09.2001
09/675601
]32[ 29.09.2000
Int. Cl.(2008.04) A61B 17/08
BOSTON SCIENTIFIC LIMITED,
WEST INDIES ISLANDS
WO/2002/028289
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] A device for performing
endoluminal fundoplication of a patient's
esophagus and stomach, comprising: a
flexible tube (121) having a distal end
adapted for insertion in the stomach
through the esophagus; a grasper (120)
disposed adjacent the distal end of the
flexible tube and configured to grasp a
selected portion of an esophageal wall; a
tissue displacement device (124) disposed
adjacent the distal end of the flexible tube
and configured to press a fundus wall of
4739
154934
‫התקן לביצוע פנדופליקציה של חלל‬
‫הצינור‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
the stomach towards the esophageal wall;
so as to form an intussuception of the
esophagus into the stomach, and a
fastening device configured to pass
through a lumen of the flexible tube
relative to the tissue displacement device
and configured to insert a fastener through
the intussusception after the
intussusception is formed so as to maintain
the esophageal wall and the fundus wall
adjacent to one another.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
‫תהליך להדרוגנציה של סטרואידים‬
‫אלקנים‬
]54[
PROCESS FOR
HYDROGENATING STEROID
ALKENES
]22[
]31[
]51[
]71[
02.11.2001
0026876.3
]32[ 03.11.2000
Int. Cl.(2008.04) C07J 73/00
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2002/046207
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
155078
[57] Process for the preparation of a 3oxo-4-azasteroid from a corresponding 4aza-androsten-3-one steroid alkene
comprising the step of hydrogenating one
]33[
GB
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
or more double bonds in the presence of
ammonium acetate, ammonium formate,
ammonium propionate, or mixtures thereof
and an appropriate catalyst.
_______
]11[]21[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
155534
4740
2009
‫שיטה והתקן להערכת מהירות מסוף‬
‫במערכת תקשורת אלחוטית‬
]54[
METHOD AND APPARATUS FOR
ESTIMATING VELOCITY OF A
TERMINAL IN A WIRELESS
COMMUNICATION SYSTEM
]22[
]31[
29.10.2001
60/244109
]32[ 27.10.2000
]33[ US
044194
26.10.2001
US
Int. Cl.(2008.04) G01S 11/00, 5/14, H04Q 7/34
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/056052
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] A method for estimating a velocity
of a terminal in a wireless communication
system, including: determining a position
of the terminal; determining a position of a
base station in communication with the
terminal; detrmining a position of each of
two or more satellites; determining a
residual rate of change of pseudo-range of
each satellite; forming a set of equations
based on the determined positions of the
terminal, the base station, and the two or
more satellites, wherein the set of
equations is further formed based on the
determined residual rates of change of
pseudo-ranges for the two or more
satellites; and estimating the velocity of
the terminal based on the set of equations;
wherein the residual rate of change of
pseudo-range for each satellite is
determined as:
ρsi = (ƒbb,I – ƒVsat,i) • λ,
where
ρsi is the residual rate of change of pseudorange for an i-th satellite,
ƒbb,I is the estimated baseband signal
frequency error for the i-th satellite,
4741
ƒVsat,i is the estimated Doppler frequency
shift for the i-th satellite, and
λ is a wavelength associated with the
signal from the i-th satellite.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
]54[
METHOD FOR THE
PRODUCTION OF 4 -(17ALPHA
SUBSTITUTED 3- OXOESTRA- 4,9
- DIEN-11 - YL)
BENZALDEHYDE -(1E OR 1Z) OXIMES
]22[
]31[
]51[
09.11.2001
10056676.6
]32[ 10.11.2000
Int. Cl.(2008.04) C07J 41/00
June 15,
155680
– 3 ‫אלפא מותמרים‬17( – 4 ‫שיטה ליצור‬
)‫ – איל‬11 – ‫ – דיאן‬4,9 – ‫אוקסואסתר‬
‫) – אוקסימים‬Z1 ‫ או‬E1(–‫בנזולדהיד‬
]33[
– ‫כ"ג בסיוון התשס"ט‬
DE
4742
2009
]71[
]87[
]74[
BAYER SCHERING PHARMA AG,
GERMANY
WO/2002/038582
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] Process for the production of 4-(17αsubstituted-3-oxoestra-4,9-dien-11β-yl)
benzaldehyde-(1E or IZ)-oximes of the
formula,
in which R1 means a hydrogen atom, a C16-alkyl radical or a CnF2n+1 radical, R2
means a C1-4-alkyl radical or
trifluoromethyl, X means an OH group in
E- or Z-position, and Y means an OC1-6-
alkyl group, an SC1-6-alkyl group or an
OCH2CnF2n+1 group, whereby n is 1, 2 or 3,
characterized in that a 3,3-dimethoxy-5α,
10α-epoxy-estr-9(11)-en-17-one of the
formula
in which R2 has the above-indicated
meaning, is converted with an active
methylene reagent in an inert solvent into a
5α, 10α-epoxy-17(S)-spiroepoxide of the
formula
4743
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
in which R2 has the above indicated
meaning, which, after regio-and
stereoselective cleavage of the 17spiroepoxy group by alkali or alkalineearth alcoholate, by alkylmercaptans in the
presence of alkali hydroxides or
potassium-tert-butanolate, by direct
cleavage with alkali mercaptides or with
perfluoroalkyl alcohols in the presence of
alkali in an inert solvent, is opened to a
17α-substituted compound of the formula
in which R1 represents a hydrogen atom, Y
means an OC1-6-alkyl group, an SC1-6-alkyl
group or an OCH2CnF2n+1 group, whereby
n is 1, 2 or 3, and R2 has the aboveindicated meaning, which optionally is
converted by reaction of the 17β-hydroxyl
group with alkyl halides or haloalkyl
fluorides in the presence of strong bases in
an inert solvent into the 17β-ethers or 17βfluoroalkyl ethers of formula (X), in which
R1 is a C1-6-alkyl radical or a CnF2n+1
radical, whereby n is 1, 2 or 3, and R2 and
Y have the above indicated meanings,
which is reacted with a 4bromobenzaldehyde ketal, magnesium and
Cu(I)Cl at temperatures of between -35oC
and room temperature to form the
corresponding 3,3-dimethoxy-5α-hydroxy17α-CH2Y-11β-benzaldehyde ketal of the
formula
in which R1 is a hydrogen atom, a C1-6
alkyl radical or a CnF2n+1 radical, whereby
n is 1, 2 or 3, R2 and Y have the aboveindicated meanings, and R3 stands for a
methyl radical or an ethylidene group,
which is converted by acid hydrolysis of
the protected groups into an 11βbenzaldehyde derivative of the formula
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4744
2009
in which R1, R2 and Y have the aboveindicated meanings and the aldehyde
function is converted selectively by
hydroxylammonium salts into a mixture of
E/Z-benzaldoximes of formula (I) in which
X means an OH group in E- or Z-position.
_______
]11[]21[
155741
‫ שימושים ותכשירים‬,‫אינטרפרונים‬
‫הקשורים בהם‬
]54[
INTERFERONS,THEIR USES AND
COMPOSITIONS RELATED
THERETO
]22[
]31[
05.11.2001
60/245754
]32[ 03.11.2000
]33[ US
60/246234
03.11.2000
US
Int. Cl.(2008.04) A61K 38/21, A61P 31/00, 33/00, 35/00, 37/00, C07K 145/55, 16/24,
C12N 15/20
PESTKA BIOMEDICAL
LABORATORIES, INC., U.S.A.
WO/2002/036627
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
[57] An isolated polypeptide comprising
an amino acid sequence greater than 97%
identical to a complete polypeptide set
forth within a sequence selected from the
group consisting of SEQ ID NO: 66, 68,
and 86 or a biologically active fragment
thereof, wherein the polypeptide or
fragment is a species with enhanced
antiviral and/or antiproliferative activity
compared to that of a wildtype interferon-α
polypeptide or fragment.
,195166
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
]11[]21[
]54[
PROMOTER FOR THE
FUNCTIONAL
CHARACTERISATION OF GPROTEIN COUPLED RECEPTORS
IN THE YEAST
SACCHAROMYCES CEREVISIAE
]22[
]31[
03.11.2001
10056899.8
4745
]32[
16.11.2000
155839
‫מקדם לאיפיון פונקציונלי של רצפטורים‬
‫ בשמרים‬G– ‫מוצמדי חלבון‬
SACCHAROMYCES CEREVISIAE
]33[
DE
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]51[
]71[
]87[
]74[
Int. Cl.(2008.04) C12N 1/19, 15/11, 15/81
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2002/040660
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A recombinant DNA fragment
consisting of the promoter having the
DNA sequence
(SEQ ID NO. 4)
________
]11[]21[
]54[
AUTOMATIC GAIN SETTING IN A
CELLULAR COMMUNICATIONS
SYSTEM
]22[
]31[
14.11.2001
60/252612
]32[ 21.11.2000
60/282660
09.04.2001
09/954591
14.09.2001
Int. Cl.(2008.04) H04B 7/26, 70/05
]51[
June 15,
155846
‫כיוון הגברה אוטומטית במערכת תקשורת‬
‫סלולרי‬
]33[
– ‫כ"ג בסיוון התשס"ט‬
US
US
US
4746
2009
]71[
]87[
]74[
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/043274
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A method for adjusting a radiofrequency (RF) power level in a cellular
communications network, the network
including a first plurality of signaltransmission-elements adapted to receive
communication signals as a first variablegain repeater coupled to a second plurality
of signal-transmission-elements adapted to
transmit the communication signals as a
second variable-gain repeater, the method
comprising: de-activating at least some of
the first plurality of signal-transmissionelements so that the communication
signals are not received in the first
plurality; de-activating at least some of the
second plurality of signal-transmission-
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
elements so that the communication
signals are not transmitted from the second
plurality; injecting a reference signal
having a predetermined injected power
level at the first plurality to signaltransmission-elements; receiving the
reference signal at the second plurality of
signal-transmission-elements; measuring a
received power level of the reference
signal at the second plurality of signaltransmission-elements; comparing the
injected and received power levels; and
responsive to the comparison, setting a
gain of at least one of the signaltransmission-elements comprised in the
first and second pluralities.
_______
]11[]21[
155926
‫גישה של קשירה מוארכת לזיהוי מהיר‬
‫שלליגנדים‬
]54[
EXTENDED TETHERING
APPROACH FOR RAPID
IDENTIFICATION OF LIGANDS
]22[
]31[
]51[
20.11.2001
60/252294
]32[ 21.11.2000
]33[ US
Int. Cl.(2008.04) C07K 1/13, C12N 15/63, C12Q 1/68, C40B 30/04, 40/10, G01N
4747
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]71[
]87[
]74[
33/53
SUNESIS PHARMACEUTICALS,
INC., U.S.A.
WO/2002/042773
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
[57] A process comprising:
(i) providing a Target Biological Molecule
(TBM) containing or modified to contain a
reactive nucleophile near a first site of
interest on the TBM;
(ii) contacting the TBM from (i) with a
library of small organic molecules in the
presence of a bifunctional small molecule
extender (SME) having a first and a second
functional group, wherein the first
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
functional group of the SME forms a
reversible covalent bond with the
nucleophile on the TBM thereby forming a
reversible TBM-SME complex, and the
second functional group of the SME forms
a reversible covalent bond with a
functional group on a member of said
library, and
(iii) identifying the library member from
(ii).
_______
]11[]21[
155945
‫ תכשירים המכילים‬,‫ביפנילקרבוקסאמידים‬
‫אותם ותהליך להכנתם‬
]54[
BIPHENYLCARBOXAMIDES,
COMPOSITIONS COMPRISING
THE SAME AND PROCESS FOR
THEIR PREPARATION
]22[
]31[
]51[
15.11.2001
00204150.7
]32[ 21.11.2000
]33[ EP
Int. Cl.(2008.04) A61K 31/16, 313/95, A61P 3/00, C07C 233/80, 237/00, 237/20,
237/40, 255/56, 323/22, C07D 207/14, 211/58
JANSSEN PHARMACEUTICA N.V.,
BELGIUM
WO/2002/042271
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]71[
]87[
]74[
[57] Compound of the formula
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4748
2009
the N-oxides, the pharmaceutically
acceptable acid addition salts and the
stereochemically isomeric forms thereof,
wherein p1, p2 and p3 are integers each
independently from 1 to 3;
each R1 is independently selected from
hydrogen, C1-4 alkyl, C1-4 alkyloxy, halo,
hydroxy, mercapto, cyano, nitro, C1-4
alkylthio or polyhalo C1-6 alkyl, amino, C1-
wherein n is an integer from 2 to 4 and the
–(CH2)n-moiety in radical (a-1) may
optionally be substituted with one or two
C1-4 alkyl; m and m' are integers from 1 to
3;
R5 and R6 are each independently selected
from hydrogen, C1-6 alkyl or aryl; X1 and
X2 are each independently selected from
CH, N or an sp2 hybridized carbon atom
and in radical (a-1) at least one X1 or X2 is
N; A is C1-6 alkanediyl substituted with
one aryl group; B represents hydroge n; C110 alkyl; aryl or heteroaryl each optionally
substituted with a group selected from
halo, cyano, nitro, C1-4 alkyloxy, amino,
C1-10 alkylamino, di(C1-10 alkyl) amino, C110 acyl, C1-10 alkylthio, C1-10
alkoxycarbonyl, C1-10 alkylaminocarbonyl
and di (C1-10 alkyl) aminocarbonyl; aryl C110 alkyl; heteroaryl C1-10 alkyl; C3-10
cycloalkyl; polyhalo C1-6 alkyl; C3-6
alkenyl; C3-6 alkynyl; NR7R8; or OR9;
wherein R7 and R8 each independently
represent hydrogen, C1-10 alkyl, aryl or
4749
alkylamino and di (C1-4 alkyl) amino;
each R2 is independently selected from
hydrogen, C1-4 alkyl, C1-4 alkyloxy, halo, or
trifluoromethyl; R3 is hydrogen or C1-4
alkyl; each R4 is independently selected
from hydrogen, C1-4 alkyl, C1-4 alkyloxy,
halo, or trifluoromethyl; Z is a bivalent
radical of formula
4
heteroaryl each optionally substituted with
a group selected from halo, cyano, C1-4
alkyloxy, amino, C1-10 alkylamino, di (C1-10
alkyl) amino, C1-10 acyl, C1-10 alkylthio, C110 alkylaminocarbonyl and di (C1-10 alkyl)
aminocarbonyl; aryl C1-10 alkyl, heteroaryl
C1-10 alkyl, C3-10 cycloalkyl, C7-10
polycycloalkyl, polyhalo C1-6 alkyl, C3-8
alkenyl, C3-8 alkynyl, fused benzo-C5-8
cycloalkyl, and wherein R7 and R8 taken
together with the nitrogen atom to which
they attached may form a saturated
heterocyclic radical having from 4 to 8
carbon atoms; and wherein R9 represents
C1-10 alkyl, aryl or heteroaryl each
optionally substituted with a group
selected from halo, cyano, nitro, C1-4
alkyloxy, amino, C1-10 alkylamino, di (C1-10
alkyl) amino, C1-10 acyl, C1-10 alkylthio, C110 alkylaminocarbonyl and di (C1-10 alkyl)
aminocarbonyl; aryl C1-10 alkyl; heteroaryl
C1-10 alkyl; C3-10 cycloalkyl; C7-10
polycycloalkyl; polyhalo C1-6 alkyl; C3-8
alkenyl; alkynyl; or fused benzo C5-8
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
cycloalk; wherein in the foregoing
definitions aryl and heteroaryl are
optionally substituted with a group
selected from halo, cyano, nitro, C1-4
alkyloxy, amino, C1-10 alkylamino, di(C1-10
alkyl) amino, C1-10 acyl, C1-10 alkylthio, C110 alkoxycarbonyl, C1-10
alkylaminocarbonyl and di (C1-10 alkyl)
aminocarbonyl.
______
]11[]21[
155960
‫תרכובת לקטם לעיכוב השחרור או‬
‫סינתזה של פפטיד בטא–אמילואיד‬
]54[
LACTAM COMPOUND TO
INHIBIT BETA-AMYLOID
PEPTIDE RELEASE OR
SYNTHESIS
]22[
]31[
]51[
]71[
05.11.2001
60/249552
]32[ 17.11.2000
]33[ US
Int. Cl.(2008.04) A61K 31/55, A61P 25/28, C07D 223/16
ELI LILLY AND COMPANY, U.S.A.
ELAN PHARMACEUTICALS, INC.,
U.S.A.
WO/2002/047671
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
alaninyl))-(S)-1-amino-3-methyl-2,3,4,5tetrahydro-1H-3-benzazepin-2-one:
[57] The compound of the formula N(((S)-2-Hydroxy-3-methyl-butyryl)-1-(L-
_______
]11[]21[
]54[
TRANSGENIC
TRANSCHROMOSOMAL
RODENTS FOR MAKING HUMAN
ANTIBODIES
June 15,
– ‫כ"ג בסיוון התשס"ט‬
155977
‫מכרסמים טרנסכרומוזומלים טרנסגניים‬
‫ליצור נוגדנים ממקור אנושי‬
4750
2009
]22[
]31[
]51[
]71[
]87[
]74[
30.11.2001
60/250340
]32[ 30.11.2000
]33[ US
Int. Cl.(2008.04) A01K 670/27, A61K 393/95, C07K 147/35, 16/24, 16/28, C12N
15/85, 5/20, C12P 21/08
MEDAREX, INC., U.S.A.
KYOWA HAKO KIRIN CO., LTD.,
JAPAN
WO/2002/043478
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
[57] A mouse capable of producing
human antibodies, which carries a
transchromosome comprising
an unrearranged entire human antibody
heavy chain locus and the centromere of
human chromosome 14, and a transgene
that is inserted into a mouse chromosome
and has an unrearranged human antibody
light chain locus.
_______
]11[]21[
156030
‫נוגדנים אנושיים‬
]54[
HUMANIZED ANTIBODIES
]22[
]31[
]51[
06.12.2001
60/251892
]32[ 06.12.2000
]33[ US
Int. Cl.(2008.04) A61K 393/95, A61P 25/28, C07K 16/18, C12N 15/09, 15/13, C12P
21/02
WYETH, U.S.A.
ELAN PHARMA INTERNATIONAL
LTD., IRELAND
WO/2002/046237
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]71[
]87[
]74[
[57] A humanized antibody or binding
fragment thereof comprising a humanized
light chain variable region comprising
complementarity determining regions
4751
(CDRs) from the 3D6 immunoglobulin
light chain variable region sequence of
SEQ ID NO:2 and a humanized heavy
chain comprising CDRs from the 3D6
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
antibody specifically binds to Aβ.
antibody heavy chain variable region of
SEQ ID NO:4, wherein the humanized
_______
]11[]21[
156084
‫מכשיר חישה‬
]54[
SENSING DEVICE
]22[
]31[
]51[
]71[
26.11.2001
09/721893
]32[ 25.11.2000
]33[ US
Int. Cl.(2008.04) G06K 11/00, 21/00, 9/00
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2002/042989
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] A sensing device (101) for sensing
region identity data and generating
movement data when the sensing device is
moved relative to a region of a surface, the
region identity data being indicative of an
identity of the region, the movement data
being indicative of the sensing device
relative to the region, the surface having
disposed upon it coded data (3) indicative
of at least one region associated with the
surface, the sensing device including:
region identity sensing means (132)
configured to sense the region identity data
using at least some of the coded data,
wherein redundantly encoded orientation
data indicative of the orientation of the
coded data relative to the surface is
embedded in the coded data; motion
sensing means configured to generate the
movement data; and communications
June 15,
means (112) configured to communicate
the region identity data and the movement
data to a computer system; wherein the
motion sensing means is configured to
generate the movement data using at least
some of the coded data; wherein the coded
data is also indicative of a plurality of
reference points of the region, the motion
sensing means being configured to
generate the movement data on the basis of
the sensing device's movement relative to
at least one of the reference points; and
wherein the coded data includes a plurality
of tags, each of which is indicative of an
identity of a region within which the tag
lies, and of reference point of the region,
the region being associated with the
surface, the reference point being
indicative of the position of the tag within
the region.
– ‫כ"ג בסיוון התשס"ט‬
4752
2009
_______
]11[]21[
]54[
ORIENTATION SENSING DEVICE
]22[
]31[
]51[
]71[
26.11.2001
09/722088
]32[ 25.11.2000
Int. Cl.(2008.04) G06K 21/00
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2002/042993
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] A sensing device (101) for
generating position data and orientation
data when positioned or moved relative to
a surface, having coded data disposed
therein or thereon, the sensing device
including: a position sensor configured to
generate the orientation data, using at least
some of the coded data, and to generate the
position data, using at least some of the
coded data and using the orientation data,
4753
156085
‫מכשיר חישה להתמצאות‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
the orientation data being indicative of
three dimensions of a rotational orientation
of the sensing device relative to the
surface, the position data being indicative
of at least two dimensions of a position, of
the sensing device relative to the surface;
and a transmitter configured to
communicate at least the position data to a
computer system.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
]54[
MULTIFUNCTIONAL VEHICLE
LOCK
]22[
]51[
]71[
27.05.2003
Int. Cl.(2008.04) E05B 17/04
RAV-BARIACH VEHICLE
PROTECTION LTD.
EYAL ARTSIELY
DEKEL PATENT LTD.,
18 MENUHA VENEHALA ST.,
REHOVOT 76209
]72[
]74[
156153
‫ יבנה‬,‫רב בריח הגנה לרכב בע"מ‬
‫אייל ארציאלי‬
,‫דקל פטנט בע"מ‬
‫ רחובות‬,27 ‫ חדר‬18 ‫מנוחה ונחלה‬
[57] A method for locking a vehicle
accessory, comprising: providing a
cylinder lock comprising a tumbler (30)
rotatable about a rotational axis, a coupling
member (42) rotationally linked to said
tumbler, wherein rotation of said tumbler
rotates said coupling member, a first
vehicle locking element (18) connected to
said coupling member, and a second
vehicle locking element (20) connected to
said coupling member, wherein rotation of
said coupling member moves said first
vehicle locking element in a translatory
movement along a first axis (22) and
simultaneously moves said second vehicle
locking element in a translatory movement
along a second axis angled at a non-zero
angle with respect to said first axis, and
wherein at least one of said first and
June 15,
‫מנעול רכב רב שימושי‬
second vehicle locking elements comprises
a locking attachment for locking a vehicle
accessory; and rotating said tumbler about
said rotational axis to rotate said coupling
member and to move said first and second
vehicle locking elements, thereby causing
said locking attachment to lock said
vehicle accessory, wherein said coupling
member comprises a worm drive
connected to said first vehicle locking
element, and wherein said first vehicle
locking element is connected to said
coupling member by a pin that fits in a
helical groove formed in said worm drive,
and further comprising rotating said
coupling member, wherein as said
coupling member rotates, said pin
translates along said first axis guided by
said helical groove.
– ‫כ"ג בסיוון התשס"ט‬
4754
2009
_______
]11[]21[
156154
‫שיטה ומערכת לשינוע ואחסון סחורות‬
]54[
METHOD AND SYSTEM FOR
TRANSPORTING AND STORING
COMMODITIES
]22[
]31[
]51[
]71[
26.11.2001
60/253870
]32[ 29.11.2000
]33[ US
Int. Cl.(2008.04) B65B 31/00, B65D 88/74
THE STATE OF ISRAEL, MINISTRY
‫ משרד החקלאות ופיתוח‬,‫מדינת ישראל‬
OF AGRICULTURE AND RURAL
‫ מרכז‬,‫ מינהל המחקר החקלאי‬,‫הכפר‬
DEVELOPMENT, AGRICULTURAL
‫ בית דגן‬,‫וולקני‬
RESEARCH ORGANIZATION,
VOLCANI CENTER
GRAINPRO, INC., U.S.A.
SHLOMO NAVARRO, TOM DE
‫ טום דברוין‬,‫שלמה נברו‬
BRUIN, PHILIPPE VILLERS
WO/2002/044058
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]72[
]87[
]74[
[57] A method of storing and transporting
a commodity comprising: placing the
commodity onto at least one skid; moving
the at least one skid having the commodity
thereon into a first flexible hermetic
container; storing the commodity in the
first flexible hermetic container for at least
a specific time period; disinfesting the
commodity while the commodity is in the
first flexible hermetic container; moving
the commodity stored inside the first
flexible hermetic container to a
4755
substantially rodent-proof standard
shipping container wherein moving the
commodity includes removing the skid
having the commodity thereon from the
first flexible hermetic container and
placing the skid having the commodity
thereon into the shipping container; and
transporting the shipping container with
the commodity, wherein the method is
done while minimizing manual handling
and loading of said commodity.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
‫שיטה לייצור אימידאזוטריאזינונים‬
‫מותמרים בסולפונאמיד‬
]54[
METHOD FOR PRODUCING
SULFONAMIDE-SUBSTITUTED
IMIDAZOTRIAZINONES
]22[
]31[
]51[
]71[
05.12.2001
10063108.8
]32[ 18.12.2000
Int. Cl.(2008.04) C07D 487/04
BAYER HEALTHCARE AG,
GERMANY
WO/2002/050076
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
156278
]33[
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] Process for the preparation of
compounds of the formula
in which
R1 represents hydrogen or straight-chain or
branched alkyl having up to 4 carbon
atoms,
R2 represents straight-chain alkyl having
up to 4 carbon atoms,
R3 and R4 are identical or different and
represent a straight-chain or branched alkyl
chain having up to 5 carbon atoms, which
is optionally substituted up to two times in
an identical or different manner by
hydroxyl or methoxy,
or
R3 and R4, together with the nitrogen atom,
form a piperidinyl, morpholinyl or
thiomorpholinyl ring or a radical of the
formula
in which
R7 denotes hydrogen, formyl, straight chain or branched acyl or alkoxycarbonyl
each having up to 6 carbon atoms, or
straight-chain or branched alkyl having up
to 6 carbon atoms, which is optionally
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4756
2009
mono-to disubstituted, in an identical or
different manner, by hydroxyl, carboxyl,
straight-chain or branched alkoxy or
alkoxycarbonyl each having up to 6 carbon
atoms, or denotes C3-8-cycloalkyl,
and the heterocycles mentioned under R3
and R4, formed together with the nitrogen
atom, are optionally mono-to disubstituted,
in an identical or different manner, if
appropriate also geminally, by hydroxyl,
formyl, carboxyl, straight-chain or
branched acyl or alkoxycarbonyl each
having up to 6 carbon atoms, and/or
heterocycles mentined under R3 and R4,
formed together with the nitrogen atom,
are optionally substituted by straight-chain
or branched alkyl having up to 6 carbon
atoms, which is optionally mono-to
disubstituted, in an identical or different
manner, by hydroxyl or carboxyl,
and/or the heterocycles mentioned under
R3 and R4, formed together with the
nitrogen atom, are optionally substituted
by piperidinyl or pyrrolidinyl linked via N,
R5 and R6 are identical or different and
represent hydrogen, straight-chain or
branched alkyl having up to 6 carbon
atoms, hydroxyl or straight-chain or
branched alkoxy having up to 6 carbon
atoms, characterized in that compounds of
the formula
in which
R1, R2, R5 and R6 have the meanings
indicated above,
are reacted with sulphuric acid to give
compounds of the formula
in which
R1, R2, R5 and R6 have the meanings
indicated above,
and then with thionyl chloride and the
product thus obtained is reacted in situ in
an inert solvent with an amine of the
formula
in which
R3 and R4 have the meaning indicated
above,
and, if appropriate, reacted to give the
corresponding salts, hydrates or N-oxides.
_______
]11[]21[
4757
156422
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫שימוש בתרכובות אזטידינון מותמרות‬
‫להכנת תרופה לסיטוסטרולמיה‬
]54[
USE OF SUBSTITUTED
AZETIDINONE COMPOUNDS
FOR MANUFACTURING OF
SITOSTEROLEMIA
MEDICAMENT
]22[
]31[
]51[
25.01.2002
60/264645
]32[ 26.01.2001
]33[ US
Int. Cl.(2008.04) A61K 31/70, 313/97, A61P 3/06, 9/10, C07D 205/08, 205/12,
401/04, 403/12, 405/10, 409/04, 413/10, C07H 17/02, 3/04
SCHERING CORPORATION, U.S.A.
WO/2002/058696
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]71[
]87[
]74[
[57] Use of at least one sterol absorption
inhibitor selected from the group of
compounds of formulae (l)-(lX) below
(a) Formula (1):
or isomers or pharmaceutically acceptable
salts or solvates of the compounds of
Formula (l) or of the isomers thereof,
wherein in Formula (l) above:
Ar1 is R3-substituted aryl;
Ar2 is R4-substituted aryl;
Ar3 is R5-substituted aryl;
Y and Z are independently selected from
the group consisting of –CH2-, -CH(lower
alkyl)-and –C(dilower alkyl)-;
A is –O-, -S-, -S(O)- or –S(O)2-;
R1 is selected from the group consisting of
–OR6, -O(CO)R6, -O(CO)OR9 and –
O(CO)NR6R7; R2 is selected from the
group consisting of hydrogen, lower alkyl
and aryl; or R1 and R2 together are =O;
q is 1, 2 or 3;
p is 0, 1, 2, 3 or 4;
R5 is 1-3 substituents independently
selected from the group consisting of –
OR6, O-(CO)R6, -O(CO)OR9, -O(CH2)19
6 7
6 7
5OR , -O(CO)NR R , -NR R , 6
7
6
NR (CO)R , -NR (CO)OR9, NR6(CO)NR7R8, -NR6SO2-lower alkyl, NR6SO2-aryl, -CONR6R7, -COR6, SO2NR6R7, S(O)0-2-alkyl, S(O)0-2-aryl, O(CH2)1-10-COOR6,-O(CH2)1-10CONR6R7,
o-halogeno, m-halogen, o-lower alkyl, mlower alkyl, -(lower alkylene)-COOR6, and
–CH=CH-COOR6;
R3 and R4 are independently 1-3
substituents independently selected from
the group consisting of R5, hydrogen, plower alkyl, aryl, -NO2-CF3 and phalogeno;
R6, R7 and R8 are independently selected
from the group consisting of hydrogen,
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4758
2009
lower alkyl, aryl and aryl-substituted lower
alkyl; and
R9 is lower alkyl, aryl of aryl-substituted
lower alkyl;
(b) Formula (ll):
or isomers thereof, or pharmaceutically
acceptable salts or solvates of the
compounds of Formula (ll) or of the
isomers thereof, wherein in Formula (ll)
above:
A is selected from the group consisting of
R2-subsituted heterocycloalkyl, R2substituted heteroaryl, R2-substituted
benzofused heterocycloalkyl, and R2
substituted benzofused heteroaryl;
Ar1 is aryl or R3-substituted aryl;
Ar2 is aryl or R4-substituted aryl;
Q is a bond or, with the 3-position ring
carbon of the azetidinone, forms the spiro
group
R1 is selected from the group consisting of
-(CH2)q-, wherein q is 2-6, provided that
when q forms a spiro ring, q can also be
zero or 1;
-(CH2)e-G-(CH2)r-, wherein G is –O-, C(O)-, phenylene, -NR8- or –S(O)0-2-e is 0-
5 and r is 0-5, provided that the sum of e
and r is 1-6;
-(C2-C6 alkenylene)-; and
-(CH2)f-V-(CH2)g-, wherein V is C3-C6
cycloalkylene, f is 1-5 and g is 0-5,
provided that the sum of f and g is 1-6;
R5 is
‫׀‬
‫׀‬
‫׀‬
‫׀‬
‫׀‬
‫׀‬
‫׀‬
-CH-, -C(C1-C5 alkyl)-, -CF-, -C(OH)-, -C(C6H4-R9)-, -N-, or -+NO-;
‫׀‬
R6 and R7 are independently selected from
when R6 is –CH=CH- or –C(C1-C6
the group consisting of CH2-, -CH(C1-C6
alkyl)=CH-, a is 1; provided that when R7
alkyl)-, -C(di-(C1-C6) alkyl), -CH=CHis –CH=CH- or –C(C1-C6 alkyl)=CH-, b is
and –C(C1-C6 alkyl)=CH-; or R5 together
1; provided that when a is 2 or 3, the R6's
6
5
with an adjacent R , or R together with an
can be the same or different, and provided
adjacent R7, form a –CH=CH- or a –
that when b is 1 or 3, the R7s can be the
CH=C(C1-C6 alkyl)-group;
same or different, and when Q is a bond,
a and b are independently 0, 1, 2 or 3,
R1 also can be:
provided both are not zero; provided that
4759
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
M is –O-, -S- -S(O)- or –S(O)2-;
X, Y and Z are independently selected
from the group consisting of –CH2-, CH(C1-C6 alkyl)- and –C(di-( C1-C6)
alkyl);
R10 and R12 are independently selected
from the group consisting of –OR14, O(CO)R14, -O(CO)OR16 and –
O(CO)NR14R15; R11 and R13 are
independently selected from the group
consisting of hydrogen, (C1-C6) alkyl and
aryl; or R10 and R11 together are =O, or
R12 and R13 together are =O;
d is 1, 2 or 3;
h is 0, 1, 2, 3 or 4;
s is 0 or 1; t is 0 or 1; m, n and p are
independently 0-4; provided that at least
one of s and t is 1, and the sum of m, n, p,
s and t is 1-6; provided that when p is 0
and t is 1, the sum of m, s and n is 1-5; and
provided that when p is 0 and s is 1, the
sum of m, t and n is 1-5;
v is 0 or 1;
j and k are independently 1-5, provided
that the sum of j, k and v is 2-5;
R2 is 1-3 substituents on the ring carbon
atoms selected from the group consisting
of hydrogen, (C1-C10) alkyl, (C2-C10)
alkenyl, (C2-C10) alkynyl, (C3-C5)
cycloalkyl, (C3-C6) cycloalkenyl, R17substituted aryl, R17-substituted benzyl,
R17-substituted benzyloxy, R17-substituted
aryloxy, halogeno, -NR14R15, NR14R15 (C1C6 alkylene)-, NR14R15C(O)(C1-C6
alkylene)-, -NHC(O)R16, OH, C1-C6
alkoxy, -OC(O)R16, -COR14, hydroxy (C1C6) alkyl, (C1-C6) alkoxy (C1-C6) alkyl,
NO2, -S(O)0-2R16, -SO2NR14R15 and –(C1C6 alkylene) COOR14-; when R2 is a
substituent on a heterocycloalkyl ring, R2
is as defined, or is =O or
and, where R2 is a substituent on a
substitutable ring nitrogen, it is hydrogen,
(C1-C6) alkyl, aryl, (C1-C6) alkoxy,
aryloxy, (C1-C6) alkylcarbonyl,
arylcarbonyl, hydroxy, -(CH2)118 18
6CONR R ,
wherein J is –O-, -NH-, NR18- or –CH2-;
R3 and R4 are independently selected from
the group consisting of 1-3 substituents
independently selected from the group
consisting of (C1-C6) alkyl, -OR14, O(CO)R14, -O(CO)OR16, -O(CH2)1-5 OR14,
-O(CO) NR14R15, -NR14R15, NR14(CO)R15, -NR14(CO)OR16, NR14(CO)NR15R19, -NR14SO2R16, COOR14, -CONR14R15, -COR14, SO2NR14R15, S(O)0-2R16,
-O(CH2)1-10-COOR14, -O(CH2)114 15
14
10CONR R , -(C1-C6 alkylene)-COOR ,
-CH=CH-COOR14, -CF3, -CN, -NO2 and
halogen;
R8 is hydrogen, (C1-C6) alkyl, aryl (C1-C6)
alkyl, -C(O)R14 or –COOR14;
R9 and R17 are independently 1-3 groups
independently selected from the group
consisting of hydrogen, (C1-C6) alkyl, (C1C6) alkoxy, -COOH, NO2, -NR14R15, OH
and halogeno;
R14 and R15 are independently selected
from the group consisting of hydrogen,
(C1-C6) alkyl, aryl and aryl-substituted (C1C6) alkyl; R16 is (C1-C6) alkyl, aryl or R17 –
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4760
2009
substituted aryl;
R18 is hydrogen or (C1-C6) alkyl; and
R19 is hydrogen, hydroxy or (C1-C6)
alkoxy;
(c) Formula (lll):
or isomers thereof, or pharmaceutically
acceptable salts or solvates of the
compounds of Formula (lll) or of the
isomers thereof, wherein in Formula (lll)
above;
Ar1 is aryl, R10-substituted aryl or
heteroaryl;
Ar2 is aryl of R4-substituted aryl;
Ar3 is aryl or R5-substituted aryl;
X and Y are independently selected from
the group consisting of-CH2-, -CH(lower
alkyl)- and –C(dilower aryl)-;
R is –OR6, -O(CO)R6, -O(CO)OR9 or –
O(CO)NR6R7;
R1 is hydrogen, lower alkyl or aryl; or R
and R1 together are =O;
q is 0 or 1;
r is 0, 1 or 2;
m and n are independently 0, 1, 2, 3, 4 or
5; provided that the sum of m, n and q is 1,
2, 3, 4 or 5; R4 is 1-5 substituents
independently selected from the group
consisting of lower alkyl, -OR6, -O(CO)R6,
-O(CO)OR9, -O(CH2)1-5OR6, O(CO)NR6R7, -NR6R7, -NR6(CO)R7, NR6(CO)OR9, -NR6(CO)NR7R8, -
NR6SO2R9, -COOR6, R5 is 1-5 substituents
independently selected from the group
consisting of –OR6, -O(CO)R6, O(CO)OR9, -O(CH2)1-5OR6, O(CO)NR6R7, -NR6R7, -NR5(CO)R7, NR6(CO)OR9, -NR6(CO)NR7R8, NR6SO2R9, -COOR6, -CONR6R7, -COR6, SO2NR6R7, S(O)0-2R9, -O(CH2)0-2R9, O(CH2)1-10CONR6R7, -CF3, -CN, -NO2,
halogen, -(lower alkylene)COOR6 and –
CH=CH-COOR6; R6, R7 and R8 are
independently selected from the group
consisting of hydrogen, lower alkyl, aryl
and aryl-substituted lower alkyl; R9 is
lower alkyl, aryl or aryl-substituted lower
alkyl; and R10 is 1-5 substituents
independently selected from the group
consisting of lower alkyl, -OR6, -O(CO)R6,
-O(CO)OR9, -O(CH2)1-5OR6, O(CO)NR6R7, -NR6R7, -NR6(CO)R7, NR6(CO)OR9, -NR6(CO)NR7R8,NR6SO2R9, -COOR6, -CONR6R7, -COR6, SO2NR6R7, S(O)0-2R9, -O(CH2)1-10COOR6, -O(CH2)1-20CONR6R7, -CF3, -CN,
-NO2 and halogen;
(d) Formula (IV):
(IV)
or isomers thereof, or pharmaceutically
acceptable salts or solvates of the
4761
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
compounds of Formula (IV) or of the
isomers thereof, wherein in Formula (IV)
‫׀‬
‫׀‬
‫׀‬
above:
R1 is
‫׀‬
‫׀‬
‫׀‬
-CH-, -C(lower alkyl)-, -CF-, -C(OH)-, -C(C6H5)-, -C(C6H4-R15)-,
‫׀‬
‫׀‬
-N- or -+N O-;
‫׀‬
R2 and R3 are independently selected from
1; provided that when v is 2 or 3, the R2's
the group consisting of: -CH2-, -CH(lower
can be the same of different; and provided
alkyl)-, -C(di-lower alkyl)-, -CH=CH- and
that when u is 2 or 3, the R3's can be the
–C(lower alkyl)=CH-; or
same or different; R4 is selected from BR1 together with an adjacent R2, or R1
(CH2)mC(O)-, wherein m is 0, 1, 2, 3, 4 or
together with an adjacent R3 form a –
5; B-(CH2)q-, wherein q is 0, 1, 2, 3, 4, 5 or
CH=CH- or a –CH=C(lower alkyl)-group;
6;
u and v are independently 0, 1, 2 or 3,
B-(CH2)e-Z-(CH2), wherein Z is –O-, provided both are not zero; provided that
C(O)-, phenylene, -N(R6)- or –S(O)0-2-, e
when R2 is –CH=CH- or-C(lower
is 0, 1, 2, 3, 4 or 5 and r is 0, 1, 2, 3, 4 or 5,
alkyl)=CH-, v is 1; provided that when R3
provided that the sum of e and r is 0, 1, 2,
is- CH=CH- or –C(lower alkyl)=CH-, u is
3, 4, 5 or 6; B-(C2-C6 alkenylene)-;
B-(C4-C6 alkadienylene)-; B-(CH2)t-Z-(C2C6 alkenylene)-V-(CH2)t-, wherein V and t
C6 alkenylene)-, wherein Z is as defined
are as defined above, provided that the
above, and wherein t is 0, 1, 2 or 3,
sum of t and the number of carbon atoms
provided that the sum of t and the number
in the alkenylene chain is 2, 3, 4, 5 or 6; B of carbon atoms in the alkenylene chain is
(CH2)a-Z-(CH2)b-V-(CH2)q-, wherein Z and
2, 3, 4, 5 or 6; B-(CH2)f-V-(CH2)g-,
V are as defined above and a, b and d are
wherein V is C3-C6 cycloalkylene, f is 1, 2,
independently 0, 1, 2, 3, 4, 5 or 6, provided
3, 4 or 5 and g is 0, 1, 2, 3, 4 or 5, provided
that the sum of a, b and d is 0,1,2,3,4,5 or
that the sum of f and g is 1, 2, 3, 4, 5 or 6;
6; or R1 and R4 together form the group
B-(CH2)t-V-(C2-C6 alkenylene)-or B-(C2│
B-CH=C-;
B is selected from indanyl, indenyl,
pyrimidinyl, pyrazinyl, triazinyl,
naphthyl, tetrahydronaphthyl, heteroaryl or
imidazolyl, thiazolyl, pyrazolyl, thienyl,
W-substituted heteroaryl, wherein
oxazolyl and furanyl, and for nitrogenheteroaryl is selected from the group
containing heteroaryls, the N-oxides
consisting of pyrrolyl, pyridinyl,
thereof, or
W is 1 to 3 substituents independently
selected from the group consisting of
June 15,
lower alkyl, hydroxy lower alkyl, lower
alkoxy, alkoxyalkyl, alkoxyalkoxy,
– ‫כ"ג בסיוון התשס"ט‬
4762
2009
alkoxycarbonylalkoxy, (lower
alkoxyimino)-lower aralkyl, lower
alkanedioyl, lower alkyl lower
alkanedioyl, alkyloxy, -CF3, -OCF3,
benzyl, R7 benzyl, benzyloxy, R7benzyloxy, phenoxy, R7-phenoxy,
dioxolanyl, NO2-N(R5)(R9), N(R5)(R9)lower alkylene- N(R6)(R9)-lower
alkylenyloxy-, OH, halogeno, -CN, -N3, -
NHC(O)OR10, -NHC(O)R10, R11O2SNH-,
(R11O2S)2N-, -S(O)2NH2, -S(O)0-2R6, tertbutyldimethyl-silyloxymethyl, -C(O)R12, COOR19, -CON(R6)(R9), CH=CHC(O)R12-, lower alkyleneC(O)R12, R10C(O)(lower alkylenyloxy-,
N(R6)(R9)C(O)(lower alkylenyloxy)-,
N(R6)(R9)C(O)(lower alkylenyloxy)-and
for substitution on ring carbon atoms,
and the substituents on the substituted
heteroaryl ring nitrogen atoms, when
present are selected from the group
consisting of lower alkyl, lower alkoxy, C(O)OR10, -C(O)R10, OH, N(R8)(R9)lower alkylene-,N(R8)(R9)-lower
alkylenyloxy-, -S(O)2NH2 and 2(trimethylsilyl)-ethoxymethyl; R7 is 1-3
groups independently selected from the
group consisting of lower alkyl, lower
alkoxy, -COOH, NO2, -N(R8)(R9), OH,
and halogeno;
R8 and Rg are independently selected from
H or lower alkyl;
R10 is selected from lower alkyl, phenyl,
R7-phenyl, benzyl or R7-benzyl;
R11 is selected from OH, lower alkyl,
phenyl, benzyl, R7-phenyl or R7-benzyl;
R12 is selected from H, Oh, alkoxy,
phenoxy, benzyloxy;
-N(R8)(R9), lower alkyl, phenyl or R7phenyl;
R13 is selected from –O-, -CH2-, -NH-, N(lower alkyl)- or –NC(O)R19;
R15, R16 and R17 are independently selected
from the group consisting of H and the
groups defined for W;or R15 is hydrogen
and R16 and R17, together with adjacent
carbon atoms to which they are attached,
form a dioxolanyl ring; R19 is H, lower
alkyl, phenyl or phenyl lower alkyl; and
R20 and R21 are independently selected
from the group consisting of phenyl, Wsubstituted phenyl, naphthyl, Wsubstituted naphthyl, indenyl,
tetrahydronaphthyl, benzodioxolyl,
heteroaryl, W-substituted heteroaryl,
benzofused heteroaryl, W-substituted
benzofused heteroaryl and cyclopropyl,
wherein heteroaryl is as defined above;
(e) Formula (VB):
or isomers thereof, or pharmaceutically
acceptable salts or solvates of the
compound of Formula (VB) or of the
isomers thereof, wherein in Formula (VB):
4763
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
A is –CH=CH-, -C=C- or –(CH2)p –
wherein p is 0, 1 or 2;
B is
E is C10 to C20 alkyl or –C(O)-(C9 to C19)alkyl, wherein the alkyl is straight or
branched, saturated or containing one or
more double bonds; R is hydrogen, C1-C15
alkyl, straight or branched, saturated or
containing one or more double bonds, or
B-(CH2)r-, wherein r is 0, 1, 2, or 3; R1, R2,
and R3 are independently selected from the
group consisting of hydrogen, lower alkyl ,
lower alkoxy, carboxy, NO2, NH2, OH,
halogeno, lower alkylamino, dilower
alkylamino, -NHC(O)OR5, R6OSNH- and
–S(O)2NH2;
R4 is
wherein n is 0, 1, 2 or 3;
R5 is lower alkyl; and
R6 is OH, lower alkyl, phenyl, benzyl or
substituted phenyl,
wherein the substituents are 1-3 groups
independently selected from the group
consisting of lower alkyl, lower alkoxy,
carboxy, NO2, NH2, OH, halogeno, lower
alkylamino and dilower alkylamino;
(f) Formula (VI):
or isomers thereof, or pharmaceutically
acceptable salts or solvates of the
compounds of Formula (VI) or of the
isomers thereof, wherein in Formula (VI)
above;
R26 is H or OG1;
G and G1 are independently selected from
the group consisting of H,
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4764
2009
provided that when R26 is H or OH, G is
not H;
R, Ra and Rb are independently selected
from the group consisting of H, -OH,
halogeno, -NH2, azido, (C1-C6) alkoxy (C1C6)-alkoxy and –W-R30;
wherein W is independently selected from
the group consisting of NH-C(O), -OC(O)-, -O-C(O)-N(R31)-,-NH-C(O)N(R31)-and –O-C(S)-N(R31)-;
R2 and R6 are independently selected from
the group consisting of H, (C1-C6) alkyl,
aryl and aryl (C1-C6) alkyl; R3, R4, R5, R7,
R3a and R4a are independently selected
from the group consisting of H, (C1-C6)
alkyl, aryl (C1-C6) alkyl, -C(O) (C1-C6)
alkyl and –C(O)aryl; R30 is selected from
the group consisting of R32-substituted T,
R32-substituted-T-(C1-C6) alkyl, R32substituted-(C2-C4) alkenyl, R32substituted-(C1-C6) alkyl, R32-substituted(C3-C7) cycloalkyl and R32-substituted-(C3C7) cycloalkyl (C1-C6) alkyl;
R31 is selected from the group consisting
of H and (C1-C4) alkyl;
T is selected from the group consisting of
phenyl, furyl, thienyl, pyrrolyl, oxazolyl,
isoxazolyl, thiazolyl, isothiazolyl,
benzothiazolyl, thiadiazolyl, pyrazolyl,
imidazolyl and pyridyl; R32 is
independently selected from 1-3
substituents independently selected from
the group consisting of halogeno, (C1-C4)
alkyl, -OH, phenoxy, -CF3, -NO2, (C1-C4)
alkoxy, methylenedioxy, oxo, (C1-C4)
alkylsulfanyl, (C1-C4) alkylsulfinyl, (C1C4) alkylsulfonyl, -N(CH3)2, -C(O)NH(C1-C4) alkyl, -C(O)-N((C1-C4) alkyl2, C(O)- (C1-C4) alkyl, -C(O)- (C1-C4) alkoxy
and pyrrolidinylcarbonyl; or R32 is a
covalent bond and R31, the nitrogen to
which it is attached and R32 form a
pyrrolidinyl, piperidinyl, N-methylpiperazinyl, indolinyl or morpholinyl
group,
or a (C1-C4) alkoxycarbonyl-substituted
pyrrolidinyl, piperidinyl, Nmethylpiperazinyl, indolinyl or
morpholinyl group; Ar1 is aryl or R20substituted aryl;
Ar2 is aryl or R11-substituted aryl;
Q is a bond or, with the 3-position ring
carbon of the azetidinone, forms the spiro
group
and
R1 is selected from the group consisting of:
-(CH2)q-, wherein q is 2-6, provided that
when Q forms a spiro ring, q can also be
zero or 1; -(CH2)e-E-(CH2)r-, wherein E is
–O-, -C(O)-, phenylene, -NR22 or –S(O)0-2, e is 0-5 and r is 0-5, provided that the
sum of e and r is 1-6;
4765
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
R12 is
-(C2-C6) alkenylene-; and
-(CH2)f-V-(CH2)g-, wherein V is C3-C6
cycloalkylene, f is 1-5 and g is 0-5,
provided that the sum of f and g is 1-6;
‫׀‬
‫׀‬
‫׀‬
‫׀‬
‫׀‬
‫׀‬
‫׀‬
-CH-, -C(C1-C6 alkyl)-, -CF-, -C(OH)-, -C(C6H4-R23)-, -N-, or +NO-;
‫׀‬
R13 and R14 are independently selected
from the group consisting of-CH2-, CH(C1-C6 alkyl)-, C(di-(C1-C6) alkyl), CH=CH- and –C(C1-C6 alkyl)=CH-; or R12
together with an adjacent R13, or R12
together with an adjacent R14, form a –
CH=CH- or a –CH=C(C1-C6 alkyl)-group;
a and b are independently 0, 1, 2 or 3,
provided both are not zero; provided that
when R13 is –CH=CH- or –C(C1-C6
alkyl)=CH-, a is 1; provided that when R14
is –CH=CH- or –C(C1-C6 alkyl)=CH-, b is
1; provided that when a is 2 or 3, the R13
can be the same or different, and provided
that when b is 2 or 3, the R14s can be the
same or different; and when Q is a bond,
R1 also can be:
M is –O-, -S-, -S(O)- or –S(O)2-;
X, Y and Z are independently selected
from the group consisting of –CH2-, CH(C1-C6) alkyl-and-C(di-(C1-C6) alkyl);
R10 and R11 are independently selected
from the group consisting of 1-3
substituents independently selected from
the group consisting of (C1-C6) alkyl, OR19, -O(CO)R19, -O(CO)OR21, -O(CH2)119
19 20
19 20
5OR , -O(CO)NR R , -NR R , 19
20
19
NR (CO)R , -NR (CO)OR21, NR19(CO)NR20R25,- NR19SO2R21, COOR19, -CONR19R20, -COR19, SO2NR19R20, S(O)0-2R21, -O(CH2)1-10COOR19, -O(CH2)1-10 CONR19R20, -(C1-C6)
alkylene)-COOR19, -CH=CH-COOR19, CF3, -CN, -CN, -NO2 and halogen; R15 and
R17 are independently selected from the
group consisting of –OR19, -O(CO)R19, O(CO)OR21 and –O(CO)NR19R20;
R16 and R18 are independently selected
from the group consisting of H, (C1-C6)
alkyl and aryl; or R15 and R16 together are
=O, or R17 and R18 together are =O;
d is 1, 2 or 3;
h is 0, 1, 2, 3 or 4;
s is 0 or 1; t is 0 or 1; m, n and p are
independently 0-4; provided that at least
one of s and t is 1, and the sum of m, n, s
and t is 1-6; provided that when p is 0 and t
is 1, the sum of m, s and n is 1-5; and
provided that when p is 0 and s is 1, the
sum of m, t and n is 1-5; v is 0 or 1; j and k
are independently 1-5, provided that the
sum of j, k and v is 2-5; and when Q is a
bond and R1 is
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4766
2009
Ar1 can also be pyridyl, isoxazolyl,
furanyl, pyrrolyl, thienyl, imidazolyl,
pyrazolyl, thiazolyl, pyrazinyl, pyrimidinyl
or pyridazinyl;
R19 and R20 are independently selected
from the group consisting of H, (C1-C6)
alkyl, aryl and aryl-substituted (C1-C6)
alkyl;
R21 is (C1-C6) alkyl, aryl or R24-substituted
aryl; R22 is H, (C1-C6) alkyl, -C(O)R19 or –
COOR19;
R23 and R24 are independently 1-3 groups
independently selected from the group
consisting of H, (C1-C6) alkyl, (C1-C6)
alkoxy, -COOH NO2, -NR19R20, -OH and
halogeno; and R25 is H, -OH or (C1-C6)
alkoxy;
(g) Formula (VII):
or isomers thereof, or pharmaceutically
acceptable salts or solvates of the
compounds of Formula (VII) or of the
isomers thereof, wherein in formula (VII)
above;
Ar1 and Ar2 are independently selected
from the group consisting of aryl and R4substituted aryl; Ar3 is aryl or R5substituted aryl;
X, Y and Z are independently selected
from the group consisting of –CH2-, CH(lower alkyl)-and –C(dilower alkyl)-;
R and R2 are independently selected from
the group consisting of –OR6, -O(CO)R6, O(CO)OR9 and –O(CO)NR6R7;
R1 and R3 are independently selected from
the group consisting of hydrogen, lower
alkyl and aryl;
q is 0 or 1;
r is 0 or 1;
m, n and p are independently 0, 1, 2, 3 or
4;
provided that at least one of q and r is 1,
and the sum of m, n, p, q and r is 1, 2, 3, 4,
5 or 6; and provided that when p is 0 and r
is 1, the sum of m, q n is 1, 2, 3, 4 or 5; R 4
is 1-5 substituents independently selected
from the group consisting of lower alkyl, OR6, -O(CO)R6, -O(CO)OR9, -O(CH2)16
6 7
6
7
5OR , -O(CO)NR R , -NR (CO) , 6
R7
9
NR (CO) , -NR6(CO)OR , NR6(CO)NR7R8, -NR6SO2R9, -COOR6, CONR6R7, -COR6, -SO2NR6R7, -S(O)0-2R9,
-O(CH2)1-10-COOR6, -O(CH2)16 7
6
10CONR R , -(lower alkylene)COOR , CH=CH-COOR6, -CF3, -CN, -NO2 and
halogen; R5 is 1-5 substituents
independently selected from the group
consisting of –OR6, -O(CO)R6, O(CO)OR9, -O(CH2)1-5OR6, O(CO)NR6R7, -NR6R7, -NR6(CO)R7, NR6(CO)OR9, -NR6(CO)NR7R8, NR6SO2R9, -COOR6, -CONR6R7, -COR6, SO2NR6R7, -S(O)0-2R9, -O(CH2)1-10COOR6, -O(CH2)1-10 CONR6R7, -(lower
alkylene)COOR6 and –CH=CH-COOR6;
R6, R7 and R8 are independently selected
from the group consisting of hydrogen,
lower alkyl, aryl and aryl-substituted lower
alkyl; and R9 is lower alkyl, aryl or arylsubstituted lower alkyl; and
(h) Formula (IX):
4767
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
or isomers thereof, or pharmaceutically
acceptable salts or solvates of the
compounds of Formula (IX) or of the
isomers thereof, wherein in Formula (IX)
above:
R26 is selected from the group consisting
of:
(a) OH;
(b) OCH3;
(c) fluorine and
(d) chlorine;
R1 is selected from the group consisting of
H,
-SO3H; natural and unnatural amino acids,
R, Ra and Rb are independently selected
from the group consisting of H, -OH,
halogeno, -NH2, azido, (C1-C6) alkoxy (C1C6)-alkoxy and –W-R30;
W is independently selected from the
group consisting of –NH-C(O)-, -O-C(O)-,
-O-C(O)-N(R31)-, NH- C(O)-N(R31)- and –
O-C(S)-N(R31)-; R2 and R6 are
independently selected from the group
consisting of H, (C1-C6) alkyl, aryl and
aryl (C1-C6) alkyl;
R3, R4, R5, R7, R3a and R4a are
independently selected from the group
consisting of H, (C1-C6) alkyl, aryl (C1-C6)
alkyl, -C(O) (C1-C6) alkyl and –C(O) aryl;
R30 is independently selected from the
group consisting of R12 substituted T, R32substituted-T-(C1-C6) alkyl, R32
substituted-(C2-C4) alkenyl, R32substituted-(C1-C6) alkyl, R32-substituted(C3-C7) cycloalkyl and R32 substituted-(C3-
C7) cycloalkyl (C1-C6) alkyl; R31 is
independently selected from the group
consisting of H and (C1-C6) alkyl; T is
independently selected from the group
consisting of phenyl, furyl, thienyl,
pyrrolyl, oxazolyl, isoxazolyl, thiazolyl,
iothiazolyl, benzothiazolyl, thiadiazolyl,
pyrazolyl, imidazolyl and pyridyl; R32 is
independently selected from 1-3
substituents independently selected from
the group consisting of H, halogeno, (C1C4) alkyl, -OH, phenoxy, -CF3, -NO2, (C1C4) alkoxy, methylendioxy, oxo, (C1-C4)
alkylsulfanyl, (C1-C4) alkylsulfinyl, (C1C4) alkylsulfonyl, -N(CH3)2, -C(O)NH(C1-C4) alkyl, -C(O)-N((C1-C4) alkyl)2,
-C(O)- (C1-C4) alkyl, -C(O)- (C1-C4)
alkoxy and pyrrolidinylcarbonyl; or R32 is
a convalent bond and R31, the nitrogen to
which it is attached and R32 form a
pyrrolidinyl, piperidinyl, N-methylpiperazinyl, indolinyl or morpholinyl
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4768
2009
group, or a (C1-C4) alkoxycarbonylsubstituted pyrrolidinyl, piperidinyl, Nmethypiperazinyl, indolinyl or
morpholinyl group; Ar1 is aryl or R10-
substituted aryl; Ar2 is aryl or R11substituted aryl; Q is –(CH2)q-, wherein q
is 2-6 or, with the 3-position ring carbon of
the azetidinone, forms the spiro group
R13 and R14 are independently selected
from the group consisting of –CH2-, -CH
(C1-C6 alkyl)-, -C(di-(C1-C6) alkyl, CH=CH- and -C(C1-C6 alkyl)=C-; or R12
together with an adjacent R13, or R12
together with an adjacent R14, form a –
CH=CH- or a –CH=C(C1-C6 alkyl)-group;
a and b are independently 0, 1, 2 or 3,
provided both are not zero; provided that
when R13 is-CH=CH-or -C(C1-C6
alkyl)=CH, a is 1; provided that when R14
is –CH=CH- or -C(C1-C6 alkyl)=CH-, b is
1; provided that when a is 2 or 3, the R13's
can be the same or different; and provided
that when b is 2 or 3, the R14's can be the
same or different; R10 and R11 are
independently selected from the group
consisting of 1-3 substituents
independently selected from the group
consisting of (C1-C6) alkyl, -OR19, O(CO)R19, -O(CO)OR21, -O(CH2)1-5OR19,
-O(CO)NR19R20, -NR19R20, -NR19(CO)R20,
-NR19(CO)OR21, -NR19(CO)NR20R25, NR19SO2R21, -COOR19, -CONR19R20, COR19, -SO2NR19R20, S(O)0-2R21,
-O(CH2)1-10-COOR19, -O(CH2)119 20
19
10CONR R , -(C1-C6 alkylene)-COOR ,
-CH=CH-COOR19, -CF3m –CN, -NO2 and
halogen; Ar1 can also be pyridyl,
isoxazolyl, furanyl, pyrrolyl, thienyl,
imidazolyl, pyrazolyl, thiazolyl, pyrazinyl,
pyrmidinyl or pyridazinyl; R19 and R20 are
independently selected from the group
consisting of H, (C1-C6) alkyl, aryl and
aryl-substituted (C1-C6) alkyl; R21 is (C1C6) alkyl, aryl or R24 substituted aryl; R23
and R24 are independently 1-3 groups
independently selected from the group
consisting of H, (C1-C6) alkoxy, -COOH,
NO2, -NR19R20, -OH and halogeno; and
R25 is H, -OH or (C1-C6) alkoxy, -COOH,
NO2, -NR19R20, -OH and halogeno; and
R25 is H, or (C1-C6) alkoxy,
or a prodrug of the at least one sterol
absorption inhibitor selected from the
group of compounds of Formulae (l)-(IX)
or pharmaceutically acceptable salt or
solvate of the at least one sterol absorption
inhibitor selected from the group of
compounds of Formula (l) – (IX) or a
mixture thereof for manufacture of a
medicament for treating or preventing
sitosterolemia in a mammal.
_______
4769
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
156558
‫נגזרות קווינוקלידין ותכשירים רפואיים‬
‫המכילים אותן‬
]54[
QUINUCLIDINE DERIVATIVES
AND MEDICINAL
COMPOSITIONS CONTAINING
THE SAME
]22[
]31[
]51[
]71[
20.12.2001
200003130
]32[ 28.12.2000
]33[ ES
Int. Cl.(2008.04) A61K 314/39, A61P 1/00, 11/00, 13/00, C07D 453/02
LABORATORIOS ALMIRALL, S.A.,
SPAIN
WO/2002/053564
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]87[
]74[
[57] Compounds of the formula
wherein B is a phenyl ring, a 5 to 10
membered heteroaromatic group
containing one or more heteroatoms
selected from N, S and O, or a
naphthalenyl, 5, 6, 7, 8-tetrahydronaphthalenyl, benzo [1,3] dioxolyl, or
biphenyl group; R1, R2 and R3 each
independently represent a hydrogen or
halogen atom, or a phenyl group, -OR7, SR7, -NR7R8, -NHCOR7, -CONR7R8, -CN,
-NO2, -COOR7 or –CF3 group, or a straight
or branched, C1 to C6 alkyl group which is
unsubstituted or is substituted by one or
more halogen atoms, hydroxy groups or C1
to C6 alkoxy group, wherein R7 and R8
each independently represent a hydrogen
atom, a straight or branched C1 to C8 alkyl
group, or together form a C3 to C8 alicyclic
ring; or R1 and R2 together form a C5 to
June 15,
C14 aromatic or C3 to C8 alicyclic ring or a
5 to 10 membered heterocyclic group
containing one or more heteroatoms
selected from N, S and O; n is an integer
from 0 to 4; A represents a group selected
from –CH=CR9-, -CR9=CH-, -CR9R10-, CO-, -O-, -S-, -S(O)-, S(O)2- and NR9,
wherein R9 and R10 each independently
represent a hydrogen atom, a straight or
branched C1 to C8 alkyl group, or together
form a C3 to C8 alicyclic ring;
m is an integer from 0 to 8, provided that
when m=0, A is not –CH2-; p is an integer
from 1 to 2 and the substitution in the
azonia bicyclic ring may be in the 2, 3 or 4
position including all possible
configurations of the asymmetric carbons;
R4 represents a group of structure;
– ‫כ"ג בסיוון התשס"ט‬
4770
2009
wherein R11 represents a hydrogen or
halogen atom, a hydroxy group, a C1 to C6
alkoxy group, a nitro group, a cyano
group, -CO2R12 or –NR12R13, wherein R12
and R13 are identical or different and are
selected from hydrogen and straight or
branched C1 to C8 alkyl groups, or a
straight or branched, C1 to C6 alkyl group
which is unsubstituted or is substituted by
one or more halogen atoms, hydroxy
groups or C1 to C6 alkoxy groups; R5
represents an alkyl group of 1 to 7 carbon
atoms, an alkenyl group containing 2 to 7
carbon atoms, an alkynyl group containing
2 to 7 carbon atoms, a cycloalkyl group of
3 to 7 carbon atoms, or a group of formula
whrein q = 1 or 2 and R11 is as defined
above; R6 represents a hydrogen atom, a
hydroxy group, a methyl group or a –
CH2OH group; and X represents a
pharmaceutically acceptable anion of a
mono or polyvalent acid.
________
]11[]21[
156601
‫תרכובות כרומן ותכשירי רוקחות המכילים‬
‫אותן‬
]54[
CHROMAN COMPOUNDS AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]22[
]31[
15.01.2002
60/262108
]32[ 16.01.2001
]33[ US
0103646-6
01.11.2001
SE
Int. Cl.(2008.04) A61K 314/96, A61P 25/06, C07D 405/00
ASTRAZENECA AB, SWEDEN
MARC CHAPDELAINE, TIMOTHY
DAVENPORT, MARKUS
HAEBERLEIN, CAREY HORCHLER,
JOHN MCCAULEY, EDWARD
PIERSON, DANIEL SOHN
WO/2002/055014
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]72[
]87[
]74[
4771
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
[57] A compound of the formula
wherein
R1 is, at each position, independently
represented by hydrogen, optionally
substituted alkyl, optionally substituted
cycloalkyl, thiomethoxy, NHA, -NA2, NHC(=O)A, aminocarbonyl, -
C(=O)NHA, -C(=O)NA2, halogen,
hydroxy, -OA, cyano or aryl; A is
optionally substituted alkyl, optionally
substituted cycloalkyl, optionally
substituted alkenyl; R2 is represented by
(i), (ii), (iii), or (iv) below;
R3 is independently at each position
represented by –H, optionally substituted
C1-6 alkyl, optionally substituted C2-6
alkenyl, optionally substituted C2-6 alkynyl,
optionally substituted C3-6 cycloalkyl or
AOH; n is 2, 3 or 4; P is a heterocyclic
ring; R6 is –H or methyl; Y is –C(=O)NH-,
-C(=O)NA-, -C(=O)N(A)-, -NHC(=O)-, C(=S)NH-, -CH2NH-, -C(=O)-C(=O)CH2-,
-CH2-, -CH2C(=O-, -C(=O)-piperazine-, NAC(=O)-, -C(=S)N(A)-, CH2NA,
NACH2 or a 5-membered heterocyclic.
R7 is a monocyclic or bicyclic aromatic
ring or a heterocycle optionally substituted
by one or more substituents selected from
R8-R9 and R10; wherein R7 is connected to
Y either by a single bond or by a ring
fusion; R8 is –CH2-, -C(=O)-, -C(=O)-, SO2-, -SO2NH-, -C(=O)NH-, -O-, -S-, S(=O)-, a single bond as tether from R7 to
R9, 5-membered heterocycle connected to
R7 by a ring fusion or a single bond as
tether; R9 optionally substituted
heterocycle, optionally substituted aryl,
optionally substituted piperazinyl-R11,
optionally substituted morpholinyl-R11,
optionally substituted thiomorpholinyl, or
–C(=O)A; R10 is optionally substituted
alkyl, optionally substituted cycloalkyl,
hydroxy, aryl, cyano, halogen, C(=O)NH2-, methylthio, -NHA, -NA2, NHC(=O)A, C(=O)NHA, C(=O)NA2, or
OA; R11 is –H, alkyl, AOH, -SO2A, SO2NH2, -SO2NHA, -SO2NA2, SO2NHAR9, -C(=O)R9, -alkylR9, C(=O)A,
C(=O)NH2, C(=O)NH2, C(=O)NHA,
C(=O)NA2 or –C(=O)OA; or a
pharmaceutically acceptable salt of said
compound.
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4772
2009
,183183
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
]11[]21[
156915
‫נגזרות של פנילאלנין אנמיד המכילות‬
‫קבוצות ציקלובוטן לשימוש כמעכבים של‬
‫אינטגרין‬
]54[
PHENYLALANINE ENAMIDE
DERIVATIVES POSSESSING A
CYCLOBUTENE GROUP FOR
USE AS INTEGRIN INHIBITORS
]22[
]31[
18.01.2002
0104418.9
]32[ 22.02.2001
]33[ GB
0114000.3
08.06.2001
GB
0127562.7
16.11.2001
GB
Int. Cl.(2008.04) A61P 37/00, C07D 213/78, 401/12, 471/04
CELLTECH R&D LTD., UNITED
KINGDOM
WO/2002/068393
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
[57] A compound of the formula
wherein
R1 is a group Ar1L2Ar2Alk- in which:
Ar1 is an optionally substituted C6-12
aromatic or nitrogen-containing
heteroaromatic group; wherein the optional
substituents are selected from one, two or
three halogen atoms, and/or C1-6 alkyl, C3-8
cycloalkyl, C1-6 hydroxyalkyl, carboxy C1-6
alkyl, C1-6 alkylthio, carboxy C1-6 alkylthio,
C1-6 alkoxy, hydroxy C1-6 alkoxy, halo C1-6
alkyl, halo C1-6 alkoxy, C1-6 alkylamino, NH2, amino C1-6 alkyl, C1-6 dialkylamino,
C1-6 alkylamino C1-6 alkyl, C1-6
dialkylamino C1-6 alkyl, amino C1-6 alkoxy,
C1-6 alkylamino C1-6 alkylamino C1-6
4773
alkoxy, C1-6 dialkylamino C1-6 alkoxy,
nitro, cyano, amidino, -OH, HC(O)-, CO2h, -CO2R5, C1-6 alkanoyl, -SH, thio C1-6
alkyl, -SO3H, -SO3R5, C1-6 alkylsulphinyl,
C1-6 alkylsulphonyl, -SO2NH2, C1-6
alkylaminosulphonyl, C1-6
dialkylaminosulphonyl, phenylaminosulphonyl, -CONH2, C1-6
alkylaminocarbonyl, C1-6
dialkylaminocarbonyl, amino C1-6 alkylaminocarbonyl, C1-6 alkylamino C1-6 alkylaminocarbonyl, C1-6 dialkylamino C1-6
alkylaminocarbonyl,
aminocarbonylamino, C1-6
alkylaminocarbonylamino, C1-6
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
chain and L2a IS A –O- or –S- atom or a –
C(O)-, -C(O)O-, -OC(O)-, -C(S)-, -S(O)-, S(O)2-, N(R8)- [where R8 is a hydrogen
atom or a straight r branched C1-6 alkyl
group], -CON(R8)-, -OC(O)N(R8)-, CSN(R8)-, -N(R8)CO-, -N(R8)C(O)O-,N(R8)CN-, -S(O)2N(R8)-, N(R8)S(O)2-, N(R8)O-, -ON(R8)-, -N(R8)N(R8)-, N(R8)CON(R8)-, -N(R8)CSN(R8)-, or –
N(R8)SO2N(R8)- group; Ar2 is an
optionally substituted arylene or nitrogencontaining heteroarylene group; wherein
the optional substituents which may be
present on Ar2 are selected from halogen
atoms, or C1-6 alkyl, halo C1-6 alkyl, C1-6
alkoxy, halo C1-6 alkoxy, -CN, -CO2CH3, NO2, -NH2, -NR5R6 and –N(R5)COCH3
group; R6 is as defined for R5; and Alk is a
chain
dialkylamino-carbonylamino, C1-6
alkylaminocarbonyl C1-6 alkylamino,
aminothiocarbonylamino, C1-6
alkylaminothiocarbonylamino, C1-6
dialkylaminothiocarbonylamino, C1-6
alkylaminothiocarbonyl C1-6 alkyl-amino,
C1-6 alkylsulphonylamino, C1-6 dialkylsulphonylamino, -NHSO2NH2, C1-6
alkylaminosulphonylamino, C1-6 dialkylaminosulphonylamino, C1-6 alkanoylamino,
amino C1-6 alkanoylamino, C1-6
dialkylamino C1-6 alkanoyl-amino, C1-6
alkanoylamino C1-6 alkyl, C1-6
alkanoylamino C1-6 alkylamino and C1-6
alkoxycarbonylamino groups;
R5 is a hydrogen atom, or a C1-6 alkyl or
C3-8 cycloalkyl group;
L2 is a covalent bond or a group L2a or –
(Alk3)L2a, where Alk3 is a C1-6 alkylene
-CH2-CH(R)-, -CH=C(R)- or –CH‫׀‬
CH2R
in which R is a carboxylic acid (-CO2H) or
a tetrazole, phosphonic acid, phosphinic
acid, sulphonic acid, sulphinic acid,
boronic acid or an acylsulphonamide
biostere thereof or a –CO2Alk7 or –
CONR5R6 group; Alk7 is straight or
branched C1-8 alkyl, C2-8 alkenyl, C2-8
alkynyl, C3-8 cycloalkyl, C3-8
heterocycloalkyl, l-methylpyrrolidinyl, 1methylpiperidinyl, 5-methyl-2-oxo[1,3]dioxol-4-yl, C3-8 cycloalkyl C1-8 alkyl,
C3-8 heterocycloalkyl C1-8 alkyl, C1-6
alkyloxy C1-6 alkyl, hydroxy C1-6 alkyl, C1-6
alkylthio C1-6 alkyl, C1-6 alkylsulfinyl C1-6
alkyl, C1-6 alkylsulfonyl C1-6 alkyl, C3-8
cycloalkyloxy C1-6 alkyl, C3-8
cycloalkylthio C1-6 alkyl, C3-8 cycloalkylsulfinyl C1-6 alkyl, C3-8 cycloalkylsulfonyl
C1-6 alkyl, C1-6 alkyloxycarbonyl C1-6 alkyl,
C1-6 alkyloxycarbonyl C1-6 alkenyl, C1-6
alkyloxycarbonyloxy C1-6 alkyl, C1-6
alkyloxycarbonyloxy C1-6 alkenyl, C3-8
cycloalkyloxycarbonyloxy C1-6 alkyl, N-diC1-8 alkylamino C1-8 alkyl, N-C6-12 aryl-NC1-6 alkylamino C1-6 alkyl, N-di-C1-8 alkylJune 15,
carbamoyl C1-8 alkyl, C6-12 aryl C1-6 alkyl,
hetero C6-10 aryl C1-6 alkyl, C6-12 aryl, C6-12
aryloxy C1-8 alkyl, C6-12 arylthio C1-8 alkyl,
C6-12 arylsulfinyl C1-8 alkyl, C6-12
arylsulfonyl C1-8 alkyl, C1-8 alkanoyloxy
C1-8 alkanoyloxy C1-8 alkyl, C4-8 imido C1-8
alkyl, C6-12 aroyloxy C1-8 alkyl, or a
triglyceride;
X is an –O- -S- atom or –N(R2)-group in
which:
R2 is a hydrogen atom or a C1-6 alkyl
group;
V is an oxygen (O) or sulphur (S) atom;
Rx, Ry and Rz which may be the same or
different is each an atom or group –
L1(Alk1)n(R3)v in which:
L1 is a covalent bond or an –O- or –Satom or a –C(O)-, -C(O)O-, -OC(O)-, C(S)-, -S(O)-, -S(O)2-, -N(R8)-, -CON(R8), -OC(O)N(R8)-, -CSN(R8)-, -N(R8)CO-, N(R8)C(O)O-, -N(R8)CS-, -S(O)2N(R8)-, N(R8)S(O)2-, -N(R8)O-, -ON(R8)-, N(R8)N(R8)-, -N(R8)CON(R8)-, N(R8)CSN(R8)-, or –N(R8)SO2N(R8)group, Alk1 is a C1-6 alkylene chain,
– ‫כ"ג בסיוון התשס"ט‬
4774
2009
R3 is a hydrogen or halogen atom or group
selected from –OR3a [where R3a is a
hydrogen atom or an optionally substituted
straight or branched C1-6 alkyl group or C33a
8 cycloalkyl group], -SR , -CN or an
optionally substituted C3-10 cycloaliphatic,
C3-10 heterocycloaliphatic, C6-12 aromatic
or C1-9 heteroaromatic group, n is zero or
the integer 1 and v is the integer 1, 2 or 3
provided that when n is zero and L1 is a
covalent bond v is the integer 1; the
optional substituents which may be present
on the cycloaliphatic or
heterocycloaliphatic groups represented by
the group R3 include one, two, three or
more substituents each selected from
halogen atoms, or C1-6 alkyl, halo C1-6
alkyl optionally substituted by hydroxyl,
C1-6 alkoxy, halo C1-6 alkoxy, thiol, C1-6
alkylthio, or –(Alk4)gR10 groups in which
Alk4 is a straight or branched C1-3 alkylene
chain, g is zero or an integer 1 and R10 is a
–OH, -SH, -N(R11)2, (in which R11 is a
hydrogen atom or a C1-6 alkyl or C3-8
cycloalkyl group) –CN, -CO2R11, -NO2, CON(R11)2, -CSN(R11)2, -COR11, CSN(R11)2, -N(R11)COR11, -N(R11)CSR11,
-SO2N(R11)2,N(R11)SO2R11,-N(R11)CON(R11)2, N(R11)CSN(R11), N(R11)SO2N(R11)2 or a
phenyl group, where two R11 atoms or
groups are present in these substituents
these may be the same or different or
joined to form a heterocyclic ring; when
the group R3 is a heterocycloaliphatic
group containing one or more nitrogen
atoms each nitrogen atom may be
optionally substituted by a group –(L6)p
(Alk5)qR12; L is –C(O)-, -C(O)O-, -C(S)-, S(O)2-, -CON(R8)-, -CSN(R8)- or
SO2N(R8)-; p is zero or an integer 1; Alk5
is a C1-6 alkylene chain; q is zero or an
integer 1; and R12 is a hydrogen atom or a
C3-10 cycloaliphatic, C3-10
heterocycloaliphatic, C6-12 aromatic or C1-9
heteroaromatic group; optional substituents
which may be present on the aromatic or
heteromatic groups represented by the
4775
group R3 include one, two, three or more
substituents, each selected from an atom or
group R13 in which R13 represents fluorine,
chlorine, bromine or iodine atoms, or C1-6
alkyl, phenyl, pyridyl, pyrimidinyl,
pyrrolyl, furyl, thiazolyl, thienyl,
morpholinyl, thiomorpholinyl, piperazinyl,
t-butyloxycarbonylpiperazinyl,
pyrrolidinyl, dioxolanyl, dioxanyl,
oxazolidinyl, thiazolidinyl, imidazolidinyl
or piperidinyl, C1-6 hydroxyalkyl, carboxy
C1-6 alkyl, C1-6 alkylthio, carboxy C1-6
alkylthio, C1-6 alkoxy, hydroxy C1-6 alkoxy,
phenoxy, pyridyloxy, thiazolyoxy,
phenylthio or pyridylthio, C4-7 cycloalkyl,
C5-7 cycloalkoxy, halo C1-6 alkyl, halo C1-6
alkoxy, C1-6 alkylamino, C6-12 aryl C1-6
alkylamino, 4-fluorobenzyl-amino and 4hydroxyphenylethylamino, -NH2, amino
C1-6 alkyl, C1-6 dialkylamino, amino C1-6
alkylamino, 3-morpholinopropylamino, C16 alkylamino C1-6 alkyl, C1-6 dialkylamino
C1-6 alkyl, amino C1-6 alkoxy, C1-6
alkylamino C1-6 alkoxy, C1-6 dialkylamino
C1-6 alkoxy, hydroxy C1-6 alkylamino,
imido, nitro, cyano, amidino, hydroxyl (OH), formyl [HC(O)-], carboxyl (-CO2H),
-CO2Alk8, C1-6 alkanoyl, benzoyl, thiol –
(SH), thio C1-6 alkyl, -SC(=NH)NH2,
sulphonyl (-SO3Alk8, C1-6 alkylsulphinyl,
C1-6 alkylsulphonyl, aminosulphonyl (SO2NH2), C1-6 alkylaminosulphonyl, C1-6
dialkylaminosulphonyl,
phenylaminosulphonyl, carboxamido (CONH2), C1-6 alkylamino-carbonyl, C1-6
dialkylaminocarbonyl, amino C1-6
alkylaminocarbonyl, C1-6 alkylamino C1-6
alkylaminocarbonyl, C1-6 dialkylamino C1-6
dialkylamino C1-6 alkylaminocarbonyl,
aminocarbonylamino, C1-6
alkylaminocarbonyl-amino, C1-6
dialkylaminocarbonylamino, C1-6
alkylaminocarbonyl C1-6 alkylamino,
aminothiocarbonylamino, C1-6
alkylaminothiocarbonylamino, C1-6
dialkylaminothiocarbonylamino, C1-6
alkylaminothio-carbonyl C1-6 alkylamino, CONHC(=NH)NH2, C1-6
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
alkylsulphonylamino, halo C1-6
alkylsulphonylamino, C1-6
dialkylsulphonylamino,
phenylsulphonylamino,
aminosulphonylamino (-NHSO2NH2), C1-6
alkylaminosulphonylamino, C1-6 dialkylaminosulphonylamino,
morpholinesulphonylamino,
morpholinesulphonyl C1-6 alkylamino,
phenylamino-sulphonylamino, C1-6
alkanoylamino, amino C1-6 alkanoylamino, C1-6 dialkylamino C1-6
alkanoylamino, C1-6 alkanoylamino C1-6
alkyl, C1-6 alkanoylamino C1-6 alkylamino,
C1-6 alkoxycarbonylamino, benzyloxy,
pyridylmethoxy, thiazolylmethoxy,
benzyloxycarbonylamino, benzyloxycarbonylamino C1-6 alkyl, thiobenzyl,
pyridylmethylthio or thiazolymethylthio
groups; Alk8 is straight or branched C1-8
The applications for division
from this application have
not yet been published
alkyl, C6-12 aryl C1-8 alkyl, C6-12 aryl, C6-12
aryloxy C1-8 alkyl, C1-8 alkanoyloxy C1-8
alkyl or a C6-12 aroyloxy C1-8 group; or Rz
is an atom or group as previously defined
and Rx and Ry are joined together to form
an optionally substituted spiro linked C3-10
cycloaliphatic or C3-10 heterocycloaliphatic
group; optional substituents which may be
present on such spiro linked groups are
selected from halogen atoms, C1-6 alkyl
groups, C1-6 alkoxy groups, halo C1-6
alkoxy groups, -CN, -CO2CH3, -NO2 and –
N(R11)2; when the spiro linked
heterocycloaliphatic group contains a
nitrogen atom this may be substituted by a
group –(L6)p(Alk5)qR12 as defined above;
R11 is a hydrogen atom, a C1-6 alkyl or a
C3-8 cycloalkyl group; and the salts,
solvates, hydrates and N-oxides thereof.
,195481,195480
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
________
]11[]21[
]54[
HIGH STRENGTH LEVER
HANDLE LOCK MECHANISM
]22[
]31[
]51[
]71[
16.01.2002
772268
]32[ 29.01.2001
Int. Cl.(2008.04) E05B 13/10
SARGENT MANUFACTURING
COMPANY, U.S.A.
WO/2002/061221
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
‫מערכת נעילה עם מוט ידית עם חוזק גבוה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] A lock mechanism for mounting in a
door, the lock mechanism comprising: a
lock core (10) adapted to fit within a first
June 15,
156938
opening in the door, the lock core
including a bearing (12, 14) a latch
mechanism including: a latch bolt frame
– ‫כ"ג בסיוון התשס"ט‬
4776
2009
adapted to fit within a second opening in
the door, the second opening extending
from an edge of the door to the first
opening in the door, the latch bolt frame
being interlocked with, attached to and
rigidly engaging the lock core, the latch
bolt frame being engaged by the second
opening in the door and the rigid
engagement between the latch bolt frame
and the lock core acting to prevent rotation
of the lock core relative to the door, and a
latch bolt (22) axially slidable within the
latch bolt frame between extended and
retracted positions; a sleeve (40)
rotationally mounted in the bearing of the
lock core, the sleeve including a shaft
portion (38) extending outward from the
bearing and the sleeve being operatively
connected to the latch mechanism to move
the latch bolt between the extended and
retracted positions as the sleeve is rotated;
a lever handle (36) mounted on the shaft
portion of the sleeve to rotate the sleeve; a
locking piece slidably mounted in the
sleeve, the locking piece sliding axially
from a locked position to an unlocked
position, the locking piece including at
least one locking lug projecting outward
from the sleeve, the locking lug engaging
the lock core in the locked position to
prevent the lever handle and sleeve from
rotating relative to the lock core and the
latch bolt frame, the locking piece further
including a latch driver, the sleeve turning
the locking piece and the locking piece
turning the latch driver, the latch driver
forming the operative connection between
the sleeve and the latch mechanism by
engaging the latch mechanism to drive the
latch bolt between extended and retracted
positions when the locking piece is in the
unlocked position and the latch driver
disengaging from the latch mechanism
when the locking piece is in the locked
position; and a key driven piece extending
through the locking piece, the key driven
piece engaging the latch mechanism when
the locking piece is in the locked position
to allow the latch bolt to be retracted by a
key cylinder when the locking piece is in
the locked position.
__________
]11[]21[
157019
]54[
ARTICULATED STENT
]22[
]51[
]62[
]71[
]74[
25.07.1995
Int. Cl.(2008.04) A61F 2/06, A61M 29/00
DIVISION FROM 114731
MEDINOL LTD.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
4777
‫סטנט מפרקי‬
‫אביב‬-‫ תל‬,‫מדינול בע"מ‬
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
HERZLIYA 46120
[57] A connector for connecting adjacent
areas of adjacent substantially tubular and
substantially rigid segments of an
articulated stent (100) the connector
comprising: a plurality of flexible links
(112), wherein each of said flexible links
includes a plurality of portions with each
pair of neighboring portions when viewed
laterally having an area of inflection
therebetween.
_______
]11[]21[
‫נשא המכיל פיברינוגן מוצק ותרומבין‬
‫מוצק‬
]54[
CARRIER WITH SOLID
FIBRINOGEN AND SOLID
THROMBIN
]22[
]31[
25.01.2002
PA200100135 ]32[ 25.01.2001
PA200100235
13.02.2001
Int. Cl.(2008.04) A61L 24/00
NYCOMED PHARMA AS, NORWAY
WO/2002/058749
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]51[
]71[
]87[
]74[
157095
[57] A solid composition consisting
essentially of
(a) a collagen carrier which has at least
two of the following physical properties:
elasticity module in the range of 10-50
N/cm2, density of 1-10 mg/cm3, chamber
diameter of more than 0.75 mm and less
]33[
DK
DK
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
than 4 mm and/or having a chamber
diameter average below 3 mm and evenly
distributed and fixed upon said carrier a
mixture of
(b) solid human fibrinogen, and
(c) solid human thrombin.
______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4778
2009
]11[]21[
157122
‫שיטה והתקן לשימוש יעיל במשאבי‬
‫תקשורת במערכת תקשורת נתונים‬
‫הנתונה במצבי עומס יתר‬
]54[
METHOD AND APPARATUS FOR
EFFICIENT USE OF
COMMUNICATION RESOURCES
IN A DATA COMMUNICATION
SYSTEM UNDER OVERLOAD
CONDITIONS
]22[
]31[
]51[
]71[
30.01.2002
09/773835
]32[ 31.01.2001
]33[ US
Int. Cl.(2008.04) H04L 12/56, 29/08, H04Q 7/00
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/062025
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] A method comprising:
detecting a request for opening a new
connection between an access terminal and
a data network for communication of data;
in response to the detected request,
determining whether an access network
between the access terminal and the data
network has an overload condition, if the
access network has the overload condition,
determining whether there are any preexisting idle open connections in the
access network, each idle open connecting
4779
having assigned communication resources;
selecting one of the pre-existing idle open
connections based on at least (a) open
connection times and (b) previous data
traffic activity of the pre-existing idle open
connections; releasing said selected preexisting idle open connections; and
allocating, to said new connection,
communication resources corresponding to
said released, selected pre-existing idle
open connection.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
157180
‫) – איבופרופאן‬R( ‫שימוש ב‬
‫מתאנסולפונאמיד ומלחיו להכנת‬
‫תרופות לטיפול ומניעת ריאקציות דחייה‬
‫של איברים מושתלים‬
]54[
USE OF (R)-IBUPROFEN
METHANESULFONAMIDE AND
SALTS THEREOF FOR THE
PREPARATION OF MEDICAMENTS
FOR THE TREATMENT AND
PREVENTION OF REJECTION
REACTIONS OF TRANSPLANTED
ORGANS
]22[
]31[
]51[
]71[
]87[
]74[
30.01.2002
MI2001A000206 ]32[ 02.02.2001
]33[ IT
Int. Cl.(2008.04) A61K 31/18, A61P 37/06, C07C 311/51
DOMPE PHA.R.MA S.P.A., ITALY
WO/2002/062330
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
[57] Use of (R)-ibuprofen
methanesulfonamide, or a non-toxic salt
thereof, for the preparation of
medicaments for the prevention or the
treatment of ischemia/reperfusion injury of
transplanted organs.
_______
]11[]21[
157181
‫רכיבים של סכין גילוח הניתנים לשימוש‬
‫עם ידית‬
]54[
DISPENSER FOR RAZOR BLADE
CARTRIDGES USED WITH A
HANDLE
]22[
]31[
]51[
]62[
]71[
]87[
]74[
18.02.1998
802382
]32[ 19.02.1997
]33[
Int. Cl.(2008.04) B26B 21/14, 21/24, 21/52
DIVISION FROM 131132
THE GILLETTE COMPANY, U.S.A.
WO/1998/036879
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
June 15,
– ‫כ"ג בסיוון התשס"ט‬
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
4780
2009
[57] A cartridge dispenser (10) for razor
blade cartridges (12) used with a handle
(63) including a housing structure (18)
defining sections (20) for receiving
respective cartridges, said housing
structure including a base, side walls (26)
and a plurality of cartridge dividers (24)
between said sections, characterized in that
said cartridge dividers include angled
dividers (42) having upper and lower
surfaces (46) that make acute angles with
said base and define angled regions for
receiving said cartridges, said angled
regions being partially bounded by an
upper surface of one angled divider and a
facing lower surface of one angled divider
and a facing lower surface of an adjacent
angled divider, said angled dividers having
upper surfaces for extending above
uppermost regions of said cartridges when
said cartridges are received in said
sections.
_______
]11[]21[
157241
‫מלחי סיפוח של חומצה מלית של‬
‫ תהליכים לייצורם ותכשירים‬,‫טרבינפין‬
‫רפואיים המכילים אותם‬
]54[
MALIC ACID ADDITION SALTS
OF TERBINAFINE, PROCESS FOR
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
]22[
]31[
]51[
]71[
]87[
]74[
06.02.2002
0103046.9
]32[ 07.02.2001
]33[ GB
Int. Cl.(2008.04) A61K 311/37, A61P 17/00, C07C 211/30
NOVARTIS AG, SWITZERLAND
WO/2002/070455
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
4781
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
BEER-SHEVA 84152
[57] A salt of the compound of the formula
with malic acid.
__________
]11[]21[
157400
‫כסא מניעת בעיות שמקורן בישיבה‬
‫ממושכת‬
]54[
CHAIR FOR THE ELIMINATION
OF PROBLEMS OF SEDENTARY
ORIGIN
]22[
]31[
14.02.2002
U20010074
]32[ 15.02.2001
]33[ FI
U20010324
23.08.2001
FI
Int. Cl.(2008.04) A47C 7/02, 7/14, B62J 1/00
EASYDOING OY, FINLAND
VELI-JUSSI JALKANEN
WO/2002/063998
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬
JERUSALEM 91450
]51[
]71[
]72[
]87[
]74[
[57] A chair comprising: a saddle shaped
seat part (13), comprising: a first curved
thigh trough, comprising: a bottom section
(101), and a first inner side section (103)
and a first outer side section (105) each
extending along opposing sides of a first
length (12) extending between a first front
section (17) and a first back section of said
first curved thigh trough; a second curved
thigh trough, comprising: a bottom section
(102), and a second inner side section
(104) and a first outer side section (106)
each extending along opposing sides of a
second length extending between a second
front section and a second back section of
June 15,
said second curved thigh trough; a leg part
(12) adapted to steadily support the chair
on a flat surface, wherein the leg part
comprises an upper part; an attaching
device (1) in said upper part for attaching
the leg part with the first curved thigh
trough and with the second curved thigh
trough; a first adjusting device (6, 7, 8)
coupled to said leg part for adjusting a
height of the seat part, and a second
adjusting device for adjusting an angle
between the first and second lengths,
wherein the second adjusting device is
adapted to provide a continuous angular
range of adjustments between the lengths,
– ‫כ"ג בסיוון התשס"ט‬
4782
2009
wherein a first central ridge (110)
longitudinal to the seat part is formed of an
edge of said first inner side section rising
from said first front section towards said
second curved thigh trough and a second
central ridge longitudinal to the seat part is
formed of an edge of said second inner
side section rising from said second front
section towards said first curved thigh
trough, and wherein each of said first and
second lengths extend away from said first
back section and said second back section,
respectively, downwards, and away from
one another, and wherein each of said first
curved thigh trough and said second
curved thigh trough is separate from the
other by a central opening generally
parallel with said first central ridge and
said second central ridge.
_______
]11[]21[
158261
‫פולינוקלאוטידים ופוליפפטידים של הגן‬
‫לאריתרופויטין‬
]54[
POLYNUCLEOTIDES AND
POLYPEPTIDES OF THE
ERYTHROPOIETIN GENE
]22[
]31[
29.03.2002
01/04603
]32[ 04.04.2001
]33[ FR
60/343163
21.12.2001
US
60/345440
04.01.2002
US
60/358598
21.02.2002
US
Int. Cl.(2008.04) A61K 38/22, C07K 145/05, C12N 15/16
GENODYSSEE, FRANCE
WO/2002/085940
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
]51[
]71[
]87[
]74[
[57] An isolated polypeptide comprising
amino acids 28 through 193 of the amino
acid sequence SEQ ID NO.2 and having
SNP G104S.
______
4783
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
158395
‫מעכב ארומאטאז להכנת תרופה לשימוש‬
‫בפוריות‬
]54[
AROMATASE INHIBITOR FOR
THE PREPARATION OF A
MEDICAMENT FOR USE IN
REPRODUCTION
]22[
]31[
]51[
]71[
17.04.2002
60/284178
]32[ 17.04.2001
]33[ US
Int. Cl.(2008.04) A61K 31/56, 45/00, 45/06, A61P 15/00, 5/24
ARES TRADING S.A.,
SWITZERLAND
ROBERT F. CASPER, MOHAMED
F.M. MITWALLY
WO/2002/083240
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD., NESS ZIONA
‫ מחלקת‬-‫פארק לתעשיות עתירות מדע‬
‫ציונה‬-‫ נס‬,‫קניין רוחקריית ויצמן‬
]72[
]87[
]74[
[57] Use of an aromatase inhibitor for the
preparation of a medicament for improving
the implantation rate for a female
infertility patient undergoing in vitro
fertilization (IVF), Gamete Intrafallopian
Transfer Procedure (GIFT), Zygote
Interfallopian Transfer Procedure (ZIFT),
Intracytoplasmic Sperm lngection (ICSI),
or Therapeutic Donor Insemination (TDI),
wherein the medicament is for
administration as one or more daily doses
of an aromatase inhibitor (Al) during an
assisted reproduction cycle, wherein the
doses of Al are selected from amounts
effective to reduce serum estradiol levels.
______
]11[]21[
158415
‫פולינוקלאוטידים ופוליפפטידים של גן ה‬
a INF– 17
]54[
POLYNUCLEOTIDES AND
POLYPEPTIDES OF THE INF
ALPHA-17 GENE
]22[
]31[
]51[
23.04.2002
01/05516
]32[ 24.04.2001
]33[ FR
Int. Cl.(2008.04) A61K 35/12, 38/21, 393/95, C07K 14/56, 16/24, C12N 15/21,
15/85, G01N 33/50
GENODYSSEE, FRANCE
WO/2002/086156
]71[
]87[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4784
2009
]74[
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[57] An isolated polynucleotide
comprising:
(a) a nuclecoide sequence having at least
95% identity with the nucleotide sequence
SEQ ID NO. 1, or its coding sequence, and
comprising at least one SNP consisting of
g771c and 808lns(a); or
(b) a nucleotide sequence complementary
to a nucleotide sequence under (a).
________
]11[]21[
]54[
ROTARY JOINTED ARM FOR A
SURGICAL TRAY
]22[
]31[
16.10.2003
60/442928
]32[ 27.01.2003
10/411517
10.04.2003
Int. Cl.(2008.04) A61B 19/00
ALCON, INC., SWITZERLAND
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]74[
[57] An arm mechanism for a surgical
tray, comprising:
(a) a rotatable lower arm (18);
(b) an upper arm (16) pivotally and
rotatably mounted to the lower arm;
(c) a tray plate rotatably mounted to the
upper arm opposite the lower arm so as to
allow the tray plate to be raised or lowered
relative to the lower arm;
4785
158464
‫זרוע מפרקית סובבת עבור מגש ניתוחים‬
]33[
US
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
(d) an extendable, position lockable gas
spring connected to the tray plate so as to
assist in the raising of the tray plate and the
holding of a vertical position of the tray
plate relative to the lower arm;
(e) an actuation lever on the gas spring to
hold the gas spring in a plurality of
extended positions; and
(f) a means for moving the actuation lever.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
158585
‫תהליכים ומתווכים להכנת אפוקסידים של‬
‫בנזיל‬
]54[
PROCESSES AND
INTERMEDIATES FOR
PREPARING BENZYL EPOXIDES
]22[
]31[
]51[
]71[
23.04.2002
60/285772
]32[ 23.04.2001
]33[ US
Int. Cl.(2008.04) C07D 301/00, 301/26, 301/28, 303/36
ELAN PHARMACEUTICALS, INC.,
U.S.A.
PHARMACIA & UPJOHN
COMPANY LLC, U.S.A.
WO/2002/085877
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] A process for preparing an exposide
of the formula:
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4786
2009
wherein
R is phenyl optionally substituted with 1,
2, 3 or 4 groups independently selected
from:
(A) C1-C6 alkyl optionally substituted with
one, two or three substituents
independently selected from C1-C3 alkyl,
halogen, hydroxy, thio, -NR10R11 where
R10 and R11 are independently hydrogen or
C1-C6 alkyl; cyano, trifluoromethyl, and
C1-C3 alkoxy,
(B) C2-C6 alkenyl or C2-C6 alkynyl,
(C) halogen, hydroxy, cyano, C1-C6 alkoxy
optionally substituted with 1, 2, or 3
fluoro,
(D) –NR12R13 where at each occurrence R12
and R13 are the same or different and
represent:
(a) –H,
(b) –C1-C8 alkyl optionally substituted
with one of:
(i) –OH,
(ii) –NH2,
(iii) phenyl,
(c) –C1-C8 alkyl optionally substituted with
1, 2, or 3 independently selected halogens,
(d) –C3-C8 cycloalkyl, -(C1-C2 alkyl) –
(C3-C8 cycloalkyl), -(C1-C6 alkyl)-O-(C1C3 alkyl), -C2-C6 alkenyl, -C2-C6 alkynyl;
or
(E) C3-C7 cycloalkyl, -C(O) (C1-C4 alkyl),
-SO2NR10R11, -C(O)NR10R11, or –SO2(C1C4 alkyl); comprising
(a) converting an ester of the formula
wherein
R is as defined above;
R1 is selected from:
(I) C1-C6 alkyl optionally substituted with
one halogen;
(II) –CH2-CH=CH2;
(III) phenyl optionally substituted with one
nitro, halogen, or cyano; and
(IV) benzyl optionally substituted on the
phenyl with nitro, halogen, or cyano; and
PROT is a nitrogen protecting group; into
a ketone of the formula
wherein R and PROT are as defined above;
and R2 is chloro, bromo, or –Si(R21)3
where each R21 is independently C1-C5
alkyl, -NR23R24 where R23 and R24 are the
same or different and represent C1-C5
alkyl, or where NR23R24 represents
piperidinyl, piperazinyl, or morpholinyl, or
phenyl optionally substituted with 1, 2, or
3 of C1-C2 alkyl, with the proviso that at
least one of the R21 groups is optionally
substituted phenyl;
(b) reducing the ketone of formula III to
the corresponding alcohol of the formula
4787
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
wherein R and R2 are as defined above;
and
(c) treating the alcohol of formula IV with
a base to yield the epoxide.
________
]11[]21[
158705
‫שיטה ליצור ערימה למחליף חום‬
]54[
METHOD OF FORMING A HEAT
EXCHANGER STACK
]22[
]51[
]71[
]74[
31.10.2003
Int. Cl.(2008.04) B23K 20/06, B23P 15/26, F28F 3/08
PESSACH SEIDEL
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
[57] A heat exchanger stack including at
least first (110) and second (120) nestable
plates formed of a plate material being
substantially unresponsive to
electromagnetic impulse welding, and
wherein each said plate includes:
(a) a generally flat central portion (12)
having a plurality of protrusions (118)
protruding from at least one surface
thereof; and
(b) at least one pair of edge portions (116,
114) generally formed non-coplanar
relative to said generally flat central
portion, wherein said at least first and
second plates are arranged in a nesting
arrangement (10) and spaced apart by said
June 15,
‫ מוצא עלית‬,‫פסח זיידל‬
,‫דר' אייל ברסלר עו"פ‬
‫ גן‬- ‫ רמת‬,11 ‫תובל‬
protrusions so as to define therebetween a
space through which a heat exchange
medium may flow, wherein said at least
first and second plates are affixed together
by electromagnetic pulse welds at a
plurality of welding locations which
include said protrusions and said at least
one pair of edge portions, and wherein said
at least first and second plates are mutually
connected at said welding locations via a
facilitator substrate (100, 102) which is
highly responsive to electromagnetic
impulse welding, and which is disposed on
at least one of said at least first and second
plates.
– ‫כ"ג בסיוון התשס"ט‬
4788
2009
________
]11[]21[
158814
‫העמסה דינמית ויצירת של של חפצים‬
‫תפקודיים בהתקן אלחוטי‬
]54[
DYNAMIC LOADING AND
CREATION OF FUNCTIONAL
OBJECTS IN A WIRELESS
DEVICE
]22[
]31[
17.05.2002
60/292051
]32[ 18.05.2001
]33[ US
10/133693
25.04.2002
US
Int. Cl.(2008.04) H04M 1/00, 1/72, 17/25
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/096074
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] A method for operating a wireless
communications device, comprising
operations of: providing multiple static
objects fixed in circuitry of the device,
each static object associated with a unique
Object ID, each static object having a
predefined entry point; providing a static
object table correlating each static object's
Object ID and entry point; providing
multiple object initiators including at least
a user interface, one or more drivers, and a
master controller; responsive to direction
of a user of the device, operating the
device to wirelessly download one or more
dynamic objects, assigning a unique
Object ID to each dynamic object, and
4789
preparing a dynamic object handler
configured to ascertain an entry point for
each dynamic object; managing activation
of the static and dynamic objects,
comprising: receiving requests from the
object initiators to activate objects, each
request including an Object ID; responsive
to each request, performing activation
operations comprising referencing the
Object ID against at least one of the
dynamic object handler and static object
table to identify an entry point for the
requested object, and activating the
requested object utilizing the identified
entry point.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
158883
‫בקרת ויסות הספק עבור בקרת ערוץ‬
‫רגילה של אות משודר ללווין עבור אפנון‬
‫מוסגל ושיטות הצפנה‬
]54[
COMMON CONTROL CHANNEL
UPLINK POWER CONTROL FOR
ADAPTIVE MODULATION AND
CODING TECHNIQUES
]22[
]31[
14.05.2002
60/290730
]32[ 14.05.2001
]33[ US
100383
18.03.2002
US
Int. Cl.(2008.04) H04B 17/07, 7/26, 70/05, H04Q 7/38
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2002/093952
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
[57] A method for determining uplink
power level by a user equipment in a
wireless digital communication system
comprising: receiving a signal over a
physical reference channel; calculating a
path loss, responsive to the transmission
over the physical reference channel, a
power setting of which is known; receiving
June 15,
an allocation of a specific uplink control
channel, the allocation indicating a
measured uplink interference level in the
channel; determining an uplink power
level based on a current path loss and the
uplink interference level; and initiating an
uplink control channel transmission having
the determined power level.
– ‫כ"ג בסיוון התשס"ט‬
4790
2009
,195540
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
]11[]21[
]54[
WEAPON AIMING SYSTEM
]22[
]31[
]51[
]71[
]87[
]74[
26.04.2002
01/06494
]32[ 17.05.2001
Int. Cl.(2008.04) F41G 5/24
GIAT INDUSTRIES, FRANCE
WO/2002/093101
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
[57] An elevation laying system for a
weapon (1), wheres it comprises first
positioning means (3) for the weapon
along a wide elevation range with respect
to a first axis of rotation offset with respect
to the centrer of gravity of the weapon, and
4791
158894
‫מערכת לכיוון כלי נשק‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
second positioning means (4) for the
weapon connected to the first means along
a narrow elevation range with respect to a
second axis of rotation (A2) passing
through the centre of gravity of the
weapon.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
]54[
FLOATABLE IN VIVO SENSING
DEVICE
]22[
]31[
20.05.2002
143259
]32[ 20.05.2001
60/297761
14.06.2001
Int. Cl.(2008.04) G01N 9/00
GIVEN IMAGING LTD.
WO/2002/095351
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]51[
]71[
]87[
]74[
‫חיישן תוך גופי בר–ציפה‬
]33[
IL
US
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
,‫פרל כהן צדק לצר‬
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬
[57] An in vivo imaging device
comprising: a housing, wherein said
housing includes a body containing a
sufficient amount of a substance lighter
than a body lumen liquid so that the device
is able to float in the body lumen liquid; an
The applications for division
from this application have
not yet been published
158972
illumination source (23) contained within
the housing for illuminating a body lumen;
an image sensor (26) contained within the
housing for sensing image signals; and a
transmitter (25) contained within the
housing for transmitting the image signals.
,194999
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4792
2009
]11[]21[
]54[
PACKET FILTERING SYSTEM
AND METHODS
]22[
]31[
]51[
]71[
11.06.2002
60/296763
]32[ 11.06.2001
Int. Cl.(2008.04) H04L 12/56, 29/06
BLUEFIRE SECURITY
TECHNOLOGIES, INC., U.S.A.
WO/2002/101968
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] A method for filtering a packet at a
network interface, comprising the steps of:
(1) receiving, at a compiler, a procedure
statement and a filter statement;
(2) processing, in a single invocation at the
compiler, the procedure statement and the
filter statement so that the procedure
statement has a table format with a
159264
‫מערכת ושיטות לסינון מנות‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
procedure index and a procedure function
and the filter statement has a 5-tuple
format with a corresponding procedure
index; and
(3) loading the procedure statement and
the filter statement from the compiler to an
interpreter.
________
4793
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
‫מתקן לאקסטרוזיה של בצק‬
]54[
APPARATUS FOR EXTRUDING
FOOD DOUGH
]22[
]31[
13.05.2003
2002-139320 ]32[ 14.05.2002
2002-235271
08.07.2002
2002-225150
01.08.2002
Int. Cl.(2008.04) A21C 11/16
RHEON AUTOMATIC MACHINERY
CO., LTD., JAPAN
SHIGERU HASHIMOTO, KIYOSHI
HASEGAWA
WO/2003/094620
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]51[
]71[
]72[
]87[
]74[
159559
[57] An apparatus for extruding food
dough comprising a rotating body installed
between an upper external cylinder and a
lower external cylinder, first and second
sealing sections arranged between the
rotating body and the upper cylinder and
between the rotating body and the lower
]33[
JP
JP
JP
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
cylinder respectively, a bearing section
supporting the rotating body, and a space
section, arranged between the sealing
sections and the bearing section, for
temporarily storing food dough penetrating
the sealing sections.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4794
2009
]11[]21[
]54[
PREPARATION OF
AMINOPYRIMIDINE
COMPOUNDS
]22[
]31[
12.07.2002
2001-213417 ]32[ 13.07.2001
2001-213418
13.07.2001
2001-310900
09.10.2001
2001-360339
27.11.2001
2002-7015
16.01.2002
2002-42076
19.02.2002
Int. Cl.(2008.04) C07D 239/28, 239/42
ASTRAZENECA UK LIMITED,
UNITED KINGDOM
WO/2003/006439
S. HOROWITZ & CO.,
ZION HOUSE,
41-45 ROTHSCHILD BLVD.,
TEL AVIV 65784
]51[
]71[
]87[
]74[
159741
‫הכנת תרכובות אמינופירימידין‬
]33[
JP
JP
JP
JP
JP
JP
,'‫ הורוביץ ושות‬.‫ש‬
‫ תל אביב‬,41-45 ‫ שדרות רוטשילד‬,‫בית ציון‬
[57] A process for preparing a 2-(Nmethyl-N-methanesulfonylamino)
pyrimidine compound of the formula
in which R is a hydrocarbyl group, which
comprises the steps of: reacting a
hydroxypyrimidine compound of the
formula
in which R is the same as above, with an
organic sulfonyl halide having the formula
R'SO2X
in which R' is a hydrocarbyl group and X
is a halogen atom, or an organic sulfonic
anhydride
4795
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
of the formula (R'SO2)2O
in which R' has the same meaning as
above, and reacting the resulting reaction
product with N-methyl-Nmethanesulfonamide.
_______
]11[]21[
]54[
HIGH VELOCITY LIQUID-GAS
MIST TISSUE ABRASION
DEVICE
]22[
]51[
]71[
]72[
]74[
08.01.2004
Int. Cl.(2008.04) A61B 17/22
TAVTECH LTD.
MICHAEL TAVGAR
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
159783
‫מכשיר לשפשוף רקמות באמצעות ערפל‬
‫נוזל–גז בעל מהירות גבוהה‬
‫ יהוד‬,‫טב טק בע"מ‬
‫מיכאל טבגר‬
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
‫ירושלים‬
[57] A device for abrading tissue, which
includes:
(a) a gas inlet port (108) connected to a
pressurized gas source;
(b) a liquid inlet port (110) connected to a
pressurized liquid source; and
(c) a mist jet delivery nozzle arrangement
(112) including
(i) at least one gas discharge nozzle
arranged to receive a flow of pressurized
gas from said gas inlet port and configured
to accelerate the flow of gas so as to
discharge it at an elevated velocity; and
(ii) at least one liquid discharge nozzle
arranged to receive a flow of liquid from
said liquid inlet port and operative to
discharge the flow of liquid into the
elevated velocity flow of gas, thereby to
similarly accelerate the velocity of the
discharged liquid as a mist of accelerated
droplets.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4796
2009
]11[]21[
159836
‫תהליך להפקת אמידים המותמרים פעם‬
N– ‫אחתב‬
]54[
PROCESS FOR OBTAINING NMONOSUBSTITUTED AMIDES
]22[
]31[
]51[
]71[
19.07.2002
09/919379
]32[ 31.07.2001
]33[ US
Int. Cl.(2008.04) C07C 231/06, 233/05, 233/57, 233/64
MILLENNIUM SPECIALTY
CHEMICALS, INC., U.S.A.
WO/2003/011816
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] A process for obtaining an amide of
the formula:
R-(CO)-NH-CH2-X
comprising reacting a nitrile of the
formula: R-CN
with:
(a) an acid; and
(b) an alkoxy-containing compound
comprising at least one alkoxy
functionality of the formula: -OCH2-X
wherein R is a hydrogen or an alkyl,
cycloalkyl, alkenyl, cycloalkenyl, alkynyl,
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
aryl, or heterocycle, which substituents are
substituted or unsubstituted; wherein X is
hydrogen or a radical having the formula –
CHR1R2 wherein R1 and R2 independently
or collectively represent hydrogen or an
alkyl, cycloalkyl, alkenyl, cycloalkenyl,
alkynyl, aryl, or heterocyclic substitutent,
or any combination thereof, and which
substituents are substituted or
unsubstituted; and wherein the alkoxycontaining compound is not a mono alkyl
sulfate or dialkyl sulfate.
_______
]11[]21[
]54[
ELECTROMAGNETIC COUPLING
]22[
]31[
]51[
]71[
]87[
]74[
18.11.2002
015061
]32[ 11.12.2001
Int. Cl.(2008.04) H01P 5/00
RAYTHEON COMPANY, U.S.A.
WO/2003/050911
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] An electromagnetic coupling (10)
comprising: a first conductor (22); a
conductive enclosure (30), enclosing a
4797
160041
‫צימוד אלקטרומגנטי‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
cavity (38, 66), wherein the first conductor
is inserted into the cavity through a first
opening (40) in the enclosure; a ground
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
plane (32) within the cavity, the ground
plane and the conductive enclosure
defining a resonant slot (36) therebetween,
wherein the first conductor is electrically
connected to the ground; and a second
conductor (58) inserted into the cavity
through a second opening in the enclosure;
wherein the conductors are on respective
opposite sides of the ground plane within
the cavity, and wherein the first and
second conductors are electromagnetically
coupled with one another via the ground
plane and the resonant slot.
_______
]11[]21[
160082
‫ תכשירים רוקחיים‬,‫נגזרות קווינולין‬
‫המכילים אותן ושימושים בהן להכנת‬
‫תכשירים לטיפול בסרטן‬
]54[
QUINOLINE DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND THEIR USE IN THE
PREPARATION OF
COMPOSITIONS FOR TREATING
CANCER
]22[
]31[
]51[
]71[
31.07.2002
60/309144
]32[ 31.07.2001
]33[ US
Int. Cl.(2008.04) A61K 31/47, A61P 35/00, C07D 2152/27
WAYNE STATE UNIVERSITY,
U.S.A.
WO/2003/011832
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]87[
]74[
[57] A compound of the formula
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4798
2009
wherein Y is F, Cl, Br, methyl or methoxy;
or a pharmaceutically acceptable salt
thereof.
_______
]11[]21[
‫משגוח לעירנות‬
]54[
ALERTNESS MONITOR
]22[
]31[
]51[
]71[
07.11.2002
PR8723
]32[ 08.11.2001
Int. Cl.(2008.04) A61B 31/13
SLEEP DIAGNOSTICS PTY LTD.,
AUSTRALIA
WO/2003/039358
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
160155
[57] An alertness monitoring system
which includes: (a) means to measure
velocity and amplitude of eyelid and eye
movement; (b) storage means to
continuously record the measurements; (c)
a data processor to calculate the blink
amplitude to velocity ratio and/or the
saccade amplitude to velocity ratio and
compare the measurements against a
predetermined scale, said scale being
]33[
AU
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
averaged measurements of the eye and
eyelid movement parameters for a sample
population measured against
predetermined incremental blood alcohol
levels; (d) a display for showing the
alertness measurement based on the scale;
or (e) an alarm means triggered by the
scale reading reaching a predetermined
limit based on the blood alcohol level
scale.
_______
4799
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
160194
‫] פירימידינים מותמרים‬d– 2,3[ ‫תיאנו‬
–‫ ו‬LH ‫בגליצין בעלי פעילות אגוניסטית‬
‫ משולבת‬FSH
]54[
GLYCINE-SUBSTITUTED THIENO
[2,3-D] PYRIMIDINE WITH
COMBINED LH AND FSH
AGONISTIC ACTIVITY
]22[
]31[
]51[
]71[
29.08.2002
01203328.8
]32[ 04.09.2001
]33[ EP
Int. Cl.(2008.04) A61K 315/05, A61P 15/08, C07D 495/04
N.V. ORGANON, THE
NETHERLANDS
WO/2003/020727
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]87[
]74[
[57] Thieno [2, 3-d] pyrimidine
derivatives of the formula:
(di)alkylamino, R2 is H, (1-4C) alkyl, (14C) alkoxy (2-4C) alkyl or hydroxy (2-4C)
alkyl; R3 and R4 can be independently
selected from H, (1-4C) alkyl and hydroxy
(1-4C) alkyl; R5 is H or (1-4C) alkyl, and
R6 can be selected from the same groups as
described for R1, or tert-butyl 5-amino-2methylthio-4-(3-((2,3-dihydroxy-prop-lyl)-glycinyl)-amino)-phenyl)-thieno [2,3d] pyrimidine-6-carboxamide.
or pharmaceutically acceptable salts
thereof, wherein
X is O or H, H;
A is S, NH, N(R6), O or a bond;
R1 is (1-4C) alkyl, (2-4C) alkenyl, phenyl
or (2-5C) heteroaryl, the phenyl or
heteroaryl ring optionally being substituted
with one or more of the group of
substituents: hydroxy, halogen, nitro,
trifluoromethyl, cyano, amino or (1-4C)
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4800
2009
]11[]21[
]54[
CRYSTALS OF OPTIONALLY
SUBSTITUTED 2-(2-PYRIDINYL)
METHYLTHIO-1HBENZIMIDAZOLES HYDRATES
AND METHOD FOR THE
PRODUCTION THEREOF
]22[
]31[
]51[
]71[
]87[
]74[
08.08.2002
10140492.1
]32[ 17.08.2001
Int. Cl.(2008.04) C07D 401/12
GRUNENTHAL GMBH, GERMANY
WO/2003/016301
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
160252
–‫ – פירידניל) מתילתיאו‬2(–2 ‫גבישים של‬
‫ –בנזאימידזולים מותמרים באופן‬H1
‫ברריתי ושיטה ליצורם‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] Crystals of compounds of the formula
in which R1, R2 and R3, identical or
different, denote hydrogen, a C1-C8 alkyl,
C3-C8 cycloalkyl, C2-C8 fluoroalkyl or
C1-C8 alkoxy residue, R4 and R5, identical
or different, denote hydrogen, a C1-C8
alkyl, C3-C8 cycloalkyl, CH2-C3-C8
cycloalkyl, C1-C8 alkoxycarbonyl, C1-C8
alkoxy, C1-C8 fluoroalkoxy, CF3-, C2-C8
fluoroalkyl or C(O)O-C1-C8 alkyl residue
and R6 denotes hydrogen or a C1-C2 alkyl
residue and x means 0.5-2.
_______
4801
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
160453
‫ריצוף ושיטה לסידור וייצור הריצוף‬
]54[
FLOORING AND METHOD FOR
LAYING AND MANUFACTURING
THE SAME
]22[
]31[
]51[
]71[
20.09.2002
0103130-1
]32[ 20.09.2001
]33[ SE
Int. Cl.(2008.04) E04B 1/38, E04F 15/04, 21/22
VALINGE INNOVATION AB,
SWEDEN
DARKO PERVAN, TONY PERVAN
WO/2003/025307
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]72[
]87[
]74[
[57] A flooring, which comprises
rectangular floorboards with long sides
(4a, 4b) and short sides (5a, 5b), said
floorboards being joined in a herringbone
pattern, long side to long side and long
side to short side, wherein said long sides
have pairs of opposing first mechanical
connecting means comprising a tongue
(10) and a tongue groove (9) for locking
together said floorboards vertically
characterized in that the flooring comprises
floorboards with a surface of laminate, and
in that said flooring comprises second
June 15,
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
mechanical connecting means comprising
an upwardly projecting locking element (8)
on one long side cooperating with a
locking groove (12) on the other long side
of an adjacent floorboard for locking
together said floorboards horizontally
whereby said connecting means allow
locking-together both horizontally and
vertically by inward angling whereby the
tongue is received in the tongue groove
and the locking element enters the locking
groove.
– ‫כ"ג בסיוון התשס"ט‬
4802
2009
________
]11[]21[
]54[
REUSABLE, SPRING DRIVEN
AUTOINJECTOR WITH SHAPE
MEMORY ALLOY DRIVE SPRING
]22[
]31[
]51[
]71[
]87[
]74[
24.06.2003
60/391322
]32[ 24.06.2002
Int. Cl.(2008.04) A61M 5/20
ALZA CORPORATION, U.S.A.
WO/2004/000395
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[57] An injection device comprising: a
housing (20); a reservoir (42) for
containing a medicament (44); a needle
(48) for delivering the medicament; and a
drive mechanism (30) capable of exerting
a force sufficient to expel the medicament
from the reservoir through the needle, the
4803
160469
‫מזרק לשימוש עצמי וחוזר המונע בקפיץ‬
‫עם קפיץ מניע המורכב מסגסוגת בעלת‬
‫יכולת חזרה לצורה קודמת‬
]33[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
drive mechanism comprising one or more
drive springs (32) formed of a shape
memory alloy, said drive springs being
situated circumferentially relative to a
drive member (34) and providing
equilateral pressure on said drive member
along the drive member length.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
160573
‫שיטת שיפור השימוש והדירוג במערכת‬
‫הודעות באופן שקוף ליישום‬
]54[
METHOD OF IMPROVING
AVAILABILITY AND
SCALABILITY IN A MESSAGING
SYSTEM IN A MANNER
TRANSPARENT TO THE
APPLICATION
]22[
]31[
]51[
]71[
25.02.2004
402052
]32[ 27.03.2003
]33[
Int. Cl.(2008.04) G06F 9/46, H04L 29/08
MICROSOFT CORPORATION,
U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]74[
[57] In a runtime messaging
infrastructure that abstracts send and
receive operations for exchanging
June 15,
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
messages with a partner endpoint over one
or more message transports, a method of
improving availability and scalability of a
– ‫כ"ג בסיוון התשס"ט‬
4804
2009
messaging application by selecting at least
one of the one or more message transports
to link with the messaging application at
runtime, the method comprising steps for:
determining at runtime at least one
appropriate transport, without the
messaging application specifying the at
least one appropriate transport at
development time, from among the one or
more transports, that meets one or more
end-to-delivery assurances specified by the
messaging application, wherein the one or
more end-to-end transport assurances
comprise at least one of: at least once
delivery, at most once delivery, in-order
delivery and session time to live; and
linking the messaging application and the
determined at least one appropriate
transport in order to exchange messages
between the messaging application and the
partner endpoint.
_______
]11[]21[
160617
‫מערכת ושיטה שידור רדיו ומכשיר שידור‬
‫ומכשור קליטה המשמשים במערכת שידור‬
‫הרדיו‬
]54[
RADIO TRANSMISSION SYSTEM
AND METHOD AND
TRANSMITTER APPARATUS
AND RECEIVER APPARATUS
USED IN THE RADIO
TRANSMISSION SYSTEM
]22[
]31[
]51[
]71[
]72[
30.08.2002
2001-262215 ]32[ 30.08.2001
]33[ JP
Int. Cl.(2008.04) H04B 1/69, 17/07, H04J 11/00, H04L 1/00, 5/02
NTT DOCOMO, INC., JAPAN
MAMORU SAWAHASHI,
HIROYUKI ATARASHI, SADAYUKI
ABETA, NORIYUKI MAEDA
WO/2003/019837
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬
JERUSALEM 91450
]87[
]74[
[57] An orthogonal frequency and code
division multiplexing (OFDM) radio
4805
transmission system configured for
parallely transmitting identical information
June 15, 2009 – ‫כ"ג בסיוון התשס"ט‬
via a plurality of sub-carriers, comprising:
a transmitter configured to transmit an
OFDM signal to a receiver and including
converting means for parallely converting
channel-coded information according to
symbols transmitted simultaneously;
spreading means for spreading a sequence
of parallelized symbols in at least one of a
frequency direction and a time direction by
a spreading code sequence having a
spreading factor determined based on a
plurality of changeable spreading factors;
and spreading factor determining means
for determining said spreading factor based
on a command provided by a device
external to the transmitter.
________
]11[]21[
160701
‫–פירימידון ותכשירים‬4–‫–מותמרות‬3 ‫תולדות‬
‫רפואיים הכוללים אותם לטפול במחולות‬
TPK1 ‫הנגרמות על ידי פעילות יתר של‬
]54[
3-SUBSTITUTED-4-PYRIMIDONE
DERIVATIVES AND
MEDICAMENTS COMPRISING
THEM FOR TREATMENT OF
DISEASES CAUSED BY TPK 1
HYPERACTIVITY
]22[
]31[
20.09.2002
2001-331675 ]32[ 21.09.2001
]33[ JP
2001-331676
21.09.2001
JP
2001-331678
21.09.2001
JP
2001-331674
21.09.2001
JP
Int. Cl.(2008.04) A61K 315/13, 315/377, 315/386, A61P 17/14, 25/28, 27/00, 3/10,
35/00, 43/00, C07D 401/14, 403/04, 403/14, 405/04, 405/14, 409/14, 413/14, 417/14,
498/10
SANOFI AVENTIS, FRANCE
MITSUBISHI TANABE PHARMA
CORPORATION, JAPAN
WO/2003/027080
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4806
2009
[57] A pyrimidone derivative of the
formula
or a salt thereof, or a solvate thereof or a
hydrate thereof wherein R1 represents a
C1-C12 alkyl group which may be
substituted; R represents any one of groups
of the formulas
wherein R2 and R3 independently represent
a hydrogen atom or a C1-C8 alkyl group;
R4 represents a benzene ring which may be
substituted, a naphthalene ring which may
be substituted, an indan ring which may be
substituted, a tetrahydronaphthalene ring
which may be substituted, or an optionally
substituted heterocyclic ring having 1 to 4
hetero atoms selected from the group
consisting of oxygen atom, sulfur atom and
nitrogen atom, and having 5 to 10 ringconstituting atoms in total; R5 represents a
C1-C8 alkyl group which may be
substituted, a C3-C8 cycloalkyl group
which may be substituted, a benzene ring
which may be substituted, a naphthalene
ring which may e substituted, an indan ring
which may be substituted, a
tetrahydronaphthalene ring which may be
substituted, or an optionally substituted
heterocyclic ring having 1 to 4 hetero
atoms selected from the group consisting
of oxygen atom, sulfur atom, and nitrogen
atom, and having 5 to 10 ring-constituting
atoms in total; R6 represents a hydrogen
atom, a C1-C8 alkyl group which may be
substituted, a benzene ring which may be
substituted; or R6 and R6 may bind to each
other to form together with the carbon to
which R5 and R6 are attached an optionally
substituted spiro carbocyclic ring having 3
to 11 ring-constituting atoms in total; R7
and R6 independently represent a hydrogen
atom or a C1-C8 alkyl group, or R7 and R8
may combine to each other to form a C2-C6
alkylene group; R9 and R10 represent a C1C8 alkyl group which may be substituted, a
C3-C8 cycloalkyl group which may be
substituted, a benzene ring which may be
substituted, a naphthalene ring which may
be substituted, an optionally substituted
heterocyclic ring having 1 to 4 hetero
atoms selected from the group consisting
of oxygen atom, sulfur atom, and nitrogen
atom, and having 5 to 10 ring-constituting
atoms in total, or R9 and R10 represent –
N(R11)(R12) wherein R11 represents a
hydrogen atom a C1-C8 alkyl group; and
4807
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
R12 represents a C1-C8 alkyl group, a
benzene ring which may be substituted, a
naphthalene ring which may be
substituted, or an optionally substituted
heterocyclic ring having 1 to 4 hetero
atoms selected from the group consisting
of oxygen atom, sulfur atom, and nitrogen
atom, and having 5 to 10 ring-constituting
atoms in total; and X represents CH2, O or
NR13 wherein R13 represents a hydrogen
atom or a C1-C8 alkyl group.
_______
]11[]21[
‫כלי לתיקון הברגות פגומות‬
]54[
TOOL FOR REPAIRING
DAMAGED SCREW THREADS
]22[
]51[
]71[
]72[
07.03.2004
Int. Cl.(2008.04) B23G 9/00
SHILO TECHNOLOGIES LTD.
MOSHE ABRAHAM, ZEEV STAHL,
BINYAMIN FREDKIN
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]74[
160766
[57] A tool for repair of damaged threads
of screws, comprising: a body (2) having a
projecting portion (4) for accommodating a
screw to be repaired and having two
recessed major surfaces and a rear portion
having a part-circular recess; two blades
(6, 6) each having a rear end hingedly
articulated in said body and a front end in
the shape of a cutting face substantially
fitting the type of thread to be repaired;
June 15,
‫ ירושלים‬,‫שילה טכנולוגיות בע"מ‬
‫ בנימין פרדקין‬,‫ זאב שטאל‬,‫משה אברהם‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
means (10, 12) to alter the distance
between said cutting faces and said
projecting portion to accommodate screws
of different diameters, and wherein said
rear ends of said blades are of part-circular
cross-section for serving as pivots when
accommodated within the part-circular
recess of the body; whereby said blades are
hingedly articulated to said body.
– ‫כ"ג בסיוון התשס"ט‬
4808
2009
_______
]11[]21[
160820
‫ הכנתם‬,‫אראלקיל–טטרה–הידרו–פירידינים‬
‫והרכבים רקחיים‬
]54[
ARALKYL-TETRAHYDROPYRIDINES, THEIR
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
SAME
]22[
]31[
]51[
14.10.2002
01/13469
]32[ 18.10.2001
]33[ FR
Int. Cl.(2008.04) A61K 314/44, A61P 29/00, C07C 57/50, C07D 211/70, 211/72,
211/94, 401/04
SANOFI AVENTIS, FRANCE
WO/2003/033466
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]71[
]87[
]74[
[57] Compounds of the formula
in which
X represents N or CH;
4809
R1 represents a hydrogen or halogen atom
or a CF3 group; n is an integer from 1 to 5;
A represents a group of the formulas
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
in which m is 1 or 2;
and their salts or solvates and their N-oxides.
_______
]11[]21[
‫התקן אימונים למשחקי כדור‬
]54[
TRAINING DEVICE FOR BALL
GAMES
]22[
]31[
]51[
]71[
]87[
]74[
01.10.2002
PA200101429 ]32[ 01.10.2001
Int. Cl.(2008.04) A63B 63/00
GLOBAL GOAL APS, DENMARK
WO/2003/028812
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
[57] A training device for ball games
comprising: a first circular ring member
(3) arranged in a first plane; a second
circular ring member (2) arranged in a
second plane being substantially parallel to
said first plane; each of said first and
second rings being of a different size
relative to the other; a plurality of bars
connecting said first and second ring
members to each other and holding them in
a spaced concentric relationship such that
June 15,
160932
]33[
DK
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
said first and second ring members have a
common axis, a plurality of openings being
defined between the ring members and the
bars, said ring members defining an inner
space; and at least two nets arranged to
catch a ball hitting one of said openings,
said nets being suspended in and extending
across said inner space between said first
and second ring members and being
connected to each other in said space along
said common axis.
– ‫כ"ג בסיוון התשס"ט‬
4810
2009
_______
]11[]21[
160997
‫עיבוד אנכי של פקודות ומידע‬
‫בארכיטקטורה של מעבד רשת‬
]54[
VERTICAL INSTRUCTION AND
DATA PROCESSING IN A
NETWORK PROCESSOR
ARCHITECTURE
]22[
]31[
19.09.2002
60/323627
]32[ 19.09.2001
]33[ US
60/372507
14.04.2002
US
60/382437
20.05.2002
US
Int. Cl.(2008.04) G06F 15/00, 15/76, 9/38, H04L 12/28, 12/56
BAY MICROSYSTEMS, INC., U.S.A.
WO/2003/025709
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]51[
]71[
]87[
]74[
[57] A method for processing an
incoming information element belonging
to a flow, the incoming information
element comprising at least one
information element segment, the method
comprising: receiving a particular one of
the at least one information element
segment; stacking the particular one of the
at least one information element segment
4811
so that a plurality of bits of the particular
one of the at least one information element
segment are parallel to each other in a
vertical direction; fetching a plurality of
instructions corresponding to the flow to
which the incoming information element
belongs; fetching a plurality of registers
corresponding to the flow to provide
adequate memory space to execute the
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
plurality of instructions without
performing a context switch; and executing
the plurality of instructions to perform a
function on the particular one of the at
least one information element segment.
_______
]11[]21[
161023
‫שיטות ליצירת חגורה רציפה עבור התקן‬
‫מפריד מסוג חגורה‬
]54[
METHODS OF FORMING A
CONTINUOUS BELT FOR A
BELT-TYPE SEPARATOR DEVICE
]22[
]31[
]51[
]71[
27.09.2002
60/325426
]32[ 27.09.2001
]33[ US
Int. Cl.(2008.04) B03C 7/08, B29C 65/00, 65/02, B29D 17/00, F16G 1/00, 3/10
SEPARATION TECHNOLOGIES
LLC, U.S.A.
WO/2002/027536
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬
P.O.B. 1426,
TEL AVIV 61013
]87[
]74[
[57] A method for joining, to each other,
a first edge of a first portion (52) of a
thermoplastic sheet and a second edge of a
second portion (54) of a thermoplastic
sheet, the method comprising: forming
angles on the first edge of the first portion
of thermoplastic sheet and on the second
edge of the second portion of
thermoplastic sheet such that the first and
second edges are inclined with respect to a
surface of the thermoplastic sheet; forming
June 15,
a first plurality of openings (50) in the first
portion of thermoplastic sheet, the
openings extending transversely to the first
edge of the first portion of thermoplastic
sheet; forming a second plurality of
openings in the second portion of
thermoplastic sheet to be joined to the first
portion of thermoplastic sheet, the
openings extending transversely to the
second edge of the second portion of
thermoplastic sheet; placing together with
– ‫כ"ג בסיוון התשס"ט‬
4812
2009
a slight overlap the first and second
inclined edges of the first and second
portions of thermoplastic sheet, such that
the first and second portions of
thermoplastic sheet fit together and include
overlapping portions; and joining the first
and second portions of thermoplastic sheet
together; and wherein the first plurality of
openings extend transversely to the first
edge of the first portion of thermoplastic
sheet beyond the overlapping portions, and
wherein the second plurality of openings in
the second portion of thermoplastic sheet
extend transversely to the second edge of
the second portion of thermoplastic sheet
beyond the overlapping portions.
_______
]11[]21[
]54[
METHOD AND DEVICE FOR
ENCRYPTION/DECRYPTION OF
DATA ON MASS STORAGE
DEVICE
]22[
]31[
]51[
]71[
25.09.2002
60/325168
]32[ 28.09.2001
Int. Cl.(2008.04) G06F 21/00, 21/24
HIGH DENSITY DEVICES AS,
NORWAY
WO/2003/027816
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
[57] Method for encryption (enciphering,
scrambling)/decryption (deciphering,
descrambling) of data items transferred to
or from a mass storage media, where the
mass storage media comprises physically
addressable areas, wherein the method
comprises the steps of: providing a
plurality of encryption/decryption
algorithms with associated
4813
161027
‫שיטה ומכשיר להצפנה ופענוח של נתונים‬
‫על גבי התקן בעל מקום אחסון גדול‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
encryption/decryption keys; and selecting
one of said plurality of
encryption/decryption algorithms with said
associated key and using said one of said
plurality of encryption/decryption
algorithms with said associated key on a
data item to be transferred to or from an
addressable area enclosing said data item
on the mass storage media, wherein the
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
selection of said one algorithm and said
associated key is determined by numbers
respectively representing locations each of
at least two physical address defining an
upper address limit and a lower address
limit of span of the addressable area
enclosing said data item on said mass
storage media.
_______
]11[]21[
161055
‫התקן ושיטה לאיתור חפץ‬
]54[
APPARATUS AND METHOD TO
LOCATE AN OBJECT
]22[
]31[
]51[
]71[
10.10.2002
01203920.2
]32[ 15.10.2001
]33[ EP
Int. Cl.(2008.04) G01N 21/01, 21/25, 35/02, G06K 9/62, G06T 7/00
DSM IP ASSETS B.V., THE
NETHERLANDS
WO/2003/034341
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] Arrangement to locate an object with
a predetermined number of marks,
comprising a light source to illuminate the
object, a sensor to receive an image of the
object and to generate image pixel data
including image pixel locations and image
pixel intensities for each image pixel
location, a processor to receive the image
pixel data and to store them in a memory,
the processor being arranged to perform
the following functions: comparing said
June 15,
image pixel intensities with a
predetermined threshold; determining
object position based on said comparing;
using a digital match mask that
corresponds with said object with said
marks, finding a best match between said
digital match mask and said object on said
object position; determining mark
positions within said object position from
said best match.
– ‫כ"ג בסיוון התשס"ט‬
4814
2009
_______
]11[]21[
161085
‫תכשיר קוטל פטריות המבוסס על נגזרת‬
‫של פירידילמתילבנזמיד ונגזרת של‬
‫ולינאמיד‬
]54[
FUNGICIDAL COMPOSITION
BASED ON A
PYRIDYLMETHYLBENZAMIDE
DERIVATIVE AND A
VALINAMIDE DERIVATIVE
]22[
]31[
]51[
]71[
13.11.2002
01/14692
]32[ 14.11.2001
]33[ FR
Int. Cl.(2008.04) A01N 43/40, C07D 213/24
BAYER CROPSCIENCE S.A.,
FRANCE
WO/2003/041501
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] Fungicidal compositions comprising:
4815
(a) at least one pyridylmethylbenzamide
derivative of the formula:
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
in which R1 is chosen from a hydrogen
atom, an alkyl radical optionally
substituted with one or more radicals
chosen from chlorine, bromine, fluorine,
iodine, alkyl, alkoxy, hydroxyl, nitro,
amino, cyano and acyl and an acyl radical
optionally substituted with one or more
radicals chosen from chlorine, bromine,
fluorine, iodine, alkyl, alkoxy, hydroxyl,
nitro, amino, cyano and acyl; R2 is chosen
from a hydrogen atom and an alkyl radical
optionally substituted with one or more
radicals chosen from chlorine, bromine,
fluorine, iodine, alkyl, alkoxy, hydroxyl,
nitro, amino, cyano and acyl; R3 and R4,
which are identical or different are
independently chosen from a halogen
atom, the hydroxyl radical, the cyano
radical, the nitro radical, the radical –SF5,
the trialkylsilyl radical, an amino radical
optionally substituted with one or more
radicals chosen from chlorine, bromine,
fluorine, iodine, alkyl, alkoxy, hydroxyl,
nitro, amino, cyano and acyl; an acyl
radical, and a group E, OE or SE, in which
E is chosen from an alkyl, alkenyl,
alkynyl, cycloalkyl, cycloalkenyl, aryl and
heterocyclyl radical, it being possible for
each of them to be optionally substituted
with one or more radicals chosen from
chlorine, bromine, fluorine, iodine, alkyl,
alkoxy, hydroxyl, nitro, amino, cyano and
acyl;
c represents 0, 1, 2, 3, or 4;
q represents 0, 1, 2, 3 or 4;
and their a griculturally acceptable
possible optical and/or geometric isomers,
tautomers and addition salts with an acid
or a base; and
(b) at least one compound (II) of the
valinamide type with fungicidal activity,
and their agriculturally acceptable isomers
and addition salts with an acid; the
compound (I)/compound (II) ratio ranging
from 1/100 to 100/1.
_______
]11[]21[
161113
‫שיטה והתקן לבקרת כח מרובת ערוצים‬
‫בעלת מקשרים הפוכים ולולאה חיצונית‬
]54[
METHOD AND APPARATUS FOR
MULTI-CHANNEL REVERSE
LINK OUTER-LOOP POWER
CONTROL
]22[
]31[
]51[
]71[
24.09.2002
09/967653
]32[ 28.09.2001
]33[ US
Int. Cl.(2008.04) H04B 1/00, 7/26, 70/05, H04J 13/00
QUALCOMM INCORPORATED,
U.S.A.
WO/2003/030401
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] A receiver in a wireless
communications system including a
reverse link fundamental channel and a
reverse link supplemental channel, said
receiver comprising: a delta computation
June 15,
module configured to produce a threshold
delta; a maintain and adjust threshold
module configured to accept a frame
erasure rate from said reverse link
fundamental channel; an adder configured
– ‫כ"ג בסיוון התשס"ט‬
4816
2009
to generate an outer-loop set point by
adding a base threshold outputted by said
maintain and adjust threshold module to
said threshold delta outputted by said delta
computation module; a comparator
configured to compare said outer-loop set
point with a receive signal strength, an
output of said comparator being utilized to
adjust a transmit power of mobile unit.
_______
]11[]21[
]54[
DETERMINATION OF CENTER
OF FOCUS BY CROSS-SECTION
ANALYSIS
]22[
]31[
]51[
]71[
10.10.2002
60/328576
]32[ 10.10.2001
Int. Cl.(2008.04) H01L 210/27
NANOMETRICS INCORPORATED,
U.S.A.
WO/2003/032085
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]87[
]74[
[57] A method of measuring parameters
relating to a lithography device comprising
the steps of providing a substrate
comprising a plurality of diffraction
structures formed on the substrate by
lithographic process utilizing the
lithography device, the diffraction
structures comprising a plurality of spaced
elements; measuring a diffraction signature
for at least three of the plurality of
4817
161274
‫קביעת מרכז פוקוס באמצעות ניתוח‬
‫החתך‬
]33[
US
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
diffraction structures by means of a
radiation source-based tool; selecting a
theoretical diffraction structure providing a
theoretical diffraction signature matching
the measured diffraction signature of
measured diffraction structures; and
determining a metric between the
calculated cross-sections to determine a
desired parameter of said lithography
device.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
161285
‫הצגה‬/‫מערכת להצגת עצמם של סידור‬
‫גרפי‬
]54[
SYSTEM FOR HOSTING
GRAPHICAL LAYOUT/
PRESENTATION OBJECTS
]22[
]31[
]51[
]71[
15.05.2003
434850
]32[ 09.05.2003
]33[
Int. Cl.(2008.04) G06F 3/14, 9/44, G09G 5/00
MICROSOFT CORPORATION,
U.S.A.
WO/2004/107308
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
[57] A graphical output layout
management system for arranging and
maintaining graphically displayed output
of programs executing on a computing
system, the graphical output layout
management system comprising: graphical
elements containing data representing
displayable content of a program;
presenters defining display states for the
June 15,
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
graphical elements, wherein a presenter of
a particular type maintains a layout
description for a corresponding graphical
element; and a presenter system, including
a presenter host interface comprising a
method for preparing a layout for a view,
according to a set of presenters associated
with graphical elements contained within
the view.
– ‫כ"ג בסיוון התשס"ט‬
4818
2009
_______
]11[]21[
]54[
COLLAPSIBLE SYRINGE
CARTRIDGE
]22[
]31[
]51[
]71[
]87[
]74[
08.11.2002
337681
]32[ 09.11.2001
Int. Cl.(2008.04) A61M 5/24, 5/28
ALZA CORPORATION, U.S.A.
WO/2003/041770
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[57] A syringe cartridge exhibiting a first
length and comprising a syringe (200) with
an associated needle (220) and a casing
that includes a fixed portion (460) and a
collapsible portion (430) wherein the
syringe is positioned through the
collapsible portion of the casing and the
4819
161336
‫מחסנית מזרק מתקפלת‬
]33[
US
,'‫ד"ר שלמה כהן ושות‬
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
syringe, the fixed portion of the casing and
the collapsible portion of the casing are
configured such that, upon application of a
force to the syringe, the collapsible portion
of the casing is motivated into the fixed
portion of the casing and the first length of
the casing is reduced.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
161390
‫תמיסות הזרקה מוכנות לשימוש של‬
‫פרצטמול המכילות פרופילן גליקול‬
‫כממס נוסף יחיד‬
]54[
READY-TO-USE PARACETAMOL
INJECTION SOLUTIONS
CONTAINING PROPYLENE
GLYCOL AS THE ONLY
COSOLVENT
]22[
]31[
]51[
]71[
]72[
]87[
]74[
15.10.2002
MI2001A002135 ]32[ 16.10.2001
]33[ IT
Int. Cl.(2008.04) A61K 311/67, 47/00, 47/10, 47/12, 9/08
BIOREN S.A., SWITZERLAND
THAO NGUYEN-XUAN
WO/2003/033026
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
[57] Ready-to-use pharmaceutical
paracetamol injection solution, obtainable
by mixing paracetamol with water,
propylene glycol as the only co-solvent,
and a citrate buffer (pH from 4.5 to 6.5),
by heating said solution from 70oC to
130oC and keeping same at said
temperature for 10 min at least.
_______
]11[]21[
]54[
WRINKLE FREE GARMENT AND
METHOD OF MANUFACTURE
June 15,
– ‫כ"ג בסיוון התשס"ט‬
161460
‫בגד ללא קמטים ושיטת ייצורו‬
4820
2009
]22[
]31[
]51[
]71[
]87[
]74[
22.07.2002
01129786.7
]32[ 18.10.2001
10/073445
11.02.2002
Int. Cl.(2008.04) A41D 27/24
GUANGDONG ESQUEL TEXTILES
CO., LTD., CHINA
WO/2003/032763
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A method for producing a wrinkle
free seam in a garment, comprising:
(a) placing a bonding element comprising
an adhesive material between two garment
components; the adhesive material having
a hot pressing melting point greater than
160oC;
(b) sewing a set of stitches traversing
through the bonding element and at least
one garment component such that at least
one seam is formed;
The applications for division
from this application have
not yet been published
]33[
CN
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
(c) providing sufficient heat and pressure
to effect the bonding of the bonding
element to at least one garment
component, wherein the adhesive material
has a peel strength of equal to or greater
than 0.5 pounds per inch, and wherein
providing sufficient heat and pressure
comprises pressing the seam at a pressure
of at least 2.5 kilograms per square
centimeter and a temperature of greater
than 160oC for about 5 to 30 seconds.
,187205
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
________
]11[]21[
]54[
4821
PACKAGING CELL CONTAINING
NUCLEIC ACID CONSTRUCTS
AND METHODS FOR
161495
‫תא אריזה המכיל מבנים של חומצות גרעין‬
‫ושיטות לאריזת וקטור נגיפי‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
PACKAGING A VIRAL VECTOR
]22[
]31[
]51[
]71[
]87[
]74[
30.10.2002
10/020472
]32[ 30.10.2001
]33[
Int. Cl.(2008.04) C12N 15/85, 5/02, 5/10, 7/01
VIRXSYS CORPORATION, U.S.A.
WO/2003/054210
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A packaging cell comprising: a first
nucleic acid construct comprising a
nucleotide sequence encoding a first
inducible promoter and a first product,
wherein the first inducible promoter
regulates expression of first product and
the first inducible promoter is selected
from the group consisting of a tetracycline
promoter/operator, a retroviral long
terminal repeat (LTR) and a steroid
promoter region; a second nucleic acid
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
construct comprising a nucleotide
sequence encoding a second inducible
promoter and a second product, wherein
the second inducible promoter is induced
by the first product and the second product
encodes a viral RNA binding protein; and
a third nucleic acid construct comprising a
nucleotide sequence encoding a third
inducible promoter and a viral gene
product, wherein the third inducible
promoter is induced by the second product.
________
]11[]21[
]54[
POXVIRUS CONTAINING
FORMULATIONS, METHODS FOR
PREPARING STABLE POXVIRUS
CONTAINING COMPOSITIONS
AND USES THEREOF
]22[
]31[
]51[
]71[
28.11.2002
PA200101831 ]32[ 10.12.2001
Int. Cl.(2008.04) A61K 392/75
BAVARIAN NORDIC A/S,
DENMARK
WO/2003/053463
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
[57] A formulation comprising (i) a
vaccinia virus having a titer of at least 106
TCID50 per mg total protein, (ii) a
disaccharide, (iii) a pharmaceutically
June 15,
161590
‫ שיטות‬,‫תכשירים המכילים פוקסיווירוס‬
‫להכנת תכשירים של פוקסיווירוס יציבים‬
‫והשימוש בהם‬
]33[
DK
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
acceptable polymer and (iv) a buffer,
wherein the buffer is not a phosphate
buffer.
– ‫כ"ג בסיוון התשס"ט‬
4822
2009
_________
]11[]21[
]54[
INFUSION PUMP
]22[
]31[
]51[
]71[
06.11.2002
2034/01
]32[ 06.11.2001
Int. Cl.(2008.04) A61M 51/42
HERMANN L. KELLER,
SWITZERLAND
WO/2003/039631
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] An infusion pump (10) comprising a
housing (11), a reservoir (20) which is
received in the housing and can be filled
with a fluid and has a piercing mandrel
(19) and outlet (30), a catheter (25), a
battery-driven delivery device (23) which
is arranged between reservoir and catheter
and whose delivery rate can be adjusted
4823
161817
‫משאבת אינפוזיה‬
]33[
CH
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
via an electronic control unit (22), the
delivery device being a tube consisting of
piezoelectric crystals and made up of at
least two tube portions (23a, 23b) and an
electric current or a voltage can be applied
to said tube portions such that the delivery
device operates according to the
piezoelectric principle.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
161838
‫מערכת ושיטה לשידור דו–כיווני של חבילות‬
‫מידע‬
]54[
BI-DIRECTIONAL PACKET DATA
TRANSMISSION SYSTEM AND
METHOD
]22[
]31[
14.08.2003
10-2002]32[ 14.08.2002
]33[ KR
0048261
Int. Cl.(2008.04) H04B 7/26, H04L 12/56, 29/06, H04Q 7/38
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2004/017578
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]51[
]71[
]87[
]74[
[57] A method of packet data
communications for a network comprising:
receiving mobile terminal capabilities
associated with header compression,
wherein the mobile terminal capabilities
include information related to a RFC2507
or Robust Header compression (ROHC)
scheme; configuring parameter
information, which relates to the RFC2507
June 15,
or Robust Header compression (ROHC)
scheme, for uplink and downlink data
transmissions based on the mobile terminal
capabilities, wherein uplink parameter
information and downlink parameter
information are separately configured; and
transmitting the configured parameter
information to a mobile terminal.
– ‫כ"ג בסיוון התשס"ט‬
4824
2009
_______
]11[]21[
161972
‫תכשירים המכילים חלקיקי צפורוקסים‬
‫אקסטיל מצופים‬
]54[
COATED PARTICULATE
CEFUROXIME AXETIL
COMPOSITIONS
]22[
]31[
]51[
]71[
21.11.2002
01500277.7
]32[ 23.11.2001
]33[ EP
Int. Cl.(2008.04) A61K 315/45, 315/46, 9/00, 9/16, 9/30
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2003/043638
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]87[
]74[
[57] A composition comprising
cefuroxine axetil in particulate form, the
particles being provided with integral
coatings of lipid or mixture of lipids which
are insoluble in water and which disperse
or dissolve on contact with gastrointestinal
fluid, a bulk sweetener and a binding
agent, characterized in that the
composition further comprises acesulfame
potassium and aspartame, present in an
amount together of 0.1 to 10% of the total
composition, and xanthan gum, present in
an amount of 0.01 to 5% of the total
composition.
________
4825
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]11[]21[
162048
‫שיטה לייצור מנגנון פתיחה המתאים‬
‫לקצבי זרימת נוזל נמוכים‬
]54[
METHOD FOR
MANUFACTURING AN ORIFICE
MECHANISM CAPABLE OF LOW
FLUID FLOW RATES
]22[
]31[
]51[
]71[
]74[
19.05.2004
460554
]32[ 12.06.2003
]33[ US
Int. Cl.(2008.04) A61M 1/12, 37/00, 5/14, 51/42
CORDIS CORPORATION, U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
[57] A method for manufacturing an
orifice mechanism, the method comprising
the steps of: providing a mandrel having a
length; helically wrapping a winding
around at least a portion of the length of
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
the mandrel; and the mandrel and the
winding defining a first channel for
carrying a drug therethrough and an inlet at
one end of the winding and an outlet at
another end of the winding.
_______
]11[]21[
‫חבק עבור משקפיים‬
]54[
CLASP FOR EYEGLASSES
]22[
]31[
]51[
]71[
]87[
]74[
15.11.2002
10/003775
]32[ 26.11.2001
Int. Cl.(2008.04) G02C 3/04
GRIPPING EYEWEAR, INC., U.S.A.
WO/2003/046643
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] Eyeglasses comprising: a frame body
(114) having a midpoint; a first temple bar
(100) pivotally engaged to a first end of
the frame body; a second temple bar (102)
pivotally engaged to a second end of the
frame body; a first magnetic means (106)
engaged with the first temple bar at a
distance from the frame body first end
June 15,
162122
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
such that the first magnetic means aligns
with the frame body midpoint when the
first temple bar is pivoted closed; a second
magnetic means (108) engaged with the
second temple bar at a distance from the
frame body second end such that the
second magnetic means aligns with the
frame body midpoint when the second
– ‫כ"ג בסיוון התשס"ט‬
4826
2009
temple bar is pivoted closed; wherein the
second magnetic means is in attractive
magnetic communication with the first
magnetic means at least when the temple
bars are pivoted closed; and wherein the
first and second magnetic means remain in
attractive magnetic communication when
the temple bars are closed but separated by
clothing material, the attractive magnetic
communication imparting a gripping force
on the clothing material sufficient enough
to substantially prevent relative movement
between the temple bars and the clothing
material.
______
]11[]21[
162271
‫תהליך ליצור תרופה‬
]54[
PROCESS FOR PRODUCING A
DRUG
]22[
]31[
]51[
]71[
30.01.2003
10208335.5
]32[ 27.02.2002
]33[ DE
Int. Cl.(2008.04) A61K 47/00, 9/00, 9/20, 9/32, 9/50, 9/52, C08F 220/18
ROHM GMBH & CO. KG,
GERMANY
WO/2003/072087
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]87[
]74[
[57] Process for producing a drug form as
a tablet, as a drug form comprising pellets
and/or in the form of an active ingredient
matrix, the tablets, pellets and/or active
ingredient matrix comprising an active
pharmaceutical ingredient and a copolymer
as coating agent and/or binder, and, if
desired, a core and pharmaceutically
customary excipients, by processing the
4827
copolymer, the active pharmaceutical
ingredient, the core if present and/or the
pharmaceutically customary excipients in a
conventional manner by melting, injection
moulding, extrusion, wet granulation,
casting, dipping, spreading, spraying or
compression to form tablets, a drug form
comprising pellets and/or an active
ingredient matrix, characterized in that a
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
copolymer is used which is composed of
20 to 34% by weight methacrylic acid
and/or acrylic acid, 20 to 69% by weight
methyl acrylate and 0 to 40% by weight
ethyl acrylate and/or, if desired, 0 to 10%
by weight further vinylically
copolymerizable monomers, with the
proviso that the glass transition
temperature of the copolymer in
accordance with ISO 11357-2, section
3.3.3, is not more than 60oC.
__________
]11[]21[
162330
,‫נגזרות חומצה פנילפרופיונית מותמרות‬
‫ תכשירי רוקחות המכילים‬,‫תהליך להכנתן‬
‫אותן והשימוש בהן בייצור תרופות לטיפול‬
‫ בין אם‬,)‫בהפרעות ליפידיות (דיסליפידמיות‬
‫קשורות ובין אם לא לעמידות לאינסולין‬
]54[
SUBSTITUTED
PHENYLPROPIONIC ACID
DERIVATIVES, PROCESS FOR
THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM AND USE THEREOF IN
THE MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF LIPID
DISORDERS (DYSLIPIDEMIAS),
WHETHER OR NOT ASSOCIATED
WITH INSULIN RESISTANCE
]22[
]31[
]51[
18.12.2002
0104334-8
]32[ 19.12.2001
]33[ SE
Int. Cl.(2008.04) A61K 311/65, 45/06, A61P 3/00, C07C 235/20, C07D 281/08,
317/34
ASTRAZENECA AB, SWEDEN
EVA-LOTTE LINDSTEDT
ALSTERMARK, LANNA LI, ANNA
CHRISTINA OLSSON
WO/2003/051821
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
ZION HOUSE,
‫ תל‬,41-45 ‫ שדרות רוטשילד‬,‫בית ציון‬
41-45 ROTHSCHILD BLVD.,
‫אביב‬
TEL AVIV 65784
]71[
]72[
]87[
]74[
[57] The S enantiomer of a compound of
the formula
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4828
2009
wherein n is 1 or 2 and pharmaceutically
acceptable salts, solvates, crystalline forms
and C1-6 alkoxymethyl esters, C1-6
alkanoyloxymethyl esters, and C3-8
cycloalkoxycarbonyloxy C1-6 alkyl esters,
and 1, 3-dioxolen-2-onylmethyl esters, C1-6
alkoxycarbonyloxyethyl esters, thereof.
_______
]11[]21[
]54[
LIQUID ACTIVE SUBSTANCE
DISPENSER FOR W.C. BOWL
]22[
]31[
]51[
]71[
]87[
]74[
21.10.2002
RE2001A000116 ]32[ 05.12.2001
Int. Cl.(2008.04) E03D 9/02, 9/03
RE.LE.VI. S.P.A., ITALY
WO/2003/048466
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] A liquid active substance dispenser
(10) for a W.C. bowl, to be housed within
the W.C. bowl, comprising a bottle (11)
for containing the active substance (R) in
the liquid state and provided with an exit
mount (12) for the active substance (R),
and a support means (20) for supporting
said bottle in an inverted position, with its
mouth facing downwards, in a position
subjected to the action of the flushing
water flow, said bottle being separate from
the support means, characterised in that the
support means comprises, for containing
the active substances a containing reservoir
4829
162342
‫מיכל לשחרור נוזל פעיל עבור אסלת‬
‫בית שימוש‬
]33[
IT
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
(21) located in a position subjected to the
action of the flushing water flow and
arranged to receive the mouth of the bottle,
a tube piece (30) positioned in said
containing reservoir to close the mouth of
the bottle; for the active substance at least
one passageway associated with said tube
piece to enable the active substance to pass
from the internal chamber of the bottle to
the containing reservoir, said containing
reservoir defining a volume for containing
a quantity of active substance which closes
said passageway for the active substance.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
162367
‫מקרר מאייד עקיף בעל לוחות מקבילים‬
‫להעברת חום ולקירור באידוי‬
]54[
INDIRECT EVAPORATIVE
COOLER HAVING PARALLEL
PLATES FOR HEAT TRANSFER
AND EVAPORATING COOLING
]22[
]31[
]51[
]71[
11.12.2002
60/341206
]32[ 12.12.2001
]33[ US
Int. Cl.(2008.04) B01F 3/04, B01J 14/00, F24F 3/14
IDALEX TECHNOLOGIES, INC.,
U.S.A.
TIMOTHY L. HEATON, ALAN D.
GILLAN, VELERIY
MAISOSTSENKO, LELAND E.
GILLIAN
WO/2003/049844
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
]72[
]87[
]74[
[57] An indirect evaporative cooler (14)
comprising:
(a) a plurality of plates having dry (9) and
wet sides, the wet sides designed to be at
least partially wet by an evaporative
liquid, the plates further forming at least
one first channel (4) per plate to guide a
working gas stream across the dry sides of
the plates, second channels (3) to guide a
product fluid stream across the dry sides of
the plates, and third channels (5) to guide
the working gas streams across the wet
sides of the plates;
June 15,
(b) a trough (72) formed in the plates to
hold and transfer the evaporative liquid to
the wet sides of the plates;
(c) wherein the plates are aligned in
parallel, spaced apart, and oriented so as to
have wet sides facing each other and dry
sides facing each other, and further
wherein, in use, the working gas stream
from the dry sides of the plates flows into
the space separating the plates on the wet
sides; and wherein, in use, the product
fluid passes across and is cooled on the dry
sides of the plates.
– ‫כ"ג בסיוון התשס"ט‬
4830
2009
_______
]11[]21[
162664
‫שימוש בסולפאט גליקוזאמינוגליקנים‬
‫בייצור תכשיר פרמצבטי למניעה ולטיפול‬
‫בהתקדמות איטית של לידה‬
]54[
USE OF SULFATED
GLYCOSAMINOGLYCANS FOR
THE MANUFACTURE OF A
PHARMACEUTICAL
PREPARATION FOR THE
PREVENTION AND TREATMENT
OF SLOW PROGRESS OF TERM
LABOR
]22[
]31[
]51[
02.01.2003
0200005-7
]32[ 02.01.2002
]33[ SE
Int. Cl.(2008.04) A61K 317/26, 317/27, 317/37, 38/11, A61P 15/04, 15/06, 7/02,
C12N 15/00
DILAFOR AB, SWEDEN
WO/2003/055499
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]71[
]87[
]74[
[57] Use of sulfated glycosaminoglycans
selected from the group consisting of
heparin sulfates, depolymerised heparin
sulfates, dermatan sulfates, depolymerised
dermatan sulfates, low molecular weight
heparins, and depolymerised heparins,
having an anti-coagulant activity of 100
BP units/mg or less, for the manufacture of
a pharmaceutical preparation for the
prevention and treatment of slow progress
of term labor.
_______
]11[]21[
]54[
4831
FEEDFORWARD LINEAR
AMPLIFIER
162695
‫מגבר לינארי המוזן במתח לפנים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]22[
]31[
]51[
]71[
]74[
23.06.2004
610284
]32[ 30.06.2003
Int. Cl.(2008.04) H03F 1/26
MOTOROLA, INC., U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
generating an offset voltage that is
designed to achieve a non-zero direct
current (DC) offset in a control signal;
combining the non-offset control signal
with the offset voltage to produce a nonzero DC offset control signal; and
adjusting the error signal based on the
control signal to produce an adjusted error
signal that is capable of reducing distortion
in the feed forward amplifier.
[57] A method for correcting distortion in
a feed forward amplifier comprising:
determining an error signal based on an
input signal and an amplified version of
the input signal; sampling an output signal
to produce an attenuated output signal;
generating a non-offset control signal
based on the attenuated output signal;
_______
]11[]21[
]54[
FOOD COOKING VESSEL WITH
TEMPERATURE INDICATING
MEANS
]22[
]31[
01.07.2004
MI2003A]32[ 14.11.2003
002201
Int. Cl.(2008.04) A47J 45/06
BALLARINI PAOLO & FIGLI S.P.A.,
ITALY
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]74[
[57] Cooking vessel (1) for preparing
food, comprising components (2,3,4)
which are arranged on the outside of the
vessel and to which a sticker (7) is
attached which has a coating which
June 15,
162813
‫כלי לבישול מזון בעל אמצע חיווי‬
‫טמפרטורה‬
]33[
IT
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
contains thermochromatic pigments,
characterized in that the sticker has
different shapes, and different thermal
sensitivities of the pigments are associated
with each of these different shapes.
– ‫כ"ג בסיוון התשס"ט‬
4832
2009
_______
]11[]21[
]54[
APPARATUS FOR INSERTION
OF A WHEELCHAIR INTO A
CAR
]22[
]51[
]71[
]74[
14.07.2004
Int. Cl.(2008.04) A61G 3/02, B60P 9/00
IGOR GAGHIS
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
[57] Apparatus (10) for insertion of a
wheelchair (20) into a motor car having a
front door adjacent the driver's seat and a
luggage compartment (25) with a high rear
door (46), said apparatus adapted to
transport automatically said wheelchair
from a transport position inside said
luggage compartment to an extended
position adjacent said front door, said
apparatus being entirely accommodated in
said luggage compartment when said
wheelchair is in said transport position,
said apparatus comprising a base unit (12)
firmly mountable to the floor of said
luggage compartment; a horizontal motion
mechanism (14) (HMM) including a strong
frame (26) mounted by one end thereof to
said base unit for horizontal rotation, and
4833
163005
‫מנגנון להכנסת כסא גלגלים לרכב‬
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
an intermediate assembly (32) rotatably
joined to the other end of said frame; a
vertical motion mechanism (16) (VMM)
mounted on said intermediate assembly;
and a capturing unit (18) mounted on said
VMM, for capturing and holding said
wheelchair, wherein in said transport
position, the plane of the wheelchair's
wheels is essentially vertical and
perpendicular to the car's longitudinal axis;
said HMM further comprises a horizontal
drive and a horizontal kinematical chain
including said strong frame and extending
between said base unit and said
intermediate assembly such that said
HMM is adapted to perform, driven by
said horizontal drive only, about half-circle
horizontal rotation of said strong frame
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
from said transport of the wheelchair in
one direction and, simultaneously, about
quarter-circle horizontal rotation of said
intermediate assembly in the opposite
direction, thereby positioning said VMM
outside the luggage compartment, with
said wheelchair adjacent to a lateral side of
said car and said plane of the wheels
approximately parallel to said longitudinal
axis of the car.
_______
]11[]21[
163010
‫תג בטחון קשיח והתקן ניתוק‬
]54[
HARD SECURITY TAG AND
DETACHING DEVICE
]22[
]31[
]51[
]71[
14.07.2004
637202
]32[ 08.08.2003
]33[ US
Int. Cl.(2008.04) E05B 73/00, G08B 13/14, 13/24, G09F 3/00
SENSORMATIC ELECTRONICS
CORPORATION, U.S.A.
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]74[
[57] A security system, comprising: a
security tag (100) to attach to an item, said
security tag having an outer wall (134),
and a detaching device having at least one
June 15,
driver rod (1806), said driver rod
penetrating said outer wall to detach said
security tag from said item.
– ‫כ"ג בסיוון התשס"ט‬
4834
2009
_______
]11[]21[
163077
‫תולדות מלחים רבעוניים של טריטרפין‬
‫ושמושים שלהן כקוטלי חיידקים וקוטלי‬
‫פטריות‬
]54[
TRITERPENE QUATERNARY
SALT DERIVATIVES AND
BACTERICIDAL AND
FUNGICIDAL USES THEREOF
]22[
]31[
]51[
]71[
21.01.2003
60/349564
]32[ 18.01.2002
]33[ US
Int. Cl.(2008.04) A01N 45/00, A61P 31/04, C07J 63/00
THE REGENTS OF THE
UNIVERSITY OF MINNESOTA,
U.S.A.
WO/2003/062260
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
[57] Compounds of the formula
wherein
each R1 is independently absent, oxy, thio,
or imino; each R2 is independently absent
or alkylene; each R3 is independently
hydrogen, N+ -containing heteroaryl, N+ containing heterocycle, or –N+RaRbRc;
provided at least one R3 is N+ -containing
4835
heteroaryl, N+- containing heterocycle, or
–N+RaRbRc; Ra, Rb, and Rc are each
independently (C1-C24) alkyl, aryl,
arylalkyl, heteroarylalkyl, heterocycle, or
heterocyclealkyl; each n is independently
0-4, provided at least one n is not 0; any
heteroaryl, heterocycle, or Ra, Rb, or Rc of
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
heterocyclealkyloxy, or -N+RaRbRcoxy; Rd
and Re are each independently hydrogen or
alkyl; any alkylene of R2 or alkyl of R3 can
optionally be substituted on carbon with
one or more oxo, hydroxy, halo, nitro,
cyano, (C1-C6) alkoxy, trifluoromethyl, COORd, or –NRdRe, and optionally
interrupted on carbon with one or more
oxy, imino, or thio, and is optionally
partially unsaturated; or an acceptable salt
thereof.
R3 can optionally by substituted on carbon
with one or more alkyl, hydroxyalkyl,
arylalkyl, heteroarylalkyl, aryl,
heterocycle, heterocyclealkyl, oxo,
hydroxy, halo, nitro, cyano, (C1-C6)
alkoxy, trifluoromethyl, -COORd, - NRdRe,
or cycloalkylalkyl; any cycloalkylalkyl can
optionally be substituted on carbon with
one or more hydroxyl, N + -containing
heteroaryl, N+ -containng heterocycle, or –
N+RaRbRcN+ - containing
heteroarylalkyloxy, N+ -containing
_______
]11[]21[
]54[
METHOD FOR EMBEDDING A
COMPONENT IN A BASE AND
FORMING A CONTACT
]22[
]31[
]51[
]71[
28.01.2003
20020190
]32[ 31.01.2002
Int. Cl.(2008.04) H05K 1/18, 3/46
IMBERA ELECTRONICS OY,
FINLAND
WO/2003/065778
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
‫שיטה לשיבוץ רכיב בבסיס ויצירת מגע‬
]33[
FI
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A method for embedding a
component in a base and for forming
electrical contacts with the component, the
method comprising taking a baseboard as
the base, making a hole in the baseboard,
placing a component in the hole, the
component having, on its first surface,
contact areas or contact protrusions for
creating electrical contacts, securing the
component in place in the hole made in the
baseboard, making an insulating layer on
at least one surface of the base, in such a
way that the insulating layer covers the
component, making contact openings for
the component in the insulating layer, and
making conductors to the contact openings
June 15,
163238
and on top of the insulating layer, in order
to form electrical contacts with the
component, characterized by making
conductive patterns on the baseboard,
selecting the position of the hole and
aligning the component in relation to the
conductive patterns made on the
baseboard, and after making the hole
laminating a tape or a tape-like film on the
second surface of the baseboard, placing
the component in the hole made in the
baseboard from the first-surface side of the
baseboard, so that the first surface of the
component lies against the tape or tapelike film and is substantially on the same
level as the second surface of the
– ‫כ"ג בסיוון התשס"ט‬
4836
2009
baseboard, securing the component in
place in the hole made in the baseboard by
filling the hole with a filter material, and
after securing the component, removing
the tape ot tape-like film laminated on the
second surface of the baseboard.
__________
]11[]21[
]54[
COOKING HOB FROM TEMPERED
GLASS OR OTHER
THERMODEGRADABLE
MATERIALS
]22[
]31[
]51[
]71[
]87[
]74[
30.01.2003
MI2002A000315 ]32[ 18.02.2002
Int. Cl.(2008.04) F24C 3/08
SABAF S.P.A., ITALY
WO/2003/069231
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A cooking hob having a supporting
surface (1) which is provided with at least
one hole (22) within which is housed at
least partially a gas burner (2) of the type
comprising a burner base (4) and a burner
head (5) having at least one flame crown,
as well as a circumferential ring (9) set
between said at least one flame crown and
said supporting surface, said
circumferential ring being set at a distance
from said supporting surface, characterised
4837
163446
‫שבכת בישול העשויה מזכוכית מורפה‬
‫או מחומרים אחרים העלולים להפגם‬
‫בחום‬
]33[
IT
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
in that said supporting surface is made of a
material the physical characteristics or
structure of which are degradable in the
proximity of heat sources, and said
circumferential ring has a plan diameter
equal to or greater than the diameter of
said flame crown and it is made of steel, or
aluminium, or aluminium alloys, or brass,
or ceramic, or plastic technopolymers with
ceramic fillers or with fibre fillers that are
resistant to high temperatures.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
163454
‫חיישן אופטי‬
]54[
OPTICAL SENSOR
]22[
]31[
]51[
]71[
12.02.2003
2002-034298 ]32[ 12.02.2002
]33[ JP
Int. Cl.(2008.04) G01J 1/20, 1/44, H01L 27/14
HAMAMATSU PHOTONICS K.K.,
JAPAN
SEIICHIRO MIZUNO, TATSUMI
YAMANAKA, YOSHIMARO FUJII
WO/2003/069288
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
,45087 .‫ד‬.‫ ת‬, ‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬
JERUSALEM 91450
]72[
]87[
]74[
[57] A photodetector comprising: a
plurality of photodiodes (PD1 to PDN)
each generating charges of an amount that
is in accordance with the intensity of
incident light; and integrating circuits (101
to 10N) each including an amplifier (11n)
having a differential pair input part at the
input end side and a drive part at the output
end side, and a capacitor (C) and a switch
(SW) which are disposed between said
June 15,
input end and said output end of said
amplifier, and, when said switch is opened,
accumulating, in the capacitor, charges
input into said input end from an abovementioned photodiode and outputting,
from said output end, a voltage that is in
accordance with the amount of charges
accumulated in said capacitor, said
plurality of photodiodes being disposed on
a first substrate (100), said capacitors and
– ‫כ"ג בסיוון התשס"ט‬
4838
2009
said differential pair input parts being
disposed on a second substrate (200), said
drive parts being disposed on a third
substrate (300), and said photodiodes and
said input ends of said integrating circuits
being electrically connected to each other
by said first substrate and said second
substrate being bump-connected to each
other.
________
]11[]21[
163483
‫כלי שייט בעל כרית אוויר‬
]54[
AIR CUSHION VESSEL
]22[
]31[
]51[
]71[
21.02.2003
20020867
]32[ 22.02.2002
]33[
Int. Cl.(2008.04) B60V 1/18, B63B 1/38
EFFECT SHIPS INTERNATIONAL
AS, NORWAY
WO/2003/070557
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]87[
]74[
[57] A high-speed marine vessel having
at least one hull, the weight of which being
supported by specified combinations of
hull elements (2), i.e. planing surfaces
(15), displacing volumes, pressurised air
cushions and surfaces being affected by
aerostatic and aerodynamic pressure at
high-speeds, characterised by air cushion
chambers (9), each of which being open
only downwardly, a step that extends
inwardly from each hull bottom so that a
plane defined by the step separates the hull
4839
NO
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬
in a planing and/or displacing portion
extending forward of the plane and a
pressurized air cushion portion extending
rearward, that every point of the edge of
the step in the plane being substantially at
the same vertical height relative to the
undisturbed water surface when the vessel
is under way, a rearward enclosure
arrangement (14, 15) defining a plane
between the longitudinal sidewalls, the air
cushion chamber ceiling and the water
surface, where the lower part of said plane
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
has a vertical location of up to 30% of the
distance from the hull bottom to the
cushion chamber ceiling, said lower part of
said plane, which may be adjustable,
further defining an angle with the water
plane of up to 20o when the vessel is under
way, said angle being measured over a
minimum horizontal length representing at
least 10% of the total length of the hull for
vessels with length below 30 meters and at
least 4% for vessels with length above 30
meters, the length of each air cushion
chamber from the transom (23) to the
middle point between the foremost point
and the rearward point of the step making
up between 45% and 85% of the total
length of the hull between the transom and
bow (22), in a side view, the profile of the
underside of the planing and displacing
surface (8) measured over a horizontal
distance from the middle point between the
formost point and the rearward point of the
step and at least 30% of the distance from
said middle point up to the bow, said
profile of the boundary line forming an
acute angle with the water surface at
speed, said air cushion chamber having an
increasing athwartships width towards the
transom, the average increase in width,
defined by an angle measured from the
middle point between the foremost point
and the rearward point of the step to the
transom should be less than 20o, angle
measured between the vessel centre line
direction and the respective sides of the
side hull at the water level when under
way, an arbitrary athwartships section
through the lowest of the forebody hull
surfaces forming an average angle with the
horizontal plane of at least 25o, the vessel
further comprising at least one diplacing
and/or planing multifunction propulsion
body (3), the length of each propulsion
body relative to the overall length of the
vessel being between 10% and 100%, all
above enabling desired positioning of the
centre of upward directed forces in relation
to the centre of gravity.
_______
]11[]21[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
163861
4840
2009
]54[
METHOD AND APPARATUS FOR
SENDING, RETRIEVING AND
PLANNING LOCATION
RELEVANT INFORMATION
]22[
]31[
]51[
]71[
03.03.2003
60/360737
]32[ 01.03.2002
Int. Cl.(2008.04) G01C 21/20
NETWORKS IN MOTION, INC.,
U.S.A.
WO/2003/074973
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] A computer-readable medium for
use in a communication device having a
processor (135), a data storage medium
(107, 110), an input device (111, 138) and
a display device (116) for providing a
graphical interface, said graphical interface
including a movable graphical pointer
(601, 604) for selecting and moving
graphical icons displayed on the graphical
interface, said computer-readable medium
including executable instructions for
causing the processor to execute the steps
‫ איחזור ותיכנון מידע‬,‫שיטה והתקן לשידור‬
‫לגבי מיקום שייך‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
of: displaying a user graphical icon (224,
215, 220) representing a user; displaying a
point-of-interest graphical icon (215, 206)
representing a point of interest; and in
response to a command signal, sending, to
the user (213), location information
associated with the point of interest, said
command signal being generated by
moving the graphical pointer to select and
move the point-of-interest graphical icon
towards the user graphical icon.
_______
]11[]21[
]54[
EXPLOSIVES LINER
]22[
06.03.2003
4841
163973
‫שכבה של חומר נפץ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]31[
]51[
]71[
]87[
]74[
0205565.5
]32[ 11.03.2002
Int. Cl.(2008.04) F42B 33/02
BAE SYSTEMS PLC, UNITED
KINGDOM
WO/2003/078919
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]33[
GB
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] Ordnance comprising a cavity (32)
filled with explosive materials (10), said
explosives material being contained in a
bag (36) within said cavity.
_______
]11[]21[
‫תכשיר להמרצת הפחתה המכיל‬
‫ניטרובנזן‬
]54[
FLOWERING STIMULANT
COMPOSITION USING
NITROBENZENE
]22[
]31[
03.04.2003
263/MAS/2002 ]32[ 10.04.2002
MAS/2002/480
24.06.2002
Int. Cl.(2008.04) A01N 27/00, 33/18
DEVI PESTICIDES PVT LTD, INDIA
WO/2003/086049
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
[57] A flowering stimulant composition
for agricultural and horticultural crops
comprising nitrobenzene as an active
ingredient with natural or synthetic
June 15,
164046
]33[
IN
IN
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
surfactant and solvent base as carriers at
the predetermined optimum ratio of 20%
active ingredient to 11% carriers and 69%
fillers and with variable ratio of 1% to
– ‫כ"ג בסיוון התשס"ט‬
4842
2009
99% of the active ingredient nitrobenzene.
_______
]11[]21[
]54[
TOOL ASSEMBLY
]22[
]51[
]71[
]72[
]74[
14.03.2004
Int. Cl.(2008.04) B23B 31/20
ISCAR LTD.
HANOCH GUY
ISCAR LTD.,
P.O.B. 11,TEFEN 24959
164069
‫מכלל‬
‫ תפן‬,‫ישקר בע"מ‬
‫חנוך גיא‬
,‫ישקר בע"מ‬
‫ תפן‬,11 .‫ד‬.‫ ת‬,
[57] A tool assembly comprising a tool
holder and a tool removably secured to a
forward end thereof; the tool having a
longitudinal tool axis and comprising a
tool head, a pull stud and a shank
therebetween; the shank tapers axially
rearwardly from the tool head to the pull
stud, the pull stud extends axially
rearwardly from the shank and comprises a
frustoconical head that tapers forwardly,
the tool holder comprises a sleeve and a
collet, the sleeve has a longitudinal sleeve
axis and comprises a cavity having a cavity
wall which opens out to a forward end
thereof, the cavity wall comprises a
forward tapering portion and a cylindrical
portion, the forward tapering portion tapers
axially rearwardly from the forward end of
the sleeve towards the cylindrical portion;
the collet is located within the cavity and
comprises a base at a rear end and at least
two bulge portions at a forward end
thereof, the base has an axially extending
cylindrical peripheral surface and each
bulge portion comprises an outer bulge
surface and an inner bulge surface, the
outer bulge surface has an axially
extending cylindrical shape and the inner
bulge surface lies on a forwardly tapering
conical surface, in a locked-position of the
tool assembly, the shank abuts the forward
tapering portion of the cavity wall, the
peripheral surface of the base abuts the
cylindrical portion of the cavity wall, and
the inner and outer bulge surfaces of each
bulge portion abut, respectively, the head
of the pull stud and the cylindrical portion
of the cavity wall.
_______
]11[]21[
4843
164121
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫מחבר צינורות‬
]54[
PIPE JOINT
]22[
]31[
19.03.2003
2002-77990
]32[ 20.03.2002
]33[
2003-4773
10.01.2003
Int. Cl.(2008.04) F16L 19/03, 23/02, 47/14
FUJIKIN INC., JAPAN
WO/2003/078884
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
[57] A pipe joint (1) comprising a first (2)
and a second (3) tubular joint member of
synthetic resin, and screw means (5) for
joining the joint members wherein each of
the joint members is provided at the
abutting end face area thereof with a flange
portion (5a), the first tubular joint member
being provided with an annular recessed
portion (7) in an abutting end face thereof
and the second tubular joint member being
provided with an annular ridge (8) on an
abutting end face thereof, wherein the
ridge of the second joint member is fitted
in the recessed portion of the first joint
member, with an outer surface of the ridge
in intimate contact with an inner surface of
the recessed portion when the pipe joint is
properly tightened up, a portion of the
abutting end face of the first joint member
positioned radially inwardly of the
recessed portion being then in intimate
contact with a portion of the abutting end
face of the second joint member positioned
radially inwardly of the ridge
approximately over the entire surface areas
thereof and a portion of the abutting end
face of the first joint member positioned
radially outwardly of the recessed portion
being then in intimate contact with a
June 15,
JP
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
portion of the abutting end face of the
second joint member positioned radially
outwardly of the ridge approximately over
the entire surface areas thereof,
characterized in that the screw means
comprises an annular male screw member
having a forward end face in bearing
contact with the flange portion of one of
the joint members, and a cap nut (6) fitted
around the other joint member and having
a top wall in bearing contact with the
flange portion of said other joint member,
and the cap nut being screwed on the male
screw member and when the pipe joint is
manually tightened up, a first gap is
present between the portion of the abutting
end face of the first joint member
positioned radially inwardly of the
recessed portion and the end portion of the
abutting end face of the second joint
member positioned radially inwardly of the
ridge, and a second gap greater then the
first gap is present between the portion of
the abutting end face of the first joint
member positioned radially outwardly of
the recessed portion and the portion of the
abutting end face of the second joint
member positioned radially outwardly of
the ridge.
– ‫כ"ג בסיוון התשס"ט‬
4844
2009
________
]11[]21[
]54[
TILT-UP CONCRETE WALL
PANEL FORM AND METHOD OF
FABRICATING SAME
]22[
]31[
]51[
]71[
13.12.2002
10/107561
]32[ 27.03.2002
Int. Cl.(2008.04) E04B 1/00
W. MICHAEL DELOACH, SR.,
U.S.A.
WO/2003/083230
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] A form for fabricating tilt-up
concrete wall sections, said form
comprising: a frame formed by a plurality
of spaced apart frame members attached
together at their ends, said frame having
interior dimensions; a reinforcing mat
formed by crisscrossed reinforcing
members; and a plurality of brackets
slidably disposed on the ends of at least
some of said reinforcing members and
being slidable toward and away from said
frame members, each of said brackets
4845
164273
‫תבנית לוח קיר לבטון להטיה אנכית ושיטה‬
‫ליצורה‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
being slid into engagement with a frame
member and securing the end of its
respective reinforcing member and being
fixed to said frame member to hold said
reinforcing mat in place within said frame
member and to provide structural integrity
to said form; said reinforcing mat having
dimensions smaller than the interior
dimensions of said frame and being
disposed within said frame with ends of its
reinforcing members located adjacent
respective ones of said frame members.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
164341
‫תולדות מותמרות של אמינו איזוקסאזולין‬
‫ושימוש בהן כנוגדות דיכאון‬
]54[
SUBSTITUTED AMINO
ISOXAZOLINE DERIVATIVES
AND THEIR USE AS ANTIDEPRESSANTS
]22[
]31[
]51[
]71[
27.03.2003
02076239.9
]32[ 02.04.2002
]33[ EP
Int. Cl.(2008.04) A61K 314/24, 315/383, C07D 261/20, 311/00, 498/04, 498/14
JANSSEN PHARMACEUTICA N.V.,
BELGIUM
WO/2003/082878
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]87[
]74[
[57] A compound of the formula
OSO2CH3, N-R10R11, alkyloxy,
alkyloxyalkyloxy,
alkyloxyalkyloxyalkyloxy,
tetrahydrofuranyloxy, alkylthio,
alkylcarbonyloxy,
alkyloxyalkylcarbonyloxy,
pyridinylcarbonyloxy,
alkylcarbonyloxyalkyloxy,
alkyloxycarbonyloxy, alkenyloxy,
alkenylcarbonyloxy and mono- or di
the pharmaceutically acceptable acid or
base addition salts thereof, the
stereochemically isomeric forms thereof
and the N-oxide form thereof, wherein: X
is CH2, N-R7, S or O; R7 is selected from
the group of hydrogen, alkyl, Ar, Ar-alkyl,
alkylcarbonyl, alkyloxycarbonyl and
mono- and di(alkyl) aminocarbonyl; R1
and R2 are each selected from the group of
hydrogen, hydroxy, cyano, halo, OSO2H,
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4846
2009
(alkyl) aminoalkyloxy; with the proviso
that at least one of R1 and R2 is N-R10R11
wherein: R10 and R11 are each,
independently from each other, selected
from the group of hydrogen, alkyl, Het, Ar,
Ar-alkyl, Het-alkyl, mono- or
di(alkyl)aminoalkyl, mono- or di(alkenyl)
aminoalkyl, alkylcarbonyl,
alkenylcarbonyl, Ar-carbonyl, Hetcarbonyl, alkyloxycarbonyl,
aminocarbonyl, mono- or di(alkyl)
aminocarbonyl, mono-or di(Ar)
aminocarbonyl, mono-or
di(alkyloxycarbonylalkyl) aminocarbonyl,
alkylcarbonyloxyalkyl,
alkenylcarbonyloxyalkyl, mono-or
di(alkyl) aminocarbonyloxyalkyl,
aminoiminomethyl,
alkylaminoiminomethyl, Nbenzylpiperazinyliminomethyl,
alkylsulphonyl and Ar-sulphonyl; or R10
and R11 may be taken together and with the
N may form a monovalent radical selected
from the group of
wherein:
R12 is selected from the group of hydrogen,
alkyl, Ar, Ar-alkyl, Ar-alkenyl,
alkylcarbonyl, alkyloxycarbonyl,
alkyloxyalkylcarbonyl and mono-or
di(alkyl) aminocarbonyl; each ring having
optionally 1, 2 or 3 double bonds and each
ring being optionally substituted with q
radicals R13, each radical R13
independently from each other selected
from the group of alkyl, oxo, Ar, Ar-alkyl,
Ar-alkenyl and alkyloxycarbonyl and q
being an integer ranging from 0 to 6; or R1
and R2 may be taken together to form a
bivalent radical –R1-R2- selected from the
group of –O-CH2-NR14-, -NR14-CH2-O-, NR15-CH2-NR14-, -NR14-CH2-CH2-O-, -OCH2-CH2-NR14-, -NR15-CH2-CH2-NR14-,
wherein R14 and R15 each, independently
from each other, are selected from the
group of hydrogen, alkyl, Ar, Ar-alkyl,
alkylcarbonyl, alkyloxycarbonyl,
alkyloxyalkylcarbonyl and mono-or
di(alkyl) aminocarbonyl; a and b are
asymmetric centres; (CH2)m is a straight
hydrocarbon chain of m carbon atoms, m
being an integer ranging from 1 to 4; Pir is
a radical according to any one of the
formulas
4847
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
optionally substituted with n radicals R8,
wherein: each R8 is independently from
each other, selected from the group of
hydroxy, amino, nitro, cyano, halo and
alkyl; n is an integer ranging from 0 to 5;
R9 is selected from the group of hydrogen,
alkyl and formyl; R3 represents an
optionally substituted aromatic homocyclic
or heterocyclic ring system together with
an optionally substituted and partially or
completely hydrogenated hydrocarbon
chain of 1 to 6 atoms long with which said
ring system is attached to the Pir radical
and of which may contain one or more
heteroatoms selected from the group of O,
N and S.
_______
]11[]21[
]54[
WORKING SYSTEM USING BRUSH
TOOL
]22[
]31[
10.10.2004
VR2003A000117 ]32[ 14.10.2003
VR2004A00002
17.02.2004
Int. Cl.(2008.04) B24D 13/14, 18/00, 3/22
TENAX SPA, ITALY
S. HOROWITZ & CO.,
ZION HOUSE,
41-45 ROTHSCHILD BLVD.,
TEL AVIV 65784
]51[
]71[
]74[
[57] A method of producing a surface
roughing, polishing, lapping, and
smoothing brush for stone material,
comprising the following steps: a first
injection molding of a mixture including at
least one moldable synthetic material in a
mold, thereby obtaining a base portion of a
brush (2) and a plurality of bristle
members (4) projecting from at least one
surface (6) of said base portion, said bristle
members being tapered from their base end
June 15,
164465
‫מערכת עבודה המשתמשת במכשיר‬
‫קרצוף‬
]33[
IT
IT
,'‫ הורוביץ ושות‬.‫ש‬
‫ תל‬,41-45 ‫ שדרות רוטשילד‬,‫בית ציון‬
‫אביב‬
to their tip end; and a second injection
molding onto said bristle members of a
solution or emulsion of at least one
granular abrasive material dispersed in a
matrix comprising at least one
thermoplastic resin, thereby obtaining
bristle members (3) having a layered
structure, said bristle members comprising
a core and an abrasive layer (5) and being
tapered from their base end to their tip end.
– ‫כ"ג בסיוון התשס"ט‬
4848
2009
_______
]11[]21[
]54[
METHOD AND SYSTEM FOR
OBTAINING POSITIONING DATA
]22[
]31[
14.04.2003
60/372,197
]32[ 15.04.2002
60/425,304
12.11.2002
Int. Cl.(2008.04) G06K 11/00
EPOS TECHNOLOGIES LIMITED,
BRITISH VIRGIN ISLANDS
WO/2003/088136
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]51[
]71[
]87[
]74[
[57] A position detection system for use
in association with computing applications,
the system comprising: a positional
element (14) for attaining a position and
comprising a first emitter for emitting a
continuous ultrasonic waveform, and a
detector arrangement (20) for detecting
said waveform in a manner permitting
164493
‫שיטה ומערכת להשגת מידע מיקומי‬
]33[
US
US
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
flixing of said position and outputting said
waveform for computation, in a manner
retentive of said position fixing ability,
characterized in that: said ultrasonic
waveform comprises: a carrier wave, and a
modulation integrated on said carrier wave
from which to derive said fixing of said
position.
_______
]11[]21[
164705
]54[
ALUMINIUM CONDUCTOR
COMPOSITE CORE REINFORCED
CABLE AND METHOD OF
MANUFACTURE
]22[
]31[
]51[
]71[
23.04.2002
60/374,879
]32[ 23.04.2002
]33[
Int. Cl.(2008.04) B29D 22/00, B32B 15/04
CTC CABLE CORPORATION, U.S.A.
4849
‫כבל אלומיום מוליך בעל ליבה מרוכבת‬
‫ושיטה לייצורו‬
US
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]87[
]74[
WO/2003/091008
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
,‫אגמון‬-‫סורוקר‬
‫ הרצליה פיתוח‬,14 ‫ רחוב שנקר‬,‫בית נולטון‬
[57] A composite core for an electrical
cable comprising: an inner core (300)
comprising a plurality of substantially
continuous reinforcing fibers of at least a
first type, the first fiber type having a
tensile strength that exceeds the tensile
strength of glass fibers; an outer core (304)
comprising a plurality of substantially
continuous fibers of at least a second type,
the second fiber type having a tensile
strength of or similar to glass fibers; and a
resin matrix, wherein the fibers of the
inner and the outer cores are embedded
therein; wherein, the fibers of the inner
core are different from the fibers of the
outer core and wherein the fibers of the
inner and outer cores are oriented
substantially parallel to the longitudinal
axis.
_______
]11[]21[
]54[
APPARATUS AND METHODS FOR
ENZYMATIC ESCHAROTOMY IN
BURN INDUCED COMPARTMENT
SYNDROME
]22[
]31[
]51[
]71[
]72[
21.04.2003
60/374,499
]32[ 23.04.2002
Int. Cl.(2008.04) A61L 15/00, 15/16
MEDIWOUND LTD.
LIOR ROSENBERG
June 15,
164711
‫מתקן ושיטות לחיתוך אנזימתי של גלד‬
‫בתסמונת לחץ מדורי מושהה כוויה‬
]33[
US
‫ יבנה‬,‫מדיוונד בע"מ‬
‫ליאור רוזנברג‬
– ‫כ"ג בסיוון התשס"ט‬
4850
2009
]87[
]74[
WO/2003/090598
WEBB & ASSOCIATES,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
,'‫ד"ר וב ושות‬
‫ רחובות‬,2189 .‫ד‬.‫ ת‬, 2 ‫רח' פקריס‬
[57] A burn treatment apparatus for nonsurgical escharotomy in burn induced
compartment syndrome in a burned limb,
said apparatus comprising:
(a) a flexible, water-impermeable generally
cylindrical or tube shaped covering layer
(3), said covering layer having an inner
surface facing the limb and and outer
surface (8), said covering layer having a
proximal sealable open end through which
the burned limb is inserted and a distal
closed end; and
(b) at least one enzymatic escharotomy
agent (2) contained within said covering
layer; wherein said covering is capable of
retaining said enzymatic escharotomy
agent in close proximity to the burned
limb; said apparatus enclosed within a
sterile sealed package evacuated from
moisture.
_______
]11[]21[
]54[
METHOD FOR OBTAINING A
STABLE 2-18F-FLUOR-2-DEOXYD-GLUCOSE (18F-FDG)
SOLUTION
]22[
]31[
]51[
]71[
]87[
]74[
23.04.2003
02076638.2
]32[ 24.04.2002
Int. Cl.(2008.04) A61K 101/02
MALLINCKRODT, INC., U.S.A.
WO/2003/090789
EITAN MEHULAL LAW GROUP,
4851
164805
– F18 –2 ‫שיטה לקבלת תמיסה יציבה של‬
)FDG F18– ( ‫–גלוקוז‬D– ‫–דאוקסי‬2–‫פלואור‬
]33[
EP
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
,‫פטנטים‬
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
[57] A method for improving
radiostability of a 18-F-fluor-deoxy-glucose
(18F-FDG)-solution during autoclaving,
which method comprises the steps of:
(a) provision of a 18F-fluor-deoxy-glucose
(18F-FDG)-solution, and
(b) addition of at least one buffer based on
a weak acid to the 18-F-fluor-deoxyglucose (18F-FDG)-solution, wherein said
at least one buffer is selected from the
group consisting of citrate, acetate,
ascorbate and combinations thereof.
_______
]11[]21[
164947
‫מוצרים רפואיים שמכילים ציפוי מתאים‬
‫למגע עם דם ושיטות לייצורם‬
]54[
MEDICAL PRODUCTS
COMPRISING A
HAEMOCOMPATIBLE COATING
AND METHODS FOR THEIR
PRODUCTION
]22[
]31[
15.04.2003
60/378,676
]32[ 09.05.2002
]33[ US
055.1 21 102
10.05.2002
DE
Int. Cl.(2008.04) A61K 317/27, 9/00, A61L 31/16, 33/08, A61P 35/00, 9/14
HEMOTEQ AG, GERMANY
]51[
]71[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4852
2009
]72[
]87[
]74[
ROLAND HORRES, MICHAEL
HOFFMANN, KATHARINA MARITA
LINSSEN, ERIKA HOFFMANN,
DONATO DI BIASE, VOLKER
FAUST
WO/2003/094991
WEBB & ASSOCIATES,
2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
,'‫ד"ר וב ושות‬
‫ רחובות‬,2189 .‫ד‬.‫ ת‬, 2 ‫רח' פקריס‬
[57] Medical device, wherein at least one
part of the surface of the medical device is
coated directly or via at least one
interjacent biostable and/or biodegradable
layer with a hemocompatible layer
comprising at least one compound of the
formula
wherein
n represents an integer between 4 and
1050;
Y represents a residue selected from the
group consisting of: -CHO, -COCH3, COC2H5M –COC3H7, -COC4H9, COC5H11, -COCH(CH3)2, -
COCH2CH(CH3)2, -COCH(CH3)C2H5, COC(CH3)3, -CH2COO-, -C2H4COO, C6H6COO, and –C4H8COO;
and salts of said compounds of formula
(1); and on, in and/or under the
hemocompatible layer the active agent
paclitaxel is present.
________
]11[]21[
]54[
MANUFACTURE OF BOTTLE
WITH PUSH-ON CLOSURE
]22[
]31[
]51[
]71[
06.05.2003
0210398.4
]32[ 07.05.2002
Int. Cl.(2008.04) B29C 39/00
CHARLES JONATHAN BRITTON,
UNITED KINGDOM
WO/2003/009517
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
4853
165061
‫ייצור בקבוק בעל אטם המתחבר בלחיצה‬
]33[
GB
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
[57] A method of making a bottle having
a body and a rim defining an opening for
the bottle, the opening being capable of
being closed by a push-on closure, the
bottle being made of a material which is
susceptible to deformation when heated,
the method comprising the steps of:
injection moulding in an injection
moulding apparatus a preform in the shape
of a closed-end tube with a rim at its
mouth, the rim comprising an outward
generally-radial flange having an upper
surface and a lower surface, a first detent
simultaneously formed with the flange as
an upstanding projection from the upper
surface of the flange towards the radially
inner end thereof, and a second radiallyoutward detent formed at the outer edge of
the flange, the tube depending from the
radially-inner edge of the flange; placing
the preform in a pressure moulding
apparatus at an elevated temperature with
the preform being located at least in part
by means of the second detent; moving the
flange and the first detent downwardly and
outwardly relative to the second detent so
that the upper surface of the flange now
faces inwardly and the first detent projects
inwardly into the opening for the bottle,
whereby a closure can be push-fitted onto
the rim of the bottle to engage both the
first inwardly-facing detent and the second
outwardly-facing detent; and expanding
the tube under pressure to form the body of
the bottle.
_______
]11[]21[
‫מערכת לעיבוד ממחטות נייר‬
]54[
TISSUE PROCESSING SYSTEM
]22[
]31[
]51[
]71[
]87[
01.03.2004
379342
]32[ 03.03.2003
Int. Cl.(2008.04) A61B 173/22, 19/00
KCI LICENSING, INC., U.S.A.
WO/2004/078032
June 15,
165083
– ‫כ"ג בסיוון התשס"ט‬
]33[
US
4854
2009
]74[
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
[57] A tissue processing system,
comprising: a processor (16) for
processing tissue into particles (12) for
transplantation; and a tissue extractor (30)
for extracting processed tissue from said
processor,
wherein: the processor comprises a
plurality of blades; the extractor comprises
a handle (36) and a plurality of wires (32);
the plurality of wires comprises a first end
and a second end; the first end of the
plurality of wires is hinged to the
processor; the second end of the plurality
of wires is coupled to the handle; and the
plurality of wires are positioned between
the blades.
________
]11[]21[
165177
‫תולדות אזולן ומלחים שלהן‬
]54[
AZULENE DERIVATIVES AND
SALTS THEREOF
]22[
]31[
04.08.2003
2002-226869 ]32[ 05.08.2002
]33[ JP
2003-130991
09.05.2003
JP
Int. Cl.(2008.04) A61K 31/70, 313/51, A61P 3/04, 3/10, 43/00, C07D 309/00, 309/12,
C07H 1/00
]51[
4855
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]71[
]87[
]74[
ASTELLAS PHARMA INC., JAPAN
KOTOBUKI PHARMAEUTICAL CO.
LTD., JAPAN
WO/2004/013118
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] An azulene derivative of the formula
or a salt thereof wherein R1 to R4
individually represent a hydrogen atom,
optionally substituted lower alkyl, -C(=O)optionally substituted lower alkyl, or –
optionally substituted lower alkyleneoptionally substituted aryl, R5 to R12
individually represent a hydrogen atom, an
optionally substituted lower alkyl, halogen
atom, OH, -O-optionally substituted lower
alkyl, -optionally substituted lower
alkylene-OH, -optionally substituted lower
alkylene-O-optionally substituted lower
alkyl, -O-optionally substituted lower
alkylene-O-optionally substituted lower
alkyl, -O-optionally substituted lower
alkylene-optionally substituted aryl, -
optionally substituted lower alkylene-OC(=O)-optionally substituted lower alkyl, OOH, nitro, cyano, amino, substituted
amino, or –C(=O)-O-optionally substituted
lower alkyl, and A represents a bond or an
optionally substituted lower alkylene,
wherein –A-may be bonded to any one of
the positions 1-8 of the azulene ring, and
any two of R5, R6, and R7 may form a
benzene ring together with the adjacent
carbon atoms, and wherein optionally
substituted chemical groups are substituted
with a halogen atom, -OH, -lower
alkylene-OH, -COOH, -C(=O)-O-lower
alkyl, nitro, cyano, or an amino group.
________
]11[]21[
]54[
CT DETECTOR HAVING AN
OPTICAL MASK LAYER
]22[
]31[
19.11.2004
60/525377
]32[ 26.11.2003
707407
11.12.2003
Int. Cl.(2008.04) A61B 6/03
]51[
June 15,
165310
‫גלאי טומוגרפיה ממוחשבת עם שכבת‬
‫מסכה אופטית‬
]33[
– ‫כ"ג בסיוון התשס"ט‬
US
US
4856
2009
]71[
]74[
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC,
U.S.A.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[57] A CT detector comprising: a
scintillator array (56) having a plurality of
scintillators (57) arranged along a first
plane; a photodiode array (52) having a
plurality of photodiodes (60) arranged
along a second plane different from the
first plane and parallel to the first plane,
and configured to detect illumination of
the scintillator array; the first plane and the
second plane orthogonal to a direction of
x-ray incidence on the scintillator array;
and an optical mask (88) formed of optical
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬
absorbing material and arranged and
extended in major part along a third plane
parallel to the first and the second planes,
and disposed between the scintillator array
and the photodiode array without
encroachment upon any of the first plane
or the second plane, the optical mask
configured to reduce optical transference
between a scintillator and a neighboring
photodiode, mask located closer to the
scintillator array than the plurality of
photodiodes.
_______
]11[]21[
165335
‫מכונה לניקוי משטחים‬
]54[
MACHINE FOR CLEANING
SURFACES
]22[
]51[
]71[
09.05.2003
Int. Cl.(2008.04) A46B 13/00, A47L 1/02, 11/14, E04G 23/00
CONSEJO SUPERIOR
INVESTIGACIONES CIENTIFICAS,
SPAIN
4857
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]87[
]74[
WO/2003/100192
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
[57] Machine for cleaning mainly vertical
surfaces (1) which comprises a body (2)
attached to the cable (3) of a crane (4),
brushes (5) with an actuator (6) attached to
the body with a possibility of rotation,
three or more main wheels (7) attached to
the body with the possibility of rotation
(8), the attachment being such that the
working components are in the same plane,
and further comprising a box (9) with an
open wall on the side of the surface
treated, an elastic seal (10) for the
perimeter of the open part of the box and
devices (11) to extract air from the box,
characterized in that within the box there
are one or more additional wheels, and
these additional wheels are positioned in
such a way that when the main wheels bear
against the flat surface being treated and
there is no difference in pressure between
the atmosphere and the space within the
box the distance between the additional
wheels and the surface treated has
predetermined values Li, where i is the
number of additional wheels.
_______
]11[]21[
]54[
COLOR CODED LIGHT FOR
AUTOMATED SHAPE
MEASUREMENT USING
PHOTOGRAMMETRY
]22[
]31[
]51[
24.11.2004
800499
]32[ 15.03.2004
Int. Cl.(2008.04) G01J 1/42
June 15,
165367
‫אור צבעוני מקודד למדידה אוטומטית של‬
‫צורות באמצעות פוטוגרמטריה‬
]33[
– ‫כ"ג בסיוון התשס"ט‬
US
4858
2009
]71[
]74[
NORTHROP GRUMMAN
CORPORATION, U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
[57] A method for determining the shape
of a three-dimensional object, the method
comprising: illuminating at least a portion
of a surface of the object with
electromagnetic radiation comprising a
plurality of first bands of differentiated
characteristics to form a first bands
projection; detecting the first bands
projection including the first bands of
differentiated characteristics; illuminating
at least a portion of the surface of the
object with electromagnetic radiation
comprising a plurality of second bands of
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
differentiated characteristics to form a
second bands projection, the second bands
having a different orientation than the first
bands; detecting the second bands
projection including the second bands of
differentiated characteristics; determining
the shape of the object from the detected
first bands projection and the detected
second bands projection; and displaying
the shape of the object on a screen,
printing the shape of the object and/or
storing the shape of the object on a
computer.
_______
]11[]21[
]54[
AERIAL VEHICLE CONTROLLED
AND PROPELLED BY
OSCILLATORY MOMENTUM
GENERATORS AND METHOD OF
FLYING VEHICLE
]22[
]31[
]51[
]71[
09.06.2003
10/164416
]32[ 10.06.2002
Int. Cl.(2008.04) B64C 13/00
RAMOT AT TEL AVIV
4859
165553
‫כלי רכב אווירי הנשלט ומונע על ידי‬
‫גנרטורי תנופה מחזוריים ושיטה להטסת‬
‫כלי הרכב‬
]33[
US
‫ תל‬,‫רמות ליד אוניברסיטת תל אביב בע"מ‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]72[
]87[
]74[
‫אביב‬
‫ דוד‬,‫ אברהם סייפרט‬,‫ישראל ויגננסקי‬
‫גרינבלט‬
UNIVERSITY LTD.
ISRAEL WYGNANSKY, AVRAHAM
SEIFERT, DAVID GREENBLATT
WO/2003/104078
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
[57] A vehicle capable of flight, the
vehicle comprising:
(a) at least one wing (24); and
(b) at least one oscillatory momentum
generator (22) mounted within said at least
one wing so that a thrust force (32) from
said oscillatory momentum generator is
directed outwards over said wing –
generatint air flow over a surface of said at
least one wing is created; and wherein said
thrust force exits said oscillatory
momentum generator at an angle of less
than 45 degress with respect to said surface
of said wing and wherein said thrust force
is directed to a trailing edge (58) of said
wing.
_______
]11[]21[
165581
‫תכשירים לניקוי מצעים מיקרואלקטרוניים‬
]54[
CLEANING COMPOSITIONS FOR
MICROELECTRONIC
SUBSTRATES
]22[
]31[
06.12.2004
60/386800
]32[ 07.06.2002
]33[
60/401688
07.08.2002
Int. Cl.(2008.04) C11D 7/60, G03F 7/42
MALLINCKRODT BAKER, INC.,
U.S.A.
]51[
]71[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
US
US
4860
2009
]87[
]74[
WO/2003/104901
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A silicate free cleaning composition
that is stable in strong alkaline conditions
of pH >9 and in the presence of H2O2 and
capable of cleaning photoresist and
residues from microelectronic substrates
having copper metallization and a porous
or non-porous low-κ or high-κ dielectric,
said cleaning composition being stable
when in the presence of hydrogen peroxide
oxidizing agent, said composition
consisting essentially of: from about 10 to
about 90% by weight of a polar organic
solvent having hydrogen bonding
capability and minimally or non-reactive
with an oxidizing agent, wherein the polar
organic solvent is selected from the group
consisting of dimethylpiperidone, sulfones,
and sulfolanes; from about 0.1 to about
10% by weight of a member selected from
the group consisting of a
tetraalkylammonium hydroxide, choline
hydroxide, sodium hydroxide, and
potassium hydroxide; from about 10 to
about 60% water; and from about 0.1 to
about 5% by weight of a chelating or metal
complexing agent selected from the group
consisting of trans-1,2cyclohexanediamine tetraacetic acid,
ethane-1-hydroxy-1,1-diphosphonate and
ethylenediamine tetra (methylene
phosphonic acid).
_______
]11[]21[
]54[
ELEVATING APPARATUS FOR
AN ARTILLERY GUN
]22[
]51[
]71[
08.12.2004
Int. Cl.(2008.04) F41A 27/18
ORDNANCE DEVELOPMENT AND
ENGINEERING COMPANY OF
SINGAPORE (1996) PTE LTD.,
SINGAPORE
SANFORD T.COLB & CO.,
P.O.B. 2273,
]74[
4861
165654
‫מתקן הרמה לקנה של תותח‬
,'‫ קולב ושות‬.‫סנפורד ט‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
[57] In an elevating apparatus for an
artillery gun having a breech assembly
connected to a barrel (12), the breech
assembly having a firing mechanism for
firing a projectile through an open end of
the barrel, the improvements of an
elevating apparatus comprising a support
means for supporting the barrel and breech
assembly, and three connecting members
(33, 36), the support means including three
support members (22, 40) two of which
include respective elevating mechanism
for raising and lowering the barrel,
wherein the three connecting members are
disposed in a substantially triangular
arrangement and the three connecting
members and the three support members
are disposed in a substantially tetrahedral
arrangement.
______
]11[]21[
]54[
BODY TRANSFER SYSTEM
]22[
]31[
]51[
]71[
10.06.2003
60/387545
]32[ 10.06.2002
Int. Cl.(2008.04) A61G 1/00, 10/03
CHRISTOPHER T. MCNULTY,
U.S.A.
WO/2003/103557
]87[
June 15,
165735
‫מערכת להעברת גוף‬
]33[
– ‫כ"ג בסיוון התשס"ט‬
US
4862
2009
]74[
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] A system for transferring a body
from a first surface to a second surface, the
system comprising:
(A) a housing (142) having a substantially
planar top portion configured to support a
body and having a substantially planar
bottom portion;
(B) a bottom translation mechanism (160,
170) disposed at the bottom portion and
configured to engage the first surface and
the second surface and to translate the
system back and forth between the second
surface and the first surface; and
(c) a top translation mechanism (120)
disposed at the top portion and configured
to burrow the system between the first
surface and the body as the bottom
translation mechanism transfers the system
from the second surface to the first surface.
_______
]11[]21[
]54[
SCREWDRIVER TOOL
]22[
]31[
]51[
]71[
23.12.2004
102004007066.0 ]32[ 13.02.2004
Int. Cl.(2008.04) B25B 23/14
WIHA WERKZEUGE GMBH,
GERMANY
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
]74[
4863
165955
‫מכשיר להברגת בורג‬
]33[
DE
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
JERUSALEM 91013
[57] A screwdriver tool comprising: a
driving body (12), a tool shank (10)
accommodated in the driving body so it
can rotate about its axis; and a device for
transmitting a torque from the driving
body to the tool shank which interrupts the
torque transmission when a predefined
limiting torque is exceeded, wherein: the
tool shank includes a clutch section (16)
having a non-circular cross section in a
longitudinal area accommodated in the
driving body; at least one spring element
(18) adjoins the clutch section radially
outside; and the spring element is mounted
in the driving body in a non-rotatable
manner with respect to the axis of the tool
shank and in a radially deflectable manner,
with respect to the axis of the tool shank,
against its spring force.
_______
]11[]21[
]54[
APPARATUS FOR ALTERING
THE BODY TEMPERATURE OF A
PATIENT
]22[
]31[
]51[
]71[
09.07.2003
10/193635
]32[ 11.07.2002
Int. Cl.(2008.04) A61F 7/00
LIFE RECOVERY SYSTEMS HD,
LLC, U.S.A.
June 15,
166150
‫מערכת לשינוי טמפרטורת הגוף של‬
‫מטופל‬
]33[
– ‫כ"ג בסיוון התשס"ט‬
US
4864
2009
]87[
]74[
WO/2004/006814
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
[57] Apparatus (21) for adjusting the
body temperatue of a patient (31), said
apparatus comprising: an enclosure (25)
defining an interior apace (27) for
receiving at least a portion of a patient's
body therein, said enclosure being
configured for substantially sealingly
enclosing said portion of the patient's body
within the interior space, said enclosure
being generally contiguous with the
patient's body, said enclosure having an
inlet (35) for receiving heat transfer liquid
(39) into said interior space for flow over
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
the patient's body in direct liquid contact
therewith to promote heat transfer between
the patient's body and said heat transfer
liquid, and an outlet in fluid
communication with the interior space of
the enclosure for exhausting said heat
transfer liquid from the enclosure, said
enclosure comprising a liquid impermeable
outer layer (285) and a layer of batting
(293) comprising a body-facing layer (289)
said batting layer being capable of carrying
said liquid throughout the enclosure.
_______
]11[]21[
]54[
CASCADING CLOSED LOOP
CYCLE POWER GENERATION
AND METHOD FOR
CONVERTING HEAT TO USEFUL
ENERGY
]22[
]31[
18.07.2003
10/199257
10/377114
4865
]32[
22.07.2002
03.03.2003
166382
‫ייצור אנרגיה בצורה מחזורית בלולאת מפל‬
‫סגורה ושיטה להמרת חום לאנרגיה יעילה‬
]33[
US
US
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]51[
]71[
Int. Cl.(2008.04) F01K 1/00, 25/00, 25/06, 25/08, 7/00, 7/34
DANIEL H. STINGER, U.S.A.
FAROUK ASLAM MIAN, U.S.A.
]87[
]74[
WO/2004/009965
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] A method for generating energy, the
method comprising: providing a working
fluid; increasing the pressure of the
working fluid; dividing the working fluid
into multiple streams, including at least a
first stream (A1 A2 A3 A4) and a second
stream (B1, B2, B3, B4); transferring a
first amount of heat energy from an energy
source to the first stream and subsequently
transferring a second amount of heat
energy from the first stream to the second
stream; extracting a first amount of useful
energy from the first stream; extracting a
second amount of useful energy from the
second stream; merging the first stream
with the second stream; and reducing the
first stream and the second stream to a
minimum pressure, the minimum pressure
being approximately equal to or below the
vapor pressure of the working fluid at an
ambient temperature.
_______
]11[]21[
]54[
METHOD FOR
MANUFACTURING CUTTING
INSERTS
]22[
]51[
]71[
27.01.2005
Int. Cl.(2008.04) B23C 5/20
ISCAR LTD.
June 15,
166530
‫שיטה לייצור שימות חיתוך‬
‫ תפן‬,‫ישקר בע"מ‬
– ‫כ"ג בסיוון התשס"ט‬
4866
2009
]72[
]74[
CAROL SMILOVICI, ASAF
BALLAS, OSAMA ATAR, BASEM
DAKWAR
ISCAR LTD.,
P.O.B. 11,TEFEN 24959
[57] A method for manufacturing a
cutting insert green body comprising the
steps of:
(i) providing top and bottom dies and top
and bottom punches associated therewith
and slidably reciprocable relative thereto;
each die comprising opposed die abutment
and die mounting faces and a die inner
peripheral surface extending therebetween,
the die inner peripheral surface comprising
an inner first peripheral surface extending
from the die abutment face, an inner
second peripheral surface extending from
the inner first peripheral surface and
converging inwardly to a die inner edge,
and an inner third peripheral surface
extending from the die inner edge to the
die mounting face and forming a punch
tunnel; each punch comprising opposing
punch pressing and punch mounting ends,
with a punch peripheral surface extending
therebetween and forming a punch edge at
an intersection of the punch peripheral
surface and the punch pressing face;
(ii) positioning the top and bottom dies in a
closed position with the respective die
,‫ אוסמה עטר‬,‫ אסף בלאס‬,'‫קרול שמילוביץ‬
‫באסם דקואר‬
,‫ישקר בע"מ‬
‫ תפן‬,11 .‫ד‬.‫ ת‬,
abutment faces abutting, the respective
inner first and second peripheral surfaces
forming a die cavity, the bottom punch
being located in the punch tunnel of the
bottom die, and the top punch being
external to the punch tunnel of the top die;
(iii) filling the die cavity with a predetermined amount of sinterable powder;
(iv) moving the top punch into the punch
tunnel of the top die;
(v) compacting the sinterable powder by
urging the punches through the respective
punch tunnels towards each other to a
compaction position, wherein the punch
edge of the top punch and the die inner
edge of the top die are contiguous, and the
punch edge of the bottom punch and the
die inner edge of the bottom die are
contiguous, thereby forming the green
body;
(vi) moving the top die and punch away
from the bottom die and punch to an open
position, thereby enabling removal of the
formed green body.
_______
]11[]21[
]54[
4867
1,4-DIAZABICYLOALKANE
DERIVATIVES, THEIR
166821
,‫–דיאזאביציקלואלקאן‬1,4 ‫תולדות של‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫הכנתן והשימוש בהן‬
PREPARATION AND USE
]22[
]31[
]51[
]71[
]87[
]74[
29.09.2003
PA200201456 ]32[ 30.09.2002
]33[ DK
PA200201738
11.11.2002
DK
Int. Cl.(2008.04) A61K 31/55, A61P 25/00, C07D 471/08
NEUROSEARCH A/S, DENMARK
WO/2004/029053
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
[57] A 1,4-diazabicycloalkane derivative
of the formula
any of its enantiomers or any mixture of its
enantiomers, or a pharmaceuticallyacceptable addition salt thereof, or an Noxide thereof, wherein Ar represents an
aryl group selected from phenyl and
naphthyl, or a heteroaryl group selected
from furanyl, thienyl and pyridinyl, which
aromatic group may optionally be
substituted one or more times with
substituents selected from the group
consisting of C1-6 alkyl, C3-7 cycloalkyl, C37-cycloalkyl-C1-6-alkyl, C2-6-alkenyl, C2-6alkynyl, C1-6-alkoxy, C1-6 alkyl, C1-6alkoxy- C1-6 alkoxy, C3-7-cycloalkoxy, C37-cycloalkoxy- C1-6-alkyl, C3-7cycloalkoxy- C1-6-alkoxy, halogen, CF3,
CN, NO2, NH2, carboxy, carbamoyl,
amido, sulfamoyl, phenyl and benzyl.
_______
]11[]21[
166826
‫ – יל אצטמידים‬4 – ‫ דיאוקסואימידולידין‬5,2
‫ואנלוגים כמעכבים של מטלופרוטאינז‬
MMP12
]54[
2,5 – DIOXOIMIDAZOLIDIN-4-YL
ACETAMIDES AND ANALOGUES
AS INHIBITORS OF
METALLOPROTEINASE MMP12
]22[
]31[
]51[
26.08.2003
0202539-3
]32[ 27.08.2002
]33[ SE
Int. Cl.(2008.04) A61K 314/166, A61P 11/06, C07D 233/78, 401/12, 403/12, 405/12,
409/12
ASTRAZENECA AB, SWEDEN
KRISTER HENRIKSSON, AF
MUNCK, MAGNUS ROSENSCHOLD
WO/2004/020415
]71[
]72[
]87[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4868
2009
]74[
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A compound of the formula
or a pharmaceutically acceptable salt or
solvate thereof wherein X represents an
oxygen atom or a group NR4 or CH2; Y
represents NH or N-methyl; Z1 and Z2 each
independently represent an oxygen or
sulphur atom, provided that at least one of
Z1 and Z2 represents an oxygen atom;
either R1 represents hydrogen or a group
selected from C1-C6 alkyl and a saturated
or unsaturated 3- to 10-membered ring
system which may comprise at least one
ring heteroatom selected from nitrogen,
oxygen and sulphur, each group being
optionally substituted with at least one
substituent selected from halogen,
hydroxyl, cyano, carboxyl, -NR5R6, CONR7R8, C1-6 alkyl, C1-6 alkoxy, C1-6
alkylcarbonyl (oxy), -S(O)m C1-6 alkyl
where m is 0, 1 or 2, C1-6
alkylsulphonylamino, C1-6 alkoxycarbonyl
(amino), benzyloxy and a saturated or
unsaturated 5- to 6-membered ring which
may comprise at least one ring heteroatom
selected from nitrogen, oxygen and
sulphur, the ring in turn being optionally
substituted with at least one substituent
selected from halogen, hydroxyl, oxo,
carboxyl, cyano, C1-6 alkyl, C1-6
alkoxycarbonyl and C1-6 hydroxyalkyl, R2
represents hydrogen or C1-6 alkyl, and R3
represents hydrogen or C1-6 alkyl, or
R1 and R2 together with the carbon atoms
to which they are attached form a saturated
5- to 6-membered ring optionally
comprising a ring heteroatom selected
from nitrogen, oxygen and sulphur, and R3
4869
is as defined above, or R2 and R3 together
with the carbon atom to which they are
attached form a saturated 5- to 6membered ring optionally comprising a
ring heteroatom selected from nitrogen,
oxygen and sulphur, and R1 is as defined
above; R4 represents hydrogen or C1-6
alkyl; R5, R6, R7and R8 each independently
represent hydrogen or C1-6 alkyl optionally
substituted by at least one substituent
selected form hydroxyl, halogen and C1-6
alkoxy; L represents –CH2C(O) – or –
C(O)CH2-, or L represents a C2-C6 alkyl or
C2-C6 alkynyl group optionally interrupted
or terminated by at least one moiety
selected from O, NH, S, SO2 and C(O), or
L represents a C3-C6 cycloalkyl, methyl
C3-C6 cycloalkyl or C3-C6
cycloalkylmethyl group, each of the
recited groups being optionally substituted
with at least one substituent selected from
hydroxyl, halogen, C1-C4 alkyl, C1-C4
haloalkyl, C1-C4 alkoxy and C1-C4
haloalkoxy, or L represents a C3-C4
alkylene chain, the ends of which are
attached to adjacent ring carbon atoms in
the 5- to 10-membered ring system o f G2
to form a ring; G2 represented a saturated
or unsaturated 5- to 10-membered ring
system which may comprise at least one
ring heteroatom selected from nitrogen,
oxygen and sulphur, the ring system being
optionally substituted with at least one
substituent selected from halogen,
hydroxyl, cyano, nitro, C1-C6 alkyl
(optionally substituted by one or more of
June 15, 2009 – ‫כ"ג בסיוון התשס"ט‬
cyano, halogen, hydroxyl and methoxy),
C2-C6 alkenyl, C1-C6 alkoxy (optionally
substituted by one or more halogen atoms),
-S(O)n C1-C6 alkyl where n is 0,1 or 2, C1-
C6 alkylcarbonyl (amino), C1-C6
alkylcarbonyloxy, phenyl, benzyloxy, NR9R10 and a group of the formula
R9 and R10 each independently represent
hydrogen or C1-C6 alkyl optionally
substituted by at least one substituent
selected from hydroxyl, halogen and C1-C6
alkoxy; M represents a bond or –O-, -S-, C≡C-, -CH2O- or –OCH2-; G3 represents
an unsaturated 5- to 10-membered ring
system which may comprise at least one
ring heteroatom selected from nitrogen,
oxygen and sulphur, the ring system being
optionally substituted with at least one
substituent selected from halogen,
hydroxyl, cyano, nitro, C1-C6 alkyl
(optionally substituted by one or more of
cyano, halogen, hydroxyl, and methoxy),
C2-C6 alkenyl, C1-C6 alkoxy (optionally
substituted by one or more halogen atoms),
-S(O)tC1-C6 alkyl where t is 0, 1 or 2, C1C6 alkylcarbonyl (amino), C1-C6
alkylcarbonyloxy, phenyl, benzyloxy and –
NR11R12; and R11 and R12 each
independently represent hydrogen or C1-C6
alkyl optionally substituted by at least one
substitutent selected from hydroxyl,
halogen and C1-C6 alkoxy.
_______
]11[]21[
166896
‫חומרים מקשרים לריצוף ושיטות ייצור‬
]54[
PAVING BINDERS AND
MANUFACTURING METHODS
]22[
]31[
]51[
]71[
26.08.2003
10/228660
]32[ 26.08.2002
]33[
Int. Cl.(2008.04) C08L 95/00, C09D 195/00
SHELL CANADA LIMITED,
CANADA
WO/2004/018554
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
4870
2009
[57] A paving binder which is obtained
by mixing substances comprising:
(a) a fine mineral constituent;
(b) a hydrocarbon-based plasticizer;
(c) sulfur, wherein said sulfur is
incorporated into the mixture in a weight
percentage of at least about 60%; and
(d) carbon black, wherein said carbon
black is incorporated in a weight
percentage in the range from about 0.2% to
about 15% with respect to the amount of
said sulfur.
________
]11[]21[
]54[
METHOD AND APPARATUS FOR
LOCATING AND TRACKING
PERSONS
]22[
]31[
05.09.2003
60/409610
]32[ 09.09.2002
651635
29.08.2003
Int. Cl.(2008.04) G08B 1/08
PERSEPHONE, INC., U.S.A.
WO/2004/023415
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
[57] An implantable apparatus for use in
a system for locating and tracking a
person, comprising: a power source; an
individual identifier that allows for only
said device to be triggered into
positioning-related activities; a triggering
and positioning mechanism that functions
in conjunction with external systems which
are completely or in part ground-based,
air-based, water-based, or satellite-based,
or a combination thereof and which use,
but are not limited to, any of
radiofrequency, cellular, sound, light,
and/or television wave analog and/or
4871
166899
‫שיטה והתקן למיקום ועקיבה אחר אנשים‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
digital technology, for positioning and
device triggering to provide any of
positioning and non-positioning
information; a receiver, a transmitter,
wherein gross anatomic siting of said
apparatus within said person comprises
any of the person's limb, torso, neck, and
head; and means specifically adapted for
surgical fixation of said apparatus within
said person at a non-subcutaneous location
that comprises any of supramuscular,
intramuscular, submuscular, intraluminal,
and intracavitary locations.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
]54[
INK JET PRINTHEAD WITH INK
ISOLATED NOZZLE ACTUATOR
]22[
]51[
]62[
]71[
24.05.2000
Int. Cl.(2008.04) B41J 20/45
DIVISION FROM 166919
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2001/089839
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
166919
[57] An ink jet printhead comprising: at
least one nozzle chamber for holding ink;
at least one nozzle (22) defining an
opening (24) in fluid communication with
the nozzle chamber; and at least one
‫ראש מדפסת הזרקת דיו עם מפעיל לנחיר‬
‫דיו מבודד‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
actuator (28) connected to the nozzle and
isolated from the ink held in the nozzle
chamber, the actuator, in use, actuating the
nozzle to eject ink from the nozzle
chamber through the opening.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4872
2009
]11[]21[
]54[
LEVER HANDLE SUPPORT
MECHANISM
]22[
]31[
]51[
]71[
13.08.2003
243925
]32[ 13.09.2002
Int. Cl.(2008.04) E05B 9/00
SARGENT MANUFACTURING
COMPANY, U.S.A.
WO/2004/025057
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
[57] A handle support mechanism for
attachment to a lock (24) operable by first
and second handles, the handle support
mechanism comprising: a first friction
element comprising a disc (12) having a
friction surface and a first cylindrical
bearing surface (40), the first friction
element being connected to and
rotationally driven by the first handle (50)
when the first handle is turned; a second
friction element comprising a disc (14)
having a friction surface and a second
cylindrical bearing surface (42), the second
friction element being connected to and
rotationally driven by the second handle
(52) when the second handle is turned; a
4873
167040
‫מכניזם לתמיכת ידית של מנעול‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
first non-rotatable friction surface (48) in
frictional contact with the surface on the
first friction element; a second nonrotatable friction surface (49) in frictional
contact with the friction surface on the
second friction element, the first and
second fixed friction surfaces being nonrotatable relative to the lock; and a bracket
(10) holding the friction surfaces on the
first and second friction elements in
frictional contact with the first and second
non-rotatable friction surfaces, the bracket
including first (44) and second (46)
bearing holes engaging the first and second
cylindrical bearing surfaces to rotationally
hold the first and second friction elements.
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
_______
]11[]21[
167095
‫פריט של רהיט המשנה צורה‬
]54[
ITEM OF TRANSFORMABLE
FURNITURE
]22[
]31[
23.01.2003
6513
]32[ 02.09.2002
]33[ BG
107294
19.11.2002
BG
Int. Cl.(2008.04) A47B 85/04, A47C 13/00
ORT JOINT-STOCK COMPANY,
BULGARIA
WO/2004/019730
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
[57] An item of transformable furniture
consisting of two plates (5, 6) connected
with each other by a horizontal hinge joint
(4), wherein the plates can rotate around a
horizontal axis (2, 3) located at different
levels and in parallel to the axis of the
hinge joint so that the plates can switch
over between a first position as a seat (6)
and a back (5) and a second position as a
front panel (6) and a worktop (5),
respectively.
_______
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4874
2009
]11[]21[
‫מכשיר להחדרת שתלים תת–עוריים‬
]54[
IMPLANTER DEVICE FOR
SUBCUTANEOUS IMPLANTS
]22[
]31[
]51[
]62[
]71[
15.12.1998
60/068996
]32[ 29.12.1997
Int. Cl.(2008.04) A61M 37/00
DIVISION FROM 137095
INTARCIA THERAPEUTICS, INC.,
U.S.A.
WO/1999/033512
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
167247
[57] A kit for inserting an implant and
maintaining sterile conditions during
implant insertion comprising: an implanter
(10) including a handle, a rod
longitudinally fixed within the handle, a
hollow cannula longitudinally slidable on
the rod, and an actuator connected to the
cannula and longitudinally slidable in the
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
handle to move the cannula from an
extended position to a retracted position to
release the implant from the cannula; a
cutting device for making an implanting
incision in tissue; supplies for maintaining
sterility of the implant insertion process;
and wound dressings.
_______
]11[]21[
]54[
4875
SOLDER HIERARCHY FOR LEAD
FREE SOLDER JOINT
167254
‫היררכית מתכת יצוקה לחיבור מתכת נטות‬
‫עופרת‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]22[
]31[
]51[
]71[
]87[
]74[
12.09.2003
10/246282
]32[ 18.09.2002
Int. Cl.(2008.04) B23K 35/14
IBM CORPORATION, U.S.A.
WO/2004/026517
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
]33[
US
,‫מעבדות יבמ מחלקת קנין רוחני‬
‫ חיפה‬,‫אוניברסיטת חיפה הר הכרמל‬
[57] An off-eutectic solder composition
consisting essentially of between 90.099.0% Sn; between 10.0-1.0% Cu; and
having inter-metallics with a melting
temperature greater than 280 degrees C.
________
]11[]21[
167389
‫תכשירי תזונה מועשרים בלאוצין‬
]54[
LEUCINE-ENRICHED
NUTRITIONAL COMPOSITIONS
]22[
]31[
19.09.2003
60/412370
]32[ 20.09.2002
]33[ US
60/417203
09.10.2002
US
60/455921
19.03.2003
US
Int. Cl.(2008.04) A23L 1/29, A61K 311/95, A61P 35/00
NESTEC S.A., SWITZERLAND
WO/2004/026294
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
[57] A composition comprising an amino
nitrogen source, wherein the amino
nitrogen source comprises:
June 15,
(a) intact protein selected from at least one
of casein, whey protein, soy protein,
collagen or wheat protein;
(b) leucine; and
– ‫כ"ג בסיוון התשס"ט‬
4876
2009
(c) at least one of isoleucine, lysine,
methionine, phenylalanine, threonine,
tryptophan, valine, or histidine in free
and/or salt form, and wherein leucine in
free and/or salt form is present in an
amount of at least 10 to 35% by weight
based on the weight of total amino acids.
_______
]11[]21[
]54[
METHOD FOR TOOL MATCHING
AND TROUBLESHOOTING A
PLASMA PROCESSING SYSTEM
]22[
]31[
26.09.2003
60/414108
]32[ 26.09.2002
10/341913
13.01.2003
Int. Cl.(2008.04) H01J 7/24
LAM RESEARCH CORPORATION,
U.S.A.
WO/2004/030016
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] A method for testing a plasma
processing system having a chamber, an
RF power source, and a matching network,
the method comprising: generating an RF
power signal at a predetermined constant
plasma operating frequency from the RF
power source to the chamber without
igniting any plasma within the chamber;
measuring a voltage of said RF power
signal, a current of said RF power signal,
The applications for division
from this application have
not yet been published
167674
‫שיטה להתאמת כלים ולפתרון בעיות‬
‫במערכת עיבוד פלסמה‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
and a phase of said RF power signal,
received by the chamber; comprising a
value representative of an impedance of
the chamber based on said voltage, said
current, and said phase; and comparing
said value with a reference value to
determine any defects in the plasma
processing system, said reference value
representative of the impedance of a
defect-free chamber.
,170643
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
]11[]21[
]54[
LIGHTNING STRIKE
PROTECTION AND GROUNDING
OF A COMPOSITE AIRCRAFT
PANEL
]22[
07.10.2003
4877
167853
‫הגנת ברקים והארקה לפנל מרוכב של כלי‬
‫טיס‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]31[
]51[
]71[
]87[
]74[
10/269194
]32[ 11.10.2002
]33[ US
Int. Cl.(2008.04) B64C 1/00, B64D 45/02
THE BOEING COMPANY, U.S.A.
WO/2004/033293
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬
HERZLIYA 46733
[57] An aircraft panel assembly (10)
comprising: a panel core (28); a plurality
of pre-preg plies applied to said panel core
forming an internal layer of plies (34); said
plurality of pre-preg plies including an
outer ply layer (40); at least one metal foil
layer (38) permanently applied to said
outer ply layer of said internal layer of
plies, said at least one metal foil layer
providing an electrical conduit between an
outer surface (24) and a sub-structure
contact surface (26) of the aircraft panel
assembly; and an outer surface skin (44)
applied to said at least one metal foil layer,
said at least one metal foil layer positioned
between said outer surface skin and said
outer ply layer, said outer surface skin
allowing current to pass through to said at
least one metal foil.
_______
]11[]21[
]54[
EFFUSION COOLED TRANSITION
DUCT WITH SHAPED COOLING
HOLES
June 15,
– ‫כ"ג בסיוון התשס"ט‬
168196
‫צינור העברה לשפיכה מקוררת עם חורים‬
‫מעוצבים לקירור‬
4878
2009
]22[
]31[
]51[
]71[
]87[
]74[
01.05.2003
10/280173
]32[ 25.10.2002
Int. Cl.(2008.04) F02C 3/14, 7/18
POWER SYSTEMS MFG. LLC,
U.S.A.
WO/2004/040108
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
[57] An effusion cooled transition duct
(40) for transferring hot gases from a
combustor to a turbine comprising: a panel
assembly (45) comprising: a first panel
(46) formed from a single sheet of metal; a
second panel (47) formed from a single
sheet of metal; said first panel fixed to said
second panel by a means such as welding
thereby forming a duct having an inner
wall (48), an outer wall (49), a thickness
there between said walls, a generally
cylindrical inlet end (50), and a generally
rectangular axis end (54), said inlet end
defining a first plane, said exit end
defining a second plane, said first plane
oriented at an angle to said second plane; a
generally cylindrical inlet sleeve having an
inner diameter and outer diameter, said
inlet sleeve fixed to said inlet end of said
panel assembly; a generally rectangular aft
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
end frame (42), said frame fixed to said
exit end of said panel assembly; and, a
plurality of cooling holes (60) in said panel
assembly, each of said cooling holes
having a centerline (CL) and separated
from an adjacent cooling hole in the axial
and transverse direction by a distance P,
said cooling holes extending from said
outer wall to said inner wall, each of said
cooling holes drilled at an acute surface
angle β relative to said outer wall and a
transverse angle γ, each of said cooling
holes having a first diameter (D1) and a
second diameter (D2) wherein said
diameters are measured perpendicular to
said inner wall, and said second diameter
is greater than said first diameter such that
said cooling hole is generally conical in
shape.
_______
]11[]21[
]54[
4879
COPOLYMERS OF ETHYLENE
WITH ALPHA-OLEFINS
168349
‫קופולימרים של אתילן עם אלפא–אולפינים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]22[
]31[
]51[
]71[
]87[
]74[
18.12.2003
10261252.8
]32[ 20.12.2002
]33[ DE
60/451836
04.03.2003
US
Int. Cl.(2008.04) B01J 31/00, C08F 2/00, 46/42
BASELL POLYOLEFINE GMBH,
GERMANY
WO/2004/056878
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
[57] A copolymer of ethylene with αolefins which has a molar mass
distribution Mw/Mn of from 1 to 8, a
density of from 0.85 to 0.94 g/cm3, a molar
mass Mn of from 10000 g/mol to 4000 000
g/mol and a CDBl of less than 50%, the
copolymer having at least a bimodal side
chain branching distribution and wherein
the side chain branching of the maxima of
the individual peaks of the side chain
branching distribution, as determined by
crystallization analysis fractionation
(CRYSTAF®), is in each case greater than
5 CH3/1 000 carbon atoms.
,194974,194973
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
________
]11[]21[
]54[
FOOT CONTROLLER FOR
MICROSURGICAL SYSTEM
]22[
]31[
]51[
]71[
]87[
]74[
09.10.2003
10/308498
]32[ 03.12.2002
Int. Cl.(2008.04) A61B 17/00
ALCON, INC., SWITZERLAND
WO/2004/049955
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
‫בקר כפ–רגל למערכת מיקרו–ניתוח‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A method of operating a foot
controller of a microsurgical system,
comprising the steps of: providing a
microsurgical system (10), said system
comprising: a computer (18); and a foot
controller (26) operatively coupled to said
June 15,
168703
computer, said foot controller having a
foot pedal (32) with a range of motion,
said range of motion having a first area
indicative of a first surgical mode of said
microsurgical system and a second area
indicative of a second surgical mode of
– ‫כ"ג בסיוון התשס"ט‬
4880
2009
said microsurgical system, said first and
second areas separated by a detent; and
using said computer to modulate said
detent by varying a resistance felt by a
user's foot as said foot presses on said foot
pedal, wherein said varying of said
resistance comprises increasing said
resistance a first time, decreasing said
resistance, and increasing said resistance a
second time within said detent.
_______
]11[]21[
]54[
FLUID CONTROLLER
]22[
]31[
]51[
]71[
]87[
]74[
31.10.2003
2002-351564 ]32[ 03.12.2002
Int. Cl.(2008.04) F16K 31/52, 311/63
FUJIKIN INCORPORATED, JAPAN
WO/2004/051127
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A controller comprising: a valve
body (1) having a fluid channel openable
and closable with reciprocating upward
and downward movement of a valve stem
(16), a casing (2) fixed to an upper portion
of the valve body, an operating rod (3)
provided in an upper inside portion of the
casing and movable upward and
4881
168936
‫בקר נוזלים‬
]33[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
downward, drive means (4) for moving the
operating rod upward and downward, and
force amplifying means (5) provided in a
lower inside portion of the casing for
transmitting a force acting on the operating
rod to the valve stem upon amplification,
the controller being characterized in that
the force amplifying means comprises: a
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
tapered member (41) extending vertically
downward from a lower end of the
operating rod, a disk member (42)
provided at an upper end of the valve stem,
and a first pivotal member (43) and a
second pivotal member (44) arranged
between the two members and opposed to
each other with the tapered member
positioned therebetween, each of the first
and second pivotal members being
pivotally movable about an axis of a pivot
extending through a lower portion thereof,
each of the pivotal members having a plate
body (43a), an upper contact face (43b)
formed on an upper portion of the plate
body and in bearing contact with a tapered
face of the tapered member, and a lower
contact face (43c) formed on a lower
portion of the plate body and bearing on an
upper surface of the disk member, the
lower contact face of each pivotal member
being in the form of a circular-arc cam
face centered about a center line positioned
away from the axis of the pivot.
_______
]11[]21[
]54[
MISSILE SYSTEM WITH
MULTIPLE SUBMUNITIONS
]22[
]31[
]51[
]71[
]87[
]74[
27.02.2004
10/376192
]32[ 27.02.2003
Int. Cl.(2008.04) F42B 12/62
RAYTHEON COMPANY, U.S.A.
WO/2004/019764
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
–‫מערכת טיל עם מספר רב של תת‬
‫תחמושות‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
[57] A missile (10) for hitting a moving
target, the missile comprising: a booster
(12); and a submunition delivery vehicle
(14) separably coupled to the booster;
wherein the submunition delivery vehicle
includes: at least one submunition (56)
June 15,
169080
separable from the submunition delivery
vehicle; and a beacon (74) separably
coupled to the at least one submunition;
and wherein the beacon is configured to
emit a signal indicating position of the
submunition delivery vehicle.
– ‫כ"ג בסיוון התשס"ט‬
4882
2009
_______
]11[]21[
169101
‫שיטה לייצור חלבונים רקומביננטים‬
‫פוליקלונאלים‬
]54[
METHOD FOR MANUFACTURING
RECOMBINANT POLYCLONAL
PROTEINS
]22[
]31[
07.01.2004
PA2003/00008 ]32[ 07.01.2003
]33[ DK
60/438403
07.01.2003
US
60/476018
05.06.2003
US
Int. Cl.(2008.04) C12N 15/64, 15/85, 5/10, C40B 40/02
SYMPHOGEN A/S, DENMARK
WO/2004/061104
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
[57] A method for generating a collection
of cells suitable as a recombinant
4883
polyclonal manufacturing cell line, said
method comprising:
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
(a) providing a library of vectors
comprising a population of variant nucleic
acid sequences, wherein each of said
vectors comprises (1) one single copy of a
distinct nucleic acid sequence encoding a
distinct member of a polyclonal protein
comprising distinct members that bind a
particular antigen and (2) one or more
recombinase recognition sequences;
(b) introducing said library of vectors into
a host cell line, wherein the genome of
each individual cell of said host cell line
comprises recombinase recognition
sequences, matching those of the vector, at
a single specific site in its genome;
(c) ensuring the presence in said cells of
one or more recombinases so that the
variant nucleic acid sequences of step (a)
are integrated site-specifically in the cells
of the host cell line, where said one or
more recombinases is/are either (i)
expressed by said cells into which said
nucleic acid sequence is introduced; (ii)
operatively encoded by the vectors of step
(a); (iii) provided through expression from
a second vector; or (iv) provided to the cell
as a protein; and
(d) selecting cells comprising an integrated
copy from said library of variant nucleic
acid sequences.
_______
]11[]21[
169251
‫שיטה והתקן למדידת מידע מצב ערוץ‬
]54[
METHOD AND APPARATUS FOR
MEASURING CHANNEL STATE
INFORMATION
]22[
]31[
]51[
]62[
]71[
20.03.2001
09/539224
]32[ 30.03.2000
]33[ US
Int. Cl.(2008.04) H04B 17/07, 7/04, 7/06, 7/26, H04J 11/00, 15/00, H04L 27/26
DIVISION FROM 151397
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/076110
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] A method of transmitting in a multiantenna communication system,
comprising: assigning each of a plurality
of antennas with a different one of a
plurality of groups of subbands, wherein
June 15,
each of the plurality of groups includes a
different subset of the plurality of
subbands and wherein the plurality of
subbands of a first group are
noncontiguous; and transmitting from the
– ‫כ"ג בסיוון התשס"ט‬
4884
2009
plurality of antennas simultaneously using
the plurality of groups of subbands,
wherein the transmitting from each
antenna occurs on the group of subbands
assigned to the antenna.
,195020
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_______
]11[]21[
169491
]54[
CUTTING INSERT
]22[
]51[
]71[
]72[
30.06.2005
Int. Cl.(2008.04) B23B 27/16, B23C 5/20
ISCAR LTD.
CAROL SMILOVICI, ASAF
BALLAS
ISCAR LTD.,
P.O.B. 11,TEFEN 24959
]74[
[57] A double-sided reversible and
indexable cutting insert comprising:
identical opposing first and second end
faces (28); a peripheral side surface (32)
extending between said first and second
end faces, the peripheral side surface
comprising Y major side surfaces and Y
minor side surfaces, Y being an integer,
each minor side surface (34)
interconnecting two adjacent major side
surfaces; a clamping through-bore
4885
‫שימת חיתוך‬
‫ תפן‬,‫ישקר בע"מ‬
‫ אסף בלאס‬,'‫קרול שמילוביץ‬
,‫ישקר בע"מ‬
‫ תפן‬,11 .‫ד‬.‫ ת‬,
extending between, and opening out to, the
first and second end faces; a median plane
(M) located between, and spaced apart
from, the first and second end faces; and a
through-bore axis (T) extending
perpendicularly through the median plane,
with the cutting insert having Y-fold
rotational symmetry about the throughbore axis; wherein: each minor side
surface is a section of single cylindrical
surface having a radius ©, the radius ©
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
being greater than a minor side surface
distance (D) between said each minor side
surface and the through-bore axis.
_______
]11[]21[
‫מעלית‬
]54[
ELEVATOR
]22[
]31[
]51[
]71[
]72[
01.10.2003
20030153
]32[ 31.01.2003
Int. Cl.(2008.04) B66B 11/08, 7/10
KONE CORPORATION, FINLAND
ESKO AULANKO, JORMA
MUSTALAHTI
WO/2004/067429
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
]87[
]74[
[57] An elevator without a counterweight
having an elevator car (1), in which the
elevator car is suspended by hoisting ropes
(3) comprising a single rope or several
parallel ropes, said elevator having a
traction sheave (5) which moves the
elevator car by the hoisting ropes, wherein
the hoisting ropes have portions going
June 15,
169664
]33[
FI
,‫אגמון‬-‫סורוקר‬
‫ הרצליה פיתוח‬,14 ‫ רחוב שנקר‬,‫בית נולטון‬
upwards and downwards from the elevator
car, and the rope portions going upwards
from the elevator car are under a first rope
tension (T1) which is greater than a second
rope tension (T2), which is the rope tension
of the rope portions going downwards
from the elevator car, the elevator
including a compensating system for
– ‫כ"ג בסיוון התשס"ט‬
4886
2009
keeping a ratio (T1,/T2) between the first
rope tension and the second rope tension
substantially constant, the elevator car is
connected to the hoisting ropes by at least
one diverting pulley (9, 10, 12, 13) from a
rim of which the hoisting ropes go
upwards from both sides of the diverting
pulley, and at least one diverting pulley
from the rim of which the hoisting ropes
go downwards from both sides of the
diverting pulley, and a suspension ratio of
both upward rope portions and downward
rope portions is at least 2:1 roping.
_______
]11[]21[
]54[
FLOORING SYSTEMS AND
METHODS FOR INSTALLATION
]22[
]31[
08.03.2004
0300626-9
]32[ 06.03.2003
0302865-1
29.10.2003
Int. Cl.(2008.04) E04F 15/04
VALINGE INNOVATION AB,
SWEDEN
WO/2004/079130
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]51[
]71[
]87[
]74[
[57] A flooring system comprising
rectangular floorboards (1, 1') which are
mechanically lockable, in which system
each individual floorboard along its long
sides (4a, 4b) has a pair of opposing
4887
169926
‫מערכות ריצוף ושיטות להרכבה‬
]33[
SE
SE
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
connecting means for locking together said
floorboard with similar, adjoining
floorboards both vertically and
horizontally and along its short sides (5a,
5b) has a pair of opposing connecting
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
means, wherein the connecting means of
the floorboards are designed so as to allow
locking-together of the long sides by
angling along a upper joint edge,
characterized in that said pair of opposing
connecting means of said short sides are
adapted for locking the floorboards only
horizontally, the system comprises two
different types of floor-board the
connecting means of one type of floorboard along one pair of opposite edge
portions being arranged in a mirrorinverted manner relative to the
corresponding connecting means, along the
same pair of opposite edge portions of the
other type of floorboard.
_______
]11[]21[
]54[
REDUCING TEMPERATURE
STABILIZATION TIME OF AN IR
DETECTOR IN THE J-T
CRYOGENIC COOLING
PROCESS
]22[
]51[
]71[
11.08.2005
Int. Cl.(2008.04) F25B 9/02
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]72[
]74[
DOV LAVI
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
170266
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫דב לביא‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A system for quickly cooling an
object (18) to a stable cryogenic
temperature, said system comprising a
refrigerant container (24) containing
cryogenic gas pressure, a refrigerant
container valve (26), a J-T cooler (21)
June 15,
‫הפחתת זמן סטביליזציה של טמפרטורה‬
T – J ‫ בתהליך קירור קריוג'ני‬IR ‫של גלאי‬
comprising an expansion valve, a transfer
line (22) for transferring said cryogenic
gas from said refrigerant container through
said cooler into an enclosed volume (12)
that surrounds and/or is in good thermal
contact with said object when said
– ‫כ"ג בסיוון התשס"ט‬
4888
2009
refrigerant container valve is opened, and
one or more pressure release valves (28)
adjusted to release gas from the interior of
said enclosed volume when the pressure
inside said enclosed volume rises above a
predetermined pressure; said system
characterized in that it additionally
comprises a temperature measuring device
(34) to measure the temperature of said
object, an open/close valve (32) for
controlling the passage of said gas from
the interior to the exterior of said enclosed
volume, and a controller that opens said
open/close valve when said refrigerant
container valve is opened to begin
releasing said refrigerant from said
container and closes said open/close valve
when said temperature measuring device
indicates that the temperature of said
object has been lowered to a
predetermined temperature.
_______
]11[]21[
]54[
HERBICIDAL MIXTURES
COMPRISING A SAFENER
]22[
]31[
]51[
]71[
10.03.2004
60/453976
]32[ 13.03.2003
Int. Cl.(2008.04) A01N 43/80, 61/00
BASF AKTIENGESELLSCHAFT,
GERMANY
WO/2004/080172
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]87[
]74[
[57] A herbicidal mixture comprising
(A) a 3-heterocyclyl-substituted benzoyl
derivative selected from the group of 4-[2chloro-3-(3-methyl-isoxazol-5-yl)-4methylsulfonyl-benzyl]-1-methyl-5hydroxy-1H-pyrazole, 4-[2-methyl-3-(3methyl-isoxazol-5-yl)-4-methylsulfonylbenzoyl]-1-methyl-5-hydroxy-1H-pyrazole
4889
170302
‫תערובות קוטלי עשבים המכילות חומר מגן‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
and 4-[2-methyl-3-(4,5-dihydroisoxazol-3yl)-4-methylsulfonylbenzoyl]-1-methyl-5hydroxy-1H-pyrazole; or one of its
environmentally compatible salts,
(B) a safening effective amount of
cloquintocet, or its environmentally
compatible salts, amides, esters and
hydrates;
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
and, if desired,
© at least one herbicidal compound from
the group of the acetyl-CoA carboxylase
inhibitors (ACC), acetolactate synthase
inhibitors (ALS), amides, auxin herbicides,
auxin transport inhibitors, carotenoid
biosynthesis inhibitors,
enolpyruvylshikimate 3-phosphate
synthase inhibitors (EPSPS), glutamine
synthetase inhibitors, lipid biosynthesis
inhibitors, mitosis inhibitors,
protoporphyrinogen IX oxidase inhibitors,
photosynthesis inhibitors, synergists,
growth substances, cell wall biosynthesis
inhibitors and a variety of other herbicides.
_______
]11[]21[
170489
‫קופולימרים ותכשירי רוקחות המכילים‬
‫אותם‬
]54[
COPOLYMERS AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]22[
]31[
24.03.2004
2003-080389 ]32[ 24.03.2003
]33[ JP
2003-355853
16.10.2003
JP
2003-426598
24.12.2003
JP
Int. Cl.(2008.04) A61K 38/16, C08F 216/20, 8/12, C08G 653/32
DAIICHI SANKYO COMPANY
LIMITED, JAPAN
WO/2004/085500
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]51[
]71[
]87[
]74[
[57] A copolymer or a pharmacologically
acceptable salt thereof, which contains, as
constitutional units,
June 15,
(a) one or more structural units which may
be the same or different from each other
and which are represented by the formula
– ‫כ"ג בסיוון התשס"ט‬
4890
2009
wherein:
m is an integer of from 3 to 100,
Alk represents an alkylene group having
from 1 to 6 carbon atoms, and R1 and R2
are the same or different and each
represents a hydrogen atom or an alkyl
group having from 1 to 6 carbon atoms
that may optionally be substituted with at
least one substituent selected from the
group consisting of ydroxyl groups,
halogen atoms and aryl groups having
from 6 to 14 carbon atoms that may
optionally be substituted with from 1 to 5
substituents selected from Substituents A
defined below, and
(b) one or more structural units which may
be the same or different from each other
and which are represented by the formula
wherein:
the formula –NR4R5, wherein R4 and R5
3
R represents
are the same or an alkyl group having from
a hydroxyl group,
1 to 6 carbon atoms that may optionally be
an alkoxy group having from 1 to 6 carbon
substituted with at least one substituent
atoms that may optionally be substituted
selected from the group consisting of
with at least one substituent selected from
ydroxyl groups, halogen atoms and aryl
the group consisting of ydroxyl groups,
groups having from 6 to 14 carbon atoms
halogen atoms and aryl groups having
that may optionally be substituted with
from 6 to 14 carbon atoms that may
from 1 to 5 substituents selected from
optionally be substituted with from 1 to 5
Substituents A defined below; Substituents
substituents selected from Substituents A
A are selected from alkyl groups having
defined below, an aryloxy group having
from 1 to 6 carbon atoms, alkoxy groups
from 6 to 14 carbon atoms that may
having from 1 to 6 carbon atoms, halogen
optionally be substituted with from 1 to 5
atoms, ydroxyl groups, nitro groups and
substituents selected from Substituents A
carboxy groups.
defined below, or a group represented by
________
]11[]21[
]54[
4891
METHOD AND MEANS FOR
PRODUCING A MAGNETICALLY
INDUCED DESIGN IN A COATING
CONTAINING MAGNETIC
172363
‫שיטה לייצור הרכב מגנטי בעטיפה‬
‫המכילה חלקיקים מגנטיים‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
PARTICLES
]22[
]31[
]51[
]71[
]87[
]74[
29.06.2004
03015090.8
]32[ 03.07.2003
Int. Cl.(2008.04) B41M 3/14
SICPA HOLDING S.A.,
SWITZERLAND
WO/2005/002866
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL
69710
]33[
EP
,‫ריינהולד כהן ושותפיו‬
‫ רמת החייל‬,'‫א‬26 ‫רחוב הברזל‬
[57] A device for magnetically
transferring indicia, such as a design or an
image, to a wet coating composition
applied to a substrate, such as a sheet or a
web, said coating composition comprising
at least one type of magnetic or
magnetizable particles, and said device
comprising a body of permanent-magnetic
material, the said magnetic material is
permanently magnetized in a direction
substantially perpendicular to a surface of
said body, characterized in that the said
surface of said body carries indicia in the
form of engravings, causing perturbations
of its magnetic field, and the said body is
either a flat plate, or a cylindrically curved
plate, preferably mounted on a rotatable
cylinder on a printing machine.
_______
]11[]21[
]54[
DOCUMENT FILE FOLDERS
AND A STAND FOR LEAFING,
REMOVING AND INSERTING
SHEETS THEREIN
]22[
]51[
]71[
11.06.2006
Int. Cl.(2008.04) B42F 13/08, 13/16
AMIR SCHNEIDSCHER
BORIS ZEGELMAN
]72[
AMIR SCHNEIDSCHER, BORIS
ZEGELMAN
AMIR SCHNEIDSCHER,
8 HILLEL ST.
JERUSALEM 94581
]74[
176244
‫ הוצאה או‬,‫תיקים למסמכים ומתקן לדפדוף‬
‫הכנסה של דפים‬
‫ ירושלים‬,‫אמיר שניידשר‬
‫ ירושלים‬,‫בוריס זגלמן‬
‫ בוריס זגלמן‬,‫אמיר שניידשר‬
,‫אמיר שניידשר‬
‫ ירושלים‬,8‫הלל‬
[57] A device (160) for selectively
removing or inserting separate document
sheets (4) with perforations from or into a
folder (150) with front (5) and back (1)
cover sheets and an elongated metal plate
fastened to said back cover sheet and
June 15,
having bendable legs (3) onto which said
document sheets are inserted wherein said
back and front cover sheets have
perforations coinciding with the
perforations in said document sheets, and
when said front cover sheet is unfolded by
– ‫כ"ג בסיוון התשס"ט‬
4892
2009
360o, thereby bringing said front cover
sheet to be adjacent to said back cover
sheet, said perforations in said front cover
sheet coincide with said perforations in
said back cover sheet, the device
comprising:
(a) a base (17);
(b) an openable/closeable clamp (12)
wherein said clamp is hingedly fixed onto
said base; and
(c) prongs (14) fixed onto said base,
wherein said prongs comprise attaching
elements (23) to align and to attach said
legs with said prongs, wherein the free
ends of said clamp are disconnected or
connected with the free ends of said
prongs, and wherein said prongs can pass
through said perforations of said cover
sheets and said document sheets together
with said bendable legs which are bent
upwards, thereby enabling the insertion of
said folder containing said documents onto
said prongs, and locking said prongs and
said legs in an aligned position.
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 – 1968
________
]11[]21[
177501
‫שיטות ומכשיר להפיכת חומר מקודד‬
‫אופטית לבלתי קריא‬
]54[
METHODS AND APPARATUS FOR
RENDERING AN OPTICALLY
ENCODED MEDIUM
UNREADABLE
]22[
]31[
25.06.1999
60/090682
]32[ 25.06.1998
]33[ US
09/338959
24.06.1999
US
Int. Cl.(2008.04) B32B 3/00, G11B 7/24
DIVISION FROM 140476
FLEXPLAY TECHNOLOGIES, INC.,
U.S.A.
WO/1999/067085
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
,12704 .‫ד‬.‫ ת‬, 5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
]51[
]62[
]71[
]87[
]74[
4893
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫הרצליה‬
HERZLIYA 46733
[57] A method for making an optically
readable media unreadable, comprising
steps of: providing the media with a layer
that is comprised of a volatile component
and at least one other component;
removing at least some of volatile
component; and causing an increase in at
least one of photoabsorption or scattering
or surface roughness with the remaining
component.
_______
]11[]21[
]54[
PACIFIER
]22[
]51[
]71[
25.01.2007
Int. Cl.(2008.04) A61J 17/00
AVTIPUS PATENTS AND
INVENTIONS LTD.
DANIELLA EISENBERG
URI MUSSAFFI
]74[
DANIELLA EISENBERG,
9 GEDEROT STREET
SAVION 53526
180940
‫מוצץ מתקפל‬
‫ מושב‬,‫אב טיפוס פטנטים והמצאות בע"מ‬
‫בני עטרות‬
‫ סביון‬,‫דניאלה אייזנברג‬
‫ סביון‬,‫אורי מוצפי‬
,‫דניאלה אייזנברג‬
‫ סביון‬,9‫הגדרות‬
from contact with a plane, and in the nonidle state thereof said nipple stands out
from said plane, thereby enabling being
used by an infant;
(b) a cylinder;
(c) a sliding plug fitting closely inside the
bore of said cylinder;
(d) a spring keeping said plug secured to
an opening of said cylinder, said nipple
being connected to said plug.
[57] A pacifier, comprising: a nipple; a
protection cap; and a connection
mechanism, for connecting said nipple to
said cap, said connection mechanism
comprising:
(a) a springy element wherein in the idle
state of said springy mechanism said
nipple is entirely protected by said cap
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 – 1968
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4894
2009
________
]11[]21[
]54[
TUBE DISPENSER
]22[
]51[
]71[
18.10.2007
Int. Cl.(2008.04) B65D 35/30
GOLAN SHALIT
GOLAN MUALEM
]74[
GOLAN SHALIT,
P.O. BOX 8034
9/1 HA'MAHARAL DISKIN
STREET
BEIT SHEMESH 99564
186734
‫מנפק שפופרתי‬
‫ בית שמש‬,‫גולן שליט‬
‫גולן מועלם‬
,‫גולן שליט‬
‫ בית שמש‬,8034 .‫ד‬.‫ ת‬, 9/1‫המהר"ל דיסקין‬
[57] A tube-dispenser (2) comprising: a
rigid piston (18) deployed inside the tube
of said dispenser, for pushing the
substance stored inside said dispenser
towards the outlet of said dispenser; and a
non-return mechanism, for preventing said
piston from falling back, wherein said nonreturn mechanism comprises: a ribbed
surface (32) deployed at the internal wall
of said tube, said ribbed surface being one
or more stripes along said tube; and at least
one dowel element correspondingly to said
ribbed surface, said element being attached
to said piston; wherein said piston
comprises one or more depressions (30)
correspondingly to said one or more stripes
and said at least one dowel element is
attached within said one or more
depressions.
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 – 1968
_______
]11[]21[
]54[
EDUCATIONAL GAME
]22[
]51[
13.05.2008
Int. Cl.(2008.04) A63F 7/36
191408
‫משחק חינוכי‬
‫ באר שבע‬,‫סמיון פצורסקי‬
4895
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
]74[
,‫סמיון פצורסקי‬
‫ באר שבע‬,14/15‫חיים לנדאו‬
SEMION PECHERSKI,
14 HAIM LANDAU STREET
APT#15, BEER-SHEVA 84789
[57] A educational game comprising: a
structure rotating around a vertical axis: a
plurality of frames, each connected to said
structure, each of said frames having a
geometrical form, each of said frames
having a basket suspended therefrom; and
a plurality of bricks, each having a form
corresponding to the geometrical form of
one of said frames; wherein the size of said
game corresponds to the motoric skills of
an infant player and wherein said
geometrical forms of said frames and of
said bricks correspond to the pattern
recognition skills of said infant player;
thereby improving the pattern recognition
skills of said infant player along with
improving motoric skills thereof.
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 – 1968
_______
]11[]21[
193578
‫שיטה ומערכת לתאימת ספקטראלית‬
‫לאחור בתקשורת‬
]54[
METHOD AND SYSTEM FOR
COMMUNICATION SPECTRAL
BACKWARD COMPATIBILITY
]22[
]31[
15.01.2003
10/055197
]32[ 21.01.2002
]33[
10/119421
09.04.2002
Int. Cl.(2008.04) H03C 1/00, 1/52, H04B 1/00
DIVISION FROM 153968
COPPERGATE COMMUNICATIONS
LTD.
]51[
]62[
]71[
June 15,
– ‫כ"ג בסיוון התשס"ט‬
US
US
‫ תל אביב‬,‫קופרגייט תקשורת בע"מ‬
4896
2009
]74[
BOROCHOV, KORAKH & CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
[57] A multiple generation
communications device comprising: a
signal generator, generating a second
generation bandwidth baseband signal; a
memory element; a controller; a switch,
coupled with said controller, said signal
generator and said memory element; a
carrier signal generator, providing a
second generation carrier signal; a
,'‫בורוכוב קורח ושות‬
‫אביב‬-‫ תל‬,58100 .‫ד‬.‫ ת‬, ‫מגדל כלל עתידים‬
modulator, coupled with said switch and
said carrier signal generator, wherein said
memory element contains a shaped copy of
a first generation formed Baseband signal,
shaped so at to recreate said first
generation format Baseband signal when
modulated with said second generation
carrier signal and demodulated with
respect to a first generation carrier signal.
_______
4897
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫פטנטים‬
‫‪PATENTS‬‬
‫פטנטים שניתנו‬
‫‪PATENTS GRANTED‬‬
‫‪139951‬‬
‫‪152346‬‬
‫‪153003‬‬
‫‪153652‬‬
‫‪154623‬‬
‫‪156088‬‬
‫‪156836‬‬
‫‪157448‬‬
‫‪145190‬‬
‫‪163941‬‬
‫‪164997‬‬
‫‪166912‬‬
‫‪168746‬‬
‫‪157871‬‬
‫‪158281‬‬
‫‪159188‬‬
‫‪159884‬‬
‫‪161096‬‬
‫‪162161‬‬
‫‪162797‬‬
‫‪174358‬‬
‫‪148144‬‬
‫‪149458‬‬
‫‪150826‬‬
‫‪151460‬‬
‫‪4898‬‬
‫‪2009‬‬
‫‪139873‬‬
‫‪152242‬‬
‫‪152879‬‬
‫‪153566‬‬
‫‪154464‬‬
‫‪156027‬‬
‫‪156807‬‬
‫‪157390‬‬
‫‪144315‬‬
‫‪163785‬‬
‫‪164949‬‬
‫‪166886‬‬
‫‪168613‬‬
‫‪157659‬‬
‫‪158191‬‬
‫‪159118‬‬
‫‪159814‬‬
‫‪161082‬‬
‫‪162070‬‬
‫‪162771‬‬
‫‪173648‬‬
‫‪148109‬‬
‫‪149387‬‬
‫‪150775‬‬
‫‪151458‬‬
‫‪184501‬‬
‫‪139598‬‬
‫‪141965‬‬
‫‪152859‬‬
‫‪153561‬‬
‫‪154377‬‬
‫‪155662‬‬
‫‪156774‬‬
‫‪157148‬‬
‫‪144203‬‬
‫‪146607‬‬
‫‪164819‬‬
‫‪166109‬‬
‫‪168612‬‬
‫‪138100‬‬
‫‪158080‬‬
‫‪159021‬‬
‫‪159580‬‬
‫‪160980‬‬
‫‪161937‬‬
‫‪162764‬‬
‫‪172424‬‬
‫‪147961‬‬
‫‪149286‬‬
‫‪150615‬‬
‫‪151396‬‬
‫‪184500‬‬
‫‪139410‬‬
‫‪141893‬‬
‫‪152855‬‬
‫‪153514‬‬
‫‪154367‬‬
‫‪155633‬‬
‫‪156586‬‬
‫‪157037‬‬
‫‪143436‬‬
‫‪146300‬‬
‫‪164738‬‬
‫‪165768‬‬
‫‪168611‬‬
‫‪135744‬‬
‫‪157992‬‬
‫‪158908‬‬
‫‪159572‬‬
‫‪160839‬‬
‫‪161840‬‬
‫‪162688‬‬
‫‪163462‬‬
‫‪147736‬‬
‫‪149152‬‬
‫‪150149‬‬
‫‪151127‬‬
‫‪152211‬‬
‫‪139272‬‬
‫‪141726‬‬
‫‪152702‬‬
‫‪153455‬‬
‫‪154248‬‬
‫‪155524‬‬
‫‪156563‬‬
‫‪157012‬‬
‫‪143337‬‬
‫‪146019‬‬
‫‪164305‬‬
‫‪165603‬‬
‫‪167539‬‬
‫‪98304‬‬
‫‪157978‬‬
‫‪158870‬‬
‫‪159414‬‬
‫‪160615‬‬
‫‪161808‬‬
‫‪162474‬‬
‫‪163330‬‬
‫‪147347‬‬
‫‪148363‬‬
‫‪150009‬‬
‫‪150991‬‬
‫‪152124‬‬
‫‪128348‬‬
‫‪141635‬‬
‫‪152696‬‬
‫‪153356‬‬
‫‪154031‬‬
‫‪155523‬‬
‫‪156525‬‬
‫‪156974‬‬
‫‪143140‬‬
‫‪145856‬‬
‫‪164303‬‬
‫‪165601‬‬
‫‪167316‬‬
‫‪169814‬‬
‫‪157973‬‬
‫‪158760‬‬
‫‪159374‬‬
‫‪160425‬‬
‫‪161399‬‬
‫‪162473‬‬
‫‪163166‬‬
‫‪179818‬‬
‫‪148292‬‬
‫‪149897‬‬
‫‪150973‬‬
‫‪151878‬‬
‫‪127892‬‬
‫‪140828‬‬
‫‪152642‬‬
‫‪153267‬‬
‫‪153918‬‬
‫‪155323‬‬
‫‪156185‬‬
‫‪156911‬‬
‫‪124567‬‬
‫‪145602‬‬
‫‪164254‬‬
‫‪165410‬‬
‫‪167029‬‬
‫‪169000‬‬
‫‪157960‬‬
‫‪158691‬‬
‫‪159342‬‬
‫‪160402‬‬
‫‪161203‬‬
‫‪162437‬‬
‫‪162899‬‬
‫‪178532‬‬
‫‪148275‬‬
‫‪149836‬‬
‫‪150897‬‬
‫‪151648‬‬
‫כ"ג בסיוון התשס"ט –‬
‫‪114778‬‬
‫‪140720‬‬
‫‪152348‬‬
‫‪153215‬‬
‫‪153777‬‬
‫‪155263‬‬
‫‪156162‬‬
‫‪156905‬‬
‫‪120558‬‬
‫‪145504‬‬
‫‪164059‬‬
‫‪165186‬‬
‫‪167025‬‬
‫‪168772‬‬
‫‪157918‬‬
‫‪158586‬‬
‫‪159295‬‬
‫‪159993‬‬
‫‪161173‬‬
‫‪162215‬‬
‫‪162829‬‬
‫‪178531‬‬
‫‪148262‬‬
‫‪149700‬‬
‫‪150883‬‬
‫‪151616‬‬
‫‪June 15,‬‬
‫פטנטים שחודשו‬
‫‪PATENTS RENEWED‬‬
‫‪96391‬‬
‫‪96536‬‬
‫‪96696‬‬
‫‪110622‬‬
‫‪111589‬‬
‫‪111683‬‬
‫‪111800‬‬
‫‪111860‬‬
‫‪111900‬‬
‫‪111928‬‬
‫‪111979‬‬
‫‪112168‬‬
‫‪126144‬‬
‫‪127129‬‬
‫‪127458‬‬
‫‪127711‬‬
‫‪127794‬‬
‫‪130741‬‬
‫‪131026‬‬
‫‪133068‬‬
‫‪135798‬‬
‫‪135975‬‬
‫‪136086‬‬
‫‪136175‬‬
‫‪136268‬‬
‫‪136387‬‬
‫‪136469‬‬
‫‪136521‬‬
‫‪136621‬‬
‫‪136698‬‬
‫‪136765‬‬
‫‪136954‬‬
‫‪137576‬‬
‫‪139951‬‬
‫‪142703‬‬
‫‪145190‬‬
‫‪146738‬‬
‫‪148634‬‬
‫‪149649‬‬
‫‪150883‬‬
‫‪151491‬‬
‫‪152348‬‬
‫‪152971‬‬
‫‪96387‬‬
‫‪96522‬‬
‫‪96671‬‬
‫‪110188‬‬
‫‪111588‬‬
‫‪111680‬‬
‫‪111793‬‬
‫‪111859‬‬
‫‪111899‬‬
‫‪111925‬‬
‫‪111977‬‬
‫‪112146‬‬
‫‪125939‬‬
‫‪127121‬‬
‫‪127457‬‬
‫‪127663‬‬
‫‪127792‬‬
‫‪130739‬‬
‫‪131023‬‬
‫‪132621‬‬
‫‪135797‬‬
‫‪135949‬‬
‫‪136076‬‬
‫‪136167‬‬
‫‪136262‬‬
‫‪136362‬‬
‫‪136448‬‬
‫‪136510‬‬
‫‪136619‬‬
‫‪136690‬‬
‫‪136742‬‬
‫‪136886‬‬
‫‪137422‬‬
‫‪139911‬‬
‫‪142623‬‬
‫‪144552‬‬
‫‪146708‬‬
‫‪148196‬‬
‫‪149523‬‬
‫‪150775‬‬
‫‪151460‬‬
‫‪152346‬‬
‫‪152966‬‬
‫כ"ג בסיוון התשס"ט –‬
‫‪96380‬‬
‫‪96506‬‬
‫‪96666‬‬
‫‪110125‬‬
‫‪111533‬‬
‫‪111679‬‬
‫‪111791‬‬
‫‪111850‬‬
‫‪111895‬‬
‫‪111923‬‬
‫‪111976‬‬
‫‪112145‬‬
‫‪124581‬‬
‫‪127120‬‬
‫‪127436‬‬
‫‪127518‬‬
‫‪127791‬‬
‫‪129913‬‬
‫‪131000‬‬
‫‪131534‬‬
‫‪135744‬‬
‫‪135946‬‬
‫‪136075‬‬
‫‪136163‬‬
‫‪136249‬‬
‫‪136359‬‬
‫‪136441‬‬
‫‪136496‬‬
‫‪136585‬‬
‫‪136683‬‬
‫‪136738‬‬
‫‪136874‬‬
‫‪137114‬‬
‫‪139873‬‬
‫‪141988‬‬
‫‪144315‬‬
‫‪146607‬‬
‫‪147961‬‬
‫‪149458‬‬
‫‪150771‬‬
‫‪151458‬‬
‫‪152242‬‬
‫‪152954‬‬
‫‪96362‬‬
‫‪96487‬‬
‫‪96657‬‬
‫‪109641‬‬
‫‪111519‬‬
‫‪111678‬‬
‫‪111742‬‬
‫‪111845‬‬
‫‪111874‬‬
‫‪111922‬‬
‫‪111960‬‬
‫‪112068‬‬
‫‪121886‬‬
‫‪127055‬‬
‫‪127435‬‬
‫‪127511‬‬
‫‪127790‬‬
‫‪129870‬‬
‫‪130959‬‬
‫‪131426‬‬
‫‪135623‬‬
‫‪135914‬‬
‫‪136067‬‬
‫‪136160‬‬
‫‪136241‬‬
‫‪136335‬‬
‫‪136440‬‬
‫‪136474‬‬
‫‪136582‬‬
‫‪136674‬‬
‫‪136735‬‬
‫‪136855‬‬
‫‪137095‬‬
‫‪139642‬‬
‫‪141914‬‬
‫‪144203‬‬
‫‪146363‬‬
‫‪147824‬‬
‫‪149286‬‬
‫‪150508‬‬
‫‪151260‬‬
‫‪152238‬‬
‫‪152712‬‬
‫‪June 15, 2009‬‬
‫‪96333‬‬
‫‪96486‬‬
‫‪96635‬‬
‫‪109014‬‬
‫‪111506‬‬
‫‪111677‬‬
‫‪111733‬‬
‫‪111840‬‬
‫‪111872‬‬
‫‪111917‬‬
‫‪111952‬‬
‫‪112027‬‬
‫‪121555‬‬
‫‪126962‬‬
‫‪127395‬‬
‫‪127507‬‬
‫‪127787‬‬
‫‪128835‬‬
‫‪130755‬‬
‫‪131416‬‬
‫‪135578‬‬
‫‪135905‬‬
‫‪136065‬‬
‫‪136153‬‬
‫‪136227‬‬
‫‪136327‬‬
‫‪136439‬‬
‫‪136473‬‬
‫‪136578‬‬
‫‪136655‬‬
‫‪136734‬‬
‫‪136835‬‬
‫‪137089‬‬
‫‪139598‬‬
‫‪141726‬‬
‫‪143556‬‬
‫‪146267‬‬
‫‪147736‬‬
‫‪149267‬‬
‫‪150347‬‬
‫‪151127‬‬
‫‪151708‬‬
‫‪152702‬‬
‫‪96332‬‬
‫‪96473‬‬
‫‪96604‬‬
‫‪99823‬‬
‫‪111499‬‬
‫‪111651‬‬
‫‪111705‬‬
‫‪111834‬‬
‫‪111870‬‬
‫‪111914‬‬
‫‪111951‬‬
‫‪112024‬‬
‫‪119274‬‬
‫‪126920‬‬
‫‪127383‬‬
‫‪127481‬‬
‫‪127749‬‬
‫‪128348‬‬
‫‪130745‬‬
‫‪131239‬‬
‫‪135552‬‬
‫‪135902‬‬
‫‪136044‬‬
‫‪136142‬‬
‫‪136225‬‬
‫‪136307‬‬
‫‪136419‬‬
‫‪136472‬‬
‫‪136572‬‬
‫‪136649‬‬
‫‪136732‬‬
‫‪136817‬‬
‫‪137016‬‬
‫‪139272‬‬
‫‪140828‬‬
‫‪143425‬‬
‫‪146019‬‬
‫‪146933‬‬
‫‪149152‬‬
‫‪149897‬‬
‫‪151106‬‬
‫‪151672‬‬
‫‪152696‬‬
‫‪96265‬‬
‫‪96428‬‬
‫‪96601‬‬
‫‪96804‬‬
‫‪111345‬‬
‫‪111630‬‬
‫‪111689‬‬
‫‪111831‬‬
‫‪111864‬‬
‫‪111905‬‬
‫‪111950‬‬
‫‪112023‬‬
‫‪114778‬‬
‫‪126838‬‬
‫‪127374‬‬
‫‪127466‬‬
‫‪127738‬‬
‫‪127838‬‬
‫‪130744‬‬
‫‪131169‬‬
‫‪135542‬‬
‫‪135886‬‬
‫‪136028‬‬
‫‪136136‬‬
‫‪136200‬‬
‫‪136298‬‬
‫‪136416‬‬
‫‪136471‬‬
‫‪136556‬‬
‫‪136647‬‬
‫‪136718‬‬
‫‪136814‬‬
‫‪136980‬‬
‫‪138363‬‬
‫‪140720‬‬
‫‪142929‬‬
‫‪145856‬‬
‫‪146916‬‬
‫‪149029‬‬
‫‪149841‬‬
‫‪150991‬‬
‫‪151648‬‬
‫‪152692‬‬
‫‪96263‬‬
‫‪96408‬‬
‫‪96549‬‬
‫‪96699‬‬
‫‪111127‬‬
‫‪111617‬‬
‫‪111685‬‬
‫‪111802‬‬
‫‪111863‬‬
‫‪111904‬‬
‫‪111942‬‬
‫‪111997‬‬
‫‪112179‬‬
‫‪126210‬‬
‫‪127157‬‬
‫‪127459‬‬
‫‪127736‬‬
‫‪127795‬‬
‫‪130742‬‬
‫‪131027‬‬
‫‪133341‬‬
‫‪135883‬‬
‫‪136026‬‬
‫‪136117‬‬
‫‪136198‬‬
‫‪136285‬‬
‫‪136415‬‬
‫‪136470‬‬
‫‪136524‬‬
‫‪136634‬‬
‫‪136706‬‬
‫‪136766‬‬
‫‪136975‬‬
‫‪138100‬‬
‫‪140712‬‬
‫‪142710‬‬
‫‪145535‬‬
‫‪146890‬‬
‫‪148962‬‬
‫‪149700‬‬
‫‪150897‬‬
‫‪151616‬‬
‫‪152522‬‬
‫‪4899‬‬
‫‪153267‬‬
‫‪153495‬‬
‫‪153679‬‬
‫‪154218‬‬
‫‪154623‬‬
‫‪155481‬‬
‫‪156088‬‬
‫‪156807‬‬
‫‪157454‬‬
‫‪158080‬‬
‫‪158740‬‬
‫‪159648‬‬
‫‪160296‬‬
‫‪161203‬‬
‫‪161840‬‬
‫‪162235‬‬
‫‪162771‬‬
‫‪163754‬‬
‫‪164738‬‬
‫‪165603‬‬
‫‪167316‬‬
‫‪173893‬‬
‫‪4900‬‬
‫‪2009‬‬
‫‪153263‬‬
‫‪153469‬‬
‫‪153652‬‬
‫‪154138‬‬
‫‪154602‬‬
‫‪155197‬‬
‫‪156066‬‬
‫‪156796‬‬
‫‪157448‬‬
‫‪157973‬‬
‫‪158691‬‬
‫‪159572‬‬
‫‪159999‬‬
‫‪161173‬‬
‫‪161813‬‬
‫‪162215‬‬
‫‪162764‬‬
‫‪163462‬‬
‫‪164701‬‬
‫‪165601‬‬
‫‪166912‬‬
‫‪173648‬‬
‫‪153252‬‬
‫‪153468‬‬
‫‪153629‬‬
‫‪154083‬‬
‫‪154593‬‬
‫‪155042‬‬
‫‪156061‬‬
‫‪156774‬‬
‫‪157390‬‬
‫‪157918‬‬
‫‪158616‬‬
‫‪159374‬‬
‫‪159993‬‬
‫‪161150‬‬
‫‪161808‬‬
‫‪162161‬‬
‫‪162691‬‬
‫‪163445‬‬
‫‪164303‬‬
‫‪165597‬‬
‫‪166886‬‬
‫‪172424‬‬
‫‪184501‬‬
‫‪153237‬‬
‫‪153467‬‬
‫‪153566‬‬
‫‪154056‬‬
‫‪154549‬‬
‫‪154894‬‬
‫‪155922‬‬
‫‪156726‬‬
‫‪157302‬‬
‫‪157914‬‬
‫‪158535‬‬
‫‪159342‬‬
‫‪159971‬‬
‫‪161096‬‬
‫‪161659‬‬
‫‪162157‬‬
‫‪162688‬‬
‫‪163425‬‬
‫‪164254‬‬
‫‪165567‬‬
‫‪166759‬‬
‫‪171710‬‬
‫‪184500‬‬
‫‪153210‬‬
‫‪153450‬‬
‫‪153561‬‬
‫‪154031‬‬
‫‪154464‬‬
‫‪154728‬‬
‫‪155880‬‬
‫‪156501‬‬
‫‪157148‬‬
‫‪157839‬‬
‫‪158481‬‬
‫‪159115‬‬
‫‪159910‬‬
‫‪160924‬‬
‫‪161632‬‬
‫‪162081‬‬
‫‪162687‬‬
‫‪163365‬‬
‫‪164059‬‬
‫‪165153‬‬
‫‪166559‬‬
‫‪169972‬‬
‫‪178532‬‬
‫‪153209‬‬
‫‪153356‬‬
‫‪153514‬‬
‫‪153918‬‬
‫‪154377‬‬
‫‪154719‬‬
‫‪155876‬‬
‫‪156255‬‬
‫‪157037‬‬
‫‪157704‬‬
‫‪158354‬‬
‫‪159021‬‬
‫‪159884‬‬
‫‪160692‬‬
‫‪161524‬‬
‫‪162065‬‬
‫‪162474‬‬
‫‪163105‬‬
‫‪163941‬‬
‫‪165071‬‬
‫‪166089‬‬
‫‪169814‬‬
‫‪178531‬‬
‫‪153173‬‬
‫‪153324‬‬
‫‪153508‬‬
‫‪153916‬‬
‫‪154367‬‬
‫‪154717‬‬
‫‪155524‬‬
‫‪156178‬‬
‫‪157012‬‬
‫‪157531‬‬
‫‪158229‬‬
‫‪158982‬‬
‫‪159789‬‬
‫‪160684‬‬
‫‪161399‬‬
‫‪162061‬‬
‫‪162349‬‬
‫‪162928‬‬
‫‪163907‬‬
‫‪164997‬‬
‫‪166020‬‬
‫‪168610‬‬
‫‪178092‬‬
‫כ"ג בסיוון התשס"ט –‬
‫‪153022‬‬
‫‪153315‬‬
‫‪153496‬‬
‫‪153849‬‬
‫‪154313‬‬
‫‪154635‬‬
‫‪155523‬‬
‫‪156162‬‬
‫‪156907‬‬
‫‪157470‬‬
‫‪158147‬‬
‫‪158908‬‬
‫‪159728‬‬
‫‪160425‬‬
‫‪161214‬‬
‫‪161997‬‬
‫‪162275‬‬
‫‪162797‬‬
‫‪163807‬‬
‫‪164747‬‬
‫‪165621‬‬
‫‪168528‬‬
‫‪178091‬‬
‫‪June 15,‬‬
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
94101
94238
109369
156149
4901
94135
94265
109406
92697
94153
94267
109426
149206
94160
102055
109431
149311
94192
108518
109458
149327
94193
109344
109464
June 15, 2009
94201
109349
109475
94233
109352
109487
– ‫כ"ג בסיוון התשס"ט‬
‫פטנטים שחודשו לעשרים שנה‬
‫‪PATENTS RENEWED FOR 20 YEARS‬‬
‫‪157105‬‬
‫‪4902‬‬
‫‪2009‬‬
‫‪156911‬‬
‫‪156836‬‬
‫‪154873‬‬
‫‪154248‬‬
‫‪151417‬‬
‫‪148864‬‬
‫כ"ג בסיוון התשס"ט –‬
‫‪135517‬‬
‫‪June 15,‬‬
‫פטנטים שפג תוקפם‬
‫‪PATENTS EXPIRED‬‬
‫‪88129‬‬
‫‪88204‬‬
‫‪88242‬‬
‫‪104845‬‬
‫‪88088‬‬
‫‪88196‬‬
‫‪88240‬‬
‫‪88336‬‬
‫כ"ג בסיוון התשס"ט –‬
‫‪88087‬‬
‫‪88187‬‬
‫‪88235‬‬
‫‪88307‬‬
‫‪88083‬‬
‫‪88151‬‬
‫‪88234‬‬
‫‪88303‬‬
‫‪June 15, 2009‬‬
‫‪88081‬‬
‫‪88149‬‬
‫‪88233‬‬
‫‪88297‬‬
‫‪88074‬‬
‫‪88143‬‬
‫‪88223‬‬
‫‪88275‬‬
‫‪88063‬‬
‫‪88142‬‬
‫‪88211‬‬
‫‪88266‬‬
‫‪106893‬‬
‫‪88062‬‬
‫‪88132‬‬
‫‪88208‬‬
‫‪88265‬‬
‫‪104953‬‬
‫‪4903‬‬
Patents for which applications have
been filed for extension of the patent
term under chapter 4, part B1 of the
Patents Law
92208
June 15,
‫פטנטים שלגביהם הוגשו בקשות‬
‫להארכת תקופת ההגנה על פי פרק‬
‫ לחוק הפטנטים‬1'‫ד' סימן ב‬
95572
– ‫כ"ג בסיוון התשס"ט‬
4904
2009
‫ה לחוק‬64 ‫הודעה לפי סעיף‬
1967-‫הפטנטים התשכ"ז‬
‫בכוונת רשם הפטנטים ליתן צו‬
‫להארכת תקופת הגנה ע"פ פרק‬
,‫ לחוק הפטנטים‬1‫ סימן ב‬,'‫ד‬
‫ לגבי הפטנט‬1967-‫התשכ"ז‬
:‫המפורט מטה‬
NOTICE under section 64E of the
Patents Law, 5727-1967
It is the intention of the
Commissioner of Patents to grant an
order for the extension of the period
of protection of the following patent
in accordance with Chapter Four,
Article Two bis, of the Patents Law,
5727-1967
No. of basic patent:
Title of invention:
The order will be in effect until:
:‫מס' פטנט בסיסי‬
:‫שם האמצאה‬
9/4/2012
:‫הצו יעמוד בתוקפו עד ליום‬
]a– 1,2[ ‫–פירידול‬H4–‫–טטראהידרו‬5,6,7,8–]‫ –פיפרידינילאלקיל‬1–)‫–יל‬3–‫–(בנזיסוקסאזול‬4[–3
‫ הכנתם ותכשירי רוקחות המכילים אותם‬,‫–אונים דו–מותמרים‬4–‫פירימידין‬
DISUBSTITUTED 3-[4-(BENZISOXAZOL-3--YL)-1-PIPERIDINYLALKYL]-5,6,7,8TETRAHYDRO-4H-PYRIDOL [1,2-a]
PYRIMIDIN-4-ONES, THEIR
PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
Proprietors:
:‫בעלי הפטנט‬
92208
JANSSEN PHARMACEUTICA N.V.
Any person desiring to oppose the
‫כל המעוניין להתנגד למתן צו‬
said grant of an order may, within
‫הארכה רשאי תוך שלושה‬
three months from the date of this
‫ להגיש‬,‫חודשים מתאריך יומן זה‬
journal, serve to the Commissioner
‫התנגדות‬
‫לרשם הפטנטים הודעה‬
of Patents a notice of opposition
‫בדרך‬
,‫ו לחוק‬64 ‫לפי סעיף‬
under Section 64F of the Law, as
‫ לתקנות‬3 ‫הקבועה בתקנה‬
prescribed by Rule 3 of the Patent
Regulations (extension of period of
‫הפטנטים (הארכת תקופה הגנה‬
protection – procedure of
,‫– סדרי דין בבקשה לצו‬
application for order, opposition to
,)‫ ובבקשה לביטול‬,‫בהתנגדות לצו‬
order, application to annul) 57581998-‫התשנ"ח‬
1998.
4905
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫הודעה‬
NOTICE
Under section 73 of the Patents Law, 57271967
Application has been filed for erasure of the
patent recorded below
No. of patent:
Acceptance published in journal no:
Journal no:
Proprietors
,‫ לחוק הפטנטים‬73 ‫הודעה לפי סעיף‬
1967–‫התשכ"ז‬
‫הוגשה בקשה למחיקת הפטנט המפורט‬
.‫מטה‬
117175
'‫מס‬
:‫פטנט‬
7/2005
: '‫קיבול פורסם ביומן מס‬
:‫שם בעל הפטנט‬
DAIICHI SANKYO
COMPANY LIMITED
Title of invention:
:‫שם האמצאה‬
‫חלבון המעכב אוסטאוקלסטוגנזה‬
OSTEOCLASTOGENESIS INHIBITORY FACTOR PROTEIN
Any person may oppose the said application
within three months from the date of this
Patents Journal, as prescribed by section 73 of
the law and by regulation 92 of the Patent
Regulations, 5728-1968
June 15,
– ‫כ"ג בסיוון התשס"ט‬
‫כל אדם רשאי להתנגד לבקשה האמורה תוך‬
‫ כפי‬,‫שלושה חודשים מתאריך יומן פטנטים זה‬
‫ לתקנות‬92 ‫ לחוק ובתקנה‬73 ‫שנקבע בסעיף‬
1968–‫ תשכ"ח‬,‫הפטנטים‬
4906
2009
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
‫שינוי שם הבעלים‬
CHANGE OF NAME OF PROPRIETORS
No. of Patent:
Previous name:
:‫מס' פטנט‬
:‫השם הקודם‬
116032 ,109954
PIRELLI CAVI S.P.A.
:‫השם החדש‬
New name:
PIRELLI S.P.A.
No. of Patent:
Previous name:
:‫מס' פטנט‬
:‫השם הקודם‬
116032 ,109954
PIRELLI CAVI E SISTEMI S.P.A.
:‫השם החדש‬
New name:
PIRELLI S.P.A.
No. of Patent:
Previous name:
:‫מס' פטנט‬
:‫השם הקודם‬
116032 ,109954
PIRELLI S.P.A.
:‫השם החדש‬
New name:
PIRELLI & C.S.P.A.
4907
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
142512
No. of Patent:
Previous name:
:‫מס' פטנט‬
:‫השם הקודם‬
PERMATEX GMBH
:‫השם החדש‬
New name:
DUPONT PERFORMANCE COATINGS GMBH & CO. KG
,154070 ,151646 ,138847 ,132652 ,123333
,167607 ,166955 ,166016 ,165949 ,155386
183557 ,171753 ,171470 ,170869 ,170564
No. of Patent:
:‫מס' פטנט‬
:‫השם הקודם‬
Previous name:
ELBION AG
:‫השם החדש‬
New name:
ELBION GMBH
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4908
2009
‫שינוי בעלות‬
CHANGES IN PROPRIETORSHIP
No. of Patent:
Previous Proprietors:
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
132652
ELBION GMBH
New Proprietors:
BOEHRINGER INGELHEIM VETMEDICA
GMBH
No. of Patent:
Previous Proprietors:
:‫הבעלים החדשים‬
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
171753
ELBION GMBH
New Proprietors:
BOEHRINGER INGELHEIM VETMEDICA
GMBH
No. of Patent:
Previous Proprietors:
:‫הבעלים החדשים‬
:‫מס' פטנט‬
:‫הבעלים הקודמים‬
171753
:‫הבעלים החדשים‬
New Proprietors:
ELBION GMBH
4909
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4910
2009
JP
KR
LK
LU
LV
MX
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Mexico
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property Organization (W.I.P.O.)
South Africa
4911
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
43433, 43434, 43435
25(01)
10. 12.2006
‫סוג‬
‫מיפרומאל מיגון בע"מ‬
MIFROMAL MIGUN LTD.
‫פרופיל‬
Profile
Class
43684
23(04)
28. 1.2007
‫סוג‬
‫) בע"מ‬1995( ‫ אינטרנשיונל‬.‫ו‬.‫ל‬.‫ג‬
G.L.V. INTERNATIONAL (1995)
LTD.
‫תעלה גמישה‬
Flexible duct
Class
43700
9(03)
30. 1.2007
‫סוג‬
‫שי ליפשיץ‬
SHAY LIFSCHITZ
‫אריזה‬
Packing
Class
43758
18(02)
7. 2.2007
‫סוג‬
BROTHER INDUSTRIES LTD.
Toner cartridge
Convention date (Japan)
10.8.2006
‫מחסנית דיו‬
)‫(ארצות הברית‬
)‫האמנה (יפן‬
‫תאריך אמנה‬
43822
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4912
2009
Class
‫סוג‬
6(01)
21. 2.2007
AMINACH BEDDING &
FURNITURE MANUFACTURING
LTD.
‫עמינח תעשית רהיטים ומזרונים‬
‫בע"מ‬
‫מיטה‬
Bed
Class
43934, 45066
23(02)
8. 3.2007
‫סוג‬
VIEGA GMBH & CO.KG
Drain
Convention date (OHIM)
Class
27.9.2006
43968
9(03)
22. 3.2007
‫נקז‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫כתר פלסטיק בע"מ‬
KETER PLASTIC LTD.
‫פח‬
Bin
Class
44057
7(04)
16. 4.2007
‫סוג‬
‫יהודה גליק‬
YEHUDA GLIK
‫מושיט‬
Dispenser
Class
44136
26(05)
7. 5.2007
‫סוג‬
NEW PRODUCTS INTERNATIONAL INC.
‫מתקן תאורה לספר‬
Book light
Class
44196
9(05)
15. 5.2007
OREN YORAM PACKAGING LTD.
‫סוג‬
‫אורן יורם אריזות בע"מ‬
‫שקית לנשיאת עציצים‬
Carrying bag for pots
44219
4913
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
Class
‫סוג‬
19(06)
24. 5.2007
KABUSHIKI KAISHA PILOT CORPORATION (ALSO TRADING AS
PILOT CORPORATION)
‫עט כדורי‬
)‫(ארצות הברית‬
)‫האמנה (יפן‬
‫תאריך אמנה‬
Ball point pen
28.11.2006
Convention date (Japan)
44311
25(03)
5. 6.2007
Class
‫סוג‬
‫אופן בע"מ‬-‫חן‬
CHAN-OFAN LTD.
‫מתקן חנייה לאופניים‬
Bicycle parking rack
44356, 44358
9(03)
14. 6.2007
Class
‫סוג‬
RONALD H. BERMAN
Beverage container
12.1.2007
Convention date (U.S.A.)
Class
44360
25(01)
14. 6.2007
‫מיכל למשקאות‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫ריטייל פלוס בע"מ‬
RETAIL PLUS LTD.
‫פרופיל‬
Profile
Class
44372
15(07)
18. 6.2007
‫סוג‬
ARCELIK ANONIM SIRKETI
‫מקרר‬
Refrigerator
Class
44401
25(01)
21. 6.2007
DOMA MARKETING FOR
BUILDING AND TRADE (1996)
LTD.
June 15,
– ‫כ"ג בסיוון התשס"ט‬
‫סוג‬
)1996( ‫דומא שיווק לבניין וסחר‬
‫בע"מ‬
4914
2009
‫אביזר לבניה‬
Construction accessory
Class
44413
6(01)
28. 6.2007
‫סוג‬
GILI GLICKMAN
‫גילי גליקמן‬
Chair for baby feeding
‫כסא אוכל של תינוק‬
Class
44415, 44416, 44417,
44418, 44419, 44420
6(04)
28. 6.2007
C.I.Q. LTD. AND PLASTOKIT LTD.
‫סוג‬
‫קיו בע"מ ופלסטוקיט בע"מ‬.‫אי‬.‫סי‬
‫שידה‬
Chest of drawers
Class
44496
8(06)
12. 7.2007
‫סוג‬
‫בועז כהן‬
BOAZ COHEN
‫ידית‬
Handle
Class
44599
6(13)
2. 8.2007
‫סוג‬
OCEAN QUAY LTD.
‫כיסוי שמש לספה‬
Sun lounger cover
Class
44699
10(01)
28. 8.2007
‫סוג‬
‫שלי שפיר‬
BOAZ COHEN
‫שעון‬
Clock
Class
44722
9(03)
30. 8.2007
‫סוג‬
SMART UP
‫קופסא למשחק‬
Box for a game
4915
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
Class
44758
11(02)
4. 9.2007
‫סוג‬
GABOR DOMOKOS AND PETER VARKONYI
‫פריט אורנמנטלי‬
Ornamental object
Class
44808
9(03)
18. 9.2007
‫סוג‬
COLGATE-PALMOLIVE COMPANY
Container and pump
Convention date (U.S.A.)
22.3.2007
Class
‫מיכל ומשאבה‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
44902
20(03)
18. 10.2007
‫סוג‬
‫אמיר פונדמיסקי‬
AMIR FUNDAMINSKY
‫שבשבת‬
Pinwheel
Class
45046
24(02)
13. 11.2007
‫סוג‬
‫קיו קור בע"מ‬
Q-CORE LTD.
‫מסך ניתק עם משאבה פריסטלטית‬
Detachable screen and peristaltic pump
Class
45066
23(02)
8. 3.2007
‫סוג‬
VIEGA GMBH & CO.KG
‫נקז‬
Drain
Class
45103
22(01)
26. 11.2007
FOBUS INTERNATIONAL LTD.
June 15,
– ‫כ"ג בסיוון התשס"ט‬
‫סוג‬
‫פובוס אינטרנשיונל בע"מ‬
4916
2009
‫התקן לחגורת נרתיק‬
Device for belt holster
45392
26(04)
23. 01.2008
Class
‫סוג‬
‫ד'פלוס הפקות בע"מ‬
DEPLUS PRODUCTIONS LTD.
‫גוף תאורה‬
Light source
Class
45413
1(01)
24. 1.2008
‫סוג‬
SOCIETE DES PRODUITS NESTLE S.A.
‫חטיף שוקולד‬
Chocolate bar
Class
45491, 45492
6(04)
7. 2.2008
‫סוג‬
‫עוזגום בע"מ‬
OZ GUM LTD.
‫מתלה‬
Rack
Class
45517, 45518, 45519
4(02)
14. 2.2008
‫סוג‬
‫פאפאיה אופנה בע"מ‬
PAPAYA FASHION LTD.
‫סוליה‬
Sole
Class
45540
14(03)
18. 2.2008
‫סוג‬
‫וואי בע"מ‬.‫איי‬
I. WAY MOBILE LTD.
‫מסך שרותים סלולרים לרכב‬
Cellular services screen for a car
Class
45588
10(01)
2. 3.2008
‫סוג‬
SHAHAR PELEG
‫שחר פלג‬
Reflective clock
‫שעון מראה‬
4917
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
45589
11(02)
2. 3.2008
Class
‫סוג‬
‫שחר פלג‬
SHAHAR PELEG
‫מדבקה מגנטית‬
Magnetic sticker
Class
45683, 45684, 45685,
45686, 45687
25(01)
13. 3.2008
‫סוג‬
‫משה סלס‬
MOSHE SELES
‫פרופיל‬
Profile
45690, 45691
25(01)
16. 3.2008
Class
P.L.H. LIGHTING ENGINEERING
LTD.
‫סוג‬
‫ה הנדסת תאורה בע"מ‬.‫ל‬.‫פ‬
‫פרופיל‬
Profile
45734
22(01)
25. 3.2008
Class
‫סוג‬
STURM, RUGER & COMPANY, INC.
Pistol
28.9.2007
Convention date (U.S.A.)
Class
45763, 45764, 45765,
45767, 45768, 45770,
45771, 45772
11(01)
31. 3.2008
‫אקדח‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
June 15,
– ‫כ"ג בסיוון התשס"ט‬
4918
2009
45773, 45774
6(06)
31. 3.2008
Class
‫סוג‬
‫עדי גליק‬
ADI GLICK
‫יחידת הארכה לשולחן‬
Table extension unit
Class
45823, 45825, 45827,
45829, 45831, 45832,
45834, 45835
11(01)
14. 4.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
45872
7(02)
17. 4.2008
‫סוג‬
CAFFE' D'ITALIA S.R.L.
Scalding appliance
22.10.2007
Convention date (U.S.A.)
Class
‫כלי לחליטה‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
45875
7(01)
17. 4.2008
‫סוג‬
VILLEROY & BOCH AG
Tableware set
Convention date (OHIM)
Class
24.10.2007
45914
23(04)
5. 5.2008
‫מערכת כלי שולחן‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫טוויטופלסט בע"מ‬
TWITOPLAST LTD.
Airflow distributor for airconditioning
systems
4919
‫מפלג זרימת אוויר במערכת מיזוג אוויר‬
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
Class
45917, 45918, 45919,
45921
11(01)
5. 5.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
45924
25(01)
6. 5.2008
ALUMA ALUMINUM SOLUTIONS
LTD.
‫סוג‬
‫אלומה פתרונות באלומיניום‬
‫בע"מ‬
‫פרופיל‬
Profile
Class
45960
11(02)
18. 5.2008
‫סוג‬
QUEST GIFTS & DESIGN, INC.
‫כוס קידוש‬
Kiddush cup
Class
45966
9(05)
19. 5.2008
‫סוג‬
‫ חביב אחזקות בע"מ‬.‫ג‬.‫ש‬
S.G. HAVIV HOLDINGS LTD.
‫ידית לשקית‬
Bag handle
Class
45997
19(04)
25. 5.2008
‫סוג‬
‫משה ישר‬
MOSHE YASHAR
‫סימניה‬
Bookmark
Class
June 15,
– ‫כ"ג בסיוון התשס"ט‬
46017
7(02)
‫סוג‬
4920
2009
28. 5.2008
KENWOOD LIMITED
Electric kettle
Convention date (OHIM)
Class
‫קומקום חשמלי‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
29.11.2007
46034
8(07)
2. 6.2008
‫סוג‬
‫מולטילוק טכנולוגיות בע"מ‬
MUL-T-LOCK TECHNOLOGIES
LTD.
‫חיפוי למנעול‬
Cover for lock
Class
46038, 46039, 46040
25(01)
3. 6.2008
‫סוג‬
‫יגאל בלכר‬
IGAL BLECHER
‫פרופיל‬
Profile
Class
46047
12(15)
5. 6.2008
‫סוג‬
THE GOODYEAR TIRE & RUBBER COMPANY
‫צמיג‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Tire
Convention date (U.S.A.)
Class
20.12.2007
46110
7(02)
19. 6.2008
‫סוג‬
KENWOOD LIMITED
‫מצנם‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Toaster
Convention date (OHIM)
Class
5.6.2008
46161, 46162, 46163,
46164
11(01)
30. 6.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
4921
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
Class
46231, 46232, 46233,
46234
11(01)
10. 7.2008
‫סוג‬
H. STERN COMERCIO E INDUSTRIA S.A.
‫תכשיט‬
Jewel
Class
46250
13(03)
10. 7.2008
‫סוג‬
‫דוד זילברברג‬
DAVID ZILBERBERG
‫שקע‬
Socket
Class
46251
7(01)
10. 7.2008
‫סוג‬
VILLEROY & BOCH AG
Tea and coffee service
Convention date (OHIM)
Class
16.1.2008
46256
3(01)
13. 7.2008
‫מערכת כלים לשתיית תה וקפה‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫שחר פלג‬
SHAHAR PELEG
‫אוחז מפתחות‬
Key holder
Class
46268
26(03)
15. 7.2008
‫סוג‬
HEIC HORNBACHNER ENERGIE INNOVATION CONSUL TING
GMBH
Outdoor lighting
Convention date (OHIM)
June 15,
– ‫כ"ג בסיוון התשס"ט‬
31.1.2008
‫תאורת חוץ‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
4922
2009
‫מדגמים שחודשו‬
‫‪DESIGNS RENEWED‬‬
‫‪33460‬‬
‫‪38673‬‬
‫‪38790‬‬
‫‪38933‬‬
‫‪38972‬‬
‫‪39039‬‬
‫‪39742‬‬
‫‪31277‬‬
‫‪38659‬‬
‫‪38789‬‬
‫‪38923‬‬
‫‪38962‬‬
‫‪39037‬‬
‫‪39741‬‬
‫כ"ג בסיוון התשס"ט –‬
‫‪31045‬‬
‫‪38658‬‬
‫‪38771‬‬
‫‪38832‬‬
‫‪38961‬‬
‫‪39036‬‬
‫‪39740‬‬
‫‪30990‬‬
‫‪38607‬‬
‫‪38769‬‬
‫‪38808‬‬
‫‪38948‬‬
‫‪39036‬‬
‫‪39388‬‬
‫‪40949‬‬
‫‪June 15, 2009‬‬
‫‪30946‬‬
‫‪38606‬‬
‫‪38750‬‬
‫‪38799‬‬
‫‪38947‬‬
‫‪39027‬‬
‫‪39199‬‬
‫‪40948‬‬
‫‪30945‬‬
‫‪38458‬‬
‫‪38749‬‬
‫‪38797‬‬
‫‪38946‬‬
‫‪39008‬‬
‫‪39050‬‬
‫‪40947‬‬
‫‪30944‬‬
‫‪37105‬‬
‫‪38708‬‬
‫‪38796‬‬
‫‪38945‬‬
‫‪39005‬‬
‫‪39048‬‬
‫‪40397‬‬
‫‪30505‬‬
‫‪33627‬‬
‫‪38674‬‬
‫‪38795‬‬
‫‪38934‬‬
‫‪39004‬‬
‫‪39046‬‬
‫‪40396‬‬
‫‪4923‬‬
‫מדגמים שבוטלו‬
DESIGNS VOID
21773
30027
37986
38097
38115
38128
38155
21774
30038
37987
38102
38116
38130
38156
21806
30055
37998
38103
38121
38131
39385
Dr. Meir Noam
Commissioner of Patents,
Designs and Trade Marks
June 15,
– ‫כ"ג בסיוון התשס"ט‬
21847
30061
38029
38105
38122
38132
29976
30063
38087
38106
38122
38133
29987
30064
38090
38109
38123
38135
29988
37981
38091
38113
38125
38141
29989
37982
38094
38114
38126
38154
‫ד"ר מאיר נועם‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬
4924
2009
‫כ"ג בסיוון התשס"ט –‬
‫‪June 15, 2009‬‬
‫‪4925‬‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫‪NAME INDEX‬‬
‫מולטילוק טכנולוגיות בע"מ ‪151656‬‬
‫מולטילוק טכנולוגיות בע"מ ‪156153‬‬
‫סמיון פצורסקי ‪191408‬‬
‫פסח זיידל ‪158705‬‬
‫קופרגייט תקשורת בע"מ ‪193578 ,153968‬‬
‫קינג גרין בע"מ ‪144369‬‬
‫רב בריח הגנה לרכב בע"מ ‪156153‬‬
‫רב‪-‬בריח מוצרי בטחון בע"מ ‪151656‬‬
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
‫‪165553‬‬
‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫‪170266‬‬
‫רשף יקותיאלי ‪150372‬‬
‫שילה טכנולוגיות בע"מ ‪160766‬‬
‫‪ABBOTT LABORATORIES 134905‬‬
‫‪ABERSHAM TECHNOLOGIES‬‬
‫‪LIMITED 152379‬‬
‫‪ABES DALY 139824‬‬
‫‪ADVANCED TISSUE SCIENCES, INC.‬‬
‫‪145892‬‬
‫‪AKZO NOBEL N.V. 160194‬‬
‫‪ALCON, INC. 158464‬‬
‫‪ALCON, INC. 168703‬‬
‫‪ALEXANDER GAIGER 142216‬‬
‫‪ALEXANDER KRICHEVSKY 163005‬‬
‫‪ALEXIS BIOTECH LIMITED 139950‬‬
‫‪ALK-ABELLO A/S 138339‬‬
‫‪ALMIRALL AG 156558‬‬
‫‪ALZA CORPORATION 160469, 161336‬‬
‫‪ALZA CORPORATION 167247‬‬
‫‪AMIR SCHNEIDSCHER 176244‬‬
‫‪ANALYTICAL BIOLOGICAL‬‬
‫‪SERVICES, INC. 151674‬‬
‫‪APPLIED RESEARCH SYSTEMS ARS‬‬
‫‪HOLDING N.V. 143994‬‬
‫כ"ג בסיוון התשס"ט –‬
‫‪June 15, 2009‬‬
‫אב טיפוס פטנטים והמצאות בע"מ‬
‫‪180940‬‬
‫אבס דאלי ‪139824‬‬
‫אורי מוצפי ‪180940‬‬
‫אי‪.‬טי‪.‬אמ ייצור כלים מיוחדים ‪164069‬‬
‫אלכסנדר קריצ'בסקי ‪163005‬‬
‫אמיר שניידשר ‪176244‬‬
‫אנזימוטק בע"מ ‪145503‬‬
‫אנקוטון בע"מ ‪128720‬‬
‫אס‪.‬איי‪.‬אס מכון שולוב למדע בע"מ‬
‫‪137820‬‬
‫בוריס זגלמן ‪176244‬‬
‫ברמד‪ ,‬שותפות מוגבלת ‪143599‬‬
‫גולן מועלם ‪186734‬‬
‫גולן מועלם ‪186734‬‬
‫גולן שליט ‪186734‬‬
‫גולן שליט ‪186734‬‬
‫גיוון אימג'ינג בע"מ ‪158972‬‬
‫דניאלה אייזנברג ‪180940‬‬
‫טב טק בע"מ ‪159783‬‬
‫טבע תעשיות פרמצבטיות בע"מ ‪152179‬‬
‫יצחק לבטן ‪128720‬‬
‫ישקר בע"מ ‪169491 ,166530 ,164069‬‬
‫ישקר בע"מ ‪169491 ,166530‬‬
‫מאיר גיטליס ‪186734‬‬
‫מדיוונד בע"מ ‪164711‬‬
‫מדינול בע"מ ‪157019‬‬
‫מדינת ישראל‪ ,‬משרד החקלאות ופיתוח‬
‫הכפר‪ ,‬מינהל המחקר החקלאי‪ ,‬מרכז‬
‫וולקני ‪156154‬‬
‫‪i‬‬
ARES TRADING S.A. 158395
ASTELLAS PHARMA INC. 165177
ASTRAZENECA AB 143806, 153167,
154077, 154466, 156601, 162330, 166826
ASTRAZENECA UK LIMITED 159741
ASUBIO PHARMA CO., LTD. 132030
AVENTIS HOLDINGS INC. 150638
AVENTIS PHARMA S.A. 151428
AVENTIS PHARMACEUTICALS INC.
150638
AVTIPUS PATENTS AND
INVENTIONS LTD. 180940
BAE SYSTEMS PLC 163973
BALLARINI PAOLO & FIGLI S.P.A.
162813
BASELL POLYOLEFINE GMBH
168349
BASF AKTIENGESELLSCHAFT
170302
BASF PLANT SCIENCE GMBH 148564
BASF SE 145333, 152297
BAVARIAN NORDIC A/S 161590
BAY MICROSYSTEMS, INC. 160997
BAYER CROPSCIENCE S.A. 161085
BAYER HEALTHCARE AG 156278
BAYER SCHERING PHARMA AG
148405, 155680
BERMAD, LIMITED PARTNESHIP
143599
BIONICHE LIFE SCIENCES INC.
150196
BIOREN S.A. 161390
BLUEFIRE SECURITY
TECHNOLOGIES, INC. 159264
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM
129354
BOLDER BIOTECHNOLOGY, INC.
144259
BORIS ZEGELMAN 176244
BOSTON SCIENTIFIC LIMITED
154934
CELLTECH R&D LTD. 147992, 156915
CHARLES JONATHAN BRITTON
165061
June 15,
– ‫כ"ג בסיוון התשס"ט‬
CHELATOR LLC 151031
CHRISTOPHER T. MCNULTY 165735
CIDWAY TECHNOLOGIES LTD.
128720
COMPOSITE TECHNOLOGY
CORPORATION 164705
CONSEJO SUPERIOR
INVESTIGACIONES CIENTIFICAS
165335
COPPERGATE COMMUNICATIONS
LTD. 153968, 193578
CORDIS CORPORATION 162048
CORIXA CORPORATION 142216
CTC CABLE CORPORATION 164705
CURIS, INC. 129620
DAIICHI SANKYO COMPANY
LIMITED 170489
DAN L. DIETZ TRUST 162122
DANIEL H. STINGER 166382
DANIELLA EISENBERG 180940
DEVI PESTICIDES PVT LTD 164046
DILAFOR AB 162664
DOMPE PHA.R.MA S.P.A. 157180
DOMPE S.P.A. 157180
DSM IP ASSETS B.V. 161055
E.I. DUPONT DE NEMOURS AND
COMPANY 151267
EASYDOING OY 157400
EFFECT SHIPS INTERNATIONAL AS
163483
ELAN PHARMA INTERNATIONAL
LTD. 156030
ELAN PHARMACEUTICALS, INC.
155960, 158585
ELI LILLY AND COMPANY 137552,
155960
ENCOTONE LTD. 128720
ENZYMOTEC LTD. 145503
EPOS TECHNOLOGIES LIMITED
164493
ETM PRECISION TOOLS
MANUFACTURING LTD. 164069
FAROUK ASLAM MIAN 166382
ii
2009
FERRER INTERNACIONAL, S.A.
151165
FERTON HOLDING S.A. 148724
FLEISSNER GMBH & CO.
MASCHINENFABRIK 151088
FLEXPLAY TECHNOLOGIES, INC.
177501
FUJIKIN INC. 164121
FUJIKIN INCORPORATED 164121
FUJIKIN INCORPORATED 168936
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC
165310
GENENTECH, INC. 129354, 153375
GENODYSSEE 158261, 158415
GENOMIC PROFILING SYSTEMS,
INC. 147038
GIAT INDUSTRIES 158894
GILEAD SCIENCES, INC. 129497,
142910
GIVEN IMAGING LTD. 158972
GLAXO GROUP LIMITED 155078,
161972
GLAXOSMITHKLINE BIOLOGICALS
S.A. 153506
GLOBAL GOAL APS 160932
GOLAN MUALEM 186734
GOLAN MUALEM 186734
GOLAN SHALIT 186734
GOLAN SHALIT 186734
GRAINPRO, INC. 156154
GRIPPING EYEWEAR, INC. 162122
GRUNENTHAL GMBH 160252
GUANGDONG ESQUEL TEXTILES
CO., LTD. 161460
HAMAMATSU PHOTONICS K.K.
163454
HEMOTEQ AG 164947
HERMANN L. KELLER 161817
HIGH DENSITY DEVICES AS 161027
HMR PHARMA INC. 150638
HONEYWELL INTERNATIONAL INC.
151982
IDALEX TECHNOLOGIES, INC.
162367
IGOR GAGHIS 163005
IMBERA ELECTRONICS OY 163238
INTARCIA THERAPEUTICS, INC.
167247
INTERDIGITAL TECHNOLOGY
CORPORATION 152556, 158883
ISAAC J LABATON 128720
ISCAR LTD. 164069, 166530, 169491
ISCAR LTD. 166530, 169491
JANSSEN PHARMACEUTICA N.V.
155945
JANSSEN PHARMACEUTICA N.V.
164341
JOHN N. RASSIAS 150695
KABUSHIKI KAISHA TOPCON 151898
KCI LICENSING, INC. 165083
KING GREEN LTD. 144369
KIRIN HOLDINGS KABUSHIKI
KAISHA 155977
KISSEI PHARMACEUTICAL CO.,
LTD. 148384
KONE CORPORATION 169664
KOTOBUKI PHARMAEUTICAL CO.
LTD. 165177
KYOWA HAKKO KIRIN CO., LTD.
155977
L. MOLTENI & C. DEI FRATELLI
ALITTI-SOCIETA'DI ESERCIZIO
S.P.A. 153447
LABORATOIRES SERONO SA 143994
LABORATORIOS ALMIRALL, S.A.
156558
LAM RESEARCH CORPORATION
167674
LEADD B.V. 144228
LG ELECTRONICS INC. 161838
LIFE RECOVERY SYSTEMS HD, LLC
166150
LINKSHARE CORPORATION 152446
LTS LOHMANN THERAPIESYSTEME AG 141033
IBM CORPORATION 167254
MALLINCKRODT BAKER, INC.
iii
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
165581
MALLINCKRODT, INC. 164805
MEDAREX, INC. 155977
MEDINOL LTD. 157019
mediwound ltd. 164711
MEIR GITLIS 186734
MERCK PATENT GMBH 145333
MICROSOFT CORPORATION 160573,
161285
MILLENNIUM SPECIALTY
CHEMICALS, INC. 159836
MITSUBISHI TANABE PHARMA
CORPORATION 160701
MONASH UNIVERSITY 143892
MOTOROLA, INC. 162695
MUL-T-LOCK SECURITY PRODUCTS
LTD. 151656
MUL-T-LOCK TECHNOLOGIES LTD.
151656
MUL-T-LOCK TECHNOLOGIES LTD.
156153
N.V. ORGANON 160194
NANOMETRICS INCORPORATED
161274
NESTEC S.A. 167389
NETWORKS IN MOTION, INC. 163861
NEURALAB LIMITED 156030
NEUROSEARCH A/S 166821
NORTHROP GRUMMAN
CORPORATION 165367
NOVARTIS AG 134498, 139735,
157241, 167389
NTT DOCOMO, INC. 160617
NYCOMED PHARMA AS 157095
OBTECH MEDICAL AG 151138
OLIVEIRA & IRMAO, S.A. 153663
ORDNANCE DEVELOPMENT AND
ENGINEERING COMPANY OF
SINGAPORE (1996) PTE LTD. 165654
ORLANDI SPA 151088
ORT JOINT-STOCK COMPANY
167095
June 15,
– ‫כ"ג בסיוון התשס"ט‬
PERSEPHONE, INC. 166899
PESSACH SEIDEL 158705
PESTKA BIOMEDICAL
LABORATORIES, INC. 155741
PFIZER PRODUCTS, INC. 147563,
152771
PHARMACIA & UPJOHN COMPANY
LLC 158585
POWER SYSTEMS MFG. LLC 168196
QINGZHONG KONG 152484
QUALCOMM INCORPORATED
150606
QUALCOMM INCORPORATED
155534, 155846, 157122, 158814,
161113, 169251
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. 170266
RAMOT AT TEL AVIV UNIVERSITY
LTD. 165553
RAV-BARIACH VEHICLE
PROTECTION LTD. 156153
RAYTHEON COMPANY 160041
RAYTHEON COMPANY 169080
RE.LE.VI. S.P.A. 162342
RESHEF YEKUTIELY 150372
RHEON AUTOMATIC MACHINERY
CO., LTD. 159559
ROHM GMBH & CO. KG 162271
S.I.S. SHULOV INSTITUTE FOR
SCIENCE LTD. 137820
SABAF S.P.A. 163446
SANOFI AVENTIS 160701, 160820
SANOFI-AVENTIS DEUTSCHLAND
GMBH 155839
SARGENT MANUFACTURING
COMPANY 156938, 167040
SCHERING CORPORATION 156422
SEATTLE GENETICS, INC. 146950
SEMION PECHERSKI 191408
SENSORMATIC ELECTRONICS
CORPORATION 163010
SEPARATION TECHNOLOGIES LLC
161023
SHELL CANADA LIMITED 166896
iv
2009
v
SHILO TECHNOLOGIES LTD. 160766
SICPA HOLDING S.A. 172363
SILVERBROOK RESEARCH PTY.
LTD. 166919
SILVERBROOK RESEARCH PTY.
LTD. 156084, 156085
SLEEP DIAGNOSTICS PTY LTD.
160155
SMITHKLINE BEECHAM
CORPORATION 139733
STRATHMANN GMBH & CO.KG
150707
SUNESIS PHARMACEUTICALS, INC.
155926
SYMBOL TECHNOLOGIES, INC.
136220
SYMPHOGEN A/S 169101
OF AGRICULTURE AND RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION,
VOLCANI CENTER 156154
TOKYO ELECTRON LTD 164121
UNIVERSITY OF NORTH CAROLINA
AT CHAPEL HILL 150819
UNIVERSITY OF SOUTHERN
CALIFORNIA 152527
URI MUSSAFFI 180940
TAVTECH LTD. 159783
TENAX SPA 164465
TEVA PHARMACEUTICAL
INDUSTRIES LTD. 152179
THE BOEING COMPANY 167853
THE GILLETTE COMPANY 157181
THE JOHNS HOPKINS UNIVERSITY
152516
THE REGENTS OF THE UNIVERSITY
OF MINNESOTA 163077
THE STATE OF ISRAEL, MINISTRY
XCYTE THERAPIES, INC. 151287
VALINGE INNOVATION AB 160453,
169926
VIRXSYS CORPORATION 161495
W. MICHAEL DELOACH, SR. 164273
WAYNE STATE UNIVERSITY 160082
WIHA WERKZEUGE GMBH 165955
WISCONSIN ALUMNI RESEARCH
FOUNDATION 143036
WYETH 156030
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01M – 167717
B23D – 164023
A01N – 164389, 164713
B23Q – 157476
A23L – 161737, 162590, 164647,
173698
B26D – 164538
B29C – 169281
A47G – 169650
B41J – 172779
A47J – 162067, 169829
B60N – 161846
A61B – 137821, 146368, 149689,
151133, 152560, 160125,
161726, 162905
B60R – 157689
B65D – 160808
A61C – 154834, 160074
B65G – 152823, 161241
A61F – 154877, 157276, 187294
B66B – 157278
A61K – 126442, 143373, 145894,
147121, 150121, 151942,
152825, 155178, 156716,
157741, 158512, 159966,
161491, 161512, 163205,
163814, 167612, 167889,
170790
A61M – 138773, 155208, 165571,
165975, 167102, 168785
A63F – 169787, 191408
B01D – 150699, 150700, 168159,
173459
C02F – 158842
C07C – 139298, 143477, 148093,
151478, 253577, 154122,
159134, 259319, 175130
C07D – 109052, 136295, 142993,
152021, 152396, 153591,
153748, 153993, 154724,
155604, 156647, 156872,
158082, 160065, 160397,
163027, 165355, 167896,
167957, 168452
B01J – 165583, 170772, 188489
C07K – 122211, 125353, 146812,
161235
B01L – 164776
C08F – 167651
B23B – 164888, 167179
C08G – 137123, 142924
B23C – 165294
C08J – 127579, 154474
June 15,
– ‫כ"ג בסיוון התשס"ט‬
vi
2009
C08L – 154942
F25D – 163015
F41H – 163086
C12N – 107267, 115308, 125153,
143034, 145849, 148060,
149859, 155580, 158549,
162111
F42B – 153616, 157972, 181105
F42D – 162718
C12P – 128165, 160669
F24C – 163446
C12Q – 153971
G01B – 161018, 183570
C23C – 160411, 171439
G01N – 155343, 156444, 164200
C30B – 159165
G01S – 150074, 157098
D04B – 172110
G01T – 166392
D04H – 164916
G01A – 158190
E01C – 161246
G02B – 162705, 167668
E02B – 161694
G06F – 148263, 157810, 161629,
161722, 186289
E04B – 159191
G06K – 155156
E04F – 158855
G06T – 144588, 154451
E05B – 188006
G08B – 167827
E21B – 161172
G08G – 137123, 142924
F03G – 170396
G09B – 180562
F15B – 167305
G09F – 166594
F15D – 142446
G10K – 158837
F16D – 165098
G11B – 182673, 182674, 182675
F16H – 165842
H01H – 167023
F23G – 148223
F24F – 178224
H01L – 157355, 160113, 160705,
183720
F25K – 144443
H01R – 159162
vii
June 15, 2009
– ‫כ"ג בסיוון התשס"ט‬
H01S – 163523
H02N – 156126
H04B – 143429, 157317, 157439,
161520, 182059, 185886
H04N – 159372
H04J – 149269, 156935, 157450, 157858,
182118
H04L – 161489, 162120, 183719
H04M – 156772
H04N – 149759, 161180, 162119
H04Q – 161519, 162121
June 15,
– ‫כ"ג בסיוון התשס"ט‬
viii
2009
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
‫ ירושלים‬,‫הופק והודפס במדפיס הממשלתי‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER